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Thesis Summary 
This thesis examined the macro-structural and micro-structural changes in 
Huntington’s disease (HD) in order to improve understanding of the temporal and 
spatial patterns of neurodegeneration, and the functional relevance of these changes. 
Translational techniques were employed using genetic mouse models of HD in 
combination with a patient cohort to examine grey and white matter changes with a 
particular focus on white matter microstructure.  
 
In the patient cohort, the cognitive profile was examined using a cognitive 
battery not before applied in HD. Specific deficits were found in set-shifting and 
flexibility, verbal reasoning, working memory and paired associate learning, along with 
subtle differences in response inhibition that were sensitive to disease burden. A 
composite cognitive score was produced to examine the relationship between 
cognitive function and brain structure. A multi-modal examination of white matter 
tract-specific microstructural measurements revealed abnormalities in the corpus 
callosum and cingulum bundle that were sensitive to disease burden (chapter 4). In 
chapter 5, multiple analysis techniques converged to reveal tissue macrostructure 
abnormalities that were also sensitive to disease burden in HD. Cortical changes were 
less consistent, and unlike the microstructure findings, white matter macrostructural 
abnormalities were not related to disease burden. 
 
In chapters 6 and 7, genetic mouse models of HD were used to examine 
changes across the disease course, and to pilot an interventional design. In vivo 
diffusion MRI and T2-weighted MRI sequences were acquired at 2 different time points 
in the HdhQ150 knock-in model of HD and imaging data is presented alongside 
behavioural results and immunohistochemistry. In chapter 7, an environmental 
modification regime was tested in the YAC128 mouse model using in vivo MRI. 
Environmental intervention reduced the degree of disease-related atrophy, altered 
tissue microstructure and improve motor but not cognitive performance in YAC128 
mice.  
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1. General Introduction 
 
1.1 What is Huntington’s disease? 
Despite reports suggesting the existence of Huntington’s disease from as early 
as the 17th century (Lanska, 2000), Huntington’s disease (HD), or hereditary chorea as 
it was originally termed, was first succinctly described in 1872 by an American 
physician, George Huntington (Huntington, 1967). Chorea, Latin for dance, describes 
the dance-like, rhythmic movements that characterise the motor component of HD, 
distinguishable from other chorea disorders by its late onset of symptoms and 
hereditary nature (Lanska, 2000).  
 
Today, HD is recognised as a genetically-inherited progressive and fatal 
neurodegenerative disease with an estimated prevalence of 5-10 cases per 100,000 in 
the Caucasian population in North America and Western Europe (Gil & Rego, 2008; 
Harper, 1992), with the prevalence varying by ethnic origin and different predisposing 
genetic profiles in each population (Agostinho, Santos, Alvarenga, & Paiva, 2013).  In 
the United Kingdom, more recent estimates suggest that the prevalence of diagnosed 
HD is substantially higher than previously estimated,  with 12.3 cases in every 100,000 
in 2010 (Evans et al., 2013).  
The disease is caused by a dominant mutation on an autosomal chromosome, 
meaning that men and women are at equal risk of inheriting the disease and one 
inherited copy of the mutated gene is necessary to produce the disease. There is 
currently no cure and the disease is fatal approximately 20 years after the onset of 
motor symptoms (Rinaldi et al., 2012).  
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The HD gene - Huntingtin 
In the human body, we possess approximately 30,000 genes. The devastating 
effects of HD are caused by a mutation in just one of these genes – the Huntingtin, or 
HTT gene. In 1993, the Huntington’s Disease Collaborative Research team (Group, 
1993) discovered the genetic cause of HD, a mutation triggered by an expansion in the 
number of trinucleotide repeats in an unstable DNA region of the HTT gene, located on 
the short arm of chromosome 4 (4p16.3). This discovery has allowed predictive genetic 
testing to identify gene-positive individuals prior to the onset of symptoms.  
 
Trinucleotide repeats    
 
In the normal HTT gene, the three DNA bases cytosine, adenine and guanine 
(CAG) form a trinucleotide which codes for glutamine. The HTT gene codes for the 
Huntingtin (HTT) protein, with each trinucleotide producing a glutamine unit, thus 
forming a polyglutamine tract. Whereas in the normal HTT gene, the CAG trinucleotide 
is repeated less than 36 times, in the mutant HTT gene, this section of trinucleotide 
repeats is pathologically expanded above a threshold which alters the form of the 
protein (Nance, Mathias-Hagen, Breningstall, Wick, & McGlennen, 1999) and results in 
an elongated stretch of glutamine near the N-terminal tail of the protein (Zuccato, 
Valenza, & Cattaneo, 2010). 
 
 The threshold for complete penetrance and the cause of the HD phenotype is 
around 37-39 CAG repeats. Individuals with “intermediate” CAG repeats ranging from 
27-35 tend to have a normal phenotype, however the expanded CAG repeat is 
somatically unstable, undergoing progressive length increases over time (De Rooij, De 
Koning Gans, Roos, Van Ommen, & Den Dunnen, 1995; V. Wheeler et al., 2007; V. C. 
Wheeler et al., 1999) thus  “intermediate” CAG repeats are at an increased risk of 
expanding into the pathological range when transmitted to offspring, usually upon 
paternal transmission (Pearson, 2003; V. Wheeler, et al., 2007). Somatic instability is 
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tissue-specific, with particularly high levels found in the striatum and cortex (Kennedy 
et al., 2003; V. Wheeler, et al., 1999) and occurs in post-mitotic neurons (Gonitel et al., 
2008;  Shelbourne et al., 2007). 
 
The number of CAG repeats is inversely related to the age of symptom onset 
and despite being the strongest determining factor (Persichetti et al., 1996; Wexler et 
al., 2004),  additional environmental and genetic factors also affect the age of onset 
(Wexler, et al., 2004). Juvenile-onset HD is a rarer more severe form of the disease, 
associated with >50 CAG repeats, earlier disease onset and quicker disease progression 
(Persichetti, et al., 1996).  
 
In order to understand the pathological mechanism of the mutant HTT protein, 
the physiological function of the wild-type HTT protein must first be understood.  
Several functions of wild-type HTT have been suggested and a number of molecular 
and cellular abnormalities associated with mutant HTT elucidated, although the 
relative roles, interactions and timings remain under active investigation (Zuccato, et 
al., 2010). A number of studies have suggested that wild-type HTT may be a scaffold 
protein involved in the coordination of other proteins for intracellular transport and 
signalling processes (S. H. Li & Li, 2004). The wild-type HTT gene has a pro-survival role; 
in the absence of normal Huntingtin, there is a reduction in the survival and 
phenotypic stability of neural cells (O'Kusky, Nasir, Cicchetti, Parent, & Hayden, 1999; 
Rigamonti et al., 2000).  
 
Abnormal cellular and molecular mechanisms in HD include mitochondrial 
dysfunction and impaired calcium signalling due to the accumulation of polyglutamine 
tract fragments in the cell cytoplasm (Damiano et al., 2013; Napoli et al., 2013; 
Rosenstock et al., 2010; Yano et al., 2014; Zhang et al., 2008), abnormal protein-
protein interaction, impaired gene transcription, intranuclear inclusions due to the 
translocation of mutant HTT fragments to the nucleus, altered vesicular transport and 
recycling (Cui et al., 2006; DiFiglia et al., 1997; R. Smith et al., 2009; Zuccato, et al., 
2010), altered NMDA receptor activity (Heng, Detloff, Wang, Tsien, & Albin, 2009; 
1. General Introduction  2014
 
4 
 
Tallaksen-Greene, Janiszewska, Benton, Ruprecht, & Albin, 2010; Young et al., 1988), 
and defective glutamatergic and dopaminergic neurotransmitter systems (Crook & 
Housman, 2012; B. R. Miller & Bezprozvanny, 2010; Mittal & Eddy, 2013). It is known 
that some of these abnormalities are driven by the presence of the mutant protein and 
a toxic gain of function (Imarisio et al., 2008; Sipione & Cattaneo, 2001), for example, 
mutant but not wild-type huntingtin directly causes defects in mitochondria activity 
(Panov et al., 2002), however the loss of the normal HTT protein also contributes to HD 
neuropathology through a toxic loss of function (Schulte & Littleton, 2011).  
Huntingtin (HTT) protein expression and localisation  
HTT is ubiquitously expressed throughout the central nervous system, in 
peripheral tissues and during embryonic development (Strong et al., 1993), and in 
human tissue, expression is at the highest level in the brain (T. Group, 1993). HTT  is 
also expressed in non-human mammalian tissue (Aronin et al., 1995; Sharp et al., 
1995) and has been detected throughout all stages of embryonic and postnatal mouse 
development as well as throughout the adult mouse brain. HTT protein is located in 
many subcellular compartments and organelles, including in cell bodies, dendrites and 
nerve terminals, the Golgi body, endoplasmic reticulum, synaptic vesicles, 
microtubules and mitochondria (DiFiglia et al., 1995; C. Gutekunst et al., 1995; C 
Gutekunst et al., 1999; Sharp, et al., 1995; Trottier et al., 1995). Such diversity in 
localisation impedes the ability to define the proteins function.  
 
Studies of HTT expression in the human brain are able to directly compare 
normal and mutant protein expression in the same person because of the dominant 
nature of HD. Most people with the mutation are heterozygotes, carrying the mutant 
HTT protein on one allele and a normal HTT protein on the non-affected allele. 
Western blot analyses of cultured cells and tissue from HD patients have shown 
differential expression between the mutant and normal alleles. A relative reduction in 
mutant HTT expression has been shown in the cerebral cortex, frontal cortex and 
cerebellum in most studies (Ide, Nukina, Masuda, Goto, & Kanazawa, 1995; Persichetti 
Cardiff University  2014
 
5 
 
et al., 1995; Persichetti, et al., 1996; Trottier, et al., 1995) although other studies 
report no difference in expression (Schilling et al., 1995). Evidence suggests the length 
of the pathological CAG repeat is related to both the degree of reduced expression 
(Gutekunst, et al., 1995; Persichetti, et al., 1996) and the localisation of expression 
changes, with longer CAG repeats associated with a more diffuse reduction in 
expression.  
 
Along with western blot analyses, RNA in situ hybridization has been used to 
measure and localise RNA expression. HTT-messenger-RNA (mRNA) contains the 
information for just the HTT protein, following transcription of the HTT gene in a DNA 
strand. Normal HTT mRNA expression has been shown in both the human and rat brain 
predominantly in neurons, with glial expression present but to a lesser degree 
(Landwehrmeyer et al., 1995; Strong, et al., 1993). Similarly, immunohistochemical 
studies in human, monkey, and rat brain suggest that HTT is localized throughout the 
neuronal cytoplasm and is enriched in some nerve endings (DiFiglia, et al., 1995; C. 
Gutekunst, et al., 1995; Sharp, et al., 1995). Regional differences in the density of 
mRNA staining have been shown in both the rat and human brain, with the highest 
mutant mRNA expression found in dentate gyrus cells, hippocampal pyramidal cells, 
and cerebellar Purkinje and granular cells (Strong, et al., 1993).   
 
.Mutant HTT also interferes with the transcriptional machinery at different 
levels (Martin et al., 2011). Non-coding micro-RNAs act as post-transcriptional 
regulators of gene expression and play an important role in neuronal development and 
differentiation as well as maintaining the function of mature neurons. Lee et al. (2011) 
showed a reduction of total miRNA levels in two different mouse models of HD at 
symptomatic time points, suggesting miRNA expression or processing may be affected 
in HD. The mutant HTT gene also interferes with the activities of DNA-binding 
transcription factors by forming intracellular aggregates, leading to insoluble inclusion 
bodies which bind and sequester additional proteins, impairing the functioning of 
numerous transcription factors (Davies et al., 1997; DiFiglia, et al., 1997; Kazantsev, 
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Preisinger, Dranovsky, Goldgaber, & Housman, 1999; Kazantsev et al., 2002; Steffan et 
al., 2000). 
Symptoms of Huntington’s disease 
Huntington’s chorea was re-named Huntington’s disease in the 1980’s based on 
the recognition that symptoms were more widespread than purely chorea and 
included non-motor symptoms (Roos, 2010). Although the formal diagnosis of 
manifest HD is based on the presence of motor abnormalities, deficits in other 
domains are frequently present prior to this point, known as the pre-symptomatic or 
prodromal stage of HD. The non-motor symptoms of HD have been shown to be more 
highly associated with functional decline and increased burden for the families of 
individuals affected (Hamilton et al., 2003; Paulsen, 2011; Paulsen et al., 2010; Peavy 
et al., 2010). In all symptom domains, the profile of deficits changes with disease 
progression.  
Cognitive profile  
As early as 15 years prior to the onset of a motor deficit, subtle emotion 
recognition deficits and poorer cognitive performance are observed compared to 
gene-negative controls (Stout et al., 2011). Pre-symptomatic gene-carriers are 
impaired at recognising facial expressions, with a particular deficit in recognising 
disgust, shown to be related to decreased insula activation (Hennenlotter et al., 2004).  
 
Moving closer to disease onset, impairments in visuomotor performance, 
working memory and executive function start to emerge (Kirkwood et al., 2000; Papp, 
Kaplan, & Snyder, 2011). Nearly 40% of pre-symptomatic participants were found to 
meet criteria for mild cognitive impairment, the transitional stage between normal 
cognition and dementia (Duff et al., 2010). Processing speed is affected, with slowed 
cognitive processing becoming progressively worse closer to disease onset, with 
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evidence suggesting underlying caudate nucleus and prefrontal cortical involvement 
(Ho et al., 2003; Rothlind, Brandt, Zee, Codori, & Folstein, 1993; Snowden, Craufurd, 
Thompson, & Neary, 2002; Sánchez-Pernaute et al., 2000). Slowed processing is also a 
feature of HD in the motor (bradykinesia) and psychiatric (depression, apathy) domain, 
and shown to have a similar or overlapping neural basis (Hickie et al., 1999; Zamboni, 
Huey, Krueger, Nichelli, & Grafman, 2008).  
 
More pronounced memory deficits are not commonly observed until the 
advanced disease stage (Bamford, Caine, Kido, Cox, & Shoulson, 1995; Snowden, et al., 
2002), and thought to be driven by deficits in memory retrieval as opposed to storage 
(Rohrer, Salmon, Wixted, & Paulsen, 1999). The prevalence of dementia in HD is 
difficult to estimate, because it is heavily dependent on the criteria used. There is 
currently no universally accepted criterion for diagnosing dementia in HD (Paulsen, 
2011), with most criteria focused on dementia features in Alzheimer’s Disease (Peavy, 
et al., 2010), and thus not correctly reflecting the unique set of deficits in HD. Unlike in 
Alzheimer’s Disease, where the profile of deficits is thought to be more cortical in 
nature, in manifest HD, the cognitive deficit profile is regarded as ‘subcortical’ at least 
in the earlier stages, with deficits in the attentional domain, immediate memory 
domain, executive functioning, and visuospatial domain (Butters, Wolfe, Martone, 
Granholm, & Cermak, 1985; Ho, et al., 2003) whereas semantic memory and delayed 
recall memory are less affected (Ho, et al., 2003; Kirkwood, et al., 2000). Psychomotor 
skill in particular was found to decline in early and moderate HD (Ho, et al., 2003; 
Taylor & Hansotia, 1983).  
 
Executive dysfunction are a feature of both pre- and symptomatic HD and 
appear to be specific, with deficits seen in pre- and early HD on the Stroop test (Holl, 
Wilkinson, Tabrizi, Painold, & Jahanshahi, 2013; Tabrizi et al., 2013), which measures 
inhibition of pre-potent responses, whereas performance on the Iowa Gambling task 
which measures risky decision-making, did not differ compared to controls (Holl, et al., 
2013). This specific pattern of executive deficits may reflect the difference in neural 
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substrate; both executive functioning and inhibitory processes used in the Stroop task 
are mediated by striatal-cortical connections, both shown to be dysfunctional in early 
HD. In contrast, risky decision-making involves the ventromedial caudate and its 
cortical connections, known to be spared in early HD (Holl, et al., 2013). Manifest HD 
participants have been shown to have deficits in tests of verbal fluency (Ho, et al., 
2003; Holl, et al., 2013), which measure internally guided word search and production 
and require the person to both suppress the retrieval and production of inappropriate 
words and monitor their output accordingly. The decline in verbal fluency over time is 
less marked compared to other executive function tasks, such as the Stroop (Ho, et al., 
2003), however this could be due to floor effects. Moreover, when considering the 
multiple neurocognitive impairments that are evident in HD, evidence for a selective 
executive deficit should be  in excess of the average performance deficit across a range 
of other cognitive tasks that do not impose heavy executive demands (Laws, 1999; E. 
Miller, 1984). A meta-analysis of 30 studies found that the verbal fluency deficits were 
not differentially larger in magnitude than the deficits in verbal intelligence or speed, 
suggesting that fluency deficits in HD may stem not primarily from executive 
dysfunction but slowed cognitive processing speed and/or a deficit in verbal ability 
(Henry, Crawford, & Phillips, 2005).  
Psychiatric profile 
The Europe-wide REGISTRY study containing patients at all disease stages found 
that 20% of patients had severe psychiatric problems (Orth et al., 2011). Psychiatric 
symptoms have been shown to be related to reduced functional capacity in cross-
sectional and longitudinal studies alike (Duijn, Reedeker, Giltay, Roos, & Mast, 2010; 
Epping et al., 2013; Tabrizi, et al., 2013), and of the three symptom domains, represent 
the most distressing aspect of HD for patients and their families (Hamilton, et al., 
2003).  
 
In the pre-symptomatic stage, increased apathy, anxiety, depression, 
perseveration, irritability and suicidal ideation have all been observed (Duff et al., 
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2007; Epping, et al., 2013; Fiedorowicz, Mills, Ruggle, Langbehn, & Paulsen, 2011; 
Tabrizi et al., 2009; Tabrizi, et al., 2013). Depression symptoms in the pre-symptomatic 
stage did not increase with proximity to formal HD diagnosis (Epping, et al., 2013), 
unlike the majority of cognitive symptoms. This dissociation suggests that although 
some of the neuropsychiatric symptoms in HD are related to cognitive deficits (M. 
Smith, Mills, Epping, Westervelt, & Paulsen, 2012), an independent mechanism may 
underlie the neuropsychiatric phenotype.  
 
Apathy, a symptom of both pre- and symptomatic HD, includes a loss of 
initiation, spontaneity, motivation, interest and concern about self-care. The 
prevalence of apathy as well as other loss-of-affect psychiatric symptoms in HD is likely 
to be underestimated due to sampling bias, as participants experiencing such 
symptoms are less likely to participate in a study. Unlike depression, the prevalence 
and severity of apathy is known to increase with disease progression (Duijn, et al., 
2010; Kingma, van Duijn, Timman, van der Mast, & Roos, 2008; Tabrizi, et al., 2013). 
Prevalence rates vary between 34-76% for apathy and 33-69% for depression, 
depending on disease stage and measurement criteria (Craufurd, Thompson, & 
Snowden, 2001; Kulisevsky et al., 2001; Leroi & Michalon, 1998; Murgod et al., 2001; 
Paulsen et al., 2005; Paulsen, Ready, Hamilton, Mega, & Cummings, 2001; van Duijn, 
Kingma, & van der Mast, 2007). Apathy has also shown to be highly related to worse 
global and executive functioning and medication use, especially neuroleptics and 
benzodiazepines (Duijn, et al., 2010). There are inconsistent findings on the 
relationship between depression and apathy in HD (Duijn, et al., 2010; Levy et al., 
1998; Paulsen, et al., 2001). 
 
Irritability is a prominent symptom of both pre- and symptomatic HD with an 
estimated prevalence of between 38-73% across different studies (Craufurd, et al., 
2001; Kulisevsky, et al., 2001; Murgod, et al., 2001; J. Paulsen, et al., 2001) and has 
been shown to be associated with impulsivity and aggression, presumed to be driven 
by an underlying disruption to emotional processing circuitry between the amygdala 
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and medial orbitofrontal cortex (Klöppel et al., 2010). Anxiety is also a prominent 
symptom, with prevalence estimated between 34% and 61% depending on the sample 
and rating scale used (Craufurd, et al., 2001; Kulisevsky, et al., 2001; Murgod, et al., 
2001; Paulsen, et al., 2005;  Paulsen, et al., 2001). Less commonly experienced 
psychiatric symptoms include psychosis, delusions, hallucinations (Craufurd & 
Snowden, 2002; Paulsen, et al., 2001) and obsessive and compulsive symptoms, with 
obsessive symptoms being twice as prevalent as compulsive symptoms (Anderson, 
Louis, Stern, & Marder, 2001). Suicidal ideation has been shown to be co-morbid with, 
and predicted by depression, anxiety and irritability (Wetzel et al., 2011), as well as by 
alcohol and drug abuse. In a large study of symptomatic HD patients, 19% reported 
current suicidal ideation (Wetzel, et al., 2011).  
Motor profile 
Even before the clinical onset of a motor deficit, subtle motor symptoms are 
detectable, including oculomotor deficits, reduced force when protruding the tongue, 
slowed movement speed and reaction time, and abnormalities in muscle stretch 
(Kirkwood, et al., 2000; Penney et al., 1990; M. A. Smith, Brandt, & Shadmehr, 2000). 
This suggests that the sensitivity of the measures determines the clinical definition of 
onset, and supports the search for biomarkers to more accurately define different 
disease stages.  
 
Formal diagnosis of adult-onset onset HD is commonly made after the onset of 
a profile of motor symptoms, which frequently includes chorea (Folstein, 1989; Snell, 
MacMillan, Cheadle, & Fenton, 1993). In addition to chorea, motor symptoms in early 
HD commonly include coordination deficits, reduced control over handwriting, 
oculomotor dysfunction and rigidity (Phillips, Bradshaw, & Chiu, 1994; Tabrizi, et al., 
2009). In contrast, in the middle stage of HD, involuntary movements are often more 
pronounced, dystonia, chorea and parkinsonism are present, and difficulties with 
balance, speech, gait, swallowing and manual dexterity are experienced, along with a 
slowing in the production of voluntary movements (Girotti, Marano, Soliveri, & 
Cardiff University  2014
 
11 
 
Geminiani, 1988; Young, Shoulson, & Penney, 1986). In the more advanced stages of 
HD, assistance with self-care is required as the disease renders the individual unable to 
walk and speak due to a combination of deficits including rigidity and bradykinesia. 
Serious weight loss is often observed, along with loss of bladder and bowel control and 
problems with swallowing are evident due to loss of control of the throat muscles 
(Folstein, 1989; Kirkwood, Su, Conneally, & Foroud, 2001; Young, et al., 1986). Rigidity 
and bradykinesia can be present from the onset of symptoms in juvenile -onset HD and 
also in some cases of adult onset disease (Hayden, 1980; Quarrell, 2014). 
Neuropathology in Huntington’s disease 
 
Grey matter pathology 
Despite the ubiquitous pattern of HTT protein expression, at the cellular level, 
mutant HTT results in the loss of specific neuronal populations in the striatum and 
cerebral cortex, and insoluble HTT protein aggregates form specifically in the nucleus, 
cytoplasm, and neuronal processes (DiFiglia, et al., 1997; C Gutekunst, et al., 1999). 
The protein aggregates have been found to occur in higher concentrations in the 
cortex than in the striatum (Gutekunst, et al., 1999) whilst the precise role of these 
aggregates in HD is still under debate (e.g. Arrasate & Finkbeiner, 2012). More recent 
work suggests that HTT aggregates may be an adaptive cellular response rather than 
play a causative role in HD pathology. The formation of neuronal inclusions (HTT 
aggregates) was found to reduce both the level of diffuse mutant HTT and the risk of 
striatal neuronal death, with the risk of neuronal death becoming independent of the 
level of mutant HTT only after the formation of inclusions, compared to a highly 
correlated relationship prior to inclusion formation (Arrasate, Mitra, Schweitzer, Segal, 
& Finkbeiner, 2004). Taken together, this suggests that neuronal inclusions may signal 
a new adapted neuronal state (Arrasate, et al., 2004; J. Miller et al., 2010), although 
further research is required to unpick the specific responses in different neuronal 
subsets.  
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Atrophy is most severe in the striatum, comprised of the caudate nucleus and 
the putamen, with postmortem studies reporting a mean volume decrease of 58% in 
the striatum in HD brains (Lange, Thörner, Hopf, & Schröder, 1976; J. P. Vonsattel & 
DiFiglia, 1998). Post-mortem studies also report atrophy elsewhere in the basal 
ganglia, in the globus pallidus as well as in the thalamus and in the cerebral cortex (de 
la Monte, Vonsattel, & Richardson, 1988; J. Vonsattel et al., 1985), suggesting that 
striato-thalamo-cortical circuity is particularly vulnerable in HD. In the striatum, 
approximately 95% of the neurons are γ-aminobutyric acid (GABA)-ergic projection 
medium spiny neurons (MSN’s), whilst approximately 5% are interneurons. In HD, 
pathology occurs specifically in the MSN’s whereas striatal interneurons are typically 
unaffected or only mildly affected at late stages of the disease (Reiner et al., 1988). 
Specific sub-types of MSN’s in the striatum are also differentially vulnerable in HD, 
depending on their projection targets and neurochemical content. There are two 
different output projection pathways of the striatum: a “direct” pathway, which 
projects axons mono-synaptically to the internal segment of the globus pallidus or to 
the substantia nigra, and an “indirect” pathway, which projects axons poly-synaptically 
to the external segment of the globus pallidus, as shown simplistically in Figure 1.1. In 
HD, the enkephalin containing MSN’s which project along the indirect pathway to the 
external globus pallidus die in the early stages of the disease (Deng et al., 2004), 
causing disinhibition of the external globus pallidus, which in turn causes inhibition in 
the subthalamic nucleus (STN), altering the excitation in the globus pallidus internal 
(GPi) and from there the firing rate of the thalamus. An increase in thalamic firing to 
neurons in the motor cortex produces the motor symptoms which define the clinical 
onset of the disease. In contrast, the MSN’s that contain substance P and are involved 
in the direct pathways projecting to the GPi are affected later in the disease course 
(Albin, Qin, Young, Penney, & Chesselet, 1991; Albin et al., 1992; Albin et al., 1990). 
Nevertheless, morphometric changes to the dendritic trees of surviving MSN’s have 
also been found, with evidence of both regenerative and degenerative changes such as 
re-curving terminal dendritic branches, abnormal growth and formation of new 
collaterals, and local increase or decrease in spine density, suggesting dendritic 
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pathology may be biphasic (Graveland, Williams, & DiFiglia, 1985). 
 
The basal ganglia is not purely a motor system as once thought (Evarts & Thach, 
1969), but is also involved in learning and memory, and many of the cognitive 
symptoms in HD may also be due to the altered circuitry between the basal ganglia 
and frontal cortex. For example, lesioning the caudate causes cognitive deficits in 
primate models (Divac, Rosvold, & Szwarcbart, 1967). 
 
A number of functionally distinct cortico-striatal loops (Figure 1.2) have been 
proposed (G. E. Alexander, et al., 1990), which fit with subsequent work showing the 
somato-topic organisation of the basal ganglia (Miyachi et al., 2006; Nambu, 2011) and 
may explain the heterogeneity of symptoms experienced in HD. The proposed core  
Figure 1.1 Direct and indirect pathways of the basal ganglia. (Adapted from Alexander & 
Crutcher (1990). Dashed lines represent pathways affected in HD. Abbreviations: GPe : 
external segment of the globus pallidus, GPi: internal segment of the globus pallidus, S. 
Nigra ret : substantia nigra reticulate, S. Nigra comp: substantia nigra compacta. 
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Figure 1.2. Proposed basal ganglia-thalamocortical loops (Adapted from (G. E. 
Alexander, et al., 1990). Abbreviations: GPi, internal segment of the globus pallidus; 
SNr, substantia nigra pars reticular; VP, ventral pallidum; Lat, lateral; MD, Medial 
Dorsal nucleus of thalamus (MDmc, medial dorsal pars magnocellularis; pm-MD, 
paramedian portion of the MDmc; MDpc, medial dorsa pars parvocellularis; MDpl, 
medial dorsal pars paralamellaris), VA; Ventral Anterior nucleus (VAmc, ventralis 
anterior pars magnocellularis; VApc, ventralis anterior pars parvocellularis), VL, 
Ventral Lateral nucleus (VLm, ventralis lateralis pars medialis; VLo, ventralis 
lateralis pars oralis).  
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circuits arise from different cortical areas and project topographically to the striatum, 
and then onto the globus pallidum/substantia nigra, before being projected to specific 
thalamic nuclei and back to the frontal cortex.  
 
Degeneration in the cerebral cortex also contributes to disease pathology with 
volumetric loss of up to 29% found post-mortem (de la Monte, et al., 1988) and may 
be more involved in the cognitive and psychiatric symptoms experienced. Pyramidal 
neurons have been found to be particularly vulnerable in layers III and V (J. Vonsattel, 
et al., 1985) whereas overall neuronal loss is most prominent in layers V and VI 
(Selemon, Rajkowska, & Goldman-Rakic, 2004) and associated with a decrease in 
dorsolateral prefrontal cortical thickness and an increase in glial cell density in layer VI 
(Selemon, et al., 2004). The neuronal loss in layer VI is important because layer VI 
neurons do not project to the striatum, thus suggesting that cortical pathology is not a 
secondary effect of Wallerian degeneration of axon terminals from the striatum but is 
instead an independent primary process (Ramaswamy & Kordower, 2012).  
White matter pathology 
White matter atrophy and a reduction in ferritin iron levels in white matter 
have been found even at the pre-symptomatic stage of HD (Bartzokis & Tishler, 2000; 
Ciarmiello et al., 2006; J. Paulsen, et al., 2010). There is now an increasing body of 
research showing white matter abnormalities are a feature of HD independent of 
neuronal loss (Beglinger et al., 2005; Fennema-Notestine et al., 2004; Stefan Klöppel et 
al., 2008; Mario Mascalchi et al., 2004; Myers et al., 1991; Nopoulos, Epping, Wassink, 
Schlaggar, & Perlmutter, 2011; Paulsen et al., 2008; Reading et al., 2005; H. Rosas et 
al., 2010; Tabrizi, et al., 2009; Weaver et al., 2009). Despite volumetric white matter 
loss of 29–34% being reported in post-mortem HD brains over 20 years ago (de la 
Monte, et al., 1988), the precise role of white matter in the disease pathology remains 
unclear. White matter is composed of axons, which carry the electrical impulses from 
one neuron to another, as well as myelin, which is a fatty layer which when wrapped 
around axons increases neural signal conduction velocity by allowing for the saltatory 
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conduction of action potentials. It is unclear in HD whether axons, myelin, or both are 
affected, and how white matter changes contribute to neuropathology. One possibility 
is that a single event triggers a cascade of cellular alterations, including changes to 
white matter, whereas an alternative scenario is that white matter degeneration may 
independently contribute to HD pathology. Changes in white matter can occur due to a 
number of factors, including degeneration and loss of axons, degeneration of myelin, a 
direct effect of loss of grey matter volume in the form of Wallerian degeneration, or a 
combination of some or all of these.  
 
In HD, it is known that mutant HTT aggregates localise in the axons as well as in 
neurons (H. Li, Li, Yu, Shelbourne, & Li, 2001; X. J. Li, 1999; Sinadinos et al., 2009). The 
presence of HTT aggregates in the axon may physically interfere with normal axonal 
trafficking of proteins and membrane bound organelles, and there is now a substantial 
body of research showing disrupted axonal transport in HD (H. Li, et al., 2001; J. Y. Li & 
Conforti, 2013; X. J. Li, 1999; Sinadinos, et al., 2009). In addition to axonal changes, 
there is also evidence suggesting that myelin breakdown contributes to white matter 
atrophy in HD (Bartzokis, Lu, Tishler, & Fong, 2007). There are a number of research 
findings which indirectly implicate myelin; it is known that cholesterol is needed for 
myelin formation during development (Dietschy & Turley, 2004; Saher et al., 2005) and 
cholesterol metabolism impairments have been associated with several 
neurodegenerative disorders, including HD (Valenza et al., 2007; Valenza & Cattaneo, 
2010, 2011; Valenza et al., 2005). In addition, thinner myelin sheaths and decreased 
expression of myelin based protein have been found in mouse models of HD (Xiang et 
al., 2011). 
Candidate white matter pathways in HD 
The impact of the HTT mutant gene on specific white matter pathways is not 
known, and likewise, the specific contribution any white matter abnormality makes to 
the clinical features of the disease is not understood. There are a number of candidate 
white matter pathways that require investigation.  
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Motor Pathways HD is clinically defined by the onset of motor symptoms; 
therefore the motor pathways in the brain are hypothesised to be affected. In the 
human brain, the thalamus, basal ganglia, cerebellum, and brain stem are all involved 
in movement, thus it is hypothesised that the white matter pathways between these 
areas may be altered in HD.  A recent diffusion MRI study supports this, with 
symptomatic HD patients found to have altered tensor based metrics (see section 2.3) 
in the caudate-paracentral and putamen-motor tracts (Poudel et al., 2014). The motor 
cortex includes the primary motor cortex, premotor cortex and supplementary motor 
area, all of which are somatotopically organized, and through various cortical afferent 
and efferent pathways controls motor coordination, planning, initiation and 
performance. The different cortical areas play different roles in motor function. The 
primary motor cortex is involved in the execution of movement, the premotor cortex is 
involved in motor control, including movement preparation and sensory and spatial 
guidance, whereas the supplementary motor area (SMA), made up of the pre-SMA and 
SMA proper (Y. Matsuzaka, Aizawa, & Tanji, 1992) is involved in motor task sequencing 
Figure 1.3 Candidate white matter pathways affected in HD, showing the white 
matter tracts in relation to the three symptom domains. Many tracts are likely to 
play a role in multiple domains.  
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and movement initiation (Passingham, 1994). The SMA proper has efferent and 
afferent projections to the primary motor cortex and is involved in movement 
execution, whereas the pre-SMA, receiving inputs from the prefrontal cortex and the 
cingulate motor areas, is involved in movement decision-making. The motor cortex 
contains both pyramidal cells and other projection neurons, with a different 
proportion of the two neuronal classes depending on the cortical layer. The anterior 
and anterior-mid body of the corpus callosum contains fibers which connect the 
motor, premotor and supplementary motor areas in each hemisphere (Hofer & Frahm, 
2006), thus the corpus callosum is also a candidate motor pathway affected in HD. 
Previous work has found altered diffusion tensor metrics in the corpus callosum in 
both pre- symptomatic and symptomatic HD patients compared to controls and 
importantly a correlation between these metrics and motor scores (Dumas et al., 
2012).  
 
The pyramidal motor pathways are involved in the voluntary control of 
movements and include the corticobulbar and corticospinal pathways. These long 
axons originate in the motor cortex and travel via the internal capsule through the 
midbrain to the cerebellar peduncle. Volume loss in the internal capsule of HD patients 
has previously been reported (Della Nave et al., 2010), with the degree of atrophy 
found to correlate with motor impairment (Jech et al., 2007). Recent work using 
diffusion MRI has found differences in tensor based metrics bilaterally in the 
corticospinal tract in symptomatic HD patients, whereas pre-symptomatic patients 
were found to have elevated iron in the left corticospinal tract specifically between the 
brain stem and thalamus, but no differences in terms of diffusion MR metrics. 
Importantly, the tensor based metrics in the corticospinal tract correlated with motor 
function score in both groups of patients, suggesting that abnormalities in the 
corticospinal tract may have functional significance in HD (Phillips et al., 2014).  
 
The cerebellum is involved in coordinating muscle activity, equilibrium and tone 
and although previously overlooked, a handful of recent studies suggest the 
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cerebellum and its connections may play a role in the neuropathology of HD 
(Dougherty, Reeves, Lesort, Detloff, & Cowell, 2013; Georgiou-Karistianis, Stout, et al., 
2013). The major cerebellar tracts are the spino-cerebellar, connecting the spinal cord 
and the cerebellum, the vestibulo-spinal, connecting the vestibular system and the 
cerebellum, cortico-ponto-cerebellar, connecting the cortex, pons and cerebellum and 
the dentato-rubro-thalamic connecting the dentate nucleus of the cerebellum, the red 
nucleus and the thalamus.  
 
Cognitive pathways The basal ganglia are involved in many functional 
pathways affecting emotional, motivational, associative and cognitive processing along 
with motor function. Atrophy to basal ganglia structures is a pathological feature of 
HD, explaining the myriad of cognitive, emotional and motor symptoms experienced. 
Planning and problem-solving ability as well as working memory performance were 
found to be associated with frontal white matter volume and striatal volume in pre-
symptomatic HD patients (Papp et al., 2013). Similarly, reduced BOLD activity was 
found in both pre-symptomatic and manifest HD participants relative to controls in the 
thalamus as well as the anterior cingulate gyrus during a spatial working memory task, 
(Georgiou-Karistianis, Poudel, et al., 2013), suggesting that frontocortical-striatal 
connections may be involved in the cognitive symptoms experienced in HD.  
 
The fornix is a major white matter bundle projecting from the hippocampus to 
other brain structures, including some of the structures known to be affected in HD, 
such as the thalamus and nucleus accumbens, and is one of the most important 
anatomical structures related to memory. Given the memory deficits observed in HD 
(Bamford, et al., 1995; Dumas, van den Bogaard, Middelkoop, & Roos, 2013), it is 
plausible that fornix microstructure may be affected. In line with this, tensor based 
metrics in the fornix were found to be altered in HD participants compared to controls 
in a whole-brain diffusion MRI analysis (Della Nave, et al., 2010) although it has yet to 
be established whether fornix microstructure is related to cognitive deficits in HD.  
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The cingulum connects the cingulate cortex with the prefrontal cortex, 
premotor regions, cortical association areas in the parietal and occipital lobes, 
parahippocampal cortex and the thalamus (Mufson & Pandya, 1984) and has been 
implicated in Alzheimer’s disease and mild cognitive impairment (Y. L. Chang et al., 
2014). Given that atrophy has been observed in the thalamus and in the cerebral 
cortex in HD (de la Monte, et al., 1988; J. Vonsattel, et al., 1985), and that there are 
phenotypic overlaps between HD and Alzheimer’s disease, the cingulum deserves 
attention as a potential candidate white matter tract affected in HD. Despite this, the 
cingulum has not been examined in a tract-specific analysis in HD before, and is 
reconstructed for the first time in HD participants in chapter 4.  
 
 Finally, along with being involved in motor function, the corpus callosum also 
contains fibers involved in cognitive function. Thinning of the corpus callosum has 
been found in post-mortem HD brains (Vonsattel, et al., 1985) and in vivo 
abnormalities found with MRI (see 2.2 and 2.3), and in early stage HD, cognitive scores 
were found to correlate with tensor based metrics obtained in the corpus callosum 
(Dumas, et al., 2012). In chapters 4, 6 and 7, corpus callosum microstructure is 
explored in patients and mouse models respectively.  
 
Pathways related to emotional / psychiatric symptoms. It is less clear which 
pathways may relate to the psychiatric symptoms in HD specifically, simply because 
this area has received less research attention. However, limbic system circuitry has 
been found to be associated with psychiatric symptoms in the non-HD population. The 
fornix and cingulum bundles are the most prominent white matter fiber tracts within 
the limbic system and measures of volume and tissue microstructure in the cingulum 
have been found to be associated with psychiatric disorders including depression, 
obsessive compulsive disorder and schizophrenia (Fitzsimmons, Schneiderman, et al., 
2014; Keedwell et al., 2012; Szeszko et al., 2005), Similarly, fornix microstructure has 
been found to be altered in a number of psychiatric conditions (Fitzsimmons, Hamoda, 
et al., 2014; Via et al., 2014).  
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Prefrontal cortical connections are also likely to be involved in psychiatric 
symptoms. A functional BOLD study observed that reduced activity in the prefrontal 
cortices in symptomatic HD patients was associated with increased neuropsychiatric 
disturbance within the domains of executive dysfunction, pathological impulses, 
disinhibition, and depression (Gray et al., 2013). A separate BOLD study found that 
emotion-related dysfunctions were associated with a disruption in the striatal-
thalamo-cortical loop (Dogan et al., 2014).   
Inflammation in HD and Gliosis 
There is mounting evidence that various inflammatory processes may mediate 
neuropathology in HD (Kaushik & Basu, 2013; Sapp et al., 2001; Silajdžić et al., 2013). A 
normal inflammatory response in the brain begins with the activation of microglia, 
which are immune cells which when activated have a protection and repair role, acting 
as phagocytes to remove pathogens and cellular debris and signalling the release of 
inflammatory mediators (cytokines and chemokines). If this neuroinflammatory 
response is an acute response, the release of inflammatory mediates may trigger 
oxidative and nitrosative stress, however, the short-lived nature of the responses does 
not have a detrimental effect on neuronal health long-term. In contrast, a chronic and 
self-perpetuating immune response with chronic microglia activation and sustained 
inflammatory mediator release results in increased oxidative and nitrosative stress and 
subsequent neuronal cell death and disease advancement. Chronic neuroinflammation 
has been associated with a range of neurodegenerative disease including HD, with 
elevated levels of inflammatory cytokines and chemokines found in the plasma of 
patients with HD as well as in pre-symptomatic HD gene-carriers (Björkqvist et al., 
2008; Wild et al., 2011). Mutant huntingtin has been shown to be expressed in 
microglia (Shin et al., 2005) and in vivo imaging, in vitro and postmortem studies 
converge in showing that microglia are activated in both pre-symptomatic and 
symptomatic HD (Sapp, et al., 2001; Tai et al., 2007a, 2007b). Huntingtin-induced 
immune activation is not confined to the CNS, with peripheral immune system 
dysfunction also reported in HD (Björkqvist, et al., 2008; Dalrymple et al., 2007). Thus, 
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it is evident that inflammation plays a role in HD, although the precise details and the 
interaction between CNS and PNS pathology have yet to be established. 
Animal models of Huntington’s disease 
 
Lesion models 
In the broadest terms, animal models of HD are either non-genetic or genetic 
models. Prior to the discovery of the HD gene in 1993, HD research was reliant on non-
genetic models, where cell death was induced to model the neuropathology seen in 
HD. Cell death can be induced either by the delivery of excitotoxins or metabolic toxins 
which disrupt mitochondria functioning. Whereas metabolic toxins provide a higher 
level of neuropathological validity compared to excitotoxic lesions, selecting affecting 
medium spiny neurons in a progressive manner (Borlongan, Koutouzis, & Sanberg, 
1997; Brouillet et al., 1993), the inter-animal variability and the incidence of gross non-
specific striatal damage are higher (Dunnett & Rosser, 2004). The most commonly used 
excitotoxic agents are quinolinic acid, a NMDA-selective glutamate agonist, and kainic 
acid, a non-NMDA glutamate agonist, which induce cell death by binding to their 
cognate receptors on striatal neurons. Quinolinic acid is currently the most widely used 
neurotoxin in HD animal models because it causes preferential degeneration of GABA-
ergic neurons, the same class of neurons affected in HD, whilst sparing other cells such 
as cholinergic interneurons (Schwarcz, Whetsell, & Mangano, 1983). The degree of cell 
loss is preferential for transplantation studies, however the main limitation of 
excitotoxic models is the lack of association with the genetic cause of HD; lesions do 
not produce mutant HTT, mice do not develop neuronal inclusions, and cell death is 
sudden and not progressive.  
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Genetic models 
Genetic models of HD incorporate a similar genetic defect to that seen in 
patients, allowing for the study of early pathological, cellular and molecular alterations 
caused by the mutation, which is not possible in patients in vivo. Genetic models do 
not suffer the same degree of variance in terms of disease stage and number of CAG 
repeats as in human studies, allowing for more experimental control. The majority of 
genetic models of HD are in mice, however, transgenic rat models (von Hörsten et al., 
2003), primate models (Yang et al., 2008), and genetically modified models in C. 
elegans (Faber, Voisine, King, Bates, & Hart, 2002), drosophila melanogaster (Warrick 
et al., 1998), zebrafish (Schiffer et al., 2007) and sheep (Jacobsen et al., 2010) have 
been created.  
 
Genetic animal models can take one of three forms. Knock-out models were 
the first to be developed (Duyao et al., 1995; Nasir et al., 1995; Zeitlin, Liu, Chapman, 
Papaioannou, & Efstratiadis, 1995) whereby the HTT gene was removed from the 
genome entirely. A knock-out model was useful in determining the function of the HTT 
gene, with knock-out animals not surviving embryonic development, demonstrating 
the crucial role HTT plays in embryogenesis (Duyao et al., 1995; Nasir et al., 1995; 
Zeitlin, Liu, Chapman, Papaioannou, & Efstratiadis, 1995. More recently, conditional 
knock-out models have been developed, where the Huntingtin gene can be eliminated 
from the specific organ being studied as opposed to every organ where Huntingtin is 
expressed, and inducible knock-out models allow the gene to be knocked at a specific 
time, such as after development.    
 
Whereas knock-out models are useful for understanding the function of the 
gene, transgenic and knock-in models are more suitable as models of HD, where 
questions about disease progression and intervention outcomes can be assessed. In 
transgenic models, the mutant gene is inserted randomly into the animal genome in 
addition to the two normal copies of endogenous huntingtin (Htt) (Barnes et al., 1994). 
Transgenic models have tended to produce an acute, and fast-acting phenotype (see 
1. General Introduction  2014
 
24 
 
Table 1.2) although more recently, transgenic models have been generated which 
express longer fragments, or the full-length human mutant HTT gene, such as the yeast 
artificial chromosome (YAC) (Hodgson et al., 1999a; Slow et al., 2003a) and bacterial 
artificial chromosome (BAC) models (Gray et al., 2008), which produce a more 
progressive phenotype.  
 
Knock-in models have the CAG repeat mutation inserted into the endogenous 
animal Huntingtin (Htt) gene via homologous recombination (Lin et al., 2001) or the 
animal exon 1 is replaced with the pathologically expanded human exon 1 (Ishiguro et 
al., 2001; Wheeler et al., 2000). The gene is not over-expressed as there is no change in 
the number of copies of the gene, and the use of the endogenous Hdh promoter 
means that these models should produce a similar expression profile to that seen in the 
human condition and allow expression of the complete mutant gene. Knock-in mice can 
be homozygous or heterozygous for the mutation and produce a very mild phenotype 
and protracted time course to disease onset, as shown in Table 1.1 and Table 1.2. 
 
This thesis includes work on mouse models of HD (chapters 6 and 7). Tables 1.2 
and 1.3 show the different animal models of HD and the associated phenotype and 
neuropathology. There is a wide range in time course in the development of 
neuropathological and behavioural deficits as well as a range in the phenotype 
displayed in various transgenic and knock-in lines. The two mouse lines used in this 
thesis are outlined in bold, and are well characterised lines. The R61/2 mouse models 
have been the most studied (Mangiarini et al., 1996). These mice have a severe 
phenotype and neuropathology occurs early in life, with a relatively quick progression 
of symptoms and reduced lifespan, making the model less appropriate for long-term 
studies, such as those evaluating the long-term effects of therapeutic interventions.  
An alternative transgenic HD mouse model is the yeast artificial chromosome (YAC) 
mouse model, which was created by cloning an artificial yeast vector that contained an 
expanded polyglutamine repeat into the mouse genome (Hodgson, et al., 1999a). The 
transgenic YAC128 mouse model expresses the entire human huntingtin gene with 120 
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CAG repeats (Slow et al., 2003b) and recapitulates many of the features of human HD 
including a progressive phenotype, motor abnormalities from 3 months of age, striatal 
atrophy at 8 months old, and cortical atrophy seen at 12 months old (Slow, et al., 
2003b). The YAC128 mouse model was developed specifically with the testing of 
therapeutics in mind; the HD-related phenotypes of the YAC128 mice show phenotypic 
uniformity with low inter-animal variability (Slow, et al., 2003b), age-dependent 
striatal neurodegeneration, and a longer lifespan compared to the commonly used 
R6/1 and R6/2 mouse lines. The HdhQ150 mouse model (Lin, et al., 2001), which is 
characterised in chapter 6, is a knock-in model that expresses full length mutant Htt, 
and contains a 150 CAG repeat insertion. HdhQ150/Q150 mice display a progressive motor 
deficit which manifest at approximately 100 weeks old on the rotarod test, balance 
beam, and activity measures, with an abnormal gait and clasping phenotype also 
evident (Heng, Tallaksen-Greene, Detloff, & Albin, 2007). Cognitive deﬁcits appear 
prior to motor deﬁcits, as is the case in the human disease (Brooks, Betteridge, 
Trueman, Jones, & Dunnett, 2006). Neuropathological changes include striatal cell loss 
(M. Heng, et al., 2007), nuclear aggregates in the dorsal striatum, nucleus accumbens 
and piriform cortex, with fewer aggregates in the cortex, cerebellum and hippocampus 
(Lin, et al., 2001).  
 Behavioural phenotyping in animal models of HD 
Behavioural testing is necessary to characterise the phenotype of different 
mouse models of HD, and can be used as an outcome measure to assess disease 
progression and the effect of therapeutic interventions. Different tests can be used to 
assess different symptoms of HD (Brooks & Dunnett, 2009) including motor, cognitive 
and emotional functioning. In the motor and cognitive domain, the majority of tests 
require a training period to acclimatise the mouse to the new environment and ensure 
anxiety-related behaviour is not being measured.  
 
 In the motor domain, the rotarod test (B. Jones & Roberts, 1968) and balance 
beam (Perry et al., 1995) are both commonly used to assess motor coordination and 
1. General Introduction  2014
 
26 
 
balance. The rotarod test involves placing the animal on a rotating beam either at a 
fixed or accelerating speed, and measuring the latency to fall from the rod over a 
number of trials and is used to assess motor coordination, motor learning, balance and 
endurance (Alvarez-Fischer et al., 2008; Schallert, Fleming, Leasure, Tillerson, & Bland, 
2000). The balance beam involves placing the animal on a beam of varying diameters, 
with the ability to traverse it considered to be an indicator of balance; the number of 
paw slips and time taken to traverse the beam are measured over a given time period. 
Locomotor activity can be assessed in a number of ways and for varying periods of 
time. 24-hour monitoring allows activity to be examined across the circadian cycle, 
whereas shorter monitoring times are also sensitive to anxiety-related behaviours. A 
variety of circular (de Visser, van den Bos, Kuurman, Kas, & Spruijt, 2006) and square 
(L. Menalled et al., 2009) open-field tests measure general activity levels in an open 
arena using different tracking methods, either by manual recording, or more recently, 
using automated methods such as infrared beams, and video-tracking, with differing 
degrees of sensitivity. When first placed in the centre of the arena, a healthy non-
mutant mouse will typically run to the walled edges of the arena and explore the 
perimeter of the arena. Over time with habituation, anxiety levels will reduce and the 
mouse will explore more central regions of the arena. Gait is commonly assessed by 
painting the feet of animals and examining the pattern of footprints; transgenic HD 
mice have been shown to display irregularly spaced shorter strides and an uneven left–
right step pattern compared with the evenly spaced and accurately positioned 
footprints of wild-type mice (Carter et al., 1999). Limb clasping behaviour, where the 
fore and hindlimbs are clasped together when the mouse is suspended by the tail, is 
also commonly seen in HD mice and although the precise neurological reason for this 
response is not known, it is a sign of neurological and motor abnormality. Grip strength 
can be measured either by assessing the ability of a mouse to remain clinging to an 
inverted grid, or hanging on a wire with its forepaws for a period of time (Brooks, 
Higgs, Jones, & Dunnett, 2012), or by measuring the force required to loosen the 
mouse’s grip on a bar. Other observational measures such as the presence of a tremor, 
abnormal limb displacements, and righting reflex are also used.  
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Cognitive tasks are commonly delivered using either operant chambers (see 
Figure 1.4) or some form of maze. Cognition is more challenging to assess as tests 
often require a long period of training for the mouse to be able to learn the task. 
Operant learning paradigms are commonly run in operant boxes, or ‘Skinner boxes’, 
such as the nine-hole box, where an array of 9-holes is used as the response location, 
and mice must learn to poke their nose into the holes in response to a light inside the 
hole. Depending on the task, reinforcements can be provided in the chambers based 
on the mouse’s response. Various different operant paradigms have been designed for 
the operant boxes, such as the five-choice serial reaction time (5-CSRT) test, which is a 
test of attentional function (Humby, Laird, Davies, & Wilkinson, 1999) and requires the 
mouse to respond rapidly to stimuli appearing at random in one of five holes in the 
array, with reaction time and accuracy as outcome measures. This is of interest in HD 
models as various facets of attention have been reported to be affected in individuals 
with HD (Hart et al., 2012; Hart et al., 2013; Thompson et al., 2010). 
Sequence learning tasks are an extension of the choice reaction time task, where the 
mouse now needs to respond to a sequence of stimuli, rather than just one. Sequence 
learning is of interest in HD because research has shown the ability to acquire and act 
upon serial order information depends on the basal ganglia (Kermadi & Joseph, 1995; 
Mushiake & Strick, 1993, 1995). 
 
 
 
 
 
 
 
 
 
 
 Figure 1.4 An example of an operant chamber. In this example, there are 9-holes 
with LED’s behind each.  
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The serial implicit learning task (Trueman, Brooks, & Dunnett, 2005) is one such 
task, where the majority of sequences are random, but embedded within the task is a 
predictable task, where the location of the second stimuli can be fully predicted from 
the specific location of the first stimuli. Aside from the time required to train the mice 
to achieve a baseline score, a second disadvantage with using operant chambers is the 
necessity for food restriction during training/testing periods, which may have varying 
effects within a cohort depending on differences in genotype, sex, strain, or 
metabolism (Trueman, Dunnett, & Brooks, 2012).  
 
The Morris water maze (Morris, Garrud, Rawlins, & O'Keefe, 1982) is the classic 
test for assessing spatial memory and involves releasing the mouse into a pool 
containing opaque water and the mouse must learn to find a hidden platform to 
escape (Lipp and Wolfer, 1998). Healthy, wild-type mice learn to quickly find the 
platform, and once the platform is removed, continue to search in the same quadrant 
in which the platform was previously location, suggesting spatial retention and defined 
as spatial reference memory. Performance on the Morris water maze is well 
established as being dependent on hippocampal function (Bannerman et al., 1999; 
Morris, et al., 1982; Whishaw, 1995). 
 
  The spatial alternation T-maze task is commonly used to assess discrimination 
learning and working memory (Deacon & Rawlins, 2006). The apparatus is in the form 
of a T placed horizontally, and animals are placed at the base of the T and allowed to 
choose one of the goal arms adjoining the other end of the stem. If two trials are 
performed in quick succession, on the second trial the rodent tends to choose the arm 
not visited before without reinforcement, reflecting memory of the first choice and 
termed 'spontaneous alternation' (Dember & Richman, 1989) which has been found to 
be sensitive to dysfunction of the hippocampus, cerebellum, thalamus and substantia 
innominata (Lalonde, 2002). Variants of the task include a ‘forced choice alternation’ 
where entry to the alternate arm is prevented on the first run, and reinforcement is 
presented at the end of the arm (Deacon & Rawlins, 2006).  
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The water T-maze apparatus has been used to design a set-shifting task in which the 
rodent must learn a rule and then switch to a different rule, which is dependent on the 
prefrontal cortex (Birrell & Brown, 2000). Set-shifting deficits are observed in HD 
patients (Lawrence, Sahakian, Rogers, Hodge, & Robbins, 1999), and YAC128 mice 
were found to show set-shifting deficits on the adapted T-maze protocol (Brooks et al., 
2012). Other cognitive tests, such as the radial arm maze (8 arms in a radial 
configuration around a central starting point) have the advantage that working and 
reference memory can be assessed simultaneously (Olton, 1979; Olton & Papas, 1979).  
 
The psychiatric and emotional features of HD are most challenging to 
characterise in animal models, as internal symptoms such as delusions, hallucinations 
and suicidal ideation cannot be assessed. There are however a number of tests which 
are thought to measure more overt symptoms, such as depression, anxiety and 
anhedonia. The Porsolt forced swim test is a commonly used paradigm to assess 
depression-like behaviour and antidepressant action in rodents (Porsolt, Bertin, & 
Jalfre, 1978) and involves measuring the degree of mobility of mice when forced to 
swim in a restricted space with no escape option. Increased immobility is interpreted 
as a marker for reduced motivation, and a depressive state. Nevertheless, the motor 
deficit and weight loss seen in HD mice may affect the validity of this test specifically in 
HD mice. The sucrose intake test is a test of anhedonia, or the inability to experience 
pleasure. A reduction in sucrose consumption and preference compared to healthy 
control mice is interpreted as a reduction in reward sensitivity (Willner, Towell, 
Sampson, Sophokleous, & Muscat, 1987).  Anxiety can also be inferred from freezing 
behaviour in the open-field test previously described, and from behaviour on the 
elevated plus maze, in which rodents are placed at the junction of the four arms of the 
maze, facing an open arm, and entries/duration in each arm are recorded (Walf & Frye, 
2007). 
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Treatment options in Huntington’s disease 
There are currently no treatments available to alter the course of HD, with 
treatment options limited to symptomatic therapies. As HD has a heterogeneous 
phenotype, with each patient experiencing a different profile of symptoms, 
symptomatic treatment options and their effectiveness differ between individuals 
and across the disease time course. As with other disorders aiming to treat multiple 
symptoms, side effects of one treatment are likely to exacerbate other symptoms. 
An ideal treatment for HD would prevent neuronal death that occurs as a 
consequence of the mutant HTT gene and precede the emergence of symptoms. 
There are currently two main targets to prevent neuronal loss in HD, the first being 
a cellular target which aims to replace lost neurons and/or provide nutritional and 
survival support to reduce cell loss in diseased tissue, whereas the second option is 
a genetic target to ablate the mutant huntingtin protein. 
 
Symptomatic treatments Pharmacotherapy treatment options for motor 
symptoms include the dopamine depleter tetrabenazine, benzodiazepines (e.g. 
diazepam) and neuroleptics (e.g. risperidone), whereas treatment options for non-
motor symptoms include selective serotonin reuptake inhibitor antidepressants, 
antipsychotics (Correll, Leucht, & Kane, 2004), monoamine oxidase inhibitors, and 
mood-stabilizing agents to improve impulse control.  
 
Cell-based therapies There are a number of different cell-based therapies 
that have potential in HD treatment for the future. In vivo, the most evidence exists 
for foetal primary transplants. From work in mice, rats, and monkeys in which 
embryonic striatal tissue is transplanted into the site of excitotoxic striatal lesions, 
grafts were shown to survive, grow, express a wide range of cellular markers 
characteristic of the normal striatum and improve behavioural signs associated with 
the lesion (Dunnett, Nathwani, & Björklund, 2000; Döbrössy & Dunnett, 1998; 
Mayer, Brown, Dunnett, & Robbins, 1992). Importantly, host-to-graft afferent and 
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efferent connections were shown to develop (Wictorin, 1992) and were functionally 
viable both neurochemically (K. Campbell et al., 1993; Sirinathsinghji et al., 1988; 
Sirinathsinghji, Heavens, Torres, & Dunnett, 1993) and electrophysiologically 
(Mazzocchi-Jones, Döbrössy, & Dunnett, 2009; Nakao, Ogura, Nakai, & Itakura, 
1999; Xu, Wilson, & Emson, 1991). Foetal primary transplants have since been 
taken forward to clinical trials and in the past 14 years, there have been a number 
of clinical trials which have produced mixed results, with evidence of a short-term 
but not long-term clinical improvement (Bachoud-Lévi, 2009; Bachoud-Lévi et al., 
2006; Bachoud-Lévi et al., 2000; Kopyov et al., 1998; Paganini et al., 2013; Philpott 
et al., 1997). A multi-centre study (“NEST-UK”) is also underway in the UK, with 
reports on efficacy and safety recently published (Barker et al., 2013) . Despite this, 
a fundamental constraint is the limited supply of suitable donor tissues, which 
restricts the levels of standardization and quality control required for experimental 
medicine.  
 
Alternative sources of tissue for neural transplantation have been explored, 
including human neural stem cells (Johann et al., 2007; Lee et al., 2006; J. L. 
McBride et al., 2004; Roberts, Price, Williams, & Modo, 2006; Ryu et al., 2004) 
Sources of neural stem cells which have been investigated in HD include: 1) 
embryonic stem cells (J. Song et al., 2007), which are derived from blastocysts, 2) 
foetal stem cells, with pluripotent progenitor cells taken from the embryo, foetus, 
or neonate, which are already partially committed down a neural lineage, 3) adult 
neural stem cells, with progenitor cells isolated from the adult subventricular zone 
(Vazey, Chen, Hughes, & Connor, 2006; Vazey & Connor, 2010),  4) embryonic germ 
cells that are isolated from the gonadal ridge of the embryo, 5) non-neural stem 
cells, such as adult bone marrow stem cells or umbilical cord cells, and 6) induced 
pluripotent stem cells (iPS cells) which can be generated from adult human 
fibroblasts (Consortium, 2012; Takahashi, Okita, Nakagawa, & Yamanaka, 2007). 
. In addition, in response to work showing a reduction in neurotrophic 
support required for neurogenesis in HD (Ciammola et al., 2007; Conforti et al., 
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2008; Zuccato et al., 2008; Zuccato et al., 2011) the transplantation of genetically-
engineered stem cells which over-express a range of neurotrophic factors (e.g. 
BDNF, glial-cell derived neurotrophic factor and nerve growth factor) has been 
shown to improve motor function and reduce striatal loss (Dey et al., 2010; Sadan, 
Melamed, & Offen, 2012) in rodent models of HD, although issues with poor 
survival of transplanted cells are reported (Sadan, et al., 2012).  
 
The future of these cell-based therapies beyond pre-clinical trials will 
depend on practical issues such as achieving effective and reliable tissue survival 
and integration, feasibility, long term safety and ethical and regulatory restrictions 
(Dunnett & Rosser, 2014). Nevertheless, it is hopeful that with advancements in 
knowledge and refinements in cell transplant technology, cell-based therapeutics 
may still hold promise in HD.  
 
Gene-based therapies Gene-based therapies also offer a potential powerful 
treatment option for the future, aiming to prevent the expression of the mutant 
protein in order to circumvent the cytotoxic downstream effects. Gene silencing 
involves targeting RNA to prevent the mutant HTT protein from being formed and is 
close to reaching clinical trials. One example of gene silencing is antisense therapy 
(Lu & Yang, 2012), whereby a strand of nucleic acid is synthesised specifically to 
bind to the messenger RNA produced by the HTT gene in order to inactivate it, as 
mRNA needs to be single stranded for it to be translated. This technique has proven 
hopeful when applied to transgenic mouse models of HD, with antisense 
oligonucleotides found to reduce HTT expression by approximately 75% following 
injection into the lateral ventricle (Kordasiewicz et al., 2012). There are also a 
number of genome editing technologies that have been developed in recent years, 
such as zinc finger nucleases [ZFN’s] (Gaj, Guo, Kato, Sirk, & Barbas, 2012; Y. G. Kim, 
Cha, & Chandrasegaran, 1996), transcription activator-like effector nucleases 
[TALENs] (Mussolino et al., 2011) and most recently, Clustered Regularly 
Interspaced Short Palindromic Repeats [CRISPR] (Gaj, Gersbach, & Barbas, 2013) 
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which aim to cut DNA at a specific target sequence, such as near the expanded CAG 
tract in the HD gene.  
 
As with cell-based therapies, one of the challenges for gene therapies is the 
method of delivery and the inability to stop in the event of adverse effects. Unlike 
pharmacotherapy, delivery may need to be directly into the brain and would thus 
require neurosurgery.  
 
Environmental enrichment  A less invasive and more accessible 
therapeutic avenue that has received research attention in a range of 
neurodegenerative diseases is environmental modification. Environmental 
enrichment, defined as an increased level of novelty and complexity, inducing 
enhanced sensory, cognitive and motor stimulation (Nithianantharajah & Hannan, 
2006) has been found to improve survival rates, reduce motor symptoms and 
disease-related neuropathology and decrease neuronal intranuclear inclusion load 
in mouse models of the disease (Benn et al., 2010; Hockly et al., 2002; T. L. Spires et 
al., 2004; Wood, Glynn, & Morton, 2011). Environmental enrichment may also be of 
benefit in an indirect way; research in mice who had received a unilateral quinolinic 
acid lesion of the striatum followed by an embryonic striatal graft found that 
environmental enrichment induced changes in long term potentiation and BDNF 
levels in both the intact and grafted striatum (Mazzocchi-Jones, Döbrössy, & 
Dunnett, 2011), suggesting environmental modification can improve the outcome 
of cell transplantation.  
 
Exercise Exercise based interventions conducted in both mouse models and 
HD patients have shown beneficial effects on behaviour (Busse et al., 2013; Khalil et 
al., 2013; van Dellen, Cordery, Spires, Blakemore, & Hannan, 2008) and a reduction 
in neuropathology (Harrison et al., 2013). Taken together, the results from 
environmental enrichment and exercise studies suggest that a more holistic 
approach, whereby any genetic or cellular intervention is combined with an 
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optimised environment in terms of physical, social and cognitive activity, may bring 
us closer to a disease-modifying treatment in HD.  
 
1.2 Magnetic resonance imaging to study HD 
neuropathology  
Principles of magnetic resonance imaging  
Magnetic resonance imaging (MRI) has a dichotomous history; whereas the 
principles underlying MRI were first discovered in the early 20th century, it wasn’t 
until much later, in 1973 that the first NMR image was produced, and not until the 
late 1970’s and early 1980’s that the clinical utility of MRI was recognised with the 
introduction of magnetic field gradients, which dramatically sped up the ability to 
acquire MR images. Today, more advanced sequences, gradient manipulations and 
enhanced software continue to be developed resulting in an evolving field with the 
associated clinical utility continuing to be realised.  
 
Although other nuclei have been studied, the magnetic properties of the 
hydrogen nucleus are principally utilised, namely because of the high abundance of 
hydrogen in the body. The interaction between the magnetic properties of the 
hydrogen nucleus, a strong external magnetic field (B0) and applied radio waves 
forms the basis of the MRI image. The nucleus of the hydrogen atom consists of just 
one proton, which spins in a randomly oriented fashion around its own axis, 
producing a small magnetic field with a north and south-pole and an associated 
magnetic moment vector. When the proton is placed in an external magnetic field 
(B0), two changes occur. Firstly, the dipoles of the protons are no longer randomly 
oriented, but instead line up with the direction of the magnetic field, either in a 
parallel (“spin up”) or anti-parallel (“spin down”) position. Marginally more protons 
align parallel to the external field, resulting in a net magnetic moment parallel to 
the magnetic field. Secondly, this net magnetic moment precesses about the 
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direction of the applied field. With a precessional frequency , that is directly 
proportional to the strength of the external magnetic field Bo, i.e. =Bo, where  is 
the gryomagnetic ratio. The varying molecular structures and amount of hydrogen 
atoms in different tissue types in the body affects the strength of this net 
magnetisation, and thus the precessional (Larmor) frequency. 
 
In order to achieve a MR signal, a RF pulse, which is a magnetic field 
oscillating at radio frequency, is applied perpendicularly to B0 in order to cause a 
transition between these two energy states. The electromagnetic radiation is 
absorbed by the protons, causing protons in the parallel, low-energy state to excite 
and flip into the anti-parallel state whilst precessing in-phase, consequently flipping 
the net magnetisation towards the transverse plane. The angle through which the 
net magnetisation flips is dependent on the strength and duration of the RF pulse, 
whereas the frequency of the pulse is determined by the Larmor equation (=Bo) 
introduced above. Once the RF pulse stops, the protons contributing to the net 
magnetisation start to lose their phase coherence, whilst some of the protons that 
had transitioned into the anti-parallel, high energy state give off their energy and 
flip back to the low energy, parallel state (“relaxation”), causing the net 
magnetisation to regrow in the B0 direction. During this relaxation period, a radio 
frequency signal is generated and measured by receiver coils. The rate of 
longitudinal relaxation varies between different tissue types and is known as T1. A 
second type of relaxation is transverse, or T2 relaxation which occurs in the x-y 
plane and refers to the decay of transverse magnetization as spinning dipoles lose 
phase coherence and dephase following a RF pulse. 
 
In order to gain spatial information from these signals, additional magnetic 
fields are applied using three gradient coils (X, Y, Z) which are each oriented along a 
different orthogonal axis and are used to produce deliberate variations in the main 
magnetic field to encode spatial information. The intensity of the signal received 
and thus the MR image reconstructed depends on a number of parameters 
Cardiff University  2014
 
39 
 
including: the T1 relaxation time, the T2 relaxation time and the proton density. The 
contrast of the image can be altered by changing the pulse sequence parameters, 
such as the strength, duration and timing of the RF pulse, resulting in different 
pulse programs for different purposes.  
T1- and T2-weighted MRI to examine tissue macrostructure 
The spin echo sequence is the most commonly used MRI pulse sequence 
and generally refers to an echo formed after the application of two pulses: a 90° 
excitation pulse and a 180° refocusing pulse. The echo time (TE) is the time 
between the 90° RF pulse and MR signal sampling, which corresponds to the 
maximum of the echo; the 180° refocusing pulse is applied at ½ of the TE and flips 
the dephasing individual spins to the opposite side in the x-y plane so that after 
another ½ TE, they refocus. This series is repeated at each time interval TR 
(Repetition Time) and the longer the TR, the more complete the longitudinal 
relaxation. Thus, a short TR (<1000 ms) results in a T1-weighted image as the 
differences between the longitudinal relaxation of the tissues’ magnetization is 
emphasised. In contrast, T2-weighted sequences use a long TR and TE (> 
2000/80ms), producing distinctly different image contrast. T1- and T2-weighted MRI 
sequences can be used to quantitatively examine disease pathology, as well as the 
volume, thickness and shape of brain structures.  
 
There are a number of different analysis approaches used in order to obtain 
such metrics, and the suitability of the different approaches is affected by the 
image quality and the type of neuropathology expected in the sample population. 
The software used for human image analysis is not directly translatable to pre-
clinical image analysis, due to differences in brain shape, size and anatomy. The 
simplest but most labour-intensive method is slice-by-slice manual segmentation of 
the structures of interest. This is generally considered the ‘gold standard’ reference 
method, but depends on the expertise of the rater and is thus prone to issues with 
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inter-rater reproducibility. Due to the time-consuming nature of manual 
segmentation, the majority of human morphometric studies instead use software 
which employs semi-automated and automated approaches with 3D image 
registration, electronic brain atlases and prior tissue probabilities (e.g. SPM, FSL, 
FreeSurfer, and BrainVoyager).  
 
Voxel-based morphometry (VBM) (Ashburner & Friston, 2000) and 
deformation-based morphometry (DBM) (Ashburner et al., 1998) are both 
commonly applied whole-brain automated approaches which can be used to reveal 
structural differences between groups (i.e. between healthy controls and a patient 
group). Whereas with VBM statistical analysis is performed at each voxel separately 
to look for local differences in the density, with DBM, statistical analysis is 
multivariate and performed on the deformation fields used to non-linearly register 
the voxels. 
T1- and T2- weighted MRI in HD 
In pre-symptomatic HD, both grey and white matter atrophy has been 
found, with enlarged gyri and abnormally thin sulci found globally in the cortex 
(Nopoulos, Magnotta, & Mikos, 2007). Intracranial adult brain volume has been 
found to be reduced in pre-symptomatic HD carriers (Nopoulos et al., 2010) and 
individuals with pre-symptomatic HD have been found to have significantly 
enlarged cortical grey matter volume and significantly smaller cerebral white 
matter volume compared to age-matched controls (J. Paulsen et al., 2006). White 
matter atrophy at the pre-symptomatic stage has also been found in two large-
scale longitudinal studies (Aylward et al., 2011; Paulsen, et al., 2010; Tabrizi et al., 
2012; Tabrizi et al., 2011) 
 
In a regression analysis conducted to determine whether any brain volume 
measures contributed to a prediction of estimated diagnosis, only cerebral white 
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matter volume was found to be a predictor of diagnosis proximity after total striatal 
volume was entered into the statistical model (Paulsen, 2010) whereas there was 
no relationship between grey matter atrophy and time to onset (Ciarmiello, et al., 
2006). Even in pre-symptomatic patients classified as far from symptom onset, the 
rate of white matter atrophy was significantly greater compared to healthy controls 
over a 1-year period (Tabrizi, et al., 2011), and over 2 years, the rate of change in 
white matter volume was greater than that in grey matter volume in pre-
symptomatic and early HD patients (Tabrizi et al., 2012). However, in other studies 
with pre-symptomatic groups who are far from predicted disease (motor symptom) 
onset, there was no evidence of white matter change in participants who were on 
average 18 years away from disease onset (Hobbs et al., 2010). Remarkably, when 
correcting for normal age-related changes over a 2-year period, disease-related 
atrophy was more pronounced in white matter than in the striatum in pre-
symptomatic participants (E. Aylward, et al., 2011). Likewise, in a smaller study, 
whereas white matter volume was significantly reduced in pre-symptomatic 
participants, the reduction seen in grey matter did not meet the threshold for 
significance (Ciarmiello, et al., 2006). In a smaller scale study, the isthmus of the 
corpus callosum was significantly thinner in pre-symptomatic patients compared to 
controls (Paola et al., 2012).  
 
In early HD, white matter atrophy continues to be evident (Ciarmiello, et al., 
2006; Hobbs, et al., 2010); patients had significantly lower cerebral white matter 
volume, cerebellar white matter, and corpus callosum volume than matched 
healthy subjects (Beglinger, et al., 2005; Hobbs, et al., 2010). There are 
inconsistencies in the literature for cerebral grey matter volume, with some work 
showing no difference in volume between controls and early HD participants 
(Beglinger, et al., 2005) and other work showing regionally specific cortical atrophy 
in the parietal, frontal and temporal lobes and widespread losses in the occipital 
lobes (Hobbs, et al., 2010). The rate of both global white matter loss and corpus 
callosum thinning was found to be more rapid in HD gene carriers who develop 
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symptoms earlier in life ( <40 years old; Rosas et al., 2011), whilst the entire corpus 
callosum was significantly thinner compared to healthy controls (Paola, et al., 
2012). Similarly, longer CAG repeat lengths, inversely related to age of onset 
(Andresen et al, 2007) was significantly associated with higher atrophy in the 
internal capsule as well as frontal, occipital and parietal white matter regions 
(Hobbs, et al., 2010). The splenium was found to be more atrophied than the genu 
and body of the corpus callosum in the early HD stage (Hobbs, et al., 2010). 
 
There are fewer studies with patients with more advanced stages of the 
disease, and white matter changes are often not reported (Aylward et al., 2000; R. 
Wolf, Vasic, Schönfeldt-Lecuona, Ecker, & Landwehrmeyer, 2009). In one study of 
gene-positive patients ranging from pre-symptomatic to advanced HD, a significant 
negative correlation was found between relative WM volume (corrected for 
intracranial volume) and disease duration (Ciarmiello, et al., 2006). However, a 
second follow up scan around 18 months later found no change in white matter 
volume specifically in the symptomatic patients, suggesting the rate of white 
matter atrophy may decline with disease progression.  
 
Overall, results from structural T1- and T2-weighted studies suggest the rate 
of atrophy in white matter does not follow the same course as grey matter atrophy 
in HD, with white matter atrophy beginning earlier in life prior to symptom onset, 
with less prominent changes in global grey matter volume. White matter areas 
affected tend to be widespread and not restricted to subcortical white matter, with 
both anterior and posterior regions affected. In relationship to the earlier list of 
candidate white matter pathways, these results are consistent with atrophy of the 
corpus callosum in HD pathology, and atrophy in the internal capsule suggests 
corticospinal tracts may be affected. Furthermore, atrophy in frontal, parietal and 
temporal white matter areas may implicate long association fibers, such as the 
cingulum, which connects regions in the frontal lobe with posterior regions such as 
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the posterior cingulate cortex, hippocampus, and parahippocampus (Schmahmann 
et al., 2007; Wakana, Jiang, Nagae-Poetscher, van Zijl, & Mori, 2004). 
 
Diffusion MRI to probe tissue microstructure 
Diffusion MRI is an imaging modality capable of characterising tissue 
microstructure on a scale not achievable with other in vivo imaging modalities. 
Diffusion MRI is concerned with the random bulk motion of water molecules in 
tissue. In the brain, white matter fibers are highly oriented resulting in a contrast 
between anisotropic diffusion of water due to highly orientated barriers, and 
isotropic diffusion in regions of the brain that are not directionally oriented, such as 
in grey matter and cerebrospinal fluid. 
 
Echo-planar imaging (EPI) is the most widely used method for diffusion 
imaging (Crooks et al., 1988; Turner et al., 1990) and the development of EPI in 
combination with high gradient amplitude systems allowed the clinical utility of 
diffusion MRI to be realised, with high-quality images devoid of significant motion 
artefacts attainable in clinically relevant acquisition times. The trade-off for 
increased speed is a reduction in image resolution; EPI requires high bandwidths 
which causes SNR loss and is resolved by lower image resolution.  
Tensor-based models and metrics 
The most widely used diffusion MRI approach is diffusion tensor imaging 
(DTI), which utilises a tensor model for diffusion, and assumes a 3-dimensional 
symmetrical Gaussian distribution. The diffusion weighted signal is acquired using a 
non-zero b-value with diffusion gradients applied along at least six non-collinear, 
non-coplanar directions (Basser, Mattiello, & LeBihan, 1994). Anisotropic diffusion 
is modelled as a diffusion ellipsoid and is a function of three orthogonal 
eigenvectors. The diffusivities along the eigenvectors are described by three 
eigenvalues (λ1, λ2, λ3) which determine the size and shape of the ellipsoid, and this 
1. General Introduction  2014
 
44 
 
information is represented mathematically by a tensor. The most commonly 
reported DTI indices are the mean diffusivity (also known as the apparent diffusion 
coefficient), or MD value, which refers to the average diffusivity across the three 
eigenvalues, and fractional anisotropy, or FA value, which refers to the directional 
dependence of diffusion and informs only on the rate of anisotropic diffusion in the 
voxel, which is often interpreted as an indication of the integrity of the tissue. 
The specific relationship between tissue microstructure and anisotropy is 
multifactorial. In animals, the association between radial diffusivity (the average of 
λ2 and λ3 of the diffusion tensor) and myelin content and between axial diffusivity 
(λ1 of the diffusion tensor) and axonal structure has been made (Song et al., 2003; 
Song et al., 2002; Song et al., 2005). However, it has since been shown that in areas 
containing complex fiber configurations and in voxels affected by partial volume, 
the eigenvalues of the tensor may reflect different underlying structural 
characteristics, hindering the ability to make interpretations about underlying 
tissue structure (Wheeler-Kingshott & Cercignani, 2009). 
Non-tensor based approaches 
A major limitation of the diffusion tensor model is that it can only account 
for Gaussian diffusion processes that dominate signal attenuation at relatively low 
b-values. Due to the heterogenous nature of biological tissue, with different cell 
types, barriers and compartments, the diffusion displacement probability 
distributions can deviate considerably from a Gaussian form (Cohen & Assaf, 2002). 
In recent years, a number of new methods have been developed to more 
adequately model diffusion in white matter. High angular resolution diffusion 
imaging, or HARDI, methods increase sampling in q-space to produce an improved 
diffusion profile using a variety of different approaches (Alexander, 2005; Frank, 
2002; Tuch et al., 2002). Multi-compartment approaches, such as Assaf et al’s 
(2004) composite hindered and restricted model of diffusion model (CHARMED) 
models the restricted diffusion component (intra-axonal compartments which 
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correspond to distinct fiber populations) separately from the hindered-diffusion 
component in the extra-cellular space through the use of multiple b-values per 
direction and a hybrid HARDI approach. The ability to model the intra-axonal 
diffusion may provide a more biologically specific and/or sensitive characterisation 
of white matter changes in disease. The work conducted in Chapter 4 of this thesis 
demonstrates the first application of the CHARMED model in HD.  
 
Other non-diffusion techniques are available to examine changes in myelin 
content. Multicomponent analysis of T1 and T2 relaxation data, or multicomponent 
relaxometry, is a quantitative MR technique that is sensitive to changes in myelin 
content (Deoni, Rutt, Arun, Pierpaoli, & Jones, 2008; Spader et al., 2013). This 
technique is based on the observation that there are multiple water compartments 
in a cell: the ‘free’ water that exists in both the intra- and extra-axonal space and 
water contained within the layers of the myelin sheath which has a shorter T2. Each 
water compartment has been shown to have a unique MR signal signature, and 
these signal signatures can be fitted from multiple MR images in order to calculate 
the relative signal from the myelin, known as the myelin water fraction (MWF). This 
metric has been shown to be strongly correlated with histological measures of 
myelin content (Laule et al., 2006; Webb, Munro, Midha, & Stanisz, 2003), and 
along with being more specific than DTI, is not influenced by other biological 
changes, such as inflammation (Gareau, Rutt, Karlik, & Mitchell, 2000). The work 
conducted in Chapter 5 of this thesis demonstrates the first application of the 
multicomponent driven equilibrium single-pulse observation of T1 and T2 
(mcDESPOT) model (Deoni, et al., 2008) in Huntington’s disease. 
Diffusion Tractography 
Fiber tractography is a mathematical technique to trace the fiber tract 
trajectories from the acquired diffusion MRI data and allows for the 3-dimensional 
reconstruction of white matter pathways in the brain (Basser, Pajevic, Pierpaoli, 
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Duda, & Aldroubi, 2000). Tractography algorithms can be separated into two major 
classes: deterministic and probabilistic tractography. In deterministic tractography, 
a tractogram is generated based on a best estimate of the underlying fiber 
orientation, starting from an initial user-defined ‘seed’ location and propagating 
through 3-D space according to the specific tractography algorithm until some 
termination criteria is met (i.e. curvature angle or anisotropy threshold). For 
example, in DTI tractography, the directional information from the diffusion tensor 
is used, with streamlines following the principal eigenvector (Basser, 1998). In 
contrast, probabilistic tracking uses the diffusion MR data to infer fiber orientation 
along with an estimate of orientation uncertainty in each voxel, and uses the 
estimates and uncertainty to build a probabilistic map of connections (Parker, 
2004). Streamlines are propagated from a seed point but at each propagation step, 
an orientation is chosen randomly from the underlying distribution, and a spatial 
distribution of streamlines is built. 
 
The diffusion tensor model is limited in areas of complex fiber architecture 
as it can only have a single maximum in an imaging voxel, thus a voxel-averaged 
tensor is unable to adequately describe voxels with crossing, diverging, or 
converging white matter tracts (Basser, Mattiello, & LeBihan, 1994; Lazar & 
Alexander, 2003; Pierpaoli, Jezzard, Basser, Barnett, & Chiro, 1996). This is 
particularly problematic for tractography, where white matter tracts are likely to 
traverse voxels containing multiple fiber orientations at some point along the path. 
Alternative algorithms are capable of modelling multiple fiber orientations within a 
single voxel, for example, spherical deconvolution (SD) methods estimate the fiber 
orientation distribution function f(ODF) directly (Tournier, Calamante, Gadian, & 
Connelly, 2004; Tournier et al., 2008). With this method, the expressed signal is the 
convolution over spherical coordinates of the response function with the fiber 
orientation distribution, with the response function describing the DW signal 
intensity measured as a function of orientation for a single fiber bundle (Tournier et 
al., 2004).  
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A number of different approaches use spherical deconvolution but differ in 
terms of the way the diffusion profile is obtained and the use of additional prior 
information. For example, constrained spherical deconvolution (CSD) (Tournier, 
Calamante, & Connelly, 2007; Tournier, Calamante, Gadian, & Connelly, 2004) uses 
spherical harmonics to model the high angular resolution diffusion-weighted 
imaging (HARDI) signal (Tuch et al., 2002) to generate estimates of the fiber 
orientation distribution within each imaging voxel, and has been shown in phantom 
data and in vivo data to be robust to crossing fibers (Farquharson et al., 2013; 
Tournier, et al., 2008).  
 
Diffusion MRI in HD  
The majority of studies in HD have applied diffusion MRI based on the 
tensor model, either applying whole-brain tract based spatial statistics (S. M. Smith 
et al., 2006), voxel based whole brain statistics, or region of interest based analysis. 
The research focus has been on the basal ganglia although results to date have 
been inconsistent; some studies have reported lower FA values in the putamen, 
caudate nucleus (Reading et al., 2005) and thalamus (Magnotta et al., 2009) in pre-
symptomatic gene-positive individuals whereas other studies report higher FA 
values in the putamen and pallidum (Douaud et al., 2009; Klöppel et al., 2008; 
Rosas et al., 2006) and others report no difference in FA between controls and pre-
symptomatic gene-positive individuals (Dumas et al., 2012). Lower FA values and 
higher MD values have been reported in the internal capsule and corpus callosum, 
in both pre-symptomatic and symptomatic HD patients, suggesting white matter 
changes contribute to the disease in some way (Dumas et al., 2012; Magnotta et al., 
2009; Rosas et al., 2006). One reason for the inconsistencies is the heterogeneity of 
patient groups; the average and range of CAG repeats in the patient group will vary 
between studies, as will the variance in disease stage, all of which introduces 
variance into the studies. Although ROI analysis of DTI indices is useful in examining 
a priori regions of interest, the technique has a number of limitations including bias 
in ROI selection, inter-subject variability, issues with artefacts and decreased 
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resolution when drawn onto diffusion-weighted images, versus issues with 
registration when drawn on higher resolution anatomical images. Fewer studies 
have applied diffusion tractography in HD; Bohanna et al (2011) applied 
probabilistic tractography in symptomatic HD participants to examine connectivity 
to the caudate and putamen. In HD participants relative to controls, a reduction in 
FA and an increase in MD were found in the connections between both the caudate 
and putamen and the prefrontal, primary motor, and primary somatosensory 
cortices. Crucially, motor symptoms were shown to correlate with mean diffusivity 
in sensorimotor striatal sub regions, supporting the idea that the motor cortico-
striatal circuit is selectively vulnerable in symptomatic HD (Bohanna et al., 2011).  
Pre-clinical experimental MRI as a translational tool to study HD  
MRI has the benefit of allowing disease to be studied in the living animal 
non-invasively, creating the opportunity to study disease progression and evaluate 
therapeutic efforts. Furthermore, MRI allows for the acquisition of whole brain 3-
dimensional data as opposed to highly localised histological measurements from 
tissue sections in a single plane. A mouse brain is approximately 1000 times smaller 
than a human brain in terms of total volume, thus, high field strength is required in 
order to obtain adequate SNR and resolution. Pre-clinical imaging at high field 
strength presents a number of unique technical challenges which need to be 
considered before comparisons can be made to clinical MRI. Firstly, higher 
magnetic fields shorten tissue T2 and T2* and lengthen tissue T1. Anaesthesia is 
also a requirement when scanning small animals which limits the viable in vivo scan 
time. 
 
Diffusion MRI is particularly challenging in the mouse brain; it is a low SNR 
technique due to the attenuation of the signal magnitude in diffusion weighted 
images by the diffusion sensitizing gradients. EPI sequences are required in order to 
obtain a diffusion MRI image with sufficient SNR in a time frame that can be 
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tolerated. However, EPI at high field is difficult to achieve due to the combination 
between short T2 and the amplification of a number of artefacts at higher field 
strengths. Geometric distortions due to local magnetic field inhomogeneities 
increase linearly with field strength and T2* decreases at high field, thus the 
reduction in signal amplitude during the echo train is increased, reducing the spatial 
resolution in the phase encoding direction. The frequency difference between fat 
and water is also increased linearly with field strength, resulting in more 
pronounced fat/water spatial displacement in the phase encoding direction. 
Because EPI requires high bandwidths which reduce the spatial resolution, and high 
spatial resolution is necessary because of the small size of the mouse brain, 
segmented EPI (i.e. multi-shot) sequences are necessary which increases motion 
artefacts. Image analysis software are also not as advanced for rodent imaging, with 
standard software packages having in-built human-specific priors and templates, 
and basic pre-processing steps such as image registration are more challenging.  
 
Despite these challenges, there have been a number of MRI studies in 
mouse models of Huntington’s disease. Structural (Heikkinen et al., 2012; Rattray et 
al., 2013; Sawiak, Wood, Williams, Morton, & Carpenter, 2009), functional (Cepeda-
Prado et al., 2012) and metabolic (Heikkinen, et al., 2012) imaging studies in HD 
mouse models have all revealed abnormalities of differing degrees depending on 
the mouse model used. Nevertheless, preclinical imaging in HD is still in its infancy; 
there is only a single published study applying diffusion MRI in a mouse model of 
HD, revealing white matter abnormalities in the corpus callosum (Xiang, et al., 
2011). Likewise, despite the potential, only one published study has used MRI (T2-
weighted structural) as an outcome measure for therapeutic intervention (Aggarwal 
et al., 2012) thus it remains to be seen whether different MRI sequences can 
produce sensitive outcome measures for pre-clinical therapeutic trials.  
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Aims of this thesis  
 
This thesis aims to characterise the structural brain changes that occur in 
Huntington’s disease across the disease course, using multi-modal translational 
neuroimaging. Novel imaging sequences will be used to characterise white matter 
microstructural changes in a number of different pathways implicated in HD, and 
results will be examined alongside macrostructural changes and behavioural 
results, in the context of discovering imaging biomarkers in HD. 
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2 Methods to characterise Huntington’s 
disease 
 
This methods chapter is split into two sections: ‘pre-clinical’ and ‘clinical’ 
methods. The first gives an overview of the methods used for examining structural 
changes in mouse models of HD and the second section describes the methodology 
for examining differences in a patient cohort of HD.  
 
For the MRI methods for both the pre-clinical and clinical studies, there was 
an effort to ensure the pulse sequences were as similar as possible in order for 
comparisons to be drawn. However, because of: a) differences in the relative size of 
the brain compared to the scanner bore, b) differences in magnetic field strength 
between the pre-clinical and human MR system resulting in differences in the 
Larmor frequency and relaxation parameters, and c) differences in T1 of brain tissue 
across species, there are differences in the scan parameters used between the two 
systems and experimnts. A comparison of scan parameters is shown in Table 2.1. 
2.1 Pre-clinical Methods 
In vivo methods  
Ethical statement  All experimental procedures in this thesis followed 
protocols in accordance with the United Kingdom Animals (Scientific Procedures) 
Act of 1986. All experimental procedures performed on mice were approved by 
Cardiff University Ethical Review Process Committee and carried out under Home 
Office License 30/3036. 
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Breeding In experimental chapter 6, heterozygous HdhQ150 mice on the 
original 129/Ola x C57BL6/J background (Lin, et al., 2001) were bred in-house using 
a heterozygous mutant (-/+) x heterozygous mutant (-/+) breeding regime. Male 
homozygote HdhQ150/Q150 mice and male wild-type Hdh+/+ mice were used in the 
experiment. In experimental chapter 7, YAC128 (Hodgson et al., 1999b) were 
congenic on a C57BL6/J background. This strain was initially sourced from the 
Hayden laboratory at the University of British Columbia, Vancouver, and the strain 
was maintained in-house by backcrossing on to BL/6 with every breeding cycle.  
 
Genotyping Genotype was confirmed by tail tipping at approximately 5 
weeks old and carried out commercially (Laragen Inc., Los Angeles, CA, USA).  
 
Housing All mice were housed in age- and sex-matched groups of between 
1 and 3 mice with mixed genotype cages where possible. Mice were subject to a 12-
hour light: 12-hour dark cycle with controlled room temperature (21 ± 3 °C) and 
relative humidity (60 ± 3%). All home cages contained moderate enrichment 
conditions including play tunnels and nesting material. All animal were weighed on 
a monthly basis in order to monitor general health.  
 
Behaviour Assessment . Both cognitive and motor tests are available to 
examine mouse behaviour, however cognitive testing is associated with long 
training periods which may confound MRI measures due to training-induced 
plasticity (Sagi et al., 2012). Thus, in Chapter 6 where the primary aim was to 
measure structural brain changes longitudinally, only motor testing was conducted 
to reduce learning-induced confounding effects. 
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Open-field locomotion. The open field test was conducted using Ethovision Pro 
version 2.3.19 software (Noldus Information Technology, Netherlands) to 
investigate anxiety-related and exploratory behaviour. The open field was an empty 
square test arena (81 x 81 cm) containing 9 equally-spaced quadrants, in which the 
 
animal’s activity was measured using a camcorder (Sanyo CCD camera) and the  
recording software over a 20 minute period. The software measured the centre-
point, nose point and tail base of the mouse. This allows a variety of different 
behaviours to be measured, such as locomotion (total distance moved), rearing, 
turning and freezing, as well as the amount of time spent close to the wall (an 
Table 2.1 Comparison of mouse and patient MRI parameters. RARE: Rapid 
Acquisition with Refocused Echoes. FSPGR: Fast spoiled gradient echo EPI: 
echo-planar imaging. TRSE: Twice-refocused spin echo. HARDI: high-
angular resolution diffusion imaging. TR: Repetition time. TE: Echo time.  
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anxiety-like response, termed thigmotaxis) compared to the amount of time spent 
in, and frequencies of visits to, the inner quadrants. After each animal was removed 
from the arena, it was thoroughly cleaned with alcohol wipes to remove any scent 
information that may affect behaviour.  
 
Automated home-cage analysis of activity. Animals were transferred to cages 
similar to their home cage containing access to food and water in order to test 
motor activity under non-stressed conditions. This test measured locomotion over a 
24-hour period in order to measure both the light and dark phases of the diurnal 
cycle. Clear Perspex activity chambers containing food and water were fitted with 8 
infra-red sensors (40 cm x 24 cm x 18 cm), and the total number of beam breaks 
made in 5-minute intervals were recorded over a 24-hour time period on MED 
Associate hardware and MED-PC® software (Vermont, USA). Lights were set on a 
timer to come on and go off every 12 hours, in order to study behaviour during 
periods of peak activity without experimenter interference. Animals were placed in 
the cages for 27 hours, with the first three hours not included in the main analysis 
to allow for acclimatisation and avoid detecting novelty or anxiety-related 
behaviour.   
 
Rotarod. The rotarod test (B. Jones & Roberts, 1968) is a classic test in HD and was 
used to assess overall performance in motor coordination, balance and endurance 
(Alvarez-Fischer, et al., 2008; Schallert, et al., 2000). Mice were trained and tested 
on the accelerating rotarod apparatus (Ugo Basile Research Apparatus, Varese, 
Italy). Mice were trained on 2 separate trials each lasting for 5 minutes on 2 
consecutive days on an alternating fixed / accelerating speed protocol; Figure 2.1 
shows the training protocol. The protocol involved 15 seconds of fixed speed, 
followed by a period of accelerating speed, with each successive period increasing 
in duration. During training, when mice fell off the rod (3.1cm diameter) they were 
placed back on until the full time had elapsed. The testing day followed the training 
days. On the testing day, the mice were tested twice on the accelerating version of  
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the rotarod; the speed of revolutions increased from 4 to 44 r.p.m over a maximum 
period of 300 s. The two trials were 15 minutes apart. When the mouse fell from 
the rod the latency to fall from the rod was recorded for each trial.  
 
 MRI Acquisition  All preclinical MRI was conducted on a 9.4 Tesla small 
bore (20 cm) Bruker Biospin system, equipped with BGA12-S (12 cm inner bore size, 
integrated shims) gradients. A transmit 1H 500 Watt echo-planar imaging (EPI) 
volume coil was used for all in vivo scan acquisitions. For the scans described in 
Chapter 7 (YAC128), a mouse head receive-only surface coil was used, however, for 
the remaining experiments, a phased array 4-channel surface coil was acquired and 
used for all ex vivo MRI scans and for in vivo scans described in Chapter 6. 
Paravision software (Bruker Biospin) was used for data acquisition (version 5.0 for 
data in Chapter 7, version 5.1 for data in Chapter 6). 
 
For in vivo scans, animals were anaesthetised with isofluorane (5% for 
induction, 1.8-2.2% for maintenance) mixed with carrier gas delivered at a flow rate 
of 1 litre/minute. The carrier gas changed during the course of the PhD based on 
Figure 2.1 Training procedure for the Rotarod test. An alternating 
fixed/accelerating speed protocol was used during training for a maximum of 5 
minutes. The line represents the speed of the rod in revolutions per minute 
(r.p.m). 
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advice from the Cardiff University vet. For the YAC128 mice described in Chapter 7, 
the carrier gas was 30% pure oxygen, 70% medical air, however this was less well 
tolerated by the HdhQ150 mice where longer scan times were used, and the carrier 
gas was changed to 100% pure oxygen.  
 
The magnetic field homogeneity was optimized with a localized shimming 
procedure (Fastmap, Bruker Biospin) on a volume of interest (4 x 4 x 4 mm3) placed 
in the centre of the mouse brain. A PRESS-waterline sequence (Bruker BioSpin) was 
used with outer volume suppression without water suppression to evaluate water 
line width (TR/TE = 2500/20 ms respectively) to evaluate the shim performance and 
the peak line width of the water signal was evaluated and iterations were repeated 
until all line widths < 40Hz.  
 
Animals were positioned on a heated water bed, secured using tooth and 
ear bars and inserted into a nose cone (provided by Bruker) for the delivery of 
anaesthesia. The temperature and respiration rate (Small Animal Instruments Inc, 
New York, US) were monitored throughout the scan.  
 
For the RARE T2-weighted sequences, the TR and TE values were selected 
based on the T1 and T2 relaxation times of a normal mouse brain for grey and white 
matter (Kuo, Herlihy, So, Bhakoo, & Bell, 2005). For diffusion MRI sequences, the TR 
value was selected in line with previous work detailing T1 relaxation times in the 
mouse brain at 9.4 T and the knowledge that the TR should be at least 5 times the 
T1 in order to allow the magnetization to relax to 99% of its initial value and avoid 
T1-weighting effects. In the mouse brain at 9.4 T, T1 in white matter is ~ 1.7 s (Kuo, 
Herlihy, So, Bhakoo, & Bell, 2005; van de Ven et al., 2007), thus TR should be > 8.5s. 
Table 2.1 details the scan parameters for each experiment.  Specific details can be 
found in individual experimental chapters. 
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MRI Image Processing For volumetric measurements, analysis was 
conducted using Analyze software (v 10.0, Mayo Clinic, Rochester, MA, USA).  
Diffusion weighted images were analysed using Explore DTI version 8.3 
(Leemans, et al., 2009). Diffusion images were first corrected for motion artefacts 
and eddy current induced geometric distortions (Leemans & Jones, 2009). Images 
were corrected for distortions due to motion using a global affine registration of 
each image volume to the first non-diffusion weighted volume, normalised mutual 
information was the cost-function, and the encoding vectors were then re-
orientated (Leemans & Jones, 2009) and the signal intensity modulated by the 
Jacobian determinant of the transformation (Jones & Cercignani, 2010). Skull 
stripping was performed using a brain extraction tool (Smith, 2002), modified for 
rodent brains and kindly provided by Dr David Lythgoe. The linear robust estimation 
of tensors by outlier rejection (RESTORE) algorithm was used to estimate the tensor 
and remove outliers (L.-C. Chang, Jones, & Pierpaoli, 2005); artefactual data points 
were identified by robust fitting and excluded on a voxel-by-voxel basis. The images 
were then corrected to account for contamination due to partial volume 
(Pasternak, et al., 2009).  
Ex vivo methods  
All of the solutions used in the experiments can be found in Appendix 1. 
 
Perfusion Mice were terminally anaesthetised via intraperitoneal 
injection of 0.1 ml Euthatal, and then perfused through the heart with 
approximately 60 ml of phosphate buffered saline (PBS) followed by approximately 
150 ml of 4% paraformaldehyde (PFA) in PBS (pH 7.3) at a flow rate of 30ml/min. 
After decapitation, the skulls underwent post-fixation in 4% PFA in PBS overnight 
and were transferred to a 25% sucrose solution. 
 
Ex vivo MRI tissue preparation  One week before ex vivo imaging, the 
skulls were soaked in chemical-grade PBS and washed daily ( see Appendix 1 for 
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solution) to regain some signal due to tissue rehydration (Petiet, Delatour, & 
Dhenain, 2011) and to remove all free fixative solution (Calamante et al., 2012). To 
prevent the skulls from drying out and to minimize magnetic susceptibility artefacts 
during scanning, skulls were immersed in a proton-free susceptibility-matching fluid 
(Fluorinert) in a 15ml Falcon tube on the day of the scan. Immediately after 
scanning, skulls were returned to PBS.  
 
Immunohistochemistry  For the HdhQ150 mice, skulls were removed 
following MRI and the brains then transferred to a 25% sucrose solution (in PBS) 
until they sank. Brains were then bisected at the midline with the left hemisphere 
being used for immunohistochemistry. Future planned work involves using the right 
hemisphere for electron microscopy analysis. Coronal sections of 40 um were cut 
on a freezing sledge microtome and stored at −20°C in tissue cryoprotective 
solution until staining. All brains were stained at the same time to ensure 
consistency in the staining intensity. A 1 in 6 series was stained, with sections first 
placed in a pH = 7.4 Tris buffered saline (TBS) and washed twice. Following this, 
they were incubated in a solution of 80% water / 10% methanol / 10% H2O2 (at 30% 
concentration) for 5 minutes to inhibit peroxide activity and were then washed in 
TBS (pH 7.4). After washing, a 3% horse serum solution (Invitrogen, Paisley, UK) in 
TBS + 0.2% Triton X100 (TXTBS; pH 7.4) was applied to the sections for 1 hour to 
block non-specific binding sites. Immediately after this, sections were transferred 
into the primary antibody in a solution of 1% horse serum and TXTBS (specific 
details in Experimental Chapters) and left at room temperature overnight. The 
sections were then washed several times in TBS and incubated with biotinylated 
secondary antibody (depending on the primary antibody used) at a 1:200 
concentration (Vector Laboratories, Burlingame, CA, USA) with 1% horse serum and 
TBS for 3 hours at room temperature. The sections were washed several times and 
a biotin–streptavidin (ABC) kit was then applied for 2 hours according to the 
manufacturer's instructions (Vector Laboratories). Finally, the sections were 
washed in TBS and then in 0.05M Tris non-saline (TNS). Following this, sections 
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underwent staining with diaminobenzidine (DAB; Sigma, Poole, Dorset; 0.5 mg/ml 
in fresh TNS with 3% H2O2 [30% concentrated] at 1 in 5 dilution) was applied. 
Sections were then washed in TNS followed by TBS and mounted on gelatinised 
slides and dehydrated in ascending concentrations. Counterstaining was then 
completed where relevant (details in experimental Chapter) and sections were all 
finally dehydrated in a graded alcohol series, cleared in xylene, cover slipped and 
mounted on gelatine coated slides with DPX mounting medium (RA Lamb, 
Eastbourne, UK).  
2.2 Human Methods 
Ethics 
All work with patients was first approved by the Research Ethics Committee 
(REC number 12/WA/0184), the NHS Research and Development Forum (Cardiff 
and Vale University Health Board reference 12/IBD/5488; NISCHR PCU reference 
98601) and Cardiff University School of Psychology Ethics committee. Training in 
Informed Consent was completed and an Honorary Research Passport was obtained 
in order to enter NHS clinics for recruitment purposes.  
Recruitment 
Patients were recruited from the South Wales HD service. The clinic has 
around 150-200 HD patients registered, and >95% of patients are already recruited 
on a longitudinal observational study of all stages of HD (Registry: A study by the 
European Huntington's Disease Network; MREC number 10/WSE04/7). Thus there 
were baseline motor, cognitive, psychiatric, demographic and CAG repeat data 
available. Recruitment was based on whether patients matched the following 
criteria: 
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Inclusion criteria  
 Participants had genetically-confirmed HD. Patients with cognitive 
impairment (UHDRS cognitive score <200) were the main target 
group but pre-symptomatic patients were also considered. 
Exclusion criteria 
 Participants under 18 and over 65. 
 Individuals whose attention and/or cognition was felt to be too low 
to understand or complete the tasks or to give informed consent, as 
assessed by the lead physician (Prof A. Rosser) using clinical 
judgement.  
 Individuals with any contraindications to MRI 
 Patients with neurological disorders (other than Huntington’s 
Disease) including light-induced seizures 
 Pregnant women. 
 Participants with a past history of moderate to severe head injury, 
prior or current alcohol and/or drug abuse,  
 Previous stroke or cerebral haemorrhage, or significant vascular 
disease elsewhere (peripheral vascular disease, carotid or vertebral 
artery stenosis, or previous coronary intervention), structural heart 
disease or heart failure. 
There were two recruitment pathways for HD patients. Patients who were 
already on the Registry database and thus had previously given their permission to 
be contacted by researchers through the HD clinic were contacted directly with an 
invitation letter and information sheets sent in the post. A second route was for the 
consultant neurologist (Prof A. Rosser) to identify potential participants attending 
the clinic who were not currently registered on the Registry database who met the 
inclusion and exclusion criteria of the study. These patients were informed of the 
study and given a ‘Consent to Contact’ form to indicate whether they would like to 
be contacted. Potential participants were then contacted by telephone to discuss 
the study and receive further information. If the patient was still interested in 
participating, information packs were sent in the post and followed up one week 
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later by a telephone call to arrange dates for testing sessions and to answer any 
questions.  
There were two recruitment pathways for control participants. Carers, 
spouses and /or family members of patients who had expressed interest in 
participating were contacted. For patients registered on the Registry database, 
when the initial information packs were sent, a leaflet advertising the study and 
Consent to Contact form for healthy controls was included. The second pathway 
was to recruit participants registered on Cardiff University School of Psychology 
Community Panel and through local advertising. As participants on the database are 
already consented to be contacted, an information pack containing an invitation 
letter was mailed to all participants who were either age or gender-matched to 
recruited patients, followed up by a phone call one week later. 
Participants 
 19 HD gene-positive participants (11 pre-symptomatic, 8 early 
symptomatic) and 19 healthy age-matched controls were recruited in total. 6 
healthy controls were recruited from route 1 (family members, spouses and/or 
carers), whereas the remaining 13 healthy control participants were recruited 
through advertising and participant panels. Throughout this thesis, ‘HD participants’ 
will refer to this combined pre-symptomatic and early HD group. Independent t-
tests found no difference in age between the HD and control group, t (34) = 0.106, 
p > 0.05. The healthy control group was also matched for gender and educational 
background; demographic information is shown in Table 2.2. 
 
Matching for educational attainment was conducted based on research 
showing that in comparison to people with low educational attainment, people 
with higher educational attainment have delayed symptom onset, or equivalent 
cognitive impairment despite a greater degree of neuropathology (Stern, 2009). 
Figure 2.3 shows the educational background of participants as scored using the 
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International Standard Classification of Education (ISCED) scale (Appendix 2). 
Educational information was not available for 1 patient and 1 control. The Disease 
Burden index, a measure of disease severity, was used according to the previously 
described formula (age × [CAG-35.5]), where CAG is the number of CAG repeats 
(Penney, Vonsattel, MacDonald, Gusella, & Myers, 1997) and is a presumed index of 
the cumulative toxicity of mutant Huntingtin. This indexed score was used in 
Chapters 4 and 5 to examine the relationship between a genetic marker of disease 
severity and neuropathology. 
 
17 out of 19 HD participants had been assessed with the Unified Huntington’s 
Disease Rating Scale ’99 (UHDRS) in the one-year period prior to participating in this 
study by a research nurse at the Cardiff Huntington’s Disease Centre as part of the 
Registry study. The UHDRS was developed to assess the clinical features of HD and 
includes motor, cognitive, behavioural, and functional subscales ("Unified 
Huntington's Disease Rating Scale: reliability and consistency. Huntington Study 
Group," 1996) with each section consisting of multi-step subscales, and has been 
shown to have high inter-rater reliability and internal consistency. As shown in 
Figure 2.2, the motor assessment examines 15 motor behaviours with a maximum 
score of 60 indicating maximum motor disability. The functional assessment 
contains 25 questions relating to daily functioning with a maximum score of 20 
indicating functional capacity. The independence scale is measured in percentage, 
with 100% representing no special care needed, and 10% representing tube fed / 
total bed care. The Total Functional Capacity scale (Shoulson & Fahn, 1979) is the 
main assessment tool of functional status in HD clinical care and research, designed 
to assess progression of HD in symptomatic patients with emphasis on self-care, 
mobility, and independence. A maximum score of 13 indicates full capacity in all 
domains assessed. However, this scale may be less sensitive to functional changes 
in patients far from symptom onset. The cognitive assessment score is a summation 
of performance on the verbal fluency test (letters and categories), symbol digit 
modality test, and Stroop interference test, with a score > 200 indicating cognition  
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Figure 2.2 The Unified Huntington’s Disease Rating Scale (UHDRS) (" 
Huntington Study Group," 1996) . Motor assessment graded 0 = normal, 4, = 
unable to complete task. The cognitive assessment is based on raw test scores. 
On the behavioural assessment, each point is graded for severity (0 – Absent, 
4 – Severe), with the prefix ‘I’ indicating that the rating is based on the 
investigator’s observations of the individuals behaviour. Functional capacity 
is graded from 0 (requiring total care) to 3 (normal) for occupation, finances 
and daily activities, and 0-2 for domestic chores (2 = normal) and care level 
(0= full time skilled nursing, 2= home) and requires yes/no responses.  
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in the normal range. The Problem Behaviour Score examines psychiatric and 
emotional symptoms including the prevalence and severity of a depressed mood, 
suicidal ideation, anxiety, irritability, anger and aggression, apathy, perseverative 
thoughts and behaviour, obsessive-compulsive behaviour, delusions and 
hallucinations, and disorientation, with a maximum score of 132 indicating severe 
and daily experiences of all of these behaviours. The availability of these 
assessment results is useful in terms of characterising the HD group in terms of 
heterogeneity of symptoms and their severity, and for comparison with other study 
cohorts. Although the majority of neuroimaging studies in HD stratify participants 
according to the presence of motor symptoms (e.g. pre-symptomatic group vs early 
symptomatic group), in this study both pre-symptomatic and early symptomatic HD 
participants were recruited. This is because there is robust evidence demonstrating 
that cognitive decline and psychiatric symptoms, together with subtle motor signs, 
become detectable well before the formal diagnosis of HD (Papoutsi, Labuschagne, 
Tabrizi, & Stout, 2014), and thus the diagnosis of ‘symptomatic HD’ is constrained 
by the sensitivity of measurements scales. The increase in statistical power 
associated with recruiting both pre-symptomatic and early symptomatic HD 
participants and including them in the same analysis may allow for more subtle yet 
informative changes to be detected.  
Consent 
After completing NHS Informed Consent training, the author took informed consent 
for all participants. Consent was taken upon arrival at the imaging centre, where 
the information sheets were discussed and an opportunity to ask any further 
questions was provided, before participants were asked to read and sign the 
consent forms. Only individuals who were considered by the consultant neurologist 
(Prof A. Rosser) to be cognitively able to understand the consent forms were  
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Figure 2.3  Educational attainment for HD and healthy control participants. The 
International Standard Classification of Education (ISCED) ordinal scale was 
used to facilitate education matching.  Key stage 1,2 : primary school, key stage 
3: comprehensive/secondary school, key stage 4: sixth form college.  
ISCED 0 Pre-primary education 
(nursery school) 
ISCED 1 Primary school (key stage 1,2) 
ISCED 2 Comprehensive school/college 
(key stage 3) 
 
ISCED 3 Sixth form (key stage 4) 
included in this study. Participants were informed of their right to withdraw from 
the study at any point without giving a reason and were informed that they could 
request that their data be destroyed and not included in the study.  
 
 
 
 
 
 
 
 
 
 
Table 2.2 Demographic information for participants. Standard deviation in 
parentheses. CAG: repeat length of CAG mutation, m : male, f: female 
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Cognitive Testing  
The cognitive testing session was conducted prior to MRI scanning and 
lasted approximately 45 minutes after which the participant was offered a break. 
The battery was adapted from a battery of publicly available cognitive assessment 
tools that were designed and validated at the Medical Research Council Cognition 
and Brain Sciences Unit (Owen et al., 2010) and made freely available at 
http://www.cambridgebrainsciences.com. Testing was conducted in a cognitive 
testing room at Cardiff University Brain Research Imaging Centre (CUBRIC). The 
tests were conducted on a laptop (Acer Aspire 5742Z) with a 15.6 inch HD LED LCD 
screen, with responses made using a mouse unless instructed otherwise. A finger 
tapping task was also included as motor speed may confound performance on the 
cognitive tasks. The researcher was sat beside the participant for the duration of 
the test battery and was thus available to answer questions regarding the task 
instructions 
The 10 tests were chosen to cover a wide spectrum of cognitive functioning across 
a number of cognitive domains. Where tasks were timed, a timer was shown in the 
top right of the screen. Where tasks were performance based, a maximum of 3 
errors were allowed before the task terminated, the number of ‘lives’ remaining 
was shown on the right of the screen. Task difficulty was dynamically varied in a 
‘ratchet-style’ approach in which each completely successful trial was followed by a 
new trial involving increased difficulty, and each unsuccessful trial was followed by 
a new trial of reduced difficulty in order to maintain motivation.  
 
Stroop Task. The Stroop task (Stroop, 1935) is an attentional task based 
on the phenomenon of increased difficulty in naming the colour a word is printed in 
when the semantic text of that word is an incongruent colour. For example, people 
are slower to name the ink colour when the word that is written in red ink is the 
word 'green'. This difficulty in colour naming vanishes when the semantic meaning 
of the word is the same (congruent) as the text colour (e.g. the word ' red ' written 
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in red ink) or is semantically unrelated (e.g. the word ' window ' written in red ink) 
(Scheibe, Shaver, & Carrier, 1967). This effect is thought to be the result of 
interference caused by automatic word recognition. The task used in this study was 
a ‘double Stroop’ task, with participants being required to both respond to the  
 
colour word but also distinguish between one of two possibilities, adding an extra 
cognitive step. A single word (either ‘red’ or ‘blue’) was printed on a black 
background and displayed at the top of the screen. The colour word was printed 
either in a congruous colour (i.e. the word red printed in red ink) or in an 
incongruous colour (i.e. the word red printed in blue ink). At the bottom of the 
screen, two colour words were displayed (red, blue) and participants were required 
to indicate which of two coloured words at the bottom of the screen describes the 
colour of the ink that the word at the top of the screen is presented in, ignoring the 
word itself. 
  
As shown in Figure 2.4, the colour word mappings may be congruent, incongruent, 
or doubly incongruent, depending on whether or not the colours that a given words 
describes matches the colour that it is drawn in. The colour-word mappings were 
congruent on approximately 25% of the trials, incongruent on approximately 50% 
of trials, and doubly incongruent on 25% of trials. The correct colour mapping was 
Figure 2.4 The three different trial types on the colour-word Stroop task. 
Participants are required to select the word at the bottom of the screen that 
describes the colour of the ink in the top word.  
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presented in the bottom-left and the bottom-right of the screen an equal number 
of times. The participant solved as many problems as possible within 90 seconds. 
The total score increased by 1 after a correct response and decreased by 1 after an 
incorrect response on a trial-by-trial basis. The total score was the outcome measure.  
Grammatical Reasoning. This task was based on Baddeley’s 
grammatical reasoning test (Baddeley, 1968). As shown in Figure 2.5a, participants 
were presented with a pair of shapes displayed in the centre of the screen (e.g. a 
circle and a square) with a grammatical statement written above it, for example, 
“the circle is not smaller than the square”. Participants had to indicate (True vs. 
False) whether the sentence accurately described the relationship between the 
shapes, and had 90 seconds to complete as many trials as possible. Participants 
were instructed to work as quickly and accurately as possible. The outcome 
measure was the total number of trials answered correctly in the 90-seconds, 
minus the number answered incorrectly. Task difficulty was dynamically varied 
(increase/decrease of complexity).  
 
Paired Associate Learning.  This task required participants to remember the 
spatial location of a series of objects. Boxes are displayed at random locations on an 
invisible 5 x 5 grid and the boxes open one after another to reveal an enclosed 
object. The same objects are then displayed in random order in the centre of the 
grid and the participant must click on the boxes (in the correct location) that 
contained them. Task difficulty was varied dynamically ( ± 1 window). Participants 
were allowed to make three errors in total before the test was terminated. The 
main outcome measure was the average number of correct object-place 
associations (‘paired associates’) in the trials that were successfully completed. The 
test starts with two boxes (object-location pairs). The maximum level that could be 
achieved was 24. This task has been shown to be highly sensitive to various 
neuropathological conditions, and is commonly used to assess memory 
impairments in aging clinical populations (Gould et al., 2005).  
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Figure 2.5 Example trials from four different cognitive tasks.  
Intradimensional/Extradimensional Shift (ID/ED) task. This 
test was developed from a similar task from the CANTAB test series and is designed 
to tap prefrontal executive function, namely set-shifting or cognitive flexibility. It is 
functionally similar to the category shifting required in the Wisconsin Card Sorting 
test, with the extra-dimensional stage equivalent to the change in category in the 
Wisconsin Card Sorting Task. However this task is conceptually simpler with only 2 
distinct categories. Participants were presented with compound stimuli, which were 
composed of stimuli from 2 different object dimensions: block coloured shapes and 
coloured lines. This task required participants to learn, via trial and error, which 
stimulus, of the 2 presented on the screen, was designated as the target image. The 
2 stimuli were presented in either the top, bottom, left or right of the screen and 
participants had to use the computer mouse to select the image. Participants were 
presented with feedback after every trial (response) in the form of an auditory 
tone. Participants were initially required to respond to the compound stimuli 
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containing a target stimulus from the block shape dimension and ignore the line 
dimension. After a number of trials, the rule changes and participants need to 
respond to the second block shape (same dimension), and again ignore the line 
dimension, known as an ‘intra-dimensional (ID) reversal/switch’. A second type of 
ID rule change is an ‘intra-dimensional (ID) shift’ where the set of compound stimuli 
changes but the block shape remains the relevant dimension to respond to. Later, 
an extra-dimensional (ED) shift is introduced where the compound stimuli changes, 
but now participants need to respond to the line figures, with the previously 
trained block shapes now irrelevant. Whereas the ED shift specifically requires 
conceptual flexibility (i.e., shifting from one concept or cognitive set to another, 
such as from shape to line); the ID shift requires perceptual flexibility, or a shift 
from one exemplar to another within the same cognitive set (e.g., shape). 
 Participants had to make 6 consecutively correct responses to the target 
image. After reaching criterion, participants move onto the next stage of the test. If 
participants did not reach criterion within 30 trials, participants moved to the next 
stage of the test. If the new target stimulus was drawn from the same category as 
the previous one, this was termed ID. If it was drawn from the other category, it 
was termed ED. For each ID/ ED shift and reversal stage, trials to criterion was the 
outcome measure with 6 being the minimum and 30 being the maximum.  
 
Feature Match.  This task is designed to examine attentional processing 
and is based on the classic feature search task (Treisman & Gelade, 1980). Two grids 
are displayed on one screen, each containing a set of abstract shapes. In half of the 
trials the grids differ by shape. Participants must assess whether or not the abstract 
shapes are identical (see Figure 2.5c). Task difficulty was dynamically varied (±1 
shapes in the grid and total score changed by ± number of shapes in grid), with the 
first grids containing two abstract shapes each. The total score after 90 seconds was 
the outcome measure.  
 
Cardiff University  2014
 
71 
 
Spatial Rotations  This task is based on the mental rotation tasks first 
introduced by Shepard and Metzler (1971) and was used to measure the 
participant’s ability to mentally manipulate the spatial layout of objects. In this 
computerised version, two grids of coloured squares were displayed on either side 
of the screen with one of the grids rotated by a multiple of 90 degrees (see Figure 
2.5d). When rotated, the grids were either identical or differed by the position of 
just one square. The task was to indicate: “If you could rotate one of the panels would it 
be identical to the other or would it be different?”  
Participants were instructed that in order to gain maximum points, they must solve 
as many problems as possible within 90 seconds. After a correct response, the total 
score increased by the number of squares in the grid on that trial and the 
subsequent trial contained more squares. After incorrect responses, the total score 
decreased by the number of squares in the grid and the subsequent trial contained 
fewer squares, with the total score after 90 seconds being the outcome measure. 
For the first trial, the grids contained 4 coloured squares each. Mental rotational 
abilities are linked to perspective taking and navigation, and significantly correlated 
with route learning ability (Silverman et al., 2000).  
 
Digit Span  A computerised version of the verbal working memory 
component of the WAIS-R intelligence test (Wechsler, 1981) was used. Participants 
were presented with a sequence of digits that appear on the screen one after 
another. Subsequently, they were required to recall the sequence of numbers by 
entering them on the keyboard. Difficulty was varied dynamically (±1 digit) with the 
test terminating after 3 errors; the maximum achievable level was 25 and maximum 
level achieved was the outcome measure.  
 
Go/No-Go Task In this task examining response inhibition, participants 
were presented with one of two cues : a frequent cue, which required a rapid 
button press response within 1s of the cue appearing on the screen, and an 
infrequent cue, which required participants to not respond, and inhibit the button 
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press. Both cues were neutral stimuli and were presented in the centre of the 
screen against a black background. Following both types of cues, feedback was 
provided in terms of an auditory tone regarding the accuracy and/or speed of the 
response. There were 150 trials in total, 90% contained the frequent cue in order to 
create a prepotent tendency to respond and to increase the inhibitory effort 
required to successfully withhold responding on ‘stop’ trials where the infrequent 
cue was displayed. Reaction time was recorded for successful responses and failed 
inhibitions. The outcome measures were the total number of ‘failed stops’ to the 
infrequent cue and the number or ‘correct go’ button presses to the frequent cues,  
as well as the corresponding reaction times. The frequent cue was an image of a 
magnifying glass, and the infrequent cue was a cartoon image of a cat.  
 
Gambling Task This was a version of the Iowa Gambling task (Bechara, 
Damasio, Damasio, & Anderson, 1994) and was designed to assess decision making 
and risk-taking behaviour in a more naturalistic manner and dissociated from 
learning ability. Because there was no ‘wait’ period between responses, this task 
may also be sensitive to impulsivity. Participants were presented with 4 decks of 
cards, and were instructed to selects cards one at a time from 1 of the desks. 
Participants were instructed that each card selected would result in either winning 
money or losing money. The goal of the task was to accumulate as much money as 
Table 2.3 Reward contingencies and win/loss frequency associated with each 
deck of cards in the Gambling Task.  
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possible. After selecting a card, participants were informed how much money they 
had won or lost, with this information presented above the deck of cards. As shown 
in Table 2.3, different decks contained a higher probability of wins versus losses; 
two of the decks are advantageous, i.e., over the long run, the participant can 
expect to win money because these decks include cards that offer small rewards 
with cards that offer modest losses. There were 100 cards in total. The outcome 
measure was the total money won after 100 trials. 
 
Spatial Planning  This task was a measure of higher-level planning 
ability, requiring participants to plan ahead in order to work out the correct 
sequence of responses to complete a series of puzzles (Owen et al., 1992). 
Participants were presented with numbered tiles on the screen, arranged in 
numerical order on a grid. The tiles were then shuffled so that some were no longer 
in the correct positions. The task was to rearrange the tiles into the correct order in 
as few moves as possible by sliding them in and out of the blank spaces. 
Participants were instructed to solve as many problems as possible in 3 minutes in 
order to gain maximum points. The outcome measure was the number of problems 
solved in the time limit. 
 
Figure 2.6 Spatial Planning Task. The left panel shows the pattern to be 
achieved, the right panel shows the re-arranged tiles which need to be ordered 
using the empty blue boxes. 
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Finger Tapping Task  The Speeded Tapping Test (Reitan, 1979) was 
used as a measure of motor speed. The test was performed on the computer and 
participants were required to press a button on the keyboard as quickly as possible. 
The outcome measure was the average tapping rate over 3 trials. For consistency,  
participants were instructed to form a fist shape with their dominant hand, with 
their finger nails touching down in front of the keyboard space bar. They were then 
instructed to extend their index finger in order to contact the ‘space’ bar on the 
keyboard, and to move only their index finger to tap the space bar as quickly as 
possible. After 20 taps, the average number of taps per minute was calculated.  
MRI Acquisition  
Participants were screened for MR contraindications on the telephone prior 
to attending the Imaging Centre and again on the day of scanning. Prior to the scan 
session, all participants were shown a near-identical “mock” MRI scanner (General 
Electric), which is a model of a 3 T GE HDx MRI system but with no magnetic field. 
This can help to acclimatize volunteers to the MRI environment. 
MR data were acquired using a 3 T GE HDx MRI system (General Electric). 7 
different sequences were used to obtain measures of macrostructure and 
microstructure, with a total acquisition time of between 75-90 minutes depending 
on the heart rate of the participant. A localiser sequence was first acquired in order 
to know the position of the brain in order to prescribe the slice locations. Parallel 
imaging was used for the diffusion-weighted imaging, thus an array spatial 
sensitivity encoding (ASSET) scan was acquired to assess the sensitivity of the 8 
coils, so that fewer phase encoding directions could be sampled during EPI readout. 
Although the cost of parallel imaging is a reduction in signal to noise ratio (SNR), the 
ability to use a shorter TE and sample earlier with fewer distortions is advantageous 
for EPI based sequences.  
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 T1-weighted anatomical scan. A 3-dimensional T1-weighted FSPGR 
scan was used to characterise tissue macrostructure, with an acquisition matrix of 
256 x 256, and slice thickness of 1 mm giving a resolution of 1mm x 1mm x 1mm3, 
TR/TE of 7.904/2.996 ms. 
 
Diffusion MRI sequence . Two separate diffusion-weighted MRI acquisitions 
were collected: a sequence optimised for diffusion tensor imaging (DTI) and a 
HARDI-based sequence more suited for recovering fibre orientations through 
spherical deconvolution approaches. Both sequences were peripherally gated to 
the cardiac cycle and parallel imaging [ASSET factor = 2] was used for both. For both 
diffusion-weighted sequences, a twice-refocused spin-echo echo-planar imaging 
(EPI) sequence was used which provided whole oblique axial brain coverage; 
gradient onset times and diffusion times (δ) are shown in Table 2.4. For both 
sequences, data were acquired from 60 axial slices with a resolution of 1.8 x 1.8 x 
2.4 mm and an acquisition matrix of 96 x 96. For the sequence optimised for DTI, 
the b-value was 1000 s/mm2, the TE was 84.6 ms and data was acquired with 
diffusion encoded along 30 isotropic gradient directions with 3 non diffusion-
weighted images acquired. Cardiac-gating was used, resulting in a variable TR for 
individual participants. 
Table 2.4 Diffusion parameters for the twice-refocused spin echo (TRSE) 
sequences used, with onset time for diffusion gradients of length δ (ms). 
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For the HARDI-based sequence, the b-value was 2000 s/mm2, TE was 97.3 
ms and data was acquired with diffusion encoded along 45 optimally-ordered and 
arranged isotropic gradient directions with 3 non diffusion-weighted images 
acquired. Again, cardiac gating was used, resulting in a variable TR for individual 
participants. A higher b value was employed because higher b values have been 
shown to give better angular resolution (A. L. Alexander, Hasan, Lazar, Tsuruda, & 
Parker, 2001). It was decided to use different parameters in order to maintain a 
reasonable scan time that would be tolerated by all participants, including HD 
patients. Because there was the risk that not all scans would be run to completion, 
with the potential for issues with HD-related excessive motion, prior to acquisition, 
the gradient directions used were optimally re-ordered so that if the scan was 
stopped before completion, the measurements already taken would be uniformly 
distributed in the sampling space, compared to if randomly ordered diffusion 
direction were used. This was conducted using the approach proposed by Cook et 
al. (2007)  and using the Camino software package (P. A. Cook et al., 2006).  
 
Multi-shell diffusion MRI . For the CHARMED protocol, spin-echo 
diffusion weighted EPI sequences (TE/TR = 128.2 /17,000 ms) were performed with 
up to 38 axial slices (to cover the majority of the brain with the exception of the 
Table 2.5 CHARMED Gradient Orientations Scheme  
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temporal lobes), and a resolution of 1.8 x 1.8 x 2.4 mm3. Diffusion time (∆) and the 
diffusion gradient length time (δ) were 55.71 and 50.9 ms respectively. The 
gradient orientation scheme is shown in Table 2.5, and has been shown to be an 
optimal compromise between scanning duration and the quality of the estimated 
parameters for restricted volume fraction (De Santis, 2013). 40 gradient 
orientations are used, with 5 additional gradient orientations in the inner shell in 
order to calculate conventional DTI maps that are used as a reference in the 
registration to correct for eddy current distortions and motion (Ben-Amitay, Jones, 
& Assaf, 2011). 
 
Relaxometry The Multi-Component Driven Equilibrium Single Pulse 
Observation of T1/T2 (mcDESPOT) (S. Deoni, B. Rutt, T. Arun, C. Pierpaoli, & D. 
Jones, 2008a) protocol consisted of a combination of sagittally oriented spoiled 
gradient echo (SPGR), balanced steady state free precession (bSSFP) and inversion-
recovery prepared SPGR (IR-SPGR) sequences (Deoni et al. 2008; Deoni et al. 2008). 
All three sequences were acquired with a field of view (FOV) of 220 mm; 1.7 x 1.7 x 
1.7 mm3, and frequency encoding in the superior-inferior direction for a total scan 
time of approximately 8 minutes. The SPGR parameters were TE/TR = 2.1/4.7 ms, 
bandwidth= ±25 kHz; and flip angle (α) = [3◦, 4◦, 5◦, 6◦, 7◦, 9◦, 13◦, 18◦]. The bSSFP 
parameters were TE/TR = 1.8/3.5 ms, bandwidth= ±62.5 kHz; α = [10.6◦, 14.1◦, 
18.5◦, 23.8◦, 29.1◦, 35.3◦, 45◦, 60◦] for both phase-cycling acquisitions of 0◦ and 
180◦. Finally, the IR-SPGR parameters were TE/TR = 2.1/4.7 ms; bandwidth = ±25 
kHz; α = 5◦; inversion time = 450 ms. One patient was not scanned with the 
mcDESPOT sequence due to their weight exceeding the specific absorption rate 
(SAR) limit for this sequence. Another patient did not undergo this sequence due to 
permanent eye makeup and risk of heating.  
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MRI Image Processing  
Diffusion MRI In Chapter 4, deterministic tractography was conducted to 
examine the corpus callosum, corticospinal tract and cingulum bundle. As with the 
mouse diffusion MRI processing, pre-processing involved estimating the tensor 
using the linear RESTORE algorithm (Chang, et al., 2005) and correcting images for 
motion and eddy currents (Leemans & Jones, 2009), EPI distortions and 
contamination due to partial volume (Pasternak, et al., 2009). During the EPI 
distortion correction, both the b=1000 s/mm2 and the b= 2000 s/mm2 images were 
registered to the T1-weighted image. Given that the majority of white matter voxels 
contain multiple fiber orientations (B. Jeurissen, Leemans, Tournier, Jones, & 
Sijbers, 2012) spherical deconvolution based tracking algorithms were employed on 
the b= 2000 s/mm2 images in order to achieve a more reliable reconstruction 
(Alexander, 2005; Tuch, et al., 2002). For each voxel, the fiber orientations were 
extracted using two different, readily available spherical deconvolution approaches: 
constrained spherical deconvolution (CSD) (Tournier, et al., 2007) and damped 
Richardson-Lucy (Dell'Acqua et al., 2007; Dell'acqua, et al., 2010) along with the 
traditional tensor algorithm for comparison (Basser, et al., 2000). To estimate fiber 
orientations using CSD (Tournier, et al., 2007), the acquired diffusion signal was 
modelled as a convolution of the fibre orientation density function with the 
‘response function’ from a single fibre population, which corresponds to the 
diffusion MRI signal expected from an ideal fiber population aligned along the z-axis 
(FA > 0.7), fitted with maximum harmonic degree L = 8 (Tournier, et al., 2007; 
Tournier, et al., 2004). To estimate fiber orientations, DRL instead assumes a 
diffusion tensor model when obtaining the diffusion profile, and uses adaptive 
regularization, which includes an isotropic term to model partial volume. Specific 
tractography details are detailed in the Experimental Chapters. For the tract 
reconstructions, DTI indices were calculated from the b= 1000 s /mm2 data.  
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CHARMED  Processing of the multi-shell data was conducted using Matlab 
code written by Silvia De Santis (Cardiff University) and modified by Cyril Charron 
(Cardiff University) using the following processing stages: 
1. To correct for intra-scan motion and eddy currents, the non-diffusion 
weighted images (b = 0 s/mm2)  from the CHARMED dataset were linearly 
registered using an affine (12 degrees of freedom) technique based on 
mutual information to the first image in the diffusion MRI sequence 
(Jenkinson and Smith 2001) and the transformation matrix applied to all 
volumes.  
 
2. The gradient vectors were reoriented using the transformation matrix (A. 
Leemans & D. Jones, 2009).  
 
3. Although the most widely used approach to correct for motion and 
distortion in diffusion weighted (DW) images is to apply an affine 
registration of the DW images to the non-DW images (Haselgrove & Moore, 
1996) as in step 1, this approach only works at low b-values (up to 
1000s/mm2) where most features found in the DW images are also found in 
the non-DW image, albeit with different contrasts. At much higher b-values, 
only those parts of white matter presenting restricted diffusion 
perpendicular to the applied diffusion weighting will be visible.  The 
approach used here is to first estimate the diffusion tensor from the low b-
value images (<1000s/mm2, and affine-registered using normalized mutual 
information). The CHARMED model is then applied in a forward sense, 
assuming colinearity of the restricted and hindered components. This 
produces, for each unique diffusion-weighting, a unique ‘template’ image 
as the target for registration.  As shown by Ben-Amitay et al. (2011) this 
results in more accurate correction for motion and distortion of high b-
value images.  
 
4.  Using this template image, the high b-value (>1000 s/mm2) images were 
then co-registered to the DTI data. 
 
5. The individual estimates of shift, shear and scale obtained for each pair-
wise co-registration of a DW image to the non-DW images were then fed 
into a linear model, assuming linear dependence of eddy-current effects on 
gradient amplitude and slowly varying trends for motion. This results in a 
more robust estimate of the correction parameters.   
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6. The data was corrected for free water contamination approach, where two 
compartments (tissue / CSF) are fitted to the diffusion signal (Pasternak, et 
al., 2009). 
 
7.  Pre-processed data were fit to the parameters of the CHARMED model 
(Assaf & Basser, 2005) using a nonlinear least-square estimation procedure 
according to Assaf et al (2004).  
The outputs of the fitting routine were the intra-axonal diffusivity, the fibre 
orientation and the restricted fraction. 
 
McDESPOT FSL software was used to analyse the relaxometry data 
alongside c-code written by Sean Deoni (Brown University). The following 
processing steps were conducted:  
1. To correct for inter-scan and intra-scan motion, SPGR and bSSFP images for 
each participant were linearly registered using an affine (12 degrees of 
freedom) technique based on mutual information to the first image in the 
sequence (Jenkinson and Smith 2001). 
 
2. All images were masked using the brain extraction tool provided in FSL.  
 
 
3. To obtain B1 field and T1 maps, SPGR and IR-SPGR images were used for 
DESPOT1 with High-speed Incorporation (DESPOT1-HIFI) of RF Field 
Inhomogeneity processing as described in (Deoni et al. 2006; Deoni 2007), 
and using in-house c-code. 
 
4. The B1 field and T1 maps were then used in the calculation of the B0 field 
and T2 maps using the bSSFP data and the DESPOT2 with full modeling 
(DESPOT2- FM) algorithm (Deoni et al. 2004).  
 
5.  The high-resolution DESPOT1-HIFI and DESPOT2-FM 3D sequences were 
combined in order to fit the multi-component DESPOT model (Deoni et al. 
2008; Deoni et al. 2008).  
This model provided whole brain estimates for myelin water fraction 
(MWF), myelin water residence time and intra- and extra-cellular (IE) water and 
myelin water T1 and T2.  
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Statistical analysis 
 
For all statistical analyses, outlier profiles and QQ plots were first examined 
and values over 3 standard deviations from the mean were deemed to be extreme 
outlier values and were excluded case-wise.  
Where an ANOVA or ANCOVA analysis was used, the assumptions of the 
analysis were first tested (see Appendix 3 for results of the tests). To test whether 
the data were normally distributed, the Shapiro-Wilk test was used at α = 0.001. 
Homogeneity of regression slopes was tested for all covariates.   Levene’s test was 
used to assess homogeneity of error variance. When this test was violated, and 
when the group standard deviations were proportional to the group means, a log 
transformation (log base 10) was used. If this was not possible, then non-
parametric tests were used, as detailed in individual experimental chapters.  
When a repeated measures ANOVA was planned, Mauchly's sphericity test 
(Mauchly, 1940) was carried out as a validation to ensure the variances of the 
differences between the levels of the independent variable were equal and that the 
F-ratio was not inflated. Where the assumption of sphericity was violated, the 
Greenhouse-Geisser correction (Greenhouse & Geisser, 1959) was used which 
alters the degrees of freedom and produces an F-ratio where the Type I error rate is 
reduced.  
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3 Cognitive Characterisation of 
Huntington’s disease  
 
Chapter Summary 
The purpose of the work in this chapter was to develop a method of 
measuring cognition for use in the imaging studies in later chapters through two 
objectives. The first was to objectively measure cognitive function in a cohort of 
pre-symptomatic and early-stage HD participants across a range of domains using a 
novel battery of cognitive tests. The Cambridge Brain Sciences battery has not 
previously been reported in published work in Huntington’s Disease (HD), yet offers 
a number of advantages in comparison to more commonly used cognitive test 
batteries in HD, with quick and consistent test delivery across participants, and the 
availability of population mean data from a study of over 44,000 individuals for 
comparison (Hampshire, Highfield, Parkin, & Owen, 2012). The second objective 
was to develop a composite cognitive score using principal components analysis 
that could adequately describe the variance in the data across a number of tests, 
and that could be used in future chapters to examine the relationship with brain 
structure.  
 Introduction 
 
 
Cognitive problems are a key feature in Huntington’s disease and typically 
manifest earlier than motor symptoms. Impaired awareness is a feature of HD 
which yields self-report cognitive tests inappropriate, thus more objective 
neuropsychological test batteries are required to characterise the profile of 
changes.   It is important to be able to reliably and sensitively characterise cognitive 
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function in HD: cognitive and behavioural changes are the most highly associated 
with functional decline, can be predictive of institutionalisation, and place the 
greatest burden on families (Hamilton, et al., 2003; Nehl, Paulsen, & Group, 2004; 
Williams et al., 2010). 
 
Various neuropsychological measures have been applied to the study of pre-
symptomatic and manifest HD in order to characterise the cognitive profile at 
different disease stages and identify potential cognitive markers of disease for use 
in clinical trials. Despite this, no single cognitive measure has emerged as more 
robust than others in detecting changes or tracking disease. There is also no 
universally accepted cognitive battery for assessment in HD, although the cognitive 
section of the Unified Huntington Disease Rating Scale (UHDRS) is widely used. The 
cognitive section of the UHDRS comprises the Symbol Digit Modality Test, the 
Stroop Colour Word tests, and a Verbal Fluency test, with the summed score used 
to indicate the degree of cognitive impairment.  Alternative assessments include 
the Montreal Cognitive Assessment (MoCa) and Mini Mental State Examination 
(MMSE); the MoCa  has been found to have greater utility compared to the MMSE 
in characterising dementia in HD (Mickes et al., 2010).   The UHDRS is more 
commonly used in research either to track progression or to use as a correlate in 
brain imaging studies (e.g. (Kobal, Melik, Cankar, & Strucl, 2014; Politis et al., 2011; 
Wolf et al., 2008). Recent work has shown that the cognitive component of the 
UHDRS has low variance over time and is more reliable than either the MMSE or 
MoCA in monitoring cognitive changes in HD patients over 12 months (Toh et al., 
2014).   Despite this, many research studies in HD choose to supplement the UHDRS 
with additional cognitive tests in order to achieve a more comprehensive cognitive 
assessment (Hart et al., 2014; Holl, et al., 2013; Tabrizi, et al., 2013). 
 
There has been a wealth of research examining cognitive changes in HD, and 
this literature has been comprehensively reviewed (Craufurd & Snowden, 2002;  
Craufurd & Snowden, 2002; Dumas, et al., 2013; Harrington et al., 2012; Paulsen, 
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2011; Stout, et al., 2011). Although there are discrepancies in the literature, and 
understanding regarding the progression of cognitive decline over the disease 
course continues to be improved, in general cognitive deficits have been shown to 
emerge prior to motor symptom onset, initially as subtle deficits in domain-specific 
functions. In pre-symptomatic gene carriers there are typically no or few 
deficiencies in memory, language or global cognitive functions, with subtle deficits 
in psychomotor speed, negative emotion recognition, and in some executive 
functioning sub-domains (Duff, et al., 2010; Harrington, et al., 2012; Paulsen, Smith, 
Long, & Group, 2013; Stout, et al., 2011; Stout et al., 2012; Tabrizi, et al., 2013). 
After the onset of motor symptoms, language and global functional domains are 
thought to be spared for the longest period, with progressive cognitive decline 
resulting in dementia during the end stage of the disease (Dumas, et al., 2013).   
 
An important consideration when conducting cognitive testing in a clinical 
group for research and clinical purposes alike is the time required.  There has been 
an increasing tendency for traditional pen-and-paper tests to be adapted to 
computerised forms. The CANTAB is arguably the most well-known computerised 
battery of memory, attention and executive function (Fray & Robbins, 1996), 
whereas the Cambridge Brain Sciences battery used in this work is similar but has 
the distinct advantage of being freely available. Computer based testing benefit 
from being time efficient both in terms of experimenter and participant time. A 
shorter test time means results are more likely to be specific to true cognitive 
function and less affected by factors such as fatigue and frustration. Whereas pen-
and-paper batteries requires a high degree of training to achieve consistency from 
experimenters in terms of test delivery, with issues associated with inter- and intra-
rater reliability for delivery and scoring, computer-based tests are easy to 
administer, allowing for test delivery in a variety of environments, and can be 
administered in a consistent and controlled way. Computer based tests also allow 
measurements to be recorded that are not possible with paper based assessments, 
such as trial-specific reaction time. Whereas a major problem with pen-and-paper 
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tests is the effect of practice, alternate versions can be easily developed for 
computerised tests.  
The Cambridge Brain Science is a freely-available validated test battery that 
has not previously been applied to characterise cognitive deficits in HD. A key 
benefit of the battery is that cognitive tests are short, with each test taking 
approximately 3 minutes. Secondly, data has previously been acquired on over 
44,000 participants who completed the testing online. Thus, there is a sufficiently 
large population sample to compare against, and this data has been 
comprehensively analysed (Hampshire, et al., 2012) allowing for comparisons with 
normal population means as well as with the small well-defined matched healthy 
control group.  
 
In the current study, 10 tests were selected from the large battery of tests 
available in order to capture functioning across a wide range of cognitive domains 
include working memory, visual episodic memory, attention, reward sensitivity, 
response inhibition, verbal reasoning, planning and set-shifting.  Multiple tests were 
selected to examine executive function as the research literature suggests there 
may be domain-specific executive dysfunction in HD (Dumas, et al., 2013; A.  
Lawrence, Watkins, Sahakian, Hodges, & Robbins, 2000). Ardila et al (2013) 
proposed that executive dysfunction can be separated into two distinct classes. The 
first class, referred to as  a “metacognitive executive dysfunction syndrome” 
includes problem solving, abstracting, planning, anticipating the consequences of 
behaviour, strategy development and implementation, and working memory, and is 
associated with dorsolateral frontal damage (Ardila, 2013). A second distinct 
“motivational and emotional executive dysfunction syndrome” was proposed that is 
associated with orbitofrontal and medial frontal pathology and symptoms related 
to behavioural control (Ardila, 2013). Cognitive deficits in the “metacognitive” 
executive function domain have previously been shown in manifest HD in visuo-
spatial planning (Bäckman, Robins-Wahlin, Lundin, Ginovart, & Farde, 1997; 
Watkins et al., 2000) cognitive flexibility (Bäckman, et al., 1997; Jason et al., 1988; 
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A. Lawrence et al., 1996), and verbal fluency (Franciosi, Shim, Lau, Hayden, & 
Leavitt, 2013). In pre-symptomatic HD participants, results are more varied, which 
different studies producing contradictory findings (see Dumas et al. (2013) for a 
review). In the motivation / emotional executive function domain, deficits in 
manifest HD have been observed in response inhibition (Beste, Saft, Andrich, Gold, 
& Falkenstein, 2008), and in risky decision making (Stout, Rodawalt, & Siemers, 
2001), with evidence showing that the effect of experiencing loss on decision-
making is reduced in HD patients (Campbell, Stout, & Finn, 2004). In contrast, in 
early HD, no deficits were found on the Iowa Gambling Task which measures risky 
decision making (Holl, et al., 2013). Thus, in this study, cognitive tests were selected 
that measure executive function in both the “meta-cognitive” domain (e.g. the 
Intra-dimensional/ Extra-dimensional set shifting task and Grammatical Reasoning) 
and in the motivational/emotional domain (e.g. a version of the Iowa Gambling task 
and the Go/No-Go task).  
 
It is often necessary to form composite scores from multiple cognitive tests 
in order to provide a single summary score. One motive is to reduce the number of 
multiple comparisons, for example, when examining the relationship between 
cognition and neuropathology.  Both the UHDRS cognitive score and the MMSE are 
composite cognitive scores; however a major limitation with both is the way in 
which the cognitive elements are combined. Both the MMSE and the UHDRS 
combine the individual cognitive tests in an additive manner, despite the tests using 
different measurement scales. In contrast, the ideal approach would be to 
statistically model the individual cognitive tests so that an optimised weighting of 
the most sensitive measures are used. Moreover, the ability to combine tests in a 
manner that can capture the latent properties being measured would produce a 
composite score more reflective of the cognitive domains affected in HD. In this 
chapter, the purpose of creating a composite cognitive score was not to be able to 
distinguish HD participants from controls, but rather to produce a single score that 
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encompassed many cognitive domains to be used to analyse the relationship with 
brain structure measured using MRI.  
Declaration of Collaborations 
The Unified Huntington’s Disease Rating Scale ’99 (UHDRS) assessment was 
conducted by Kathy Price (research nurse) in a separate research session as part of 
the Registry study (MREC number 10/WSE04/7).  
Methods 
Participants 
15 HD gene-positive (asymptomatic and early HD) participants and 13 age, 
gender and education-matched healthy control participants completed the 
cognitive testing session. Demographic information is provided in Chapter 2 along 
with details of the experimental conditions.  
Cognitive Test Battery 
The 10 cognitive tests are described fully in detail in Chapter 2 and are 
available for evaluation at www.CambridgeBrainSciences.com. They were designed 
based on well-established paradigms from the cognitive neuroscience literature, to 
measure planning, reasoning, attention and working memory abilities. The tests 
took approximately 45 minutes to complete and were presented in a fixed order.  
Brief descriptions of the tests are as follows: 
 
Motor speed   The Speeded Tapping Test (Reitan, 1979) is a computerised 
test of finger tapping speed that requires a participant to press a button on the 
keyboard as quickly as possible.  Participants were instructed to use the index finger 
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on their dominant hand and instructions were provided to ensure consistency in 
the position of the hand. The outcome measure was the average tapping rate over 
3 trials.   
 
Digit Span  This test of verbal working memory required participants to 
recall a sequence of digits in the same order in which they were presented. 
Difficulty was varied dynamically (±1 digit); the outcome measure was the 
maximum number of digits recalled.  
 
Paired Associate Learning (PAL)  This task measuring visual episodic 
memory required participants to remember the spatial location of a series of 
objects. Task difficulty was varied dynamically (± 1 window). The main outcome 
measure was the maximum number of correct object-place associations (‘paired 
associates’) in the trials that were successfully completed.  
  
Gambling This test of risky decision making required participants to select 
cards one at a time from 1 of 4 decks, with each card selected resulting in either a 
gain or a loss of money (Bechara, et al., 1994). Different decks contained a higher 
probability of wins versus losses and the aim was to accumulate as much money as 
possible. The outcome measure was the total money won after 100 trials/cards 
selected.  
 
Go / No-Go This task measures response inhibition by the ability to inhibit 
prepotent responses (Verbruggen & Logan, 2008). Participants were presented with 
one of two cues: a frequent cue (90% of trials), which required a button press 
response and an infrequent cue (10% of trials), which required participants to not 
respond, and inhibit the button press. The outcome measures were the number of 
‘failed stops’ to the infrequent cue and the number or ‘correct go’ button responses 
to the frequent cue, as well as the corresponding reaction times.  
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ID/ED shift Task  This task required participants to learn, via trial and 
error, which stimulus, of the 2 presented on the screen, was designated as the 
target image. The 2 stimuli were compound images composed of 2 different object 
dimensions: block shapes and line drawings.  There were 8 stages of this test as 
shown in Figure 3.1. For each stage, the criterion was 6 consecutively correct 
responses, before moving to the next stage. If participants did not reach criterion 
within 30 trials, participants moved to the next stage of the test. For each ID/ ED 
shift and reversal stage, the number of trials to criterion was the outcome measure 
(range 6-30). In order to have a single empirical measure for set formation and 
flexibility, the sum of the number of trials for criterion for ID conditions (ID shift + ID 
reversal) was subtracted from the ED conditions (ED shift  + ED reversal), according 
to Fallon et al (2013), based on the  lower error rate typically observed for ID shifts 
compared with ED shifts. 
 
Spatial Planning  This task required participants to reposition a number 
of squares on a grid so that they are configured in ascending numerical order. 
Puzzles become progressively harder with the total number of moves required and 
the planning complexity increasing in steps. The outcome measure was the total 
number of puzzles solved within 3 minutes. 
 
Colour-word stroop A single word (either ‘red’ or ‘blue’) was displayed at the 
top of the screen, either  in a congruous colour (i.e. the word red printed in red ink) 
or in an incongruous colour (i.e. the word red printed in blue ink). At the bottom of 
the screen, two colour words were displayed (red, blue) and participants were 
required to indicate which of two coloured words at the bottom of the screen 
describes the colour of the ink that the word at the top of the screen is presented 
in, ignoring the word itself. The participant solved as many problems as possible 
within 90 seconds. The total score increased by 1 after a correct and decreased by 1 
after an incorrect response on a trial-by-trial basis.  The total score was the 
outcome measure. 
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Figure 3.1  The 8 stages of the Intra-dimensional /Extra-dimensional (ID/ED) 
Task. The red box indicates the correct response for the trial. Stages 1-4 were 
training stages.  From stage 3 onwards, images were always compounds of the 
two object dimensions (line drawings + block object). 
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Grammatical Reasoning  Participants were presented with a pair of 
shapes and a grammatical statement described the relationship between the two 
shapes (Baddeley, 1968). Participants had to indicate (True vs. False) whether the 
sentence accurately described the relationship between the shapes, and had 90 
seconds to complete as many trials as possible. The outcome measure was the total 
number of correct trials minus the number answered incorrectly. Task difficulty was 
dynamically varied.  
 
Feature Match  Participants were presented with two grids, each 
containing a set of abstract shape and were required to assess whether or not the 
abstract shapes were identical. Task difficulty was dynamically varied. The total 
score was the sum of the number of shapes in the grid for each correct trial. The 
task was terminated after 90 seconds.  
 
Spatial Rotations Two grids of coloured squares were displayed on 
either side of the screen with one of the grids rotated by a multiple of 90 degrees. 
When rotated, the grids were either identical or differed by the position of just one 
square. The task was to indicate whether the grids were identical if one of the grids 
was rotated. The total score increased or decreased by the number of squares in 
the grid on that trial for correct and incorrect responses respectively. The total 
score after 90 seconds was the outcome measure.  
Statistical analysis 
One-way analysis of covariance (ANCOVA) was used to examine differences 
in cognitive functioning between HD and control participants, controlling for the 
effect of age. The assumptions of the ANCOVA were first tested. All of the measures 
were found to be normally distributed when tested using the Shapiro-Wilk test at α 
= 0.001. Homogeneity of regression slopes was tested for all covariates added to 
the analysis. The Kruskal-Wallis non-parametic test was used to examine group 
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based differences for the ID/ED test as the assumption of normality was violated. 
The principal components analysis does not make any assumptions about the 
underlying assumption, thus the ID shift component of the ID/ED test was included 
in this analysis.  
 As well as looking at differences between controls and HD participants, one-
sample T-tests were conducted to examine differences against the population mean 
for these tests from a dataset of 44,600  participants aged 12-70 year old, as 
reported in Hampshire et al (2012). 
Where mean responses are reported, the corresponding ± standard error of 
the mean is also reported.  
Results 
The population mean from a study of 44,000 participants (Hampshire, et al., 
2012) was available for 6 of the tests used in this study.  Descriptive statistics and 
the results of statistical testing against the sample mean are shown in Figure 3.2. 
Finger tap speed 
HD participants were significantly slower (19.9%) on the test of finger 
tapping speed compared to healthy controls, t (26) = 2.76, p < 0.05.  Finger tapping 
speed did not correlate with age, p > 0.05.  In HD participants, finger tapping speed 
did not significantly correlate with disease burden, r = -.467, p > 0.05, but did 
correlated with the UHDRS motor score, r = -.703, p < 0.01. 
 Age as a confound 
Age was found to be related to cognitive performance on a number of the 
tests (see Appendix 3), thus age was added as a covariate in the analyses.  
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 Motor speed as a confound  
On 6 of the tests, a timed response was required. Thus, a correlational 
analysis was performed to examine whether motor speed confounded cognitive 
performance on these timed tests.  Because of the difference between HD and 
control participants in finger tap speed, the correlations were examined separately 
for each group and the results of the analysis are shown in Table 3.1. Finger tap 
speed was correlated with performance on the Feature Match test, r = .54, p < 0.05 
in the HD participants. The same relationship was not found in healthy control 
participants, however a comparison of regression slopes found no interaction 
between gene status, age and finger tapping speed for performance on this test, F 
(2,23) = 1.60, p > 0.05. Finger tap speed was also correlated with performance on 
the Go-No-Go task in healthy controls, specifically in the trials requiring response 
inhibition, r=-.74, p < 0.05 FDR-corrected. The same relationship was not found in 
HD participants, however a comparison of regression slopes for both groups of 
participants found there was no interaction between gene status and finger tapping 
speed for response inhibition during the Go-No-Go task, F (2, 23) = .30, p > 0.05,  
justifying the addition of motor speed as a covariate for both of these tests.  
Table 3.1 Cognitive tasks with a timed element and the corresponding correlation 
coefficient with finger tap speed. s: seconds 
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Memory domain 
Digit Span  HD participants had a digit span that was on average 1.63 
digits shorter than healthy controls, controlling for age, F (1, 25) = 7.71, p < 0.05. 
Although the test did not require timed-responses, given the requirement to enter 
digits on the laptop keyboard, it was plausible that impaired motor speed may also 
be a confound on this test.  A correlational analysis found that this was the case, 
with finger tapping speed being strongly associated with digit span only in HD 
participants, r = .765, p < 0.01, with no relationship found in controls, r = 0.025, p > 
0.05.  Repeating the ANOVA with finger tapping speed as a covariate resulted in the 
previous main effect of gene status now not being significant, F (1, 24) = .1.37, p > 
0.05. There was no relationship between disease burden and digit span, with or 
without finger tapping speed partialled out, r < 0.3, p > 0.05.   
 
Paired Associate Learning  HD participants performed significantly 
worse on the paired associate learning task compared to matched control 
participants, in which an association between an object and location was required, 
F (1,25) = 4.58, p < 0.05.  Descriptive statistics are shown in Figure 3.2. Paired 
associate learning was not related to disease burden in HD participants, r = .01, p > 
0.05.  
Top-down processes / executive functions 
Gambling Task    Overall, performance on this task was highly variable in 
both groups of participants ($57.69 ± 117.38 for healthy controls, $250.00 ± 141.79 
for HD participants). There was no difference in overall performance on the 
gambling task, with HD and control participants responding equally to rewards and 
punishments associated with specific card decks after controlling for age, F (1,25) = 
1.00, p > 0.05.  The score on this test was not related to disease burden, r = -.236, p 
> 0.05.  
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Go / No-Go On the inhibition or ‘no-go’ trials, where participants were 
required to cancel the frequent response when presented with an infrequent cue, 
participants had a high failure rate  (63.5 ± 6.69 % for controls, and 56.44 ± 6.53 % 
for HD participants) and a rapid reaction time  ( control mean = .293 ± .015 s, HD 
mean = .342 ± .027 s). Whereas there was no difference in the failure rate between 
HD and control participants (F (1, 24) = .915, p > 0.05 with motor speed as a 
covariate, F (1, 25) =.577, p > 0.05 without accounting for motor speed), HD 
participants had a longer reaction time, F (1, 23) = 5.03, p < 0.05 uncorrected, p > 
0.05 FDR-corrected.  This difference in reaction time was not found when motor 
speed was not included in the analyses as a covariate, F (1, 24) = 2.31, p > 0.05.  
On the response, or ‘go’ trials, participants had to respond with a button press to a 
frequent stimulus within 1s. Control participants had a higher success rate on these 
trials (mean = 85.74 %) compared to HD participants (mean = 74 %), although this 
difference was not statistically significant, F (1, 23) = 1.53, p > 0.05, and there was 
no difference in reaction time for successful trials (control mean = .32 ± .01 s, HD 
mean = .36 ± 0.03 s). In HD participants, disease burden was correlated with 
response accuracy to no-go trials, r = -.716, p < 0.05 uncorrected, p > 0.05 FDR-
corrected.  
 
Intra-dimensional / Extra-dimensional set shifting   
There was a significant difference between HD and control participants on a 
measure of set-formation and set-flexibility (trials to criterion on ED blocks minus ID 
blocks), F (1, 25) = 5.66, < 0.05. Set-formation and flexibility was moderately 
correlated with disease burden in HD participants although the relationship was not 
statistically significant, r = .535, p = 0.059. There was no interaction between gene 
status and shift; both groups of participants found the ED shift significantly more 
difficult than the ID shift, F (1, 26) = 42.54, p < 0.001, however, after accounting for 
age, this difference was not significant, F (1, 25) = 1.263, p > 0.05. To understand 
what was driving the difference between HD and control participants, trials 
requiring an attentional shift were examined separately from trials requiring a rule 
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reversal. There was no difference between HD and control participants in the 
median number of trials to learn the intra-dimensional shift rule, χ2 = 2.53, p > 0.05. 
The HD participants required significantly more trials to learn the extra-dimensional 
shift rule compared to control participants, χ2 = 4.26, p < 0.05; however this did not 
survive FDR-correction, p > 0.05.  In HD participants, ID shift was significantly 
correlated with disease burden, r = -.638, p < 0.05 FDR-corrected. The same 
relationship was not found for ED shift, r = .456, p > 0.05.  
 
Spatial Planning  There was no difference in the spatial planning 
performance of HD participants compared to healthy controls, F (1, 25) = 2.038, p > 
0.05.  Spatial planning ability was not related to disease burden in HD participants, r 
= -.295, p > 0.05.  
Colour-word Stroop There was no difference between HD participants 
and healthy controls in performance on the stroop task overall, controlling for age, 
F (1, 28) = 1.58, p > 0.05.  Examining the congruent, incongruent, and doubly 
incongruent trials separately also did not reveal any significant differences between 
groups in terms of accuracy or reaction time (controlling for finger tapping speed), 
all p > 0.05. Both HD and control participants performed significantly worse on this 
test compared to the large population sample (Hampshire, et al., 2012),  t (14) = -
5.94 and t (12) = -3.33 respectively, p < 0.01.   Overall stroop performance was not 
associated with disease burden, r = .194, p > 0.05. 
 
Grammatical Reasoning HD participants scored significantly lower on 
the grammatical reasoning task, F (1, 25) = 6.40, p < 0.05. HD participants 
attempted a similar number of trials compared to controls, F (1, 25) = 3.52, p > 0.05, 
thus the difference in score was caused by a higher error rate in HD participants.  
Overall grammatical score was not associated with disease burden, r = -.468, p > 
0.05, whereas the number of trials attempted was associated with disease burden, 
with increased disease burden associated with a reduction in the number of trials 
attempted, r = -.626, p < 0.05 FDR-corrected. 
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Figure 3.2 Descriptive statistics for cognitive test performance. Population cohort 
refers to the 44, 600 data sets reported in Hampshire et al (2013). Error bars 
represent ± 1 standard deviation.  * p < 0.05, ** p < 0.01, *** p < 0.001. ANOVA’s 
conducted between matched controls and HD participants were controlled for the 
effects of age.  
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Attention domain 
Feature Match There was no difference in performance between HD and 
control participants with motor speed as a covariate, F (1, 24) = .417, p > 0.05, and 
without motor speed in the analysis, F (1, 25) = 1.54, p > 0.05. Both HD and control 
participants performed significantly worse on this test compared to the large 
population sample (Hampshire, et al., 2012),  t (14) = -3.29, and t (12) = -3.18 
respectively, p < 0.01. After controlling for finger tapping speed, there was no 
relationship between disease burden and performance on this test, r = -.063, p > 
0.05.  
 
Spatial Rotations HD participants were able to mentally rotate a similar 
number of objects correctly (8.6 ± .54 rotated grids) within the time limit compared 
to control participants (8.9 ± .65 grids). HD participants made a similar number of 
errors (3.6 ± .66) compared to healthy control participants (3.8 ± .42), there was no 
statistical difference in overall performance on this task between groups, F (1, 26) 
=.084, p > 0.05. There was also no difference in average performance by HD and 
control participants and the large population sample (Hampshire, et al., 2012), t 
(14) = .041, and t (12) = -.292 respectively, p > 0.05. There was no relationship 
between disease burden and performance on this test, r = .106, p > 0.05. 
Composite cognitive score 
In order to examine the relationship between cognition and MRI measures, 
it was necessary to reduce the number of dimensions for analyses. Thus all 10 
cognitive tests were added to a principal component analysis using SPSS software 
(IBM, version 20). The number of Correct-Go and Failed-Stop responses from the 
Go/No-Go tasks were added to the analysis separately, as there was a low 
correlation (r=-0.068) between the two measures, suggesting they tap different 
cognitive processes, response execution and response inhibition. Similarly, the 
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score on intra-dimensional (ID) shift trials was added separately to the score on the 
extra-dimensional (ED) shift trials from the ID/ED task, due to the low correlation 
between the two measures (r=0.13).  In order to improve the interpretation of the 
resulting composite score; ED and ID shift were transformed:  [minimum number of 
trials to criterion (6) – achieved trials to criterion]. This resulted in a high value being 
indicative of a good performance, rather than a poor performance (number of trials 
to criterion).  
Bartlett’s test of sphericity was significant, 2 (66) = 144.19, p < .05, 
suggesting that the model is appropriate. However, the Kaiser-Meyer-Olkin 
measure of sampling adequacy was 0.579, just below the recommended value of 
0.6, and the diagonals of the anti-image correlation matrix were below 0.5 for 4 of 
the measures (Failed Stop, ID shift, gambling, and spatial rotations), indicating that 
these measures lack sufficient correlation with the other measures and supporting 
the exclusion of these items and the inclusion of the remaining measures in the 
analysis. The PCA was then recalculated with the 4 measures excluded. The Kaiser-
Meyer-Olkin measure was now 0.686, and Bartlett’s test of sphericity remained 
significant, 2 (28) = 100.79, p < .05. Oblique rotation was used based on 
correlations (>0 .3) in the component correlational matrix, suggesting overlap in 
variance. As shown in Table 3.2, the first principal component was extracted and 
these regression values used as the composite cognitive score for each participant.  
This first principal component accounted for 56.3 % of the total variance and 
included measures from 8 out of the 10 test domains.   
 
HD participants had a lower composite score (-.32 ± .22) compared to control 
participants (.34 ± .30), although this difference did not meet statistical significance 
when controlling for age, F (1, 24) = 3.40, p = 0.078.  Although underpowered [df 
=6], there was a moderate correlation between the composite cognitive score and 
performance on the UHDRS cognitive scale, r = .562, p > 0.05. There was no 
relationship between disease burden and composite cognitive score, r = -.15, p > 
0.05. 
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Table 3.2 Principal Component Analysis (PCA) of cognitive performance in all 
participants with oblique rotation. 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
It is known from previous studies that cognitive deficits commonly occur 
prior to the onset of motor symptoms in HD, although no single cognitive measure 
has emerged as superior in terms of robustly detecting changes or tracking disease.  
The use of the Cambridge Brain Sciences computerised battery in HD participants 
has not previously been reported in the published literature. Using this battery, HD 
participants were found to have deficits in verbal working memory, visual episodic 
memory and verbal reasoning, along with evidence of both psychomotor slowing 
and motor slowing.  HD participants were selectively impaired in their ability to shift 
their response set to a previously irrelevant dimension (extra-dimensional set-
shifting, [EDS]), but were not impaired when shifting attention to new exemplars of 
a previously relevant dimension (intra-dimensional shift [IDS]). By contrast, HD 
participants were not found to have impairments in three separate tests sensitive 
to frontal lobe dysfunction, namely a version of the Tower of London test of spatial 
planning ability, a visual discrimination learning paradigm and the colour-word 
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Stroop interference task. This discrepancy may be due to the many integrated 
cognitive functions that are required to perform different executive function tasks, 
resulting in many factors confounding performance on each test (Lezak, Howieson, 
& Loring, 2004). By breaking down the individual elements of the Go / No-Go task, 
it was found that HD participants did not have deficits in response inhibition 
compared to healthy controls, although they did take longer to respond to cues 
signally a ‘No-Go’ response, suggestive of psychomotor slowing. There were no 
deficits seen on a version of the Iowa Gambling task, suggesting that at this early 
stage in the disease, there are no differences in sensitivity to reward contingencies. 
 
 The selective deficit seen in EDS shifting is in agreement with Lawrence et al 
(1996) who also found impaired EDS shifting with intact IDS shifting specifically in 
early HD participants.  The same selective deficit has previously been shown in a 
cohort of neurosurgical patients with localised excisions of the frontal lobes (Owen, 
Roberts, Polkey, Sahakian, & Robbins, 1991) and in patients with early-stage 
Parkinson’s disease (Downes et al., 1989). In Parkinson’s disease, this selective 
deficit was explained in terms of a dysfunction of fronto-striatal circuity. Previous 
explanations of the selective EDS shifting deficit seen in HD suggested the inability 
to switch between response sets is caused by a breakdown of inhibitory associative 
and attentional control mechanisms controlled in part by the head of the caudate 
nucleus (A. Lawrence, et al., 1996; Robbins & Brown, 1990; Sutherland & 
Mackintosh, 1971). The lack of a deficit in spatial planning is in agreement with the 
literature, given the time limits used in the version of the task. For example, 
performance on the Tower of London spatial planning task was previously shown to 
be impaired in early HD participants but only on the most difficult   5-move 
problems, whereas deficits were not seen on less challenging tasks (A. Lawrence, et 
al., 1996). Because of the time limit imposed, it is likely in this study that the task 
did not become sufficiently difficult for differences to emerge, and is an element of 
the task that could be altered for future use.  
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 Memory deficits were observed in verbal working memory and visual 
episodic memory. Previous work has also shown a deficit in performance on the 
forward digit span, but only in manifest HD participants (Lemiere, Decruyenaere, 
Evers-Kiebooms, Vandenbussche, & Dom, 2004).  Because it was not possible in this 
study to stratify according to pre-symptomatic or early manifest status due to 
sample size limitations, it is not possible to ascertain if the significant deficit seen in 
this study were driven by changes specifically in the manifest participants or 
whether changes were also evident in the pre-symptomatic participants.  Previous 
work has shown that performance on the forward digit span test of verbal working 
memory is not susceptible to significant decline in early HD (Lemiere, et al., 2004; 
Mason et al., 2010). The lack of a relationship found between disease burden and 
digit span supports this. The deficit seen on the paired associate learning task is 
suggestive of a deficit in visual episodic memory in the very early stages of HD.  In 
the literature, there have been equivocal findings regarding the episodic memory 
impairments in HD, although a recent meta-analysis found that recall, cued recall, 
and recognition memory were are all profoundly impaired in symptomatic HD 
participants, but only slightly impaired in pre-symptomatic participants (Montoya et 
al., 2006). The results in this study of a cohort of pre-symptomatic and early-stage 
HD participants fit with this finding.   
 
 The mean performance on a number of tests in both HD participants and 
healthy matched control participants was found to differ significantly from the 
mean performance reported from a sample of 44,600 participants (Hampshire, et 
al., 2012). There are a number of factors that may explain this difference. Firstly, 
testing in this study was conducted under controlled laboratory conditions, 
whereas the population mean from the large cohort was obtained from participants 
who completed the testing on the internet. Thus, it may be that participants did not 
complete the tests alone, or completed the test multiple times and thus the higher 
mean scores can be explained by practice effects.  Secondly, the participants whom 
chose to complete the tests which were accessed via the internet can be assumed 
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to have a certain level of computer literacy, in order to be able to view the online 
advertisement and navigate to the test website. In the cohort used in this study, 
computer literacy was not uniform, for example, some participants needed 
instructions on operating the computer mouse, which may have affected 
performance.  Secondly, the healthy control group in this study were recruited 
specifically to match the HD group in terms of age, gender and education. As HD is 
typically an adult-onset neurodegenerative disease, it is likely that the average age 
was significantly greater and the range of participant ages smaller than the larger 
population sample used. Furthermore, participants were drawn from a smaller 
geographical pool, thus socioeconomic status is likely to be less varied, and the 
education level was skewed towards fewer years in education, compared to the 
sample used in Hampshire et al (2012). 
 
The influence of motor function on cognitive testing is an important factor 
that needs to be considered. Bradykinesia, or motor slowing, is a feature of the 
motor phenotype in HD (Tabrizi, et al., 2013) and was tested in this study using the 
Speed Finger Tapping test (Reitan, 1979) , with a reduced tapping speed found in 
HD participants. In contrast, psychomotor speed refers to the speed of thinking and 
acting, and is a feature of the cognitive phenotype in both pre-symptomatic and 
manifest HD (Tabrizi, et al., 2013). On the Go/No-Go task, HD participants were 
found to be significantly slower in responding to infrequent cues requiring a 
response inhibition (‘No-Go’ trials) which may be suggestive of subtle psychomotor 
slowing. It is not clear in what way motor slowing and psychomotor slowing interact 
and affect performance on tasks. In the test battery used in this chapter, this is 
important as a number of the tests have a timed element, so interpreting poor 
performance may not be specific to the cognitive domain being measured in the 
task, but may also be influenced by psychomotor and/or motor speed. Previous 
longitudinal work in HD by Hart (2013) showed that significant cognitive results 
were reduced by 20% when motor speed was taken into account, affecting the 
overall statistical outcome and interpretation of the results.  Thus, there is the risk 
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that cognitive deficits are overestimated when motor slowing is not controlled for. 
Despite this, performance on the Speeded Finger Tapping test is not commonly 
included as a covariate in the analyses of cognitive performance (Paulsen, 2011; 
Tabrizi, et al., 2013). In this study, where a significant relationship was found 
between speeded tapping and cognitive performance, motor speed was added as a 
covariate and the result with and without this covariate is reported. This proved to 
be important when examining response inhibition on the Go / No-Go task, with a 
difference in reaction time between HD and control participants specifically to trials 
requiring response inhibition only detectable when motor speed was included as a 
covariate. This suggests that the effects of motor speed deficits may dilute the 
effects of psychomotor speed deficits if not controlled for, thus masking potential 
relevant deficits in HD.   
 
A strength of this chapter was the formation of a composite cognitive score 
using a statistically sound approach in order to produce a score that was weighted 
and encompassed different aspects of cognition. This single score is more 
appropriate given the small sample size and can be used in future work to examine 
the relationship with brain structure. Furthermore, it is likely to be more sensitive 
that the UHDRS cognitive score which is formed in an ad hoc, non-optimal manner. 
In this study, only the first principal component was extracted, however with a 
greater sample size that would be more robust to multiple comparisons, it would 
also be worthwhile to examine the second and third components to avoid losing 
potentially meaningful data. 
 
A limitation with the work in this chapter is related to some of the tasks 
included in the battery of cognitive tests. Two of the tests lacked sensitivity to the 
construct being measured, potentially leading to misleading findings. As previously 
mentioned, the time limit imposed in the spatial planning task meant that the 
outcome measure, the total number of trials completed within this limit, lacked 
sensitivity. In practice, this meant that a number of participants made progress in 
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solving a problem and were close to completing the problem when the time ran 
out, and their effort on that trial was not recognised in the overall score. Whereas 
previous work has found reduced accuracy in spatial planning in early HD (Watkins, 
et al., 2000), it is difficult to ascertain whether the lack of a  difference found in this 
study is  because the cohort study included pre-symptomatic participants, or  
because the test was not a sensitive measure of performance. Similarly, the 
gambling task produced highly variable performance in both control and HD 
participants, with this variance not related to the construct under examination.  
Because there was no wait period between trials, some participants appeared to 
rapidly work through the trials disregarding the feedback information required to 
complete the task, which may explain the variance and the lack of a correlation 
with other test dimensions, leading to the test being excluded from the composite 
score. Furthermore, the overall measure of total money earned in the test is not 
informative of the strategy used by participants, which may be more sensitive to 
differences between groups. Future improvements include modifying these two 
tests to include a wait period for the gambling task, as well as a more prominent 
display of the monetary gain/loss for each trial, and for the spatial planning task to 
not be time-limited, but rather examine the number of moves taken to complete a 
set number of puzzles.   
 
Although computerised testing offers many advantages in terms of speed, 
ease and accuracy of delivery, there are a number of drawbacks that also need to 
be considered when using computer-based approaches. Irrespective of the clinical 
group, there is likely to be variance in terms of computer literacy and experience 
amongst participants, which may introduce bias in terms of response times and the 
perception that tasks are too fast spaced. For example, in the Hampshire et al. 
(2012) study, the frequency with which individuals played computer games was 
positively related to the mean cognitive score, suggesting that computing 
experience affects performance on these tests. In addition, both motor and 
cognitive deficits may interfere with the ability to adapt to a keyboard and/or 
Cardiff University  2014
 
107 
 
mouse. The effect of computing experience be minimised by including practice 
trials and an assessment of basic computer skills to use as a potential confounding 
variable in the analysis.   
A final consideration is the importance of premorbid intelligence in HD, 
which may be related to cognitive reserve and thus the rate and severity of 
cognitive decline in HD (Papoutsi, et al., 2014). In this study, attempts were made to 
account for premorbid intelligence by ensuring that the healthy control group were 
matched for educational attainment, although it is acknowledged that years in 
education may not be a sensitive marker of premorbid intelligence, especially given 
the research showing cognitive decline up 15 years before the onset of motor 
symptoms, which conceivably could affect higher education progression.  
 
 Overall, this chapter has shown that in general, the short yet extensive 
battery of computerised cognitive tests used are sensitive to cognitive changes that 
occur in pre-symptomatic and early-stage Huntington’s disease. Moving forward to 
examining changes in cognition over the disease course, a computerised battery 
such as the one used has distinct advantages over pen-and-paper tests, such as 
those used in the UHDRS cognitive battery. Computerised batteries can produce  
multiple versions of tests, minimising any effects of learning and practice that may 
confound longitudinal analyses. The computerised battery is quick to deliver and 
minimises frustration and boredom in a patient population and healthy control 
population alike, meaning that any other tests obtained following the cognitive test 
session are less confounded by fatigue or motivational issues. The ability to create a 
composite score that encompassed multiple cognitive domains allows for the 
relationship with brain structure to be explored whilst minimising the number of 
multiple comparisons required.  
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4 Higher-order deterministic tractography 
of white matter pathways in 
Huntington’s disease  
 
Chapter summary 
 
The primary aim of this chapter was to examine quantitatively the 
differences in metrics obtained from deterministic tractography reconstructions of 
white matter pathways in patients with Huntington’s disease (HD) compared to 
healthy matched controls. The second aim was to assess the correlation between 
quantitative fiber tractography metrics, cognitive and motor performance and 
disease burden in HD. 
 
Analysis was focused on data obtained from multicomponent relaxometry 
and from 3 separate diffusion MRI sequences: a diffusion sequence optimised for 
tensor based metrics, a HARDI-based sequence more suited for recovering fibre 
orientations through spherical deconvolution approaches, and a multi-shell 
diffusion MRI sequence (CHARMED). Whole-brain HARDI deterministic fiber 
tractography was conducted and the corpus callosum, cingulum bundle, and 
corticospinal tract were reconstructed in both hemispheres. Tensor based metrics, 
axon density (restricted volume fraction) and myelin water fraction were obtained 
along the tracts. Differences between HD and healthy control participants were 
examined, along with the relationship between metrics obtained along the 
reconstructed white matter tract, motor speed, cognitive function, UHDRS scores 
and disease burden in HD.  
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Introduction 
 
Despite a growing body of evidence showing that white matter plays a role 
in HD pathology, the impact of the HD mutant gene on specific white matter 
pathways is not known, and likewise, the specific contribution any white matter 
abnormality makes to the clinical features of the disease is not understood. In HD, 
the majority of investigations into white matter changes have been focused on 
either whole brain white matter (Bohanna et al., 2011; Mascalchi et al., 2004;  
Rosas et al., 2006) or a region-of-interest analysis (Matsui et al., 2013). To date, 
only a handful of studies have focused on reconstructing individual white matter 
pathways. Given the heterogeneous nature of psychiatric, cognitive and motor 
symptoms, it is plausible that multiple pathways are involved either as a direct 
effect of pathology, or are recruited as part of a compensatory network as a result 
of damage elsewhere in the brain.  
 
As described in Chapter 1, deterministic tractography is an approach to 
analysing diffusion MRI data in which white matter fiber pathways can be 
reconstructed in 3-dimensions in vivo (Jones, 2008), therefore allowing the 
comparison between anatomically known white matter pathways across groups. 
The reconstruction of fiber bundles has traditionally been carried out by the 
propagation of streamlines along the single path of least hindered diffusion, namely 
the principal eigenvector of the diffusion tensor (Basser, et al., 2000). The 
limitations of the diffusion tensor model which were described in Chapter 1 have 
resulted in the development of advanced algorithms capable of modelling multiple 
fiber orientations within a single voxel. High angular resolution diffusion imaging, or 
HARDI, methods use a large number of unique gradient orientations to acquire the 
data, with this increased sampling in q-space improving the diffusion profile (D. 
Alexander, 2005; Frank, 2002; Tuch, et al., 2002).  
 
Cardiff University  2014
 
111 
 
In this chapter, two different spherical deconvolution (SD) methods were 
implemented and compared. SD methods are capable of recovering the fiber 
orientation distribution (FOD) in each imaging voxel directly by weighting the 
measurement from each orientationally-distinct fiber population with the fraction 
of fibers with that orientation. As described in chapter 2, this is achieved by 
modelling the acquired diffusion signal as a convolution of the fiber orientation 
distribution function (fODF) with the response function from a single fiber 
population (Tournier, et al., 2004). A number of different SD approaches exist, and 
differ in terms of the way the diffusion profile is obtained and the use of a priori 
information as regularization terms. Constrained spherical deconvolution (CSD) is 
one SD method which measures the diffusion profile directly from the data, and 
contains a non-negativity constraint on the fiber orientation distribution, improving 
the accuracy of the estimation of the fODF (Tournier, et al., 2004). Without the non-
negativity constraint, noise in the data can introduce large spurious negative lobes 
in the reconstructed fiber orientation distribution which are not physically possible 
(Tournier, et al., 2008). Damped Richardson-Lucy is an alternative SD approach 
(Dell'acqua, et al., 2010) that instead assumes a diffusion tensor model when 
obtaining the diffusion profile, and uses adaptive regularization, which includes an 
isotropic term to model partial volume. Both methods will be used in this chapter 
as it is plausible that they may differ in terms of the specificity and sensitivity to 
reconstruct certain fiber pathways.  
 
In terms of the quantitative indices used to evaluate white matter pathways, 
there is still a reliance on tensor-based scalar measures in the literature, despite the 
adoption of more advanced tracking algorithms. Diffusion tensor indices have the 
advantage of being highly sensitive to local changes in diffusivity properties yet are 
inherently non-specific, containing both an interesting source of variation (e.g. axon 
density and diameter, myelin water) and an uninteresting source of variation (the 
orientational dispersion), thus it is not possible to accurately infer the biophysical 
basis of any change in tensor metric. In recent years, a number of different 
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approaches have been developed showing specificity to changes in myelination and 
axonal structure. Multi-shell diffusion MR sequences, such as Assaf et al.’s (2004) 
composite hindered and restricted model of diffusion model (CHARMED), models 
intra-axonal, or restricted diffusion, separately from extra-axonal, or hindered 
diffusion through the use of a multi-shell approach. The extra-axonal compartment 
is characterised by a single diffusion tensor, whereas the restricted intra-axonal 
compartment is characterised by impermeable cylinders with radii that follow a 
fixed Gamma distribution (Assaf & Basser, 2005; Assaf, et al., 2004). The 
parameters obtained from this approach, such as the restricted volume fraction, 
may provide more biologically sensitive and specific measures compared to tensor-
based metrics.  
 
Multicomponent analysis of T1 and T2 relaxation, or multicomponent 
relaxometry, is a quantitative MR technique that is sensitive to changes in myelin 
content (Spader et al., 2013), and is described fully in Chapter 2. The 
multicomponent driven equilibrium single-pulse observation of T1 and T2 
(mcDESPOT) proposed by Deoni and colleagues (2008b) allows for quantitative 
analysis of myelin with scan times suitable to clinical imaging research. Neither 
CHARMED or mcDESPOT acquisitions have previously been published in the HD 
literature, and may be useful in disentangling the contribution of specific white 
matter cell populations to HD pathology.  
 
In this study, the focus was on three large white matter tracts all with a well-
known structure and function and a clear hypothesis when looking for 
abnormalities in HD.  
 
Corpus Callosum 
 
The corpus callosum is the most studied white matter pathway in HD 
research. It is the largest white matter fiber tract in the brain containing more than 
200 million commissural fibers that transfer information between the two 
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hemispheres and is one of the few fiber systems that can be readily identified and 
isolated without the need for tractography, perhaps explaining the concentration of 
research attention here. The transfer of information between the two hemispheres 
is crucial for a variety of cognitive processes, such as perception, memory, 
attention, and learning (Aboitiz & Montiel, 2003; Engel, König, Kreiter, & Singer, 
1991; T. Matsuzaka et al., 1999; T. Matsuzaka et al., 1993). The majority of callosal 
fibers arise from neocortical pyramidal cells (Le Bé, Silberberg, Wang, & Markram, 
2007), which is a cell population known to be affected early on in the disease 
course of HD (Sach et al., 2004). 
 
The corpus callosum has been reported to be affected in HD using a variety 
of approaches, including TBSS (Di Paola et al., 2012; Kincses et al., 2013; Weaver, et 
al., 2009), region-of-interest based analysis (Di Paola, et al., 2012; Dumas, et al., 
2012), and tractography (Dumas, et al., 2012; Klöppel et al., 2008; Phillips et al., 
2013). Callosal thinning and reduced FA has been found in HD even in the pre-
symptomatic stage, with thinning initially only evident in the isthmus, and 
progressing in an anterior direction in the symptomatic stage of the disease, with 
the callosal body showing thinning compared to pre-symptomatic HD patients (Di 
Paola, et al., 2012). In symptomatic HD, the anterior corpus callosum was found to 
be affected using probabilistic tractography (S. Klöppel, et al., 2008). MRI metrics 
obtained from the corpus callosum have been found to correlate with behavioural 
measures in HD, with both motor and cognitive scores correlating with diffusivity 
values in the corpus callosum (Bohanna, Georgiou-Karistianis, Sritharan, et al., 
2011; Dumas, et al., 2012). 
 
 The corpus callosum is not a homogenous tract, with fibers varying in terms 
of size and age of myelination; larger and early myelinated fibers are found in 
posterior callosal regions whereas smaller and late myelinating fibers are found in 
anterior regions (Aboitiz & Montiel, 2003; Aboitiz, Scheibel, Fisher, & Zaidel, 1992). 
Thus, analysing the corpus callosum in terms of sub-divisions rather than as a 
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uniform tract may be more fruitful in understanding pathology and regional 
differences in HD in terms of changes in myelination and/or axonal structure.  
 
Corticospinal Tract 
 
The corticospinal tract is the main white matter pathway that carries motor 
signals from the spinal cord to the motor cortex. Approximately half of the 
population of white matter fibers in the corticospinal tract originate from the 
primary motor cortex (Kandel, Schwartz, & TM, 2000; Schultz, 2001), and motor 
dysfunction in HD has been found to be correlated with cell loss in the primary 
motor cortex (E. H. Kim et al., 2014; Thu et al., 2010) whilst altered functional 
(BOLD) activation in this area has been reported (Georgiou-Karistianis, Poudel, et 
al., 2013). The pathway is connected to the basal ganglia, which is the hallmark area 
of neuropathology in HD, and as with the corpus callosum, the majority of fibers 
originate from pyramidal cells in the cerebral cortex, which are known to be 
affected in HD. In terms of function, the corticospinal tract is involved in voluntary 
movement (Kandel, et al., 2000; Schultz, 2001), which is altered in HD, with reduced 
precision on a self-paced timing motor task (Rowe et al., 2010) and evidence of 
disordered eye movements (Patel, Jankovic, Hood, Jeter, & Sereno, 2012).  
 
Only a handful of studies have examined changes in the corticospinal tract in 
HD, with macrostructural changes reported in the internal capsule from VBM 
studies (Della Nave, et al., 2010; Fennema-Notestine, et al., 2004) and 
microstructural changes in the internal capsule from diffusion tensor ROI studies 
(Magnotta et al., 2009; H. Rosas, et al., 2006), whilst CAG repeat length and motor 
score were related to the degree of atrophy in the internal capsule (Hobbs, et al., 
2010). Phillips and colleagues (2014) were the first to examine the corticospinal 
tract as a distinct fiber pathway. The authors used diffusion tensor based 
tractography to reconstruct the tract in both pre-symptomatic and early-HD 
patients, and found a reduction in fractional anisotropy (FA), an increase in 
diffusivity values (radial diffusivity [RD] and axial diffusivity [AD]), and cortical 
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thinning in the primary motor cortex bilaterally in HD patients compared to both 
controls and pre-HD patients. Pre-HD patients had higher RD values compared to 
controls. A limitation of this study is the reliance on the tensor model to reconstruct 
the pathway, which can lead to erroneous fiber tractography results in areas where 
fiber bundles cross each other. This is an issue in the corticospinal tract, where the 
lateral projections to the upper extremity and face region of the motor cortex 
intersect the superior longitudinal fasciculus. Previous work has demonstrated that 
with single tensor tractography, only part of the corticospinal tract is reconstructed, 
whereas a two-tensor deterministic streamline tractography algorithm was able to 
accurately identify fiber bundles consistent with anatomy (Qazi et al., 2009). Thus, 
this limitation will be addressed in this chapter through the use of high-angular 
resolution diffusion imaging (HARDI) and tractography analysis based on spherical 
deconvolution.  
 
Cingulum Bundle  
 
The cingulum bundle is the most prominent white matter fiber tract in the 
limbic system and contains afferent and efferent fibers of different lengths (Mufson 
& Pandya, 1984) with the longest fibers running from the anterior temporal gyrus 
to the orbitofrontal cortex (Catani, Howard, Pajevic, & Jones, 2002). Anatomically, 
the tract is longitudinally oriented above the corpus callosum from the genu to the 
splenium and underlies the cingulate cortex. It is a complex tract, with work in the 
primate brain showing that the cingulum contains afferent and efferent short U 
fibers associated with the rostral, mid, and caudal cingulate cortices and 
connections to the medial and dorsal prefrontal, parietal, occipital, and temporal 
lobes (Catani, et al., 2002). 
 
The cingulum is known to be involved in attention, memory and emotions 
(Catani & Thiebaut de Schotten, 2008) and although the cingulate cortex has been 
implicated in HD, with major loss of interneurons found in the anterior cingulate 
cortex in HD (Kim, et al., 2014) and loss of pyramidal projection neurons in the 
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cingulate gyrus (Cudkowicz & Kowall, 1990) the cingulum bundle has not yet been 
examined in HD.  
 
 Reconstructions of the cingulum bundle using diffusion tractography have 
tended to portray the cingulum as a continuous white matter pathway (Catani & 
Thiebaut de Schotten, 2008) whereas the cingulum is not uniform in terms of the 
underlying function of the white matter connections, and instead consists of three 
major fiber components, originating from the thalamus, cingulate gyrus, and 
cortical association areas (Armstrong, 1990; Bürgel et al., 2006) with only a small 
fraction of the total white matter in the cingulum traversing the length of the tract. 
It was recently shown that the diffusion tensor metrics varied significantly between 
different subdivisions of the cingulum bundle corresponding to known anatomical 
connectivity (Jones, Christiansen, Chapman, & Aggleton, 2013), with the 
‘parahippocampal’, ‘retrosplenial’, and ‘subgenual’ portions of the cingulum 
forming a topographic arrangement of cingulum fibers. Whereas the subgenual 
subdivision is implicated more in top-down attentional control, goal-directed 
behaviour, motivation, reward and cognitive modulation of affect (Amft et al., 
2014; Vann, Aggleton, & Maguire, 2009), all of which are clinical features of HD, the 
retrosplenial subdivision, which contains connections to the retrosplenial cortex, 
has been implicated more in memory processes, such as scene learning and 
episodic memory (Vann, et al., 2009). The retrosplenial cortex has been shown to 
have correlated activity with the thalamus (Aggleton & Nelson, 2014; Vogt, Vogt, & 
Laureys, 2006), a key relay system in the basal ganglia, which is known to be 
affected in HD. Thus, based on the symptom profile in HD and the known 
neuropathology, it is possible that both the subgenual and retrosplenial cingulum 
fibers are affected in HD but not necessarily in the same way.  
 
Thus, the overall aim of this chapter was to characterise the tissue 
microstructure along three white matter pathways that are implicated either 
theoretically or empirically in HD using multi-modal MRI acquisitions, in order to 
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achieve both a sensitive and specific characterisation of white matter abnormalities 
in pre-symptomatic and early-stage HD.  
 
Methods 
 
Participants 
 
A sub-set of participants  comprising 14 HD gene-positive ( 10 pre-
symptomatic, 4 early HD) and 13 healthy controls underwent a more extensive MRI 
scan session to examine changes in white matter. For one HD participant, it was not 
possible to acquire all of the sequences due to severe HD-related motion in the 
scanner. For the mcDESPOT acquisition, data were not acquired for 2 HD 
participants due to specific absorption rate (SAR) concerns related to MRI 
contraindications and weight limits. The mcDESPOT data were not acquired for a 
further HD participant due to a technical fault at the end of the scan session. 
 
Psychometric data 
 
Outcome measures from the computer-based cognitive battery described 
fully in Chapter 2, were analysed using a principal components analysis (full details 
in chapter 3), and the composite cognitive values were used to examine 
relationships with white matter microstructure. In addition, the majority of HD 
participants recruited were also enrolled on the longitudinal REGISTRY study, which 
involves yearly assessments by a trained research nurse. Thus, there was data 
available from the most recent REGISTRY study (within the past 12 months), 
including the UHDRS assessment ("Unified Huntington's Disease Rating Scale: 
reliability and consistency. Huntington Study Group," 1996). The UHDRS motor 
score, total functional capacity, independence and UHDRS functional score were 
therefore also used as variables to examine relationships with white matter 
microstructure. The UHDRS cognitive score was not used as not all HD participants 
had completed this component, thus the sample size was too small to examine 
meaningful relationships. Finger tapping speed was also used as a measure of 
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motor speed, which was recorded on the day of the MRI session. For details on the 
UHDRS, see Chapter 2. 
MRI Data Acquisition 
As detailed in chapter 2, two different diffusion MRI sequences were 
acquired in order to perform the tractography analysis. Whole brain tractography 
was performed on a HARDI-based sequence more suited for recovering fibre 
orientations through spherical deconvolution approaches (b-value = 2000 s/mm2, 
45 gradient directions) and the tensor based metrics along the reconstructed tracts 
were then obtained from a co-registered diffusion sequence optimised for tensor 
based metrics (b-value = 1000 s/mm2, 30 isotropic gradient directions). A multi-
shell CHARMED sequence was acquired in order to obtain a measure of restricted 
volume fraction. The sequence used 8 shells (1093, 2188, 3281, 4375, 5469, 6563, 
7656, and 8750 s/mm2) and 40 gradient orientations. A Multi-Component Driven 
Equilibrium Single Pulse Observation of T1/T2 (mcDESPOT) (S. Deoni, et al., 2008a) 
protocol was acquired to measure myelin water fraction. The protocol combined 
spoiled gradient echo (SPGR), balanced steady state free precession (bSSFP) and 
inversion-recovery prepared SPGR (IR-SPGR) sequences according to Deoni et al. 
(2008). The acquired T1-weighted FSPGR scan was used for image registration. 
 
MRI Post-processing 
 
For the acquired diffusion images, ExploreDTI software (Leemans, et al., 
2009) was used for image pre-processing. As shown in Figure 4.1, images were 
corrected for distortions due to motion and the tensor was estimated using the 
RESTORE algorithm (Chang, et al., 2005) as detailed in Chapter 2. Images were 
corrected for EPI distortions using a non-rigid registration of the FA map to the T1-
weighted map which had the same image contrast as the participants FSPGR image. 
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There were 4 resolution steps, 20000 data samples, and the deformations were 
constrained to the phase-encoding direction of the diffusion acquisition. The 
images were then corrected to account for contamination due to free water using 
the Pasternak approach (Pasternak, et al., 2009). Free water volume fraction maps 
were examined to look for differences due to gene status.  
 
In order to obtain a measure of myelin water fraction, the image maps was 
linearly registered to the T1-weighted image using 6 degrees of freedom using 
FMRIB's Linear Image Registration Tool (FLIRT) (Jenkinson & Smith, 2001). For the 
restricted volume fraction obtained from the CHARMED analysis, linear registration 
did not produce satisfactory results, thus registration was conducted using the 
ELASTIX software (Klein, Staring, Murphy, Viergever, & Pluim, 2010; Shamonin et 
al., 2013) where the combination of a rigid and a B-spline transform is applied. All 
registrations were visually inspected for accuracy.  
 
Deterministic Tractography  
 
Deterministic whole-brain tractography (Basser, et al., 2000) was performed 
using the tensor model, and 2 different high-angular resolution diffusion imaging 
(HARDI) spherical deconvolution methods, constrained spherical deconvolution 
(CSD) (Tournier, et al., 2004; Tournier, et al., 2008) and the iterative damped 
Richardson Lucy (DRL) approach (Dell'acqua, et al., 2010). The SD approaches were 
Figure 4.1 Analysis pipeline for both the low and high b-value diffusion MRI 
images. ExploreDTI software (Leemans, et al., 2009) was used for all steps. FWC: 
free water correction (Pasternak, et al., 2009). 
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chosen due to the well-established limitations of tensor-based tracking in resolving 
voxels containing multiple fiber orientations. Many of the candidate pathways were 
in regions of crossing/kissing fiber combinations, thus tensor-based tracking was 
insufficient for this purpose.  
 
The selected tracking algorithm was able to reconstruct fibers by estimating 
the fODF peak at each seed-point and then propagating from here in 0.5 mm steps 
along the axis subtending the smallest angle to the current trajectory, thus allowing 
for multiple fiber orientations within a voxel. A fiber pathway was traced through 
the data for fibers greater than 5 mm in length and less than 500 mm in length until 
the fODF fell below an arbitrary threshold (0.1) or the direction of the pathway 
changed through an angle greater than 45°. The SH order was 8 and for both CSD 
and DRL, for one fiber profile, the expected ADC (mm2/s) was 0.0007 and FA was 
0.8. DRL algorithm parameters were α =1, algorithm iteration = 400, η =0.06 and ν 
=8 as regularisation terms.  
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Parcellation of the corpus callosum 
 
The corpus callosum was reconstructed using the Hofer and Frahm (2006) 
approach (Figure 4.2) which uses 5 vertical subdivisions to parcellate the corpus 
callosum in accordance with defined cortical connections. Briefly, a geometric 
baseline was established in the midsaggital slice by connecting the most anterior 
and posterior points of the corpus callosum. Seed points were drawn on this mid-
sagittal slice, and NOT gates used to remove spurious fibers not travelling to the 
cortical region.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 A. Schematic of corpus callosum parcellation. Reproduced from Hofer 
& Frahm (2006). B. Transcallosal fiber tracts from a single male healthy control 
subject overlaid onto native T1 reference image. Sagittal view of reconstructed 
fibers projecting into the prefrontal lobe (red), premotor and supplementary 
motor areas (yellow), primary motor cortex (green), primary sensory cortex 
(dark blue), parietal, occipital and temporal lobe (light blue).  
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Parcellation of the cortico-spinal pathway 
 
The corticospinal tract (CST) was defined as pathways between the primary 
motor cortex and the midbrain. The first ROI was drawn in the axial plane to include 
the entire cerebellar peduncle at the level of the decussation of the superior 
cerebellar peduncle, which is a clear anatomical landmark that can be seen in 
Figure 4.3, marked by an arrow. The ROI was drawn on the most dorsal slice where 
the decussation was visible. The registered T1-weighted image was used to aid in 
the identification of the central sulcus. A second ROI was then drawn in the primary 
motor cortex on the axial slice. A ‘NOT’ operation was placed in the mid-sagittal 
slice to remove any streamlines entering the contralateral hemisphere. 
 
Figure 4.3 Parcellation of the Corticospinal Tract. A. Placement of ROI on most 
dorsal axial slice where the decussation of the cerebellar peduncle (arrow) is 
seen. B. Identification of the central sulcus (red line) in the left hemisphere on 
the T1 image. C. Placement of ROI on axial slice in the primary motor cortex, D. 
Position of both ROI’s from a sagittal view, imposed on the T1 image. E. 
Reconstructed tracts in the coronal plane shown on the colour-coded principal 
component image.  
Cardiff University  2014
 
123 
 
Figure 4.4 Segmentation of the cingulum bundle. Schematic shows 
placement of ROI’s (green lines) with reference to anatomical landmarks 
(dashed lines). A-C show reconstructed tracts from one control participant 
shown colour-coded for mean diffusivity (MD) and overlaid on a T 1-
weighted image. ROI’s shown: seed point ‘OR’ gates in blue (white arrows), 
‘AND’ gates are in green (yellow arrows).  
Parcellation of the cingulum  
 
The cingulum and the subgenual and retrosplenium subdivisions were 
parcellated according to the protocol detailed by Jones et al. (2013) for all 
participants, as shown in Figure 4.4. Briefly, for each hemisphere, the parasagittal 
level that provided the most extensive visualisation of the cingulum bundle was 
identified and the position of the corpus callosum in that same plane was used to 
derive a set of fixed landmarks for subsequent ROIs. For all segmentation, “NOT” 
ROIs were occasionally placed after visual inspection to exclude any outlier tracts 
that were inconsistent with the known anatomy of the cingulum bundle. 
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 Whole Cingulum  The rostral–caudal midpoint of the body of the corpus 
callosum was first determined, defined as the mid-way point between the back of  
the curve of the genu (i.e., its most posterior part at the flexure) and the front of 
the splenium (i.e., its most anterior part at the flexure). The two AND gates were 
drawn in the coronal plane on the coronal sections five slices anterior and five slices 
posterior to the rostral–caudal midpoint. All streamlines that passed through both 
regions of interest were retained as ‘cingulum’ pathways. 
 
‘Subgenual’ subdivision  Two ROIs was employed. One ROI was in the 
same location as the caudal ROI used for the whole cingulum reconstruction (AND 2 
in Figure 4.4), and the second ROI was placed in the subgenual part of the cingulum 
on the third coronal slice caudal to the most anterior part of the genu. 
 
‘Retrosplenial’ subdivision Two ROIs were used for dissecting the 
‘retrosplenial’ subdivision. One ROI was placed in the same location as the rostral 
ROI used for the whole cingulum (AND 1 in Figure 4.4). The location of the second 
ROI was determined by finding the most ventral plane of the splenium and was 
drawn in the axial plane three axial slices above the base of the splenium.  
 
Statistical analysis 
 
A mixed-model ANOVA was used to examine the effect of HD on white 
matter pathways, with disease status (control, HD) as the between-subject variable, 
and/or segment (for corpus callosum and cingulum) and hemisphere (for cingulum 
and corticospinal tract) as within-subject factors. Where age was found to correlate 
with the dependent variable (defined as r > 0.30); age was added as a covariate to 
the analysis (see Appendix 3 for statistical tests). The assumptions of a mixed-model 
ANOVA were tested (see Appendix 3) and appropriate corrections made where 
assumptions were violated. For diffusion tensor metrics, FA and MD values were 
principally examined. Where significant main effects of interactions surviving post-
hoc analysis were found, the component AD and RD values were then examined.  
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A mixed-model ANOVA was also used to examine the effect of the choice of 
tractography algorithm, with 2 within-subject factors (callosal segment and 
algorithm) and 1 between-subject factor (gene status).  
 
A correlational analysis was conducted to assess the relationship between 
composite cognitive scores (see chapter 2 for details on PCA), motor speed on the 
Speeded Finger Tapping test, UHDRS scores and MR measures. Normality testing on 
the composite cognitive scores found data was normallydistributed at α = 0.001. 
Where age was found to be significantly correlated with any of the measures, a 
partial correlational analysis was performed with age partialled out.  
 
Results 
 
Corpus Callosum Reconstructions with different tractography algorithms 
 
There was a significant interaction between corpus callosum segment and 
tractography algorithm for FA values, F (2, 26) =10.27, p ≤ 0.001. Post-hoc analyses 
found that there was a significant effect of algorithm choice on FA values in every 
segment ( segment I : F (2,46 ) = 5.89, p ≤ 0.05 FDR-adjusted; segment II: F (2,38) = 
15.15 p ≤ 0.001 FDR-adjusted; segment III: F (2,40) = 12.31, p ≤ 0.001 FDR-adjusted, 
segment IV : F (2,36) = 16.97, p ≤ 0.001 FDR-adjusted; segment V: F (2,30) = 19.69, p 
≤ 0.001 FDR-adjusted). Paired t-tests found that DTI tracking produced significantly 
higher FA values in comparison to both CSD and DRL tracking results in callosal 
segments II – V ( all p ≤ 0.05 FDR-adjusted), whereas FA values were not 
significantly different across algorithms in the most anterior callosal segment, p > 
0.05. FA values sampled by CSD compared to DRL tracking did not differ in 
segments I – IV, whereas in the most posterior segment, DRL tracking produced 
higher FA values compared to CSD, p = 0.045 FDR-adjusted. There was no main or  
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Figure 4.5 The effect of tracking algorithm on fractional anisotropy (FA) estimates 
in different segments of the corpus callosum. Error bars represent ± standard  
error of the mean. *** represents statistical significant of p < 0.001 for the main 
effect of tractography algorithm (no post-hoc tests shown). 
 
interactive effect of tractography algorithm on MD values in the corpus callosum 
when age was added as a covariate, all p > 0.05 
 
In terms of the effect of gene status on MR measures, there was a 
discrepancy between a main effect versus an interactive effect for FA values 
estimated with CSD compared to DRL, and a difference in the degree of significance 
for MD values. Using CSD as the tractography algorithm, there was a significant 
interaction between callosal segment and gene status for FA values, F (4, 56) = 2.59, 
p ≤ 0.05. Post-hoc t-tests revealed a significant reduction in FA in segment II, which 
contains motor connections, and in segment V, which contains parietal, temporal 
and occipital connections in HD participants compared to controls, t (19) = 2.13, 
and t (17) = 2.24 respectively, p ≤ 0.05 uncorrected. This did not survive correction 
for multiple comparisons using the FDR, all p > 0.05. HD participants had 
significantly higher MD values in the corpus callosum, F (1, 18) = 4.63, p ≤ 0.05, 
although this did not survive correction for multiple comparisons. Post-hoc analysis 
Cardiff University  2014
 
127 
 
of the component eigenvalues AD and RD found no difference between HD and 
control participants, p > 0.05.  
 
In contrast, when using DRL as the algorithm, FA was significantly lower in 
HD participants compared to controls, F (1, 19) = 4.51, p ≤ 0.05 uncorrected, p > 
0.05 FDR-corrected, and there was no interaction with callosal segment, p > 0.05. 
MD was significantly higher in HD participants compared to healthy controls, F (1, 
22) = 8.14, p ≤ 0.05 FDR-corrected. Post-hoc analysis of the component eigenvalues 
AD and RD found no difference between HD and control participants for both 
algorithms, p > 0.05. All results were corrected for partial volume effects, however 
there was no effect of gene status on free water fraction, F (1, 19) = 2.99, p > 0.05 
for CSD, and F (1, 21) = 0.467, p > 0.05 for DRL. There was a trend for myelin water 
fraction to be reduced in the corpus callosum in HD participants, with the 
magnitude of difference being greater than 10% in more anterior callosal segments, 
as shown in Table 4.1. However, this difference was not statistically significant 
when derived from tractography using CSD, F (1, 15) = 1.44, p > 0.05, or from 
tractography using DRL, F (1, 18) = 2.51, p > 0.05.  
 
 Results from CSD and DRL converged to show no difference in restricted 
volume fraction (a proxy estimate of ‘axon density’) from the CHARMED analysis 
between HD and control participants, F (1, 19) = 2.83, and F (1, 23) = 1.152 
respectively, both p > 0.05. For both algorithms, and as with the other measures, 
there was a main effect of callosal segment, Greenhouse-Geisser adjusted F (2.63, 
49.94) = 6.77, and F (2.51, 57.74) = 17.74, ε = .657 and .628 respectively, both p < 
0.05, but no interaction between gene status and segment, p > 0.05.  
 
When using DTI as the tractography algorithm, there was no main effect of 
gene status for FA values across the corpus callosum, F (1,17) = 0.467, p > 0.05, 
although there was a significant difference in FA values depending on callosal 
segment, F (4,68) = 12.44, p ≤ 0.001. HD participants had significantly higher MD 
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values in the corpus callosum, F (1, 22) = 9.96 p ≤ 0.01, with no interaction across 
different callosal segments. There was no effect of gene status on myelin water 
fraction or restricted volume fraction in the corpus callosum derived from 
tractography using DTI, F (1,18) = 2.25, p > 0.05 and F (1,21) = 1.03, p > 0.05 
respectively. All results were corrected for partial volume effects, however for the 
free water fraction, there was an interaction between gene status and callosal 
segment, Greenhouse-Geisser adjusted F (2.63, 49.96) = 3.63, p ≤ .05, ε = 0.66. 
Post-hoc tests found a difference between controls and HD participants specifically 
in segment II and V, F (1, 18) = 4.58 and 6.75 respectively, p ≤ 0.05; however these 
results did not survive correction for multiple comparisons using the FDR, all p > 
0.05.  
 
Relationship between corpus callosum and disease burden in HD  
 
In measures obtained using the CSD algorithm, disease burden was 
positively correlated with free water fraction in the first 3 segments of the corpus 
callosum, r = .584 , .683,  .670 respectively, p < 0.05 uncorrected, whereas no 
relationship was found in the 4th and 5th segments, p > 0.05. Restricted volume 
fraction was negatively correlated with disease burden in the second callosal region 
which contains inter-hemisphere connections to the premotor and supplementary 
motor areas, r = -.65, n = 10, p < 0.05 uncorrected, however did this not survive 
correction for multiple comparisons. Similarly, a negative relationship was found 
between disease burden and myelin water fraction in the same callosal region 
(segment II), with a higher disease burden associated with a reduction in myelin 
water fraction in these tracts, r = -.89, n = 7, p < 0.01 uncorrected. This result did 
survive FDR-correction across myelin water fraction measures in the 5 segments, p 
< 0.05, however did not survive correction across both the 5 segments and the 4 
remaining outcome measures (FA, MD, FWF, restricted volume fraction) , with 25 
comparisons in total.  
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In measures obtained using the DRL algorithm, disease burden was 
positively correlated with free water fraction in the 2nd and 3rd segment, r = .58 and 
.69, p < 0.05 uncorrected, similar to the findings with CSD tracking. MD values were 
positively correlated with disease burden in the 3rd and 4th segments, which contain 
inter-hemispheric connections to the primary motor and primary sensory cortex 
respectively, r = .655 and .723, p < 0.05 uncorrected. The result in the 4th segment 
survived FDR-correction across MD measures in the 5 segments, p < 0.05, however 
did not survive correction for all 4 outcomes measures and 5 segments combined. 
 
Figure 4.6 Average tensor metrics in each segment of the corpus callosum 
obtained using different tractography algorithms. * p ≤ 0.05, ** p ≤ 0.01 
significant level. Error bars represent ± standard error of the mean 
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Relationship between corpus callosum and motor dysfunction  
 
In HD participants [ n =13], a negative correlation was found between 
average free water fraction across the segments of the corpus callosum 
reconstructing using DRL tracking, and finger tapping speed, r = -.609, p < 0.05 
uncorrected. Similarly, a strong negative correlation was found between free water 
fraction across the segments of the corpus callosum reconstructing using both DRL 
and CSD tracking algorithms, and UHDRS Total Functional Capacity [ n =9], r = -.899 
and -.901 respectively, p < 0.05 FDR-corrected. Additionally, for tracts sampled by 
CSD, a significant relationship was found with UHDRS motor score and FA, MD and 
restricted volume fraction in the corpus callosum, r = -.859, -.765, and -.794 
respectively, all p < 0.05 FDR-corrected. 
 
Relationship between corpus callosum and cognitive scores  
 
Partial correlations were conducted between the composite cognitive score 
produced in chapter 3, and the metrics obtained along the corpus callosum 
segments, with age partialled out. In the HD participants, and using values obtained 
from the DRL algorithm, a negative relationship was found between cognitive score 
and MD in the corpus callosum segment containing inter-hemispheric pre-motor 
and supplementary motor area connections, r = -.668, df = 8, p < 0.05 uncorrected, 
p > 0.05 FDR-corrected. The same relationship was less strong when the corpus 
callosum was reconstructed using CSD, r = -.583, p > 0.05. There were no significant 
relationships between cognitive score and average MR measures in the control 
group.  
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Cortico-spinal tract 
 
Descriptive statistics for all outcome measures are shown in Figure 4.7. 
Mixed-model ANOVA found no difference between CSD and DRL sampling for any 
measure. Both CSD and DRL algorithms found no difference between HD and 
control participants in FA and MD values in the corticospinal tract (CSD: F (1, 20) = 
1.01, and F (1, 19) = 1.74 respectively; DRL: F (1, 21) = 0.128, and F (1, 22) = 2.90 
respectively; all p > 0.05). 
 
For the non-tensor based metrics, there was also no difference in myelin 
water fraction and restricted volume fraction between HD and control participants 
using either the CSD or DRL algorithm (CSD: F (1, 16) = 2.43, and F (1, 20) = 1.74 
respectively; DRL F (1, 17) = 1.42, and F (1, 22) = 0.236 respectively; all p > 0.05). 
There was also no difference between HD and control participants for free water 
fraction (CSD: F (1, 20) = 3.24; DRL: F (1,22) = 0.260; both p > 0.05), although there 
Table 4.1 Corpus Callosum Reconstruction. Descriptive statistics for the non-
tensor based metrics using different tractography algorithms. Standard error of 
the mean shown in blue. 
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was a difference between hemispheres using CSD, with a higher fraction in the right 
corticospinal tract compared to in the left hemisphere, F (1, 20) = 6.04, p < 0.05. 
 
 Relationship between microstructure and disease burden in HD  
 
There was no relationship between disease burden and tensor based 
metrics estimated obtained using the CSD algorithm [n =12], all p > 0.05. In 
contrast, when using the DRL algorithm [n =13], a positive relationship was found 
between disease burden and MD values in the left corticospinal tract, r = .615, p < 
0.05 uncorrected, and between disease burden and free water fraction in the left 
and right hemisphere alike, r = .775 and .821 respectively, p < 0.05 FDR-corrected.  
 
Relationship between microstructure and motor/functional 
dysfunction in HD  
 
The relationship between baseline UHDRS motor scores and metrics 
obtained in the corticospinal tract was not significant, p > 0.05. A significant 
negative relationship was found between the UHDRS functional assessment (high 
score = high functional ability), which is focused on assessing whether an individual 
can engage in everyday tasks (e.g. management of finances, grocery shops), and 
MD in the left corticospinal tract, r = - .777, p < 0.05 FDR-adjusted. There was no 
relationship between MR measures obtained from either DRL and CSD in the 
corticospinal tract and finger tapping speed.  
 
For MR measures obtained using CSD whole-brain tracking, a significant 
positive correlation was also found between UHDRS motor score (high score = more 
impaired) and MD in the left and right corticospinal tract, r = .742 and .747, 
respectively, p < 0.05 FDR-corrected. There was no relationship between MR 
measures and any of the other UHDRS measures.  
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Relationship between microstructure and cognitive scores  
 
In the healthy control participants and in tracts obtained using the CSD 
algorithm, a strong positive relationship was found between FA in the left 
corticospinal tract (CST) and cognitive function, r = 0.70, p < 0.05 uncorrected, 
between myelin water fraction in the left CST and cognitive function r = 0.669, p < 
0.05 uncorrected, and between restricted volume fraction in the left CST and 
cognitive functioning, r =0 .668, p < 0.05 uncorrected. The same relationships were 
not found in HD participants, p > 0.05. 
 
 When using tracts obtained using the DRL algorithm, the relationship 
between FA and cognitive functioning, myelin water fraction and cognitive 
functioning, and restricted volume fraction and cognitive functioning were all weak 
in healthy control participants, r = .148, .085 and .08 respectively, p > 0.05 and HD 
participants alike, r = -.079, - .311, .085 respectively, p > 0.05. 
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Figure 4.7 Results from the Corticospinal Tract reconstruction. Values are shown 
from tractography using two different spherical deconvolution approaches: 
constrained spherical deconvolution [CSD] (Tournier et al., 2008)  and damped 
Richardson-Lucy [DRL] (Dell'acqua et al., 2010). Myelin water fraction obtained 
from multicomponent relaxometry, restricted volume fraction obtained from 
CHARMED, a multi-shell diffusion MR sequence. L: left hemisphere, R : right 
hemisphere. For the scatterplot, r2 = .60 and .67 for left and right hemisphere 
respectively. Error bars represent standard errors of the mean.  
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Cingulum Bundle 
 
Reconstructing the cingulum bundle was not as effective with CSD-based whole 
brain tracking compared to DRL; 8/25 of the cases produced either very poor tract 
reconstructions not representative of known anatomy, or failed to reconstruct any 
tracts. The effect of this loss of data on an already small sample size meant that any 
statistical analysis would not be robust, thus only results from DRL reconstructions 
were statistically analysed.  
Differences between HD participants and controls  
Mean tensor and non-tensor values are shown in Figure 4.8 along with 
standard errors of the mean.  
Whole cingulum For FA in the whole cingulum, there was a significant 
interaction between hemisphere and genotype, F (1, 17) = 4.76, p < 0.05. Post-hoc 
t-tests found a laterality effect in control participants, t (9) = -3.018, p < 0.5, but not 
in HD participants, t (8) = .480, p > 0.05. In the left hemisphere, FA was 10.7% 
higher in HD participants compared to controls, however this did not meet 
statistical significance, t (17) = -1.31, p > 0.05. In comparison, in the right 
hemisphere, the difference in FA between HD participants and controls was 0.79%, 
t (17) = .106, p > 0.05. There was no effect of gene status on MD values in the 
whole cingulum, F (1, 17) = .426, p > 0.05, and no interaction between gene status 
and hemisphere, F (1, 17) = .602, p > 0.05. Because of the interaction seen for FA, 
the component eigenvalues were examined. For both AD and RD values, there was 
no difference between HD and control participants, F (1, 17) = .281 and .049 
respectively, p > .05, and no interaction between gene status and hemisphere, p > 
0.05.  
There was no effect of gene status on free water fraction values in the 
whole cingulum, F (1, 18) = .217, p > 0.05. Similarly, there was no difference in 
myelin water fraction, F (1, 14) = .138, p > 0.05, or restricted fraction, F (1, 18) = 
.018, p > 0.05.  
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Subgenual Cingulum. There was no difference in FA values between HD and 
control participants in the subgenual section of the cingulum bundle, F (1, 21) = 
1.36, p > 0.05. MD values were higher in HD participants compared to healthy 
controls, F (1, 21) = 6.86, p < 0.05 uncorrected. A main effect of hemisphere was 
also found, F (1, 21) =10.12, p < 0.01 uncorrected. Post-hoc analyses of the 
component eigenvalues found that whereas there was no difference between 
groups in axial diffusivity (AD, λ1) values (F (1, 21) = 2.02, p > 0.05), radial diffusivity 
(RD; [λ2+λ3]/2) was significantly higher in HD participants (0 .54 ± .015 x10
-3 mm2/s) 
compared to healthy control participants (0.50±0.016 x10-3 mm2/s), F (1,21) = 5.43, 
p < 0.05 uncorrected, p > 0.05 FDR-adjusted.  
There was a trend towards higher free water fraction in HD participants [n = 
13, M = .344 ± .026] compared to healthy controls [n = 10, M=.268±.031] in the 
subgenual cingulum, F (1, 21) = 3.97, p = 0.059.  
Restricted volume fraction, a proxy for axon density, was found to be 
significantly reduced (-17.9% and -15.8% in the left and right hemisphere 
respectively) in HD participants compared to healthy controls, F (1, 21) = 8.50, p < 
0.05 FDR-corrected. Myelin water fraction was reduced in HD participants [n=9] 
compared to control participants [n=10] in both the left (-16.70%) and right (-
11.1%) hemisphere, however this difference did not survive statistical significance, 
F (1, 17) = 2.09, p > 0.05. 
 
Retrosplenial cingulum There was no difference in FA, MD or free water 
fraction between HD and control participants in the retrosplenial subdivision of the 
cingulum, p > 0.05. Similarly, there was no difference in myelin water fraction or 
restricted volume fraction between groups, p > 0.05. 
Relationship between microstructure and disease burden  
Whole cingulum As seen in Figure 4.8C, in the HD participants, free water 
fraction in the cingulum was positively correlated with disease burden, r = 0.746 
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and 0.669 in the left and right hemisphere respectively, p < 0.05 uncorrected, FDR-
corrected p > 0.05. 
Subgenual subdivision Free water fraction in the left subgenual division of 
the cingulum was positively correlated with disease burden in the HD participants, r 
= .577, p < 0.05 uncorrected, FDR-corrected p > 0.05, see Figure 4.8D. 
Retrosplenium subdivision There was no correlation between disease 
burden and any of the white matter microstructure measures in the retrosplenial 
subdivision, all p > 0.05, see Figure 4.8E. 
 
Relationship between cingulum and motor dysfunction  
Whole cingulum In HD participants, both finger tapping speed and UHDRS 
motor score (high score = more motor impairment) were correlated with free water 
fraction in the right cingulum, r= -.707 and .735 respectively, p < 0.05 uncorrected, 
whereas the same relationship with finger tapping speed was not present in control 
participants, p > 0.05. Both UHDRS total functional capacity and independence sub-
scales were strongly negatively associated with free water fraction in the right 
cingulum, r = -.829 and -.856 respectively, p < 0.05, although only the relationship 
with total functional capacity was significant after multiple comparison correction, 
p < 0.05 FDR-adjusted. There was no relationship between either finger tapping 
speed or UHDRS and other MR measures. 
Subgenual subdivision There was no relationship between finger tapping 
speed and MR measures in the subgenual cingulum for HD participants, all p > 0.05 
at an FDR-adjusted level. In control participants, finger tap speed was negatively 
correlated with FA values and myelin water fraction, r = -.650 and -.722 p < 0.05 
uncorrected, p>0.05 FDR-corrected.  
For the UHDRS motor score, a moderate relationship was found with free water 
fraction in the right subgenual subdivision, r = .583, p < 0.05 uncorrected, however 
p>0.05 at an FDR-adjusted level. UHDRS independence score and total functional 
capacity were not related to any microstructural measures, all p > 0.05.  
 
Chapter 4   2014
 
138 
 
 
Figure 4.8 A-B. Group differences in the cingulum bundle and its subdivisions, 
with selective effects seen in the subgenual subdivision. L: left hemisphere, R: 
right hemisphere. Error bars represent standard errors of the mean. ** p < 0.01 
uncorrected, ** < 0.001 uncorrected.  
C-E. Relationship between free water fraction (FWF) and disease burden, a 
presumed index of the cumulative toxicity of mutant huntingtin, in the whole 
cingulum and cingulum subdivisions. The relationship is significant in the whole 
cingulum and left subgenual cingulum (p<0.05 uncorrected). Line of best fit 
overlaid on scatterplots with Pearson’s r2 shown in blue and green ink for the left 
and right hemisphere respectively.  
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Retrosplenial subdivision There was no relationship between finger tapping 
speed and MR measures in the retrosplenial cingulum for control and HD 
participants alike, all p > 0.05. There was a moderate positive relationship between 
UHDRS motor scores and MD values in the left and right hemisphere, r = .591 and 
.61 respectively, p < 0.05 uncorrected, as well as with restricted volume fraction in 
the right hemisphere, r = -.663, p < 0.05 uncorrected. UHDRS independence score 
was also correlated with free water fraction in the left cingulum, r = -.753, p < 0.05 
uncorrected, FDR-adjusted p > 0.05. 
Relationship between microstructure and composite 
cognitive scores 
Whole cingulum There was no correlation between composite cognitive 
scores and any of the measures in control or HD participants, all p > 0.05.  
Subgenual subdivision Restricted volume fraction, which was shown to be 
reduced in HD participants in the above section, was found to be correlated with 
cognitive functioning in HD participants specifically, r = .585, p < 0.05 uncorrected, 
with higher cognitive functioning associated with greater axon density in this sub-
division of the cingulum. The same relationship was not significant in control 
participants, r = -.463, p > 0.05.  
Retrosplenial subdivision There was no correlation between composite 
cognitive scores and any of the measures in control or HD participants, all p > 0.05. 
 
 
Discussion 
 
 
Although the neuropathological hallmark of HD is loss of medium spiny 
neurons in the striatum, there is increasing evidence that pathology also affects 
white matter; however there is no clear consensus on whether white matter 
damage is secondary to or independent of atrophy in the grey matter. The ability to 
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characterise white matter degeneration would improve our understanding of the 
evolving process of neurodegeneration in HD, and could potentially inform future 
trials in terms of cell populations to target. In order to probe the white matter, 
multi-modal MRI measures were used to gain both a sensitive and specific 
characterisation of tissue microstructure in key white matter pathways in the brain. 
This is the first study to apply the CHARMED model in HD in order to examine the 
intra-axonal compartment separately from the extra-axonal compartment, and is 
also the first study to apply multi-component relaxometry to examine myelin water 
fraction. 
 
Corpus callosum abnormalities  
 
In line with previous work using DTI-based tractography (Phillips, et al., 
2013), a reduction in FA was found in HD participants in the corpus callosum using a 
more advanced tractography algorithm capable of resolving crossing fibers within 
the voxel. Two different SD approaches were used and a reduction in FA in HD 
participants was found with both approaches. Constrained spherical deconvolution 
(CSD)-based tracking was sensitive to specific differences in callosal regions as seen 
in a previous study (O. Phillips, et al., 2013), whereas a general reduction in FA was 
found using damped Richardson-Lucy (DRL), an alternative SD approach. HD 
participants were also found to have increased mean diffusivity (MD) in the corpus 
callosum, whereas the component eigenvalues were not significantly affected. MD 
values were not reported in the previous work (O. Phillips, et al., 2013), although 
component eigenvalues AD and RD were reported, and both were found to be 
higher in HD compared to control participants.   
 
In terms of the clinical relevance of these findings, a higher disease burden, 
calculated from the individuals age and CAG repeat length, was associated with an 
increase in mean diffusivity (MD), specifically in the the 3rd and 4th segments, which 
contain inter-hemispheric connections to the primary motor and primary sensory 
cortex respectively. MD values were significantly higher in HD participants 
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compared to controls, thus establishing a relationship between disease burden and 
microstructural abnormalities in the corpus callosum in HD. This supports the 
findings of Phillips et al. (2013), in which a correlation between callosal FA and RD 
and disease burden was reported. Finally, higher MD values were associated with a 
reduction in cognitive functioning in HD participants only, demonstrating the 
functional relevance of the microstructural changes observed.  
 
Corticospinal tract 
 
The second pathway examined in this chapter was the corticospinal tract 
(CST), which is the main motor pathway in the brain. The only previous published 
work using deterministic tractography to reconstruct the CST in HD showed a 
reduction in FA and increase in axial and radial diffusivity in symptomatic HD 
patients compared to controls, with no difference in tensor based metrics between 
controls and pre-symptomatic HD (Phillips, et al., 2014). In this study, although MD 
was increased and both myelin water fraction and restricted volume fraction were 
reduced in HD participants compared to controls, this observation was only a trend 
and did not survive statistical significance. The sample size in this study was 
considerably smaller than that used by Phillips and colleagues (2014) and did not 
stratify HD participants as pre-symptomatic and early HD, which may explain the 
differences in results. However, in agreement with the previous study, a strong 
relationship was found between disease burden (CAG repeat length in conjunction 
with age) and both MD values and free water fraction in the CST, adding support to 
the idea that white matter abnormalities in the CST are a pathological feature of 
HD.  
Cingulum bundle  
 
Finally, the cingulum bundle was reconstructed using deterministic 
tractography for the first time in HD participants. The whole cingulum was 
reconstructed as well as the subgenual and retrosplenial subdivisions of the 
cingulum separately, based on work showing distinct fiber populations within the 
cingulum (Jones, et al., 2013), which may be differentially affected in HD. Whereas 
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there were no differences found between HD and control participants in the whole 
cingulum, mean diffusivity was found to be increased, radial diffusivity was found to 
be reduced, and restricted volume fraction, a non-tensor derived proxy of axon 
density, was found to be reduced (>15%) in HD participants compared to controls in 
the subgenual subdivision of the cingulum. There was also a trend for an increase 
free water fraction and a reduction in myelin water fraction (11-16% observed 
change) in this anterior portion of the cingulum. In contrast, there were no 
differences found between HD and control participants in the retrosplenial 
subdivision.  
 
These results support the work showing distinct fiber populations in the 
cingulum bundle (Jones, et al., 2013), and suggest the subgenual cingulum is 
selectively vulnerable to neuropathology in HD. This fits with evidence showing a 
direct disease process in the anterior cingulate cortices in HD. The anterior 
cingulate cortex has previously been shown to be selectively vulnerable to 
neurodegeneration in HD (Davies et al., 1999; E. H. Kim, et al., 2014), with 
dystrophic neurites (huntingtin protein aggregates formed in axons and dendrites) 
found in the cingulate of post-mortem HD brains (Cammarata, Caponnetto, & 
Tabaton, 1993). Furthermore, it is known that the medium spiny neurons which 
selectively die in HD receive dense innervation from the anterior cingulate cortex 
(van Dellen, Deacon, York, Blakemore, & Hannan, 2001). Thus, this work suggests 
that the white matter tracts running between the striatum and anterior cingulate 
cortex are also affected, and represents the first observation of distinct 
abnormalities in this pathway in humans. Furthermore, this is the first observation 
of a reduction in restricted volume fraction in HD, and suggests that changes to 
axonal structure contribute to white matter pathology in HD.   
 
The functional relevance of a reduction in restricted volume fraction was 
examined using a correlational analysis to probe the relationship with motor speed, 
motor functioning, cognitive functioning and total functioning capacity. Whereas 
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there was no relationship with any motor measurements in the subgenual 
cingulum, a selective association was found with cognitive functioning, with an 
increase in restricted volume fraction associated with an increase in cognitive 
functioning specifically in HD participants; thus axon density in this fiber population 
may be important for cognition in HD. Although free water fraction was not 
increased in the cingulum in HD participants, it was found to be associated with 
disease burden, finger tapping speed and UHDRS motor and independence scores 
in the whole cingulum, suggesting that free water fraction is sensitive to measures 
of clinical severity.  
 
Free water fraction as a biomarker of disease severity  
 
A novel finding to emerge from this work was the relationship between 
disease burden and free water fraction in HD participants in many of the fiber 
pathways studied. The relationship survived correction for multiple comparisons 
and was strongest in the corticospinal tract, with increased disease burden 
associated with an increase in isotropic partial volume. An increase in isotropic 
partial volume along a white matter pathway is suggestive of a reduction in packing 
density in the tissue, which may be due to a number of factors such as neuronal 
loss in neighbouring grey matter, and/ or white matter atrophy, such as a loss of 
axons or demyelination. This interesting and novel finding warrants further 
attention, but demonstrates the benefit of mapping the free water volume in 
diseases where atrophy is a pathological feature. Furthermore, considering that the 
DRL algorithm for whole-brain tractography recognises the contribution of isotropic 
partial volume effects to the signal, these results suggest that DRL is more 
appropriate for whole-brain tractography in the HD brain compared to CSD, based 
on the functional relevance of free water.  
 
A surprising finding in this study was the relationship between UHDRS 
scores which were recorded months before the scan session, and microstructural 
measures in relevant white matter pathways. In both the corpus callosum and the 
Chapter 4   2014
 
144 
 
cingulum, both of which are pathways known to contain distinct fiber populations, 
there was a strong relationship between free water fraction and total functional 
capacity. The Total Functional Capacity scale (Shoulson & Fahn, 1979) is the main 
assessment tool of functional status in HD clinical care and research, designed to 
assess progression of HD in symptomatic patients with emphasis on self-care, 
mobility, and independence. The direction of the relationship indicated that 
impaired functional capacity was associated with an increase in free water in the 
corpus callosum, whereas independence in terms of self-care was associated with 
free water fraction in the cingulum. This may reflect the multiple cognitive domains 
that contribute to everyday functioning and independence, and the effect of 
mutant huntingtin on the multiple fiber populations that are contained within these 
two white matter pathways, although this warrants further investigation. White 
matter microstructure was also found to be functionally significant in the motor 
domain in HD participants, with strong relationships found between UHDRS motor 
scores and MR measures obtained along the corpus callosum and cingulum bundle. 
In the corpus callosum, there was a discrepancy between the two different tracking 
algorithms in terms of which measures were correlated, however strong 
relationships emerged for both algorithms.  
 
Non-tensor based microstructure metrics 
 
The differences seen in myelin water fraction, obtained using multi-
component relaxometry, and in restricted volume fraction, obtained using a multi-
shell diffusion MR sequence, require further study and attention. The significant 
reduction in restricted volume fraction of more than 15% found selectively in the 
subgenual cingulum in HD participants, and the trend for a reduction in restricted 
volume in HD participants in the corpus callosum suggests that axonal structure is 
affected in HD pathology at this early stage of the disease.  Thus, this work affirms 
the importance of going beyond the diffusion tensor and using more advance non-
tensor based acquisitions in clinical research. The relationship found between 
restricted volume fraction and both UHDRS motor scores and disease burden in the 
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corpus callosum, and between restricted volume fraction and cognitive functioning 
in the subgenual cingulum in HD participants, demonstrates that this metric is not 
only sensitive to differences between groups, but also sensitive to markers of 
clinical functioning and severity in HD. The differences seen in myelin water fraction 
between HD and control participants were also large (more than 10% difference), 
although not significant when correcting for multiple comparisons. Recently 
published work using R2* relaxometry found lower R2*(a marker of iron 
concentration) in the isthmus of the corpus callosum in early HD (Di Paola et al., 
2014), suggesting myelin may be affected in the corpus callosum in HD. In healthy 
control participants, myelin water fraction was found to be related to finger tapping 
speed in the subgenual division of the cingulum, and to cognitive functioning in the 
corpus callosum.  
 
Taken together, these findings are promising in terms of increasing the 
biological specificity to understand how HD affects white matter microstructure, 
and require further attention in a larger sample size. 
 
Choice of tracking algorithm  
 
Previous studies have been reliant on the diffusion tensor model to conduct 
whole brain tractography, despite the well-established limitations with this 
approach. A comparison of measures obtained from tracts sampled using the 
tensor model and the two difference SD approaches found that FA values in the 
corpus callosum obtained from DTI tracking were significantly higher than 
corresponding FA values obtained using both of the SD approaches, with no 
significant differences found between the two SD approaches. Recent work 
estimates that 90% of white matter voxels contain crossing fibers (Jeurissen, 
Leemans, & Tournier, 2010), suggesting that the diffusion tensor model is 
inadequate in the vast majority of white matter regions. Considering this, the 
current work showing that tractography performed using the tensor model leads to 
statistically different results compared to tractography algorithms capable of 
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resolving crossing fibers has serious implications for the interpretation of previous 
work showing changes in anisotropy and diffusivity measures in HD.  
 
Methodological considerations 
 
A strength of this work is that unlike previous studies, all of the tensor-
based metrics presented in this chapter have undergone correction for partial 
volume effects due to intra-voxel contamination by cerebrospinal fluid (CSF). The 
replication of previous findings in the corpus callosum (Phillips, et al., 2013) after 
correcting for partial volume demonstrates that white matter microstructural 
abnormalities in HD are a robust finding. The CHARMED model also includes a 
partial volume correction stage, whereas the code used to create myelin water 
fraction maps did not contain a compartment to model free water, which is likely to 
lead to an underestimation of myelin water fraction. Recent optimisation work has 
included a free water component in the mcDESPOT pipeline (Deoni, Matthews, & 
Kolind, 2013), and was shown to perform advantageously within partial volume 
regions. Thus, future work will involve repeating the analysis with the optimised 
code in order to achieve a more accurate estimate of myelin water fraction.  
 
A discrepancy in findings for metrics sampled using either DRL or CSD 
tracking algorithm was observed and is likely driven by a difference in statistical 
power. The sample size was marginally higher for tracts obtained using DRL 
compared to tracts reconstructed using CSD. This was because whole-brain tracking 
with CSD occasionally failed to reconstruct any tracts for a given pathway, whereas 
DRL was capable of recovering tracts more often. One reason for this difference is 
the different way in which partial volume effects are treated by the two algorithms. 
Whereas CSD uses a non-negativity constraint to reduce spurious fiber orientations, 
the damped Richardson-Lucy algorithm recognises the contribution of isotropic 
partial volume effects to the signal, and addresses this using adaptive regularization 
(Dell'acqua, et al., 2010), resulting in a reduction in the number of false positives 
and spurious fiber orientations in areas of partial volume without a cost to angular 
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resolution. In comparison, in areas of partial volume, CSD will not be able to 
adequately recover fiber orientations, producing erroneous results. This may 
explain why the cingulum reconstructions were particularly poor with CSD, with 
sub-cortical atrophy increasing the partial volume effects which would have 
affected the ability to reconstruct the subgenual subdivision of the cingulum. Thus, 
the differences seen between metrics sampled using CSD and DRL are likely due to 
differences in statistical power due to reduced numbers with CSD sampling, and 
differences in terms of accuracy in reconstructing the pathway of interest.  
 
Statistical power was affected by the methodological decision to conduct 
the tractography on a higher b-value image more suited for recovering fiber 
orientations through spherical deconvolution approaches, and then to extract the 
tensor based statistics from a lower b-value image optimized for DTI. Although 
striving for greater accuracy by using the sequences in the most optimal way, in 
practice, this meant that two complete data sets acquired with different sequences 
were required from each participant in order to gain a measure for each tract. In 
practice, with some images suffering motion artefacts, it was not always possible to 
use both images, which became problematic for achieving statistical power with a 
small sample size.  
 
Concluding comment 
 
This chapter has shown that the structural connectivity of both the corpus 
callosum and the cingulum bundle is altered in Huntington’s disease. This work 
adds a key finding to the literature with regards to the relationship between free 
water along white matter pathways and disease burden in HD, and suggests 
researchers should be both aware of, and take steps to address the issue of free 
water contamination in their analysis of diffusion MR data in Huntington’s disease. 
This work is the first to reconstruct the cingulum bundle as a distinct white matter 
fiber in HD, and using a multi-shell diffusion MRI sequence, found specific changes 
in a proxy measure of axon density. Finally, the relationship between metrics in 
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both the corpus callosum and cingulum and UHDRS clinical scores suggests an 
important functional role for these white pathways in HD.  
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5 Moving beyond volume: Macrostructural 
changes in Huntington’s disease  
 
Chapter Summary 
 
The purpose of this chapter was to quantitatively examine the differences in 
grey matter morphometrics obtained from T1-weighted MRI in patients with 
Huntington’s disease (HD) compared to healthy matched controls. The second aim 
was to assess the correlation between different measures of grey matter 
macrostructure and cognitive performance, motor function and disease burden in 
HD. 
Data analysis was conducted using a variety of approaches, including whole-
brain exploratory VBM, a region-of-interest (ROI) analysis, a surface-based analysis 
of cortical thickness, surface area and curvature, and shape based analysis of 
subcortical regions implicated in HD.  
Introduction 
 
In Chapter 1 the background literature on macro-structural changes 
previously found in HD was reviewed. The focus of research using T1- and T2-
weighted MRI in HD has predominantly been looking at regions of atrophy in 
relation to disease stage, in order to gain an understanding of the pattern of 
atrophy with disease progression. Overall, this literature suggests that whereas HD 
affects both the grey and white matter in terms of volumetric change, the rate of 
atrophy in white matter does not follow the same course as grey matter atrophy in 
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HD, with white matter atrophy beginning earlier in life prior to symptom onset, 
with less prominent changes in global grey matter volume at this stage.  
 
To examine changes in local volume, either a whole-brain hypothesis-free or 
a region-of-interest hypothesis-driven approach can be taken. Given the specific cell 
loss that is known to occur in the striatum and cerebral cortex, a region-of-interest 
(ROI) based analysis would arguably be most appropriate in HD (Aylward, et al., 
2000). For example, ROI analyses of T1-weighted images from pre-symptomatic HD 
participants from multiple research sites worldwide (n > 500) found that the 
volume of basal ganglia structures contributed more highly to the prediction of 
most motor and cognitive variables than volumes of other brain regions (Aylward et 
al., 2013). 
 
However, work showing more widespread changes in HD (Kassubek et al., 
2004; Wolf, et al., 2009) and the concept of compensatory networks in response to 
neurodegeneration (Klöppel et al., 2009) has also justified more exploratory whole-
brain approaches. Voxel based morphometry (VBM) is an automated whole-brain 
approach that allows for the anatomical localisation of differences in volume 
between two groups (Ashburner & Friston, 2000) and has been applied in a number 
of studies of HD (Hobbs, et al., 2010; Kassubek, et al., 2004; Scahill et al., 2013;  
Wolf, et al., 2009; Wolf et al., 2013). One of the limitations of VBM is that the 
accuracy of the spatial normalisation affects the results. Furthermore, there are 
inconsistencies in the way in which VBM is applied across studies. The implications 
of these inconsistencies was demonstrated in a HD dataset where it was shown that 
changing user-specified options (e.g. smoothing kernel size, software version) can 
alter the results in a way that is similar to the biologic differences being examined 
(Henley et al., 2010; Jones, Symms, Cercignani, &  Howard, 2005; Jones,  Symms,  
Cercignani, & Howard, 2005). Thus, the robustness of results obtained using VBM is 
questionable and would be strengthened by the convergence of results using 
different analysis techniques and software packages.  
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Examining the shape of specific brain structures may be an additional 
informative metric to understand how HD progresses and the relevance of 
structural changes to disease-related symptoms. Shape-based deformation analysis 
examines the localised change in the outer surface of structures and can inform on 
both the location and pattern of changes. For each participant, the displacement of 
the surface of structures can be measure against a deformable surface mesh model 
that is based on the average segmentation for all participants. Displacement of the 
surface can be inwards, representing atrophy, or outwards, representing 
hypertrophy. Considering the specific efferent and afferent connections to different 
areas within a structure, such as the sub-nuclei of the thalamus, understanding 
localised changes within a structure may be informative in terms of interpreting 
white matter changes and understanding the neural basis of specific symptoms. To 
the best of this author’s knowledge, shape analysis has only been applied in two 
studies in HD (van den Bogaard et al., 2011; Younes et al., 2014). In pre-
symptomatic HD small areas of inward displacement (representing atrophy) were 
found in the putamen, pallidum, accumbens and caudate nucleus, with the most 
pronounced inward displacement evident in the caudate and putamen in HD 
participants closest to expected diseased onset (van den Bogaard, et al., 2011). 
 
Cortical atrophy is well-documented as a site of HD pathology and there are 
a number of measurement tools available to examine changes specifically in the 
cerebral cortex. Although cortical neuronal loss is less severe than striatal neuronal 
loss, post mortem studies have reported approximately a 30% reduction in neurons 
in neocortical regions, including the associative frontal, temporal and parietal 
regions, and primary somatosensory cortices (Heinsen et al., 1994). Research in 
post-mortem brains has shown that degeneration of cortical neurons follows a 
specific pattern, with large projection neurons specifically vulnerable, especially in 
layers V and VI and to a lesser extent in layer III (Hedreen, Peyser, Folstein, & Ross, 
1991; Macdonald & Halliday, 2002), as well as in the primary motor cortex and the 
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premotor area (Macdonald & Halliday, 2002; Thu, et al., 2010). However, 
postmortem cytoarchitectural measurements have a number of limitations, with 
artefacts associated with the tissue fixation process, limited ante-mortem 
characterization, and a bias towards the late disease stage.  
 
 Thus, the availability of imaging software to generate surface-based cortical 
representations overcomes both the limitations of post-mortem studies and the 
limitations of volume-based representations. Cortical volume is influenced by both 
cortical thickness and surface area (Qiu et al., 2014), with cortical volume driven 
mostly by cortical surface area rather than cortical thickness (Im et al., 2008; 
Pakkenberg & Gundersen, 1997; Winkler et al., 2010). There is a large variability in 
the pattern of gyral folding across individuals and twin studies have provided 
evidence for a genetic influence on sulcal patterning (Im et al., 2011). Changes in 
cortical thickness may reflect a change in the size, density and arrangement of 
neurons, dendritic arborisation, change in myelination, and neuroglia, and 
therefore measuring cortical thickness can provide unique and important 
information about the effects of HD on cortical neuroanatomy not captured by 
cortical volume alone. The Freesurfer surface-based segmentation package was 
applied in this study, which uses the major sulcal and gyral patterns for inter-
subject registration and overcomes some of the limitations of VBM in terms of 
spatial normalisation. Previous analysis of cortical thickness using the PREDICT-HD 
multi-site database with more than 500 T1-weighted images from pre-symptomatic 
HD participants found that changes in cortical volume began to appear in 
participants who were classified as ‘midway to symptom onset’ with atrophy found 
mostly in the posterior and superior cerebral regions. With increased disease 
progression, changes were more evident in cortical thickness compared to surface 
area, with fewer changes in ventral and medial regions of the frontal and temporal 
cortex (Nopoulos, et al., 2010).  
Thus, there is a range of techniques available to examine grey matter 
macrostructure beyond changes in regional volume. However, each analysis 
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approach and corresponding software package comes with its own set of 
limitations. Combining different analysis methodologies to look for the convergence 
of results will improve the robustness of findings; the convergence and consistency 
of findings is important in a heterogeneous condition such as Huntington’s disease. 
The first aim of this chapter was to test whether macrostructural results obtained in 
this specific HD cohort converge to replicate findings in the literature using a range 
of analysis techniques. HD is a heterogeneous condition and in order to be able to 
interpret findings obtained from more novel MRI acquisition sequences and 
analysis techniques, it is important to ascertain how comparable the recruited HD 
cohort is in comparison to other studies. A second aim was to examine the 
relationship between tissue macrostructure and cognitive function, using a 
validated cognitive test battery that has not been applied in HD previously. It is 
known from previous studies that cognitive measures correlate with structural 
changes in HD, therefore this chapter aims to examine whether the specific battery 
used in this thesis can reflect changes in tissue macrostructure.  
Methods  
 
Participants and Data Acquisition 
 
17 HD gene-positive participants and 18 healthy controls participants had a 
T1-weighted structural MRI scan on a 3T GE system; methodological details can be 
found in Chapter 2. Scans of the two groups (HD gene positive vs. controls) were 
acquired in an interleaved fashion. For the HD gene-positive participants, a disease 
burden score was calculated as a measure of disease severity, according to the 
previously described formula (age × [CAG-35.5]), where CAG is the number of CAG 
repeats (Penney, et al., 1997). 
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Cognitive Scores 
 
The composite cognitive scores were used to examine the relationship with 
tissue macrostructure. Details of the principal components analysis to produce the 
composite scores can be found in Chapter 3.  
 
Region-of-Interest (ROI) Analysis  
 
Macrostructural changes are strongly hypothesised in the basal ganglia, thus 
a region of interest approach was used to examine changes in these areas. 
However, because HD is known to also affect more widespread areas to a lesser 
extent, exploratory whole-brain analyses were also conducted. 
 
Image Segmentation Image processing and analysis was performed 
using Freesurfer version 4.4.0 (Dale, Fischl, & Sereno, 1999; Fischl et al., 2002; 
Fischl, Sereno, & Dale, 1999). To cross-validate the segmentation results, the FMRIB 
Integrated Registration and Segmentation Tool (FIRST), a model-based 
segmentation/registration tool, was also used to generate subcortical region-of-
interest (ROI) masks from each participant's T1 anatomical image using FMRIB 
Software Library (FSL) version 5.0.1 (S. M. Smith et al., 2004). The Freesurfer image 
analysis package (http://surfer.nmr.mgh.harvard.edu/) was used for cortical 
reconstruction and parcellation of the cortex using the Desikan–Killiany atlas for 
each participant. These cortical and subcortical structure parcellations were then 
used for the volumetric analysis and vertex-based analysis. The rationale to use FSL 
FIRST and Freesurfer as registration and segmentation tools was that both tools 
have an automated set-up and therefore offer an unbiased approach.  
 
ROI Volume Analysis  ROI and intracranial volumes were calculated from 
the T1-weighted segmentations using Freesurfer (Dale, et al., 1999). Grey matter 
volume was examined in 10 ROI’s: the cerebral cortex, cerebellar cortex, thalamus, 
caudate, putamen, globus pallidum, nucleus accumbens, amygdala, hippocampus 
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and the brainstem. The hippocampus and amygdala were control regions, where 
atrophy relative to intracranial volume was not expected. 
 White matter ROI’s were cerebral white matter, cerebellar white matter, 
and the corpus callosum (anterior, mid-anterior, central, mid-posterior, posterior 
sub-sections). 
Sub-cortical ROI’s obtained from the FSL segmentation were the thalamus, 
caudate, putamen, globus pallidum, nucleus accumbens, amygdala and the 
hippocampus. Brain tissue volume and total grey and white matter volumes, 
normalised for subject head size, were estimated with SIENAX (S. M. Smith et al., 
2002), part of FSL (S. M. Smith, et al., 2004). All registrations and segmentations 
were visually inspected for accuracy.  
 
Vertex-Based Shape Analysis  To investigate localised shape 
differences in the basal ganglia and thalamus, a vertex-based analysis was 
performed which examined group differences using permutation testing 
(randomise, FSL) making use of the segmentations acquired from FIRST (FSL). FIRST 
creates a surface mesh for each subcortical structure using a deformable mesh 
model. The mesh is composed of a set of triangles and the apex of adjoining 
triangles is called a vertex. The number of vertices for each structure is fixed. In 
order to investigate group differences, the surfaces were aligned (rotation and 
translation, minimising sum-of-squares difference) to MNI152 space.  
Group comparisons of vertices were carried out using randomise (FSL) (Winkler, 
Ridgway, Webster, Smith, & Nichols, 2014), with the statistics rendered onto the 
shape surface (see Figure 5.1) to represent the signed, perpendicular distance from 
the average surface, providing a map of the localised regions where the structure 
changed significantly between groups. The results were corrected for multiple 
comparisons using the family-wise error (FWE). Again, the hippocampus was a 
control region where no group differences were expected.  
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Exploratory Analysis 
 
Surface-based Cortical Morphometry.  The automated Freesurfer 
pipeline was used to extract measures of cortical thickness, surface area and 
curvature. Processing steps included registering to a template image, intensity 
normalisation, removal of non-brain tissue, automated Talairach transformation, 
segmentation of white matter, and then the identification of the grey matter (GM) 
and white matter (WM) boundary and the pial surface (Dale, et al., 1999; Fischl, et 
al., 1999) using a tessellation technique. Neighbourhood intensity information was 
used to identify likely white matter voxels. White matter and pial surfaces were 
constructed after refining the initial surfaces generated for each hemisphere using 
surface deformation to optimally place the borders between grey and white matter, 
and between grey matter and CSF at the location where the greatest shift in 
intensity defines the transition to the other tissue class (Fischl & Dale, 2000). 
Cortical thickness is defined by Freesurfer as the average of the distance between 
the pial surface and the GM-WM boundary and the distance between the GM-WM 
boundary and the pial surface (Fischl & Dale, 2000) and was examined across every 
vertex. The surface area was computed from the surface at the boundary between 
WM and GM. The curvature was measured as 1/r, where r is the radius of an 
inscribed circle. 
 
Figure 5.1 Schematic of analysis pipeline for shape analysis performed using 
FMRIB S ftware Library (FSL) version 5.0 
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Voxel-Based Morphometry (VBM) To examine the relationship 
between gene status and volume across the whole brain without specific a priori 
regions of interest, VBM was used. VBM was performed using VBM8, a toolbox in 
SPM (version 8), and analysis followed a number of stages:  
 Images were visually inspected to ensure an appropriate level of alignment 
(within 5 cm and 20°) to a template image released with SPM.  
  T1 images were non-linearly normalised using high-dimensional DARTEL 
(Ashburner, 2007) to the Montreal Neurological Institute (MNI) ICBM 
European brain template space with 6 iterative steps. The DARTEL template 
used for the normalisation was derived from 550 healthy controls subjects 
from the IXI--‐database (http://www.brain-development.org).  
 Images were then segmented into GM, WM and CSF. Segmentation 
parameters include a very light bias regularisation (0.0001), a 60mm bias 
FWHM cut-off, warping regularisation of 4 and a sampling distance of 3 mm. 
The segmentation approach was based on an adaptive Maximum A 
Posterior (MAP) technique, whereby local parameter variations are 
modelled as slowly varying spatial functions (Rajapakse et al.1997). A priori 
information about tissue probabilities is not required and tissue probability 
maps are used only for the spatial normalisation step and not for 
segmentation as was the case in earlier VBM toolboxes.  
 In order to correct for changes in brain volume caused by the non-linear 
spatial normalisation, a non-linear modulation processing step was used so 
that comparisons could be made between absolute volumes of GM or WM 
structures. Thus, using the Jacobian determinants of the deformation field, 
images were scaled by the amount of contraction that occurred during 
normalisation so that the total amount of grey matter remains the same as 
in the original images. 
  A quality check of the segmented and normalised images was conducted.  
 Normalised segmented images were then smoothed through convolution 
with a Gaussian kernel with a Full-Width at Half-Maximum (FWHM) of 10 
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mm, in order to be comparable with the cortical thickness analysis, which 
also used a 10 mm smoothing kernel. Previous research studies in HD have 
also used a 10 mm kernel (Gavazzi et al., 2007; Jech, et al., 2007; Ruocco, 
Bonilha, Li, Lopes-Cendes, & Cendes, 2008; Thieben et al., 2002) although 
there is no consensus or consistency in the kernel size used in HD research 
(Henley, et al., 2010). 
 
 After carrying out the statistical analysis, coordinates of significant voxels 
were given in MNI space. In order to obtain an estimate of Talairach coordinates, a 
non-linear transform was implemented using a Matlab code provided at 
www.imaging.mrc-cbu.cam.ac.uk (Calder, Lawrence, & Young, 2001; Duncan et al., 
2000). Talairach software was then used to obtain neuroanatomical labels 
(Talairach Client) and these labels were checked for accuracy in the original 
statistical maps.  
 
Statistical Analysis 
 
The different types of analysis methods require different statistical 
approaches, with the number of multiple comparisons differing dramatically 
depending on whether the analysis is based on a priori ROI’s or is an exploratory 
whole-brain approach. Although it is preferable to use the same approach to 
conduct multiple comparison corrections throughout, this has not been possible 
due to software restrictions which only allow for a specific type of correction. Thus, 
a mixture of the family-wise error (FWE), which reduces the probability of any false 
discoveries, and the less-stringent false-discovery rate (FDR), which is concerned 
with the expected proportion of false discoveries, and has greater power but an 
associated increased rates of Type I errors, were used. For both multiple 
comparison correction approaches, statistics were corrected by controlling the FWE 
rate or FDR at 5%. 
Differences in ROI volume were investigated using analysis of variance 
(ANOVA) in SPSS (IBM Statistics 20), with the within factors ‘laterality’ (left, right 
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hemisphere) and the between group factor ‘gene status’ (HD gene positive, control 
gene-negative). For the corpus callosum ROI analysis, corpus callosum segment 
(anterior, mid-anterior, central, mid-posterior, posterior sub-sections) was a within-
subject factor. To normalise for age-related structural changes, age was added as a 
covariate. To normalise for inter-individual variations in head size, regional volumes 
obtained from Freesurfer were analysed with ICV as a covariate, whereas regional 
volumes obtained using FSL were analysed with total brain volume as a covariate. 
This was to ensure that the two software packages were being compared in their 
entirety, rather than use a statistic obtained from one package as a covariate in an 
analysis of regional volumes produced by a different package, introducing bias and 
reducing the ability to compare across packages. However, the consequence of this 
is that the interpretation of any group differences is not directly comparable; 
Freesurfer does not produce a whole brain volume estimate, and ICV includes all 
tissue and CSF below the skull, thus is more representative of pre-morbid brain 
volume rather than FSL’s whole brain volume, which will be more sensitive to whole 
brain atrophy caused by disease. Statistics were FDR-corrected for multiple 
comparisons.  
 
Local displacement (inwards or outwards) in shape of sub-cortical structures 
between groups was investigated using permutation testing (randomise, FSL), with 
a single F-contrast testing for group differences. Statistics were corrected for 
multiple comparisons by controlling the FWE rate. An arbitrary threshold of 6 was 
used to form supra-threshold clusters of voxels using the null distribution of the 
maximum cluster size across the image.  
To examine surface-based differences in cortical thickness, analysis was 
carried out using a general linear model (Qdec v1.2, Freesurfer) co-varying for age, 
with a FWHM smoothing of 10mm. Multiple comparisons were taken into account 
by controlling the FDR. The relationship between cortical thickness and disease 
burden in the patient group was examined using a correlational analysis. 
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Correlations between MRI findings and cognitive measures were examined 
in order to understand the functional relevance of any structural abnormalities. The 
composite cognitive score from the PCA was partially correlated with the grey 
matter and white matter volume measures, controlling for age and intracranial 
volume using SPSS.  
Statistical testing for the VBM analysis was conducted using SPM8. A 
between-subject two-tailed T-test was conducted with age and ICV as covariates, 
due to the range of ages in both groups. Both the uncorrected (p < 0.001) and FWE-
corrected p values are reported at the voxel-level and cluster level.  
Results  
 
Atrophy in HD patients 
 
Both the VBM and the ROI analyses were used to examine changes in 
volume between HD and healthy control participants. Results from the VBM 
analysis are shown in Figure 5.2. In order to cross-validate results in the ROI 
analysis, sub-cortical segmentation was conducted using two different software 
packages (FSL FIRST vs. Freesurfer). Table 5.1  shows the comparative p-values of 
the two software packages; a mixed-model ANOVA found a significant difference in 
the caudate and pallidum measures produced by the segmentation pipeline 
implemented in Freesurfer compared to FSL, with Freesurfer producing smaller 
estimates. As shown in Figure 5.3, there was no difference in intracranial volume 
(Freesurfer) between HD patients and controls, F (1, 32) = 1.43, p >0.05, whereas 
HD patients had reduced whole brain volume (FSL) of -5.8% compared to controls 
and grey matter atrophy was evident (-4.9%), F (1, 32) = 6.26 and 10.25, p < 0.05.  
 
Sub-cortical atrophy  Descriptive statistics from the ROI analysis are 
presented in Table 5.2. HD patients had significant atrophy in the caudate, 
putamen, thalamus, pallidum, nucleus accumbens and brainstem, F (1, 32) = 9.90,  
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Figure 5.2 Results of VBM Analysis. A) Grey and matter volume differences in HD 
patients, T (31) = >3.37, p < 0.001 uncorrected B) Location of significant grey 
matter clusters, C) significant white matter clusters, and D) clusters of significant 
correlation with disease burden. Clusters significant at FWE-adjusted p < 0.05. All 
statistics shown overlaid on an average T1-template image provided by SPM99 
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21.86, 8.76, 36.02, 6.81, and 12.74, respectively, p < 0.05 FDR-corrected. There was 
no difference in volume in the amygdala and hippocampus, all p > 0.05. Despite the 
differences in volumetric measures between Freesurfer and FSL, cross-validation 
with FSL also revealed sub-cortical atrophy in the HD patients in the caudate, 
putamen, thalamus, pallidum and nucleus accumbens, F(1, 32) = 11.24, 23.49, 
14.49, 17.20 and 6.81, respectively, p < 0.05 FDR-corrected, with no differences in 
the amygdala, and hippocampus, all p > 0.05.The ROI comprising the brain stem 
combined with the fourth ventricle did not differ in volume between the HD 
Table 5.1 Mixed model ANOVA results of group differences in sub-cortical 
volume based on segmentation software package. FDR-adjusted p-values * p < 
0.05, ** p < 0.01, *** p < 0.001 
Figure 5.3 Total grey matter (GM), white matter (WM), whole brain volume and 
intracranial volume (ICV) in HD patients and healthy controls.  Values shown are 
the observed unadjusted mean values. GM, WM and whole brain volumes from 
FSL analysis; ICV from Freesurfer (cm3). Error bars represent ± standard error of the 
mean. Significance is after correction for age and multiple comparisons, * p < 0.05. 
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patients and controls, p > 0.05. The magnitude of differences between HD patients 
and controls is shown in Figure 5.4 for both software segmentations.  
 
A reduction in subcortical grey matter (GM) was also found in HD 
participants in the VBM analysis at an uncorrected p value < 0.001 (FWE-corrected 
p>0.05). At the cluster level, significant clusters of volume change which survived 
FWE-correction were found bilaterally in the basal ganglia, with the left hemisphere 
cluster (size = 17980) in the caudate head (MNI coordinates [x,y,z]= -12 22 -2), 
lateral globus pallidus (16 2 -9 mm) and putamen ( -15 8 -2 mm) , and the right 
hemisphere cluster (size = 18890) in the right putamen and caudate head (MNI 
coordinates 12 8 -4; 6 10 4 ; 10 20 1 mm).  
 
Cortical atrophy There was no difference in volume in the cerebellum or 
cerebral cortex as calculated using ROI’s from Freesurfer software, p > 0.05. In the 
VBM analysis, a significant difference in volume was found in a cluster (size=13310) 
in the right superior temporal gyrus / Brodmann area 13/22 (MNI 57 -16 3 mm, 
Talairach 56 -15 4), p < 0.05 FWE-corrected.  
 
White Matter atrophy  HD patients had significant atrophy in the 
cerebral white matter and corpus callosum compared to controls, F(1, 31) = 10.16 
and 6.78 respectively, p < 0.05 FDR-corrected. There was no main effect of callosum 
segment, and no interaction between corpus callosum segment and gene status, 
both p > 0.05. There was no difference in white matter volume in the cerebellum, F 
(1, 31) = 1.82, p > 0.05. In the VBM analysis, a significant cluster which spanned 
both hemispheres and survived FWE-correction at p < 0.05 was found in the sub-
cortical WM of the basal ganglia and temporal lobe. Segmenting the brain using FSL 
software also revealed white matter atrophy (-6.7%) in the HD patients (normalised 
for head volume) compared to controls, F (1, 28) = 7.23, p < 0.05. 
 There was no correlation between grey matter and white matter volume in 
the control group (r (18) = 0.45, p > 0.05) or in the HD group, r (17) = 0.18, p > 0.05. 
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Figure 5.4 Percentage magnitude of sub-cortical atrophy in HD patients compared 
to controls depending on the software package used for segmentation  
 
Table 5.2 Descriptive statistics for raw volume measures (mm3) from segmented 
images (Freesurfer). † Measured across hemispheres. S.E.M : standard error of the 
mean. WM: white matter.  
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Relationship between volume and motor functioning  The 
average result from the Speeded Tapping Test (Reitan, 1979) was used as a 
measure of motor speed. The UHDRS motor score was used as a measure of overall 
motor functioning, whereas the UHDRS Total Functional Capacity (TFC) score was 
used as a more general measure of functioning not restricted to the motor domain. 
Partial correlations were conducted with age and either intracranial volume (for 
Freesurfer volumes) or total brain volume (for FSL volume) partialled out.   
 
When volumes were calculated using the Freesurfer segmentation pipeline, 
average finger tapping speed for HD participants was correlated with volume in the 
left and right putamen (r = 0.743 and 0.734 respectively, p < 0.1 uncorrected), 
although neither result survived correction for multiple comparisons using the FDR, 
p = 0.084 for both hemispheres. In healthy control participants, finger tapping 
speed was negatively correlated with volume in the left cerebral cortex (r = -.807, p 
< 0.01 uncorrected), and the right caudate (r = .861, p < 0.01 uncorrected), although 
neither result survived correction for multiple comparisons using the FDR, p = 0.081 
and 0.054 respectively. When volumes were calculated using the FSL segmentation 
pipeline, finger tapping speed in HD participants was significantly positively 
correlated with volume in the left and right putamen (r = .73 and .79 respectively), 
left and right caudate (r = .70 and .71 respectively), left and right thalamus (r = .67 
and .72 respectively) and in the left and right globus pallidum (r = .66 and .70 
respectively), all p < 0.05 FDR-corrected. There were no significant correlations 
between finger tapping speed and regional volume in the control participants, all p 
> 0.05.   
 For the UHDRS motor score, a strong negative relationship between motor 
score (high score = more motor impairments) and volume was found in the left and 
right putamen (r = -.812 and -.795, p < 0.05 FDR-corrected) the left and right globus 
pallidum (r = -.791 and -.793 respectively, p < 0.05 FDR-corrected) and in the right 
caudate (r = -.728, p < 0.05 FDR-corrected), as calculated using Freesurfer. When 
using volumes segmented using the FSL pipeline, the same regions were 
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significantly correlated, whereas additional significant correlations were found with 
left caudate volume (r = -.75), left and right thalami volume (r = -.68 and -.67 
respectively), and volume in the left nucleus accumbens (r =-.72), all p < 0.05 FDR-
corrected.  
Similarly, for the Total Functioning Capacity (high score = higher functional 
capacity), a strong positive relationship was found with putamen volume in the left 
and right hemisphere (r = .802 and .74, p < 0.05 FDR-corrected), and with globus 
pallidum volume in the left and right hemisphere (r = .739 and .727, p < 0.05 FDR-
corrected) when calculated using Freesurfer. When using volumes segmented using 
the FSL pipeline, a strong positive relationship was also found with putamen 
volume in the left and right hemisphere (r = .75 and .77), whereas the left nucleus 
accumbens was also positively correlated with TFC score (r = .82), all p < 0.05 FDR-
corrected.  
Using VBM, at the voxel level, finger tapping speed was positively correlated 
with volume in a cluster in the left inferior occipital gyrus in HD participants, t (12) = 
5.71 at peak voxel, k = 790, p < 0.05 FWE- and FDR-corrected. In control 
participants, there was no correlation between finger tapping speed and volume at 
the voxel-wise level after correcting for multiple comparisons, p>0.05. In HD 
participants, UHDRS motor score was negatively correlated with volume in clusters 
encompassing the left caudate head, medial globus pallidum and putamen (t (13) = 
6.10 at peak voxel, k = 2409), right caudate tail (t (13) = 7.07 at peak voxel, k = 860) , 
and right putamen and ventral posterior medial nucleus of the right thalamus (t 
(13) = 4.06 at peak voxel, k = 14640), all p < 0.05 FWE- and FDR-corrected. A 
positive correlation was found between UHDRS motor score and volume in a cluster 
in the right posterior lobe of the cerebellum, t (13) = 4.26 at peak voxel, k = 1539, p 
< 0.005 FWE- and FDR-corrected. For Total Functioning Capacity (TFC), a strong 
positive correlation was found with volume in clusters encompassing the left 
inferior occipital gyrus ( t (13) = 8.19 at peak voxel, k =5943), right inferior frontal 
gyrus and caudate body (t(13)=7.44, k=2528), left caudate head and amygdala 
(t(13)=7.26, k=6214), right paracentral lobule (Brodmann area 5 and 31), 
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(t(13)=7.10, k=1145) and right posterior insula and primary somatosensory cortex 
/postcentral gyrus (t(13)=6.02, k=1268), all p < 0.01 FWE- and FDR-corrected. 
 
Relationship between volume and cognitive performance  
When examining the relationship with cognitive functioning, partial correlations 
were conducted using the composite cognitive scores from chapter 3, with age and 
either intracranial volume (for Freesurfer volumes) or total brain volume (for FSL 
volume) partialled out. For the HD participants, there was a strong and significant 
correlation between composite cognitive functioning and left hippocampal volume 
obtained using Freesurfer, r = 0.832, p < 0.05 FDR-corrected.  The same relationship 
was not found in control participants, r = -0.043, p > 0.05. There was no correlation 
between composite cognitive scores and corpus callosum volume, cerebral white 
matter volume or cerebellum white matter volume, all p > 0.05. For volumes 
obtained using FSL segmentation, and adjusted for age and whole brain volume, 
non-significant yet moderate correlations were found with cognitive functioning in 
the right caudate and putamen and left hippocampus r = 0.571, 0.599 and 0.531 
respectively, p > 0.05. Total white matter volume and total grey matter volume 
were both correlated with composite cognitive scores in HD participants, r = -.645 
and 0.645 respectively, and in control participants, r =-.621 and 0.621, p < 0.05 
uncorrected, all p > 0.05 FDR-corrected. 
 
Using VBM, at the voxel level a number of widely distributed voxels showed 
a significant correlation in both the HD participants and healthy controls at p < 
0.0001 uncorrected. In the HD participants at the voxel level, a correlation that was 
approaching the FWE-significance threshold (p = 0.097) was found in the right 
inferior temporal gyrus corresponding the Brodmann area 19, t (11) = 5.45, z = 5.08, 
p < 0.0001 uncorrected. This same correlation was significant at the cluster level, t 
(11) = 4.02, k = 38, p < 0.001 FDR- and FWE-adjusted. Volume in a second cluster 
was also found to be positively correlated with cognitive function in HD 
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participants, in the right medial frontal gyrus, corresponding to the Brodmann area 
8, t (11) = 4.02, k = 26, p < 0.05 FDR- and FWE-corrected.  
In the control participants, analysis at the cluster-wise level found a positive 
correlation between cognitive scores and a single cluster in the grey matter in the 
right occipital lobe corresponding to Brodmann area 8 / visual association area, t 
(11) = 4.02, k = 39, p < 0.05 FDR- and FWE-adjusted, and a negative correlation in a 
single cluster in the posterior lobe of the right cerebellum, at the pyramis lobule, t 
(11) = 4.02, k = 67, p < 0.01 FDR- and FWE-corrected. There were no negative 
correlations found between cognitive function and volume at either the voxel of 
cluster level in HD participants, all p > 0.05 corrected.  
 
Relationship between volume and disease burden  From the ROI 
analysis, sub-cortical volume was strongly negatively correlated with disease 
burden in the caudate (r = -.743 and -.840 left and right respectively), putamen (r= -
.763 and -.808 left and right respectively), pallidum (-.753 and -.756, left and right 
respectively), and the left nucleus accumbens, r = -.658, all p < 0.05 FDR-corrected. 
There was no relationship between disease burden and white matter 
macrostructure, all p > 0.05. 
 
The results from a regression analysis from the voxel-wise analysis also 
found the same relationship. A correlation between disease burden and GM 
volume was found in 3 clusters: in the left basal ganglia including the pallidum and 
putamen, in the right putamen, and an additional correlation was found in the right 
inferior occipital gyrus (Brodmann area 18), all FWE-adjusted p < 0.05. As with the 
ROI analysis, there was no correlation between disease burden and WM volume in 
any voxel, FWE-adjusted p > 0.05.  
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Table 5.3 Correlation coefficients between volume and disease burden in HD 
participants (df = 14). P-values shown are uncorrected values; bold p-values 
indicate those that survive FDR correction at q< 0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cortical thinning is related to disease burden 
 
There was no difference in cortical thickness, surface area or curvature in 
HD patients relative to controls when adjusting for multiple comparisons (FDR) and 
controlling for age. Figure 5.5 shows the correlation between cortical thickness and 
disease burden in HD patients. Disease burden was found to correlate negatively 
with cortical thickness in both hemispheres in the caudal and rostral middle frontal 
cortex, precentral gyrus, isthmus cingulate gyrus, precuneus, lingual gyrus, lateral 
occipital cortex, and middle and superior temporal cortex, all p < 0.05 FDR-
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adjusted. In the left hemisphere specifically, negative correlations were also 
observed in the superior frontal and lateral orbitofrontal cortex, transverse and 
inferior temporal cortex, inferior parietal cortex, paracentral sulcus and 
supramarginal gyrus, all p < 0.05 FDR-adjusted. Surface area in the left precentral 
sulcus and right superior temporal cortex was found to positively correlate with 
disease burden, t(15) = 4.39 and 4.37 respectively, p < 0.0001 uncorrected, whereas 
surface area calculated from the pial surface rather than the GM/WM boundary 
surface, produced negative correlations with disease burden in the left middle 
temporal gyrus, left superior temporal sulcus, left lateral occipital gyrus, and right 
post-central gyrus, t(15) = -4.3, -4.04, -4.19 and -4.42 respectively, p < 0.0001 
uncorrected. None of these correlations survived FDR-correction for multiple 
comparisons. Cortical curvature was not related to disease burden, p > 0.05 FDR-
adjusted. 
 
Relationship between cortical thickness and motor 
functioning For control participants, there was no relationship between cortical 
thickness and finger tapping speed when accounting for ICV, all p > 0.001 
uncorrected. Surface area in the right posterior cingulate was positively correlated 
with finger tapping speed, t (10) = 3.90, p < 0.001 uncorrected. For HD participants, 
cortical thickness in the left paracentral, right supramarginal gyrus,  inferior parietal 
sulcus and superior frontal gyrus were positively correlated with finger tapping 
speed, after accounting for ICV,  t (11) = 3.16, 3.49,3.74 and 3.07 respectively, p < 
0.001 uncorrected. Cortical thickness was not correlated with UHDRS motor scores 
at an uncorrected p value of 0.001, whereas surface area in the right pars orbitalis 
gyrus and pericalcarine gyrus were positively correlated with UHDRS motor score, t 
(11) = 3.64 and 3.04 respectively, p < 0.001 uncorrected. None of the relationships 
survived correction for multiple comparisons using the FDR. 
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Relationship between cortical thickness and cognitive 
function  In the HD participants, there were no significant correlations between 
cortical thickness or cortical curvature and composite cognitive score, p > 0.05. 
Surface area in the left posterior cingulate gyrus was positively correlated with 
cognitive scores accounting for age, t (10) = 5.69, p < 0.0001 uncorrected, and the 
right superior parietal sulcus was negatively correlated with cognitive scores 
accounting for age, t (10) = -5.87, p < 0.0001 uncorrected. Notably, these t statistics 
were close to the threshold for FDR-significance (t = 5.73 and 5.91 for the left and 
right hemisphere respectively). When disease burden was accounted for, the 
relationship between surface area and cognitive function became weaker in the 
Figure 5.5 Correlation between cortical thickness (mm) and disease burden in HD 
patients. In the right hemisphere, negative correlations were also observed in the 
postcentral gyrus, fusiform, precuneus, and parstriangularis cortical areas, all p < 
0.05 FDR-adjusted. Colour represents t-statistic, thresholded to only include 
statistics which survive FDR-correction. Scatterplots shown are for regions where 
p < 0.0001 uncorrected, disease burden is on the x axis and cortical thickness 
(mm) on y axis. 
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posterior cingulate gyrus (t (10) = 3.44), and in the right superior parietal sulcus (t 
(10) = -4.66).  
In the control participants the correlation between cortical thickness in the 
right peri-calcarine sulcus and composite cognitive scores (t (10) = 4.86) was 
significant at p < 0.0001 uncorrected, FDR-corrected p > 0.05. Surface area was also 
positively correlated with cognitive function in the left precuneus sulcus (t (10) = 
4.04) and right superior frontal gyrus (t (10) = 4.80), and negatively correlated with 
cognitive function in right inferior parietal gyrus, t (10) = -4.25, all p < 0.0001 
uncorrected.  
 
Sub-cortical shape analysis 
 
Results of the shape analysis are shown in Figure 5.6. 
Caudate nucleus  Shape changes were more evident in the caudate head 
and body compared to the caudate tail. Some localised areas of change were seen 
in the left caudate tail. Localised inward displacement of the caudate surface (taken 
to represent local atrophy) was most pronounced in the medial caudate body in 
both hemispheres, with less change in the lateral edge.  
 
Putamen  Significant shape deformation was evident almost throughout 
the whole structure, with the exception of the most posterior lateral region and 
medial middle region. Putamen changes were consistent in both hemispheres.  
 
Thalamus Localised changes were evident throughout the middle 
thalamus, whereas the medial and lateral surfaces were unchanged. The areas of 
no effect in the medial thalamus correspond to the medial dorsal subnuclei, 
whereas the areas of change in the middle thalamus cover a number of different 
subnuclei.  
 
 Globus Pallidum  In the pallidum, shape changes were evident 
throughout the dorsal middle region, and were more widely distributed in the  
A
) 
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Figure continues onto next page… 
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ventral mid- and posterior pallidum. The medial surface was less affected, whereas 
the lateral anterior surface was altered in the left but not the right hemisphere. It is 
not clear how these shape changes relate to the globus pallidus interna and externa 
separately; whereas the interna segment is positioned medial to the externa 
segment, change is most evident in the middle of the structure, with image 
resolution not allowing for a segmentation of the internal structure boundaries.  
 
Nucleus accumbens  Shape changes were seen in the middle surface 
region, both on the superior and inferior surface, although the middle-posterior 
accumbens was only altered on the anterior surface. There were no significant 
changes on the medial and lateral surface of the accumbens.  
 
Hippocampus  The hippocampus was the control structure and no 
changes were evident throughout the surface of the structure. 
 
 
 
 
Figure 5.6 Shape analysis for sub-cortical regions, shown from different 
viewpoints. Orange regions indicate significant difference between HD and 
control participants after cluster-based multiple-comparison correction. All 
regions shown overlaid on an MNI-152 space T1-weighted 1mm image.  
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Figure 5.7 Summary of results in relation to basal-ganglia-cortical circuity in HD 
participants relative to healthy controls. GM: grey matter. WM: white matter. GP: 
globus pallidum, i: interna, e: externa. S.Nigra comp: substantia nigra compacta.  
 
 
Discussion 
   
Although it is known that macrostructural changes occur in Huntington’s 
disease prior to the onset of symptoms, this knowledge has arguably been achieved 
in a disjointed manner, with volume changes reported separately from cortical 
thickness changes, with either a region-of-interest based approach or a whole brain 
voxel or vertex-based approach. In this chapter, multiple analysis techniques were 
used to examine convergence across approaches in the same HD cohort, in order to 
build a picture of how difference findings relate to each other.  
 
It was found that regionally specific sub-cortical atrophy was 
disproportionate to whole brain atrophy in the HD participants compared to 
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controls, with the magnitude of atrophy greater than 15% in the caudate, putamen, 
pallidum and nucleus accumbens. Loss of grey matter volume was predominantly in 
sub-cortical structures. Both the ROI analysis and the surface-based analysis of the 
cortex found no abnormalities in cortical volume or cortical thickness, surface area 
or curvature. However, the whole brain voxel-based analysis found a significant 
volume change in the grey matter in the superior temporal gyrus, suggesting that 
cortical changes in HD begin in small localised areas, and supporting work showing 
a posterior-anterior gradient of cortical disease progression in HD (Rosas et al., 
2002). In complement to the microstructural changes reported in Chapter 4, 
atrophy was evident in the corpus callosum of HD participants, vindicating the 
decision to correct for partial volume effects. Cerebral white matter and white 
matter in the basal ganglia was also atrophied in HD participants, supporting the 
body of evidence for white matter involvement in HD pathology, and suggesting 
that basal ganglia circuitry may be impaired even at this early stage of the disease. 
This pattern of results supports previous work which suggested that cortical 
changes tend to occur later in the disease process compared to changes in the 
striatum and white matter (Nopoulos, et al., 2010).  
 
In line with previous work (Paulsen, et al., 2010; Tabrizi, et al., 2009), pre-
symptomatic and early HD participants were found to have smaller whole brain 
volumes and grey matter atrophy compared to age, gender and educated-matched 
healthy controls. An apparent contradiction in the results was no difference in 
intracranial volume (ICV), which is likely due to the inexact way in which ICV is 
calculated using Freesurfer software, which can lead to systematic errors compared 
to manual segmentation (Malone et al., 2014; Nordenskjöld et al., 2013; Pengas, 
Pereira, Williams, & Nestor, 2009). ICV is estimated based on a linear talairach 
transform rather than being a direct count of the voxels inside the skull, because 
the skull is not distinguishable from CSF on T1-weighted images.  
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Relationship between structure and functioning 
 
Sub-cortical atrophy was found to be functionally relevant, with a strong 
correlation found between atrophy and finger tapping speed in HD participants. In 
chapter 3, finger tapping speed was found to be significantly reduced in HD 
participants, suggestive of motor slowing. Thus, this finding suggests that motor 
slowing is related to the degree of sub-cortical atrophy. When using volumes 
segmented using the Freesurfer pipeline, a relationship was found selectively in the 
putamen, whereas when using FSL, atrophy in the caudate, putamen, thalamus and 
globus pallidum were also related to finger tapping speed.  The same relationship 
was not found in control participants.  In addition, the UHDRS motor score was also 
strongly associated with sub-cortical atrophy, with higher motor impairment 
associated with a greater degree of atrophy in numerous sub-cortical structures.  
 
In contrast, there was no significant relationship between cognitive 
functioning and sub-cortical atrophy. Both total grey matter and total white matter 
atrophy were related to the composite measure of cognitive functioning (see 
chapter 3), which suggests that global macrostructural changes may be more 
prognostic in terms of cognitive functioning at this early stage in the disease.  An 
interesting association was found between larger hippocampal volume and greater 
cognitive functioning selectively in HD participants. In addition, increased surface 
area in the posterior cingulate gyrus was associated with greater cognitive 
functioning, again selectively in HD participants. Anatomically, the posterior 
cingulate is considered to be part of the limbic system and contains strong 
reciprocal connections with cortical regions implicated in learning and memory 
functions, including the hippocampus (Maddock, 1999), thus these two 
independent findings may be functionally related. One potential explanation for 
these findings is the concept of compensatory mechanism, whereby the brain 
undergoes reorganization in response to neurodegeneration to preserve cognitive 
performance (Papoutsi, et al., 2014). As was observed in both this and the previous 
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two chapters, the severity of structural brain changes is not matched by widespread 
cognitive changes, and previous work has shown that structural brain changes 
appear years prior to cognitive decline (Tabrizi, et al., 2009; Tabrizi, et al., 2012; 
Tabrizi, et al., 2011). The recruitment of new regions to a compromised neural 
network is one mechanism which may explain this preserved cognitive 
performance. When faced with marked atrophy in sub-cortical structures centrally 
involved in cognitive functioning, recruitment of other brains regions involved in 
cognitive functioning, such as the hippocampus and connected paralimbic regions is 
plausible and requires further exploration.  
 
  A selective association between disease burden, a genetic marker of 
disease severity and cortical atrophy, sub-cortical atrophy, and topographical 
cortical thinning was found. These associations were found through a convergence 
of ROI analysis, VBM and surface-based cortical reconstructions and suggest that 
the pattern of disease progression is not global across the cortex or sub-cortical 
regions, but instead follows a selective pattern. Although cortical volume changes 
were only evident in posterior brain regions with no differences in cortical 
thickness, it was also found that cortical thinning in both anterior regions (e.g. 
superior frontal and lateral orbitofrontal cortex and middle frontal gyrus) and 
posterior regions (e.g. lateral occipital cortex and middle and superior temporal 
cortex) were related to increased disease severity. This challenges previous work 
suggesting that cortical thinning follows a posterior to anterior pattern with 
increased disease progression (H. D. Rosas, et al., 2002). The discrepancy could 
potentially be due to the limited range in terms of disease progression in this 
cohort, with pre-dominantly pre-symptomatic HD participants at different stages in 
terms of distance from disease onset, whereas a symptomatic cohort was used to 
draw conclusions about the directional trajectory of progression (Rosas, et al., 
2002). The lack of a relationship between disease burden and white matter 
macrostructure suggests that white matter atrophy occurs early in the disease 
course but remains more stable across the disease stages of HD, whereas 
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neurodegeneration of sub-cortical regions continues with increased disease 
progression.  
 
Cortical surface area was found to be differentially related to disease 
burden compared to cortical thickness in HD participants. A novel and intriguing 
finding was a discrepancy between a positive relationship between cortical surface 
area and disease burden when calculated based on surface area at the GM/WM 
boundary, and a negative relationship between surface area and disease burden 
when calculated using the pial surface area. This discrepancy could be driven by the 
uneven distribution of neuronal loss across the cortical layers (Hedreen, et al., 
1991; Sotrel et al., 1991), with selective degeneration of cells in layer VI of the 
cortex, and both cortical thinning and atrophy being especially marked in layer VI 
(Hedreen, et al., 1991; Wagster, Hedreen, Peyser, Folstein, & Ross, 1994), which is 
the cortical layer at the GM/WM boundary. Thus, surface area may be a more 
sensitive measure than cortical thickness in tracking layer-specific cortical 
neuropathology in HD.  
 
Changes to the shape of sub-cortical structures 
 
In light of the sub-cortical atrophy evident at this early disease stage, the 
final analysis in this chapter considered whether changes in these sub-cortical 
structures occur in a widely distributed and uniform way, or if structural changes 
occurs in localised regions with the structure. The shape of a structure is of interest 
given the functionally distinct white matter circuitry, for example, different 
subnuclei of the thalamus have been hypothesised to be involved in functionally 
distinct basal ganglia-thalamo-cortical loops (G. E. Alexander, et al., 1990), and D3 
dopamine receptors, affected in HD (Ariano et al., 2002), are distributed mainly in 
the ventral striatum, which contains limbic connections. There have been two 
previous studies examining the shape of sub-cortical structures in HD (van den 
Bogaard, et al., 2011; Younes, et al., 2014), both of which differ in terms of the 
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statistical models used, however both use permutation testing for validation, which 
is consistent in this study. Van den Bogaard et al (2011) found small areas of 
deviation from the norm structure in prodromal HD subjects, with fewer areas of 
shrinkage in the gene positive participants who were far from disease onset. In this 
study, with a combination of both pre-symptomatic and early HD participants, 
localised displacement of the structure surface was found in the caudate head 
more prominently than in the caudate tail, and was more prominent in the medial 
surface compared to the lateral edges. This specific localised shape change in the 
medial caudate body was also reported in the Track-HD cohort (van den Bogaard, et 
al., 2011) suggesting this result is not specific to this patient cohort but may reflect 
early localised structural change. The medial caudate is known to contain afferent 
connections from the frontal cortex and limbic system, which may explain the 
emergence of cognitive and psychiatric changes earlier on in the disease course. In 
the putamen, changes to the surface shape were found throughout the whole 
structure. It has been shown that the degree of atrophy is greatest in the putamen 
(Harris et al., 1992), thus the whole surface may be altered due to the sheer degree 
of cell loss, or it may be that the putamen contains connections that are uniformly 
affected in HD, explaining the lack of localised displacement. In the thalamus, 
localised changes were evident throughout the middle surface, with no changes in 
the medial and lateral surfaces, suggesting sub-nuclei specific changes occur in the 
thalamus early in the disease course of HD. Evidence of localised shape 
deformation was found in both the nucleus accumbens and globus pallidum in HD 
participants, with the medial surface less affected in both structures. Importantly, 
in the hippocampus, which was not shown to be atrophied in the ROI analysis and 
was thus considered to be the control region, no localised shape changes were 
found.  
 
A limitation of shape analysis is that changes in the exterior shape of a 
structure are not biologically specific, and may be reflective of a number of factors, 
such as neuronal loss and/ or white matter atrophy caused by factors such as as a 
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loss of axons or demyelination. Despite this, examining the shape of structures may 
provide new insights in localized intra-structural atrophy patterns in HD; identifying 
the specific areas of earliest change may be useful for targeting therapies to slow 
disease progression.  
 
Future work and concluding comment 
 
 Although it was not possible in this dataset due to the limited sample size 
and large number of predictors, with 10 cases recommended as the minimum per 
independent variable (Hosmer & Lemeshow, 2000), a future area of analysis in a 
larger dataset would be to conduct a logistic regression to examine whether both 
macrostructural and microstructural measures contribute to predicting gene status. 
Furthermore, a linear regression including individual cognitive tests would be 
conducted to unpick the relationship between grey and white matter volume and 
composite cognitive scores, to determine which areas of cognition are most 
affected by grey and white matter atrophy. 
 
 In conclusion, the different analyses techniques in this chapter converge to 
show alterations in sub-cortical structures in terms of volume and localised shape 
deformation, with atrophy in these structures being related to a genetic marker of 
disease burden. There was less convergence across analyses for the cerebral cortex, 
with only a voxel-based approached finding evidence for cortical atrophy in a 
localised region in the temporal lobe. Despite this, cortical volume in a localised 
region in the occipital cortex, and cortical thinning in widely distributed regions 
were found to be related to disease burden, suggesting that the cerebral cortex 
contributes to disease pathology at this early stage. Finally, evidence was provided 
to support a pathological role of white matter in HD that is functionally relevant to 
cognitive function but less sensitive to changes in disease burden, in comparison to 
grey matter structures.   
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6 Longitudinal structural imaging of the 
HdhQ150  mouse model of Huntington’s 
disease 
Chapter Summary 
 In this chapter, a knock-in mouse model was used to examine whether in 
vivo MRI can detect neuropathology both before the onset of motor signs, and at a 
second time point when motor signs are evident. Anatomical T2-weighted MRI and 
diffusion MRI sequences were acquired using a 9.4T small animal system in order to 
examine tissue macrostructure and tissue microstructure across time. The 
relationship between brain structure and motor deficits was examined at the 
symptomatic time point, and in vivo techniques are presented along with ex vivo 
high-resolution MRI and immunohistochemistry analysis.  
Introduction 
The mutant gene underlying HD was identified in 1993 (Group, 1993) and 
since then, non-human models of the disease have been developed. Genetic animal 
models have a similar genetic defect to that seen in the human disease, allowing for 
the study of early pathological, cellular and molecular alterations caused by the 
mutation, and can provide a direct measure of neuropathology, which is not 
possible in patients in vivo. A major benefit of animal models compared to patient 
studies is that they do not suffer the variance in terms of disease stage, number of 
CAG repeats and genetic background allowing for greater experimental control.  
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The longitudinal characterisation of Huntington's disease (HD) mouse lines is 
crucial in order to understand the developmental time course, nature and severity 
of phenotype progression over time (Brooks, Jones, & Dunnett, 2012) and 
ultimately be able to translate this knowledge to the human disease. A major 
benefit of being able to study disease progression with animals models is that 
whereas in patients with more advanced stages of HD it is difficult to study 
structural changes in the brain in vivo due to the incompatibility of chorea with 
MRI, with animal models the whole disease course can be studied, thus improving 
understanding of the later stages of the disease.  
 
 In recent years, MRI has been applied to animal models of disease in 
order to study changes in neuroanatomy caused by genetic mutations and/or 
pathology. The majority of MRI studies using mouse models of HD have been cross-
sectional (Carroll, Lerch, Franciosi, & Spreeuw, 2011; Cepeda-Prado, et al., 2012; 
Lerch, Carroll, Dorr, et al., 2008; Sawiak, Wood, Williams, Morton, & Carpenter, 
2009) however the primary value of pre-clinical MRI lies in the capability for within-
subject longitudinal designs with increased power and experimental control to 
study the time course of disease and evaluate therapeutic outcomes and the 
interaction with disease stage. It is important to examine neuropathology 
longitudinally with MRI as this can inform the design of future animal studies, 
allowing for the most appropriate mouse line to be selected depending on the 
purpose of the study, and providing a readout of the regional and temporal 
specificity of neuropathology. One area that has not received attention in previous 
HD mouse studies is the impact on white matter, despite white matter 
abnormalities being evident at all disease stages in the human disease (Beglinger, et 
al., 2005; Ciarmiello, et al., 2006; de la Monte, et al., 1988; Dumas, et al., 2012; 
Klöppel, et al., 2008; Paulsen, et al., 2010; Reading, et al., 2005; Rosas, et al., 2010). 
 
In order to study white matter microstructure, diffusion MRI combined with 
tractography analysis can provide in vivo 3-dimensional reconstructions of white 
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matter pathways in the brain non-invasively. However, despite diffusion MRI now 
being a routine scan sequence in human imaging, diffusion MRI of the mouse brain 
presents significant challenges. A mouse brain is approximately 1000 times smaller 
than a human brain in term of the total volume (Zhang et al, 2009). Thus, whereas 
the resolution of human brain diffusion MRI is about 1 - 2 mm per pixel, in order to 
achieve the same anatomical resolution, the resolution for mouse brain diffusion 
MRI needs to be 0.1 - 0.2 mm per pixel (Zhang et al, 2009). This is technically 
challenging in terms of achieving adequate signal to noise ratio (SNR), as SNR is 
proportional to the volume of the voxel. Although a high field system improves the 
SNR achieved, it presents its own set of problems in terms of more severe field 
inhomogeneity and a shortened tissue T2, both of which affect echo planar imaging 
(EPI) sequences which are commonly used for diffusion MRI acquisition (Le Bihan, 
Poupon, Amadon, & Lethimonnier, 2006) on account of their ability to effectively 
freeze physiological motion during the read-out. Physiological motion during the 
acquisition is a challenge, and carefully controlled anaesthesia, animal constraints 
and respiratory triggering can minimize but not remove motion effects, whilst the 
effects of anaesthesia on tissue microstructure remains relatively unexplored. 
 
As detailed in chapters 2 and 4,  when analysing MR images acquired using a 
diffusion sequence, the diffusion tensor model is inadequate for reconstructing 
white matter pathways in the human brain due to the inability to describe voxels 
with crossing fiber configurations (Seunarine & Alexander, 2009). In response to 
this, more sophisticated approaches have been developed, including spherical 
deconvolution (SD) techniques which allow recovery of the fibre orientation density 
function (fODF) in tissue irrespective of complexity. In the mouse brain, crossing 
fibers are also an issue (see Figure 6.1), yet despite this, there are currently no 
published studies where non-tensor based tractography has been applied.  
 
In this chapter, a spherical deconvolution based approach was applied to 
perform whole brain tractography analysis and gain information on tissue 
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microstructure, along with T2-weighted anatomical imaging to measure tissue 
macrostructure. The knock-in HdhQ150 mouse model was examined over the 
course of the animals’ natural lifetime. Knock-in models in HD are generated by 
homologous recombination techniques using mouse embryonic stem cells. Thus, 
the HdhQ150 mice (Lin, et al., 2001) were created by directly replacing the normal 
mouse endogenous CAG repeat length with an expanded 150 CAG sequence in the 
mouse Htt gene without affecting the rest of the endogenous sequence of the 
gene. Behaviourally, the phenotype of HdhQ150/Q150 mice has been well 
characterised longitudinally. Just as in the human disease, HdhQ150/Q150 mice display 
cognitive deficits prior to the onset of motor abnormalities, defined as the 
benchmark for formal diagnosis in humans, with extra-dimensional set-shifting 
deficits (Brooks et al., 2006) and reduced reactivity to an acoustic startle evident at 
6 months of age. Weight loss is not evident in male HdhQ150/Q150 mice until 13 
months of age when other cognitive deficits emerge, such as impairments in finding 
the submerged platform on the Morris water maze (Heng, et al., 2007).  
 
Neuropathological characterisation from ex vivo histological analysis has 
shown that HdhQ150/Q150 mice display many of the characteristics of the human 
disease including Htt aggregation that is most marked in the striatum but also 
evident to a lesser degree in the cortex, thalamus and hippocampus, as well as 
neuronal intra-nuclear inclusions (Bayram-Weston, Torres, Jones, Dunnett, & 
Brooks, 2012; Lin, et al., 2001). These neuropathological changes are evident from 
around 5 months of age followed by striatal cell loss at 8 months of age (Bayram-
Weston, et al., 2012). Thus, this mouse model was chosen because both the 
appearance of cognitive and motor symptoms follows the temporal pattern seen in 
the human disease, neuropathological specificity has been demonstrated (Brooks et 
al., 2012) and because neuropathological changes are detectable prior to the onset 
of motor signs, in line with the human literature from the pre-symptomatic disease 
stage.  
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Figure 6.1 Demonstration of crossing fibers in the mouse brain using spherical 
harmonic tractography analysis (Tournier et al., 2008). On the left, in each 
voxel, the principaldiffusion direction (sticks) and the fiber orientation 
distribution (ellipsoids) are shown, the white stars showing examples of 
voxels containing more than one fiber orientation. Right: Corpus callosum 
tracts shown in red, cingulum fibers shown in yellow. 
Based on the above research into the temporal appearance of symptoms, 7-
months was selected as the first time-point to represent the pre-symptomatic stage 
of the human condition, as cognitive deficits and neuropathology is evident in the 
absence of motor signs. 19 months of age was selected to represent the 
symptomatic time point where both cognitive and motor deficits were evident.  
Declaration of Collaborations  
In this chapter, the volumes of structures obtained from an automated 
atlas-based segmentation protocol are presented. The development of the protocol 
and the processing of the data through the pipeline were conducted by Ma Da at 
UCL as part of a collaborative project. In addition, perfusions were conducted with 
assistance from Jane Heath, a technician in the Brain Repair Group.  
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Methods 
Subjects 
Twenty-five homozygous knock-in (HdhQ150/Q150) male mice (mean CAG 
repeat length on allele 1: 147 ±7 SD, allele 2: 158 ± 5) and 25 age-matched wild type 
male mice (Hdh+/+) were used in the study. Homozygote mice were used in order to  
be comparable to published behavioural work in this mouse model (Brooks, Higgs, 
Jones, et al., 2012). Details on breeding, animal housing and genotyping are 
described in Chapter 2. Due to long separation times during MRI scanning at 7 
months, there was a problem with fighting between cage mates, thus all mice were 
individually housed from 7 months of age.  
Body weight 
As a general indicator of mouse health, mice were weighed monthly 
throughout their lifetime. In HD mouse lines, progressive weight loss is a sign of the 
advancement of the disease state and is considered as a core feature of these 
Figure 6.2 Experimental design from birth to 20 months. Wild-type mice: Hdh+/+, 
homozygous mice: HdhQ150/Q150 
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models (Brooks, Higgs, Jones, et al., 2012). 
 MRI Acquisition 
The experimental design, showing the 3 MRI sessions, is detailed in Figure 
6.2. MRI acquisition and animal preparation details are described fully in Chapter 2. 
A phased array mouse head surface coil was used in this study. Due to the long scan 
times and to improve animal health and recovery, 500 µl of glucose saline was 
administered via sub-cutaneous injection immediately prior to the MRI session and 
immediately after the MRI session. The anaesthesia protocol was amended on the 
advice of the vet following the first scan session, where 10% of the animals did not 
recover from anaesthesia. The carrier gas was changed from medical air to 100% O2 
and the scans were conducted in two separate sessions one week apart, with the 
T2-weighted structural scan first.  
 
Macrostructural MRI  For both in vivo and ex vivo acquisition, a 3D 
Turbo Rapid Acquisition with Refocused Echoes (RARE) T2-weighted scan was used. 
For the in vivo sequence, parameters were: field of view (FOV) of 1.54 x 1.54 cm, in-
plane resolution of 120 x 120 µm, matrix of 128 x 128 x 64, TR/ TE = 1750/17.5 ms, 
bandwidth 50000 Hz, RARE factor of 4, 1 average, with an acquisition time of 
approximately 1 hour 8 minutes. For the ex vivo scans, the resolution was 60um3 
with the following parameters: FOV 1.54 x 1.54cm x 1.02cm, matrix = 256 x 256 x 
168, TR/TE = 1750/17.5 ms (effective echo time = 35 ms), bandwidth 50000 Hz, 
RARE factor of 4, 3 averages, with an acquisition time of 11 hours. 
 
Diffusion MRI 27 adjacent axial slices of 320 µm in thickness were 
acquired. Navigator echoes were used to minimise distortion artefacts due to 
multiple segments. 2 averages were used to increase the signal to noise ratio (SNR). 
The in-plane resolution was 213 x 213 µm at a FOV of 2.24cm x 2.24cm and an 
acquisition matrix of 96 x 96. Partial Fourier with an acceleration factor of 
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1.35 and 23 overscan lines were used in order to reduce the acquisition time. 4 
dummy scans were used at the beginning of the acquisition in order to achieve 
magnetisation equilibrium. Respiratory-gating was used to minimise respiratory 
motion artefacts. At both time points, data were acquired with a b-value of 1000 
s/mm2 applied over 30 diffusion-weighted directions (Jones 30) in three 
dimensional space with 3 b0 images without diffusion weighting, TR/TE = 8500 
/18.70 ms, δ /Δ = 4 /9 ms. The acquisition time was on average 1 hour but varied 
depending on the rate and stability of respiration for each mouse. Post-processing 
stages are represented in Figure 6.3 and described fully in Chapter 2. 
MRI image analysis 
Atlas-based segmentation of T2-weighted images In order to 
obtain a less labour-intensive measure that was not dependent on the expertise of 
the rater, raw T2-weighted images were analysed using an automated multi-atlas 
based structural parcellation pipeline (D. Ma et al., 2014) as part of a collaboration 
with the Centre for Advanced Biomedical Imaging (CABI) in University College 
London. The following pipeline was developed by researchers at CABI and the pre-
processing steps applied by Ma Da (CABI, UCL) according to the protocol outlined in 
(D. Ma, et al., 2014).  
 
Figure 6.3 Preprocessing steps of diffusion MR data using ExploreDTI software 
(Leemans, Jeurissen, & Sijbers, 2009). 
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 Briefly, the brain was first extracted to remove non-brain tissue. This was 
achieved by creating a mask for the native subject image from multiple atlas images 
(Leung et al., 2011). The MRM atlas (Y. Ma et al., 2005; Y. Ma et al., 2008) was 
selected for use after comparing parcellation results achieved with different atlases. 
The native subject image was globally registered to all atlas images (Ourselin, 
Roche, Prima, & Ayache, 2000) and the resulting transformation matrices were then 
inverted and used to propagate all the atlas brain masks to the native image. The 
mask was dilated to enhance the contrast between brain tissue and CSF. Due to the 
high field strength, it was necessary to correct for intensity non-uniformity which 
can cause misalignment during image registration, thus the non-parametric non-
uniform intensity normalization technique (N3) (Sled, Zijdenbos, & Evans, 1998) was 
used to correct the bias field ( 
 
Figure 6.4). The affinely aligned atlas images from the brain extraction step were 
non-linearly registered to each Hdh+/+/HdhQ150/Q150 mouse image (Modat et al., 
2010) and the resulting deformation fields were then used to register the labels 
from the MRM atlas space to native space with nearest-neighbour interpolation to 
preserve the integer nature of the labels. These labels were then fused using the 
Multi-STEPS algorithm (Jorge Cardoso et al., 2013; D. Ma, et al., 2014), which 
utilised a locally normalised cross correlation similarity metric for atlas selection 
(Figure 6.4). From the labelled images, a number of regions of interest (ROI)’s were 
delineated and the total volume of these regions calculated. The total brain volume 
for the in vivo images was defined as the summed volume across all labelled brain 
regions (40 regions for the MRM atlas). ROI’s were the caudate putamen, thalamus, 
globus pallidus, hippocampus, neocortex, cerebellum and ventricles. All masks and 
labels were visual inspected for quality. 
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Figure 6.4 Atlas Based Segmentation of the HdhQ150 mouse brain. The left hand 
panel shows the raw in vivo T2-weighted image of a representative Hdh+/+ mouse 
brain at 19 months old in the coronal (top) and axial (bottom) plane. The red box 
shows areas of prominent non-uniformity. The middle plane shows the same 
brain slice after intensity non-uniformity correction. The right-hand plane shows 
the labelled regions based on the MRM atlas 
Voxel Based Analysis (VBA).  VBA was performed in SPM8 (Wellcome 
Department of Clinical Neurology, London; http://www.fil.ion.ucl.ac.uk) using the 
SPMMouse toolbox (Sawiak et al., 2009). The grey/white matter tissue priors were 
not used as the grey matter segmentation results were not satisfactory. Instead, 
grey matter segmentation was achieved using the grey matter labels from the atlas-
based approach detailed above. The intensity non-uniformity corrected images 
were registered to a C57/Bl6 atlas image (SPMmouse, Sawiak et al., 2009) using a 6-
dof rigid body and similarity registration (three translations and three rotations, 
FSL). These images were then smoothed with a 500 μm isotropic Gaussian kernel to 
reduce the effect of imperfect image registration and non-normality in the data. A 
two-tailed Student's t-test was performed voxel-wise on the data to examine 
differences in localised density; multiple comparisons were corrected for using the 
false-discovery rate (FDR) technique (Benjamini & Hochberg, 1995) with a threshold 
of  p = 0.05 for statistical significance. However, in order to control for the effect of 
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individual brain sizes, the total intracranial volume was added as a covariate, as is 
standard practice for VBA. 
 
Deterministic Tractography  For the tractography analysis of fiber 
pathways, whole-brain deterministic tracking was conducted using ExploreDTI 
(Leemans, et al., 2009). Deterministic tractography (Jeurissen, Leemans, Jones, 
Tournier, & Sijbers, 2011) was performed using the damped Richardson-Lucy 
algorithm (DRL; Dell-Acqua et al., 2010) as described in Chapter 2. The tracking 
algorithm estimated the fiber orientation distribution function (fODF) at each seed 
point and propagated in 0.05 mm steps along this direction, with an angle threshold 
of 40°; the SH order was 6. Three-dimensional reconstructions of the corpus 
callosum were then extracted from these whole-brain tractograms using multiple 
waypoint ROI’s which were drawn manually in native space on color-coded fiber 
orientation maps (Pajevic & Pierpaoli, 2000) by a single operator blinded to the 
genotype of the mouse. Representative ROIs are shown in Figure 6.5; ‘AND’ gate 
ROI’s are shown in green and select fibers that traverse both ROI’s. The corpus 
callosum was segmented with an initial ROI drawn on the colour-coded diffusion 
image in the sagittal plane on the midline slice in order to capture all the tracts 
passing through this ROI, which included many association fibers and fibers of the 
external capsule. The analysis was then restricted to the corpus callosum using two 
additional ‘AND’ gate ROI’s which were drawn in the sagittal plane in line with the 
medial cingulum in both hemispheres as visualised in the coronal plane. These two 
lateral boundaries were used to remove any external capsule pathways. Partial 
volume correction was performed to account for free water contamination as 
described in chapter 2 (Pasternak, et al., 2009) and the mean tensor based metrics 
(FA, MD) were obtained along the corpus callosum along with the free water 
fraction. 
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Perfusion 
Mice were perfused using the methodology described in Chapter 2.  
Immunohistochemistry  
The generic immunohistochemistry methodology is described in Chapter 2. 
Mouse anti-NeuN (1:1000, Millipore) was used to detect markers for neuronal 
nuclei. The sections were then washed several times in TBS and incubated with goat 
anti-mouse secondary antibody at a 1:200 concentration (Vector Laboratories, 
Burlingame, CA, USA) for 2 h at room temperature. Sections were then delipidised 
by dehydration in ascending alcohols and I hour in xylene before being counter-
stained for myelin.  
 
Staining for myelin  Solochrome (erichrome) cyanine was used to 
identify myelin. The sectioned tissue was hydrated by serial washes in 100%, 95% 
and 70% ethanol and distilled water for 5 minutes each and then immersed for 35 
minutes in solochrome cyanine solution (Appendix 1). Sections were then 
Figure 6.5 Deterministic tractography of the corpus callosum. Left: arrows 
indicate the placement of the 3 ‘AND’ gates, shown in the coronal plane overlaid 
on a colour-coded FEFA map with principal diffusion vectors shown in each voxel. 
Middle pane shows reconstructed tracts in the coronal plane, right pane shows 
the same tracts in the axial plane, both overlaid on a single subject FA map.  
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thoroughly washed in distilled water and differentiation was carried out in 10% Iron 
Alum (Appendix 1) for 2-3 minutes and halted by thorough washing in distilled 
water. Sections were dehydrated by serial washes in 70% , 95% and 100% ethanol 
for 2 minutes each, cleared in xylene, and cover-slipped with DPX mounting 
medium (RA Lamb, Eastbourne, UK).  
Assessment of Cortical Thickness 
For comparison purposes, cortical thickness was measured on 
approximately the same coronal sections for both the MRI images and the prepared 
brain sections (see Figure 6.6). Analysis was conducted using Analyze software 
(version 10.0) for the MRI images and using a Leica microscope for the mounted 
brain sections.  
 
For the mounted brain sections, measurements were made at a 5x objective 
with background correction for uneven illumination. In order to assess regional 
cortical atrophy, thickness measurements of primary motor cortex (M1) were 
taken. A vertical line was drawn covering all cortical layers from the most dorsal 
horn of the corpus callosum to the pial surface. The mean length taken was at 
approximately Bregma 1.10mm (at the section where the corpus callosum bridges 
across the two hemispheres), Bregma 0.14 mm (where the anterior commissure 
crosses the midline), Bregma -0.22mm (where the internal capsule, dorsal 3rd 
ventricle and 3rd ventricle can be seen), and Bregma -1.06 mm (where the lateral 
ventricles are lateral to the hippocampus). These sections provide consistent 
landmarks between animals and provide good coverage of the motor cortex.  
Behavioural measures 
At 20 months of age, mice were assessed for motor deficits. It was not 
possible to assess cognitive deficits due to the period of time required for training  
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Figure 6.6 Approximate Bregma positions where measures of cortical thickness 
were made. Red line indicates approximate position of cortical measurement. 
Bottom image shows representative stained sections for cortical thickness 
measures (blue = myelin, brown = neuronal cells). 
and the age of the mice. The Open Field test, locomotor activity over 24-hours, and 
Rotarod test were conducted as described in Chapter 2. For the Open Field test, 
statistical analysis was performed on the following dependent measures: total  
locomotion (cm), average time spent moving (seconds), velocity (cm/s) and rearing 
frequency. 
Statistical Analysis 
It was not possible to assess the natural attrition rates across the life span of 
the mice because some mice did not recover from exposure to anaesthesia. Thus, a 
chi-square non-parametric test was used to examine survival during the first 7 
months separately from survival during the two scan sessions. Finally, survival 
between the first and second time-point (7-19 months) was analysed separately.  
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For body weight, missing values were handled using SPSS IBM 20 Missing 
Values Analysis add-in; missing values were imputed based on expectation-
maximization estimation. A mixed model ANOVA was then used to assess 
differences in weight due to genotype over multiple time-points. Post-hoc t-tests 
were then used to assess differences in weight between Hdh+/+ and HdhQ150/Q150 
mice separately for each month, and were corrected for multiple comparisons using 
the FDR.  
For behavioural results, the correlation between weight and motor 
performance was first tested to decide if weight should be included as a covariate. 
Pearson’s correlation coefficients greater than 0.3 were treated as indicative of a 
moderate relationship and justified inclusion as a covariate. Before conducting the 
Analysis of Covariance (ANCOVA), the assumptions of homogeneity of regression 
slopes (between weight and behaviour) was tested across groups (HdhQ150/Q150 vs. 
Hdh+/+ mice) to examine whether weight interacts with genotype. Where a 
significant interaction was found and the direction of the relationship was the same 
for both HdhQ150/Q150 and Hdh+/+ mice, weight was added as a covariate and both the 
main effects of genotype and the corrected model, encompassing the contribution 
of weight, were reported, in the knowledge that the genotype effects are not fully 
separated from the effect of genotype on body weight.  
For the tractography analysis of diffusion MRI images, a repeated-measures 
analysis-of-variance (ANOVA) design was used, with the corpus callosum segment 
(genu, body, splenium) as the within-subject variable, genotype as the independent 
variable and the tensor based metrics (FA, MD, AD, RD) as the outcome measure. 
For both cortical thickness measures and volumetric analysis of T2-weighted 
images, the correlations between total brain volume (TBV) and the MRI measures 
(thickness or volume) were first tested. The homogeneity of regression slopes 
(between TBV and either cortical thickness or volume) was tested across groups 
(HdhQ150/Q150 vs. Hdh+/+ mice) to examine whether TBV interacts with genotype. 
Where an interaction was found, but results were in the same direction (i.e. a 
positive correlation found for both Hdh+/+ and HdhQ150/Q150 mice), TBV was added as 
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a covariate. An analysis of covariance (ANCOVA) approach was chosen over a 
proportional approach, whereby the ROI volume is divided by the total brain 
volume. The ANCOVA approach allowed the interactive effects resulting from a 
different relationship between the ROI and total brain volume depending on 
genotype to be incorporated into the analysis through an interaction term in the 
model. A mixed model ANCOVA was used, with hemisphere, and cortical region (4 
Bregma positions) as within-subject variables and genotype as the between-subject 
factor. For the VBA analysis, a two-tailed t-test was conducted using SPM8 software 
(Wellcome Department of Clinical Neurology, London) with total intracranial 
volume added as a covariate.  
Results  
Survival 
There was no difference in survival rate between Hdh+/+ and HdhQ150/Q150 in 
the first 7 months of life and prior to the first MRI session (χ (1, n =50) = 1.02, p > 
0.05). Similarly, for recovery from anaesthesia during the first MRI session at 7 
months old, the relationship between genotype and recovery was not significant (χ 
(1, n =49) = 0.27, p > 0.05). From 7-19 months of age, there was also no significant 
difference between survival of Hdh+/+ compared to Hdhq50 mice (χ (1, n =44) = 
1.0, p > 0.05). During the 19-month scan, there was a relationship between 
genotype and recovery from the anaesthesia; HdhQ150/Q150 mice were less likely to 
survive the scan session compared to age-matched Hdh+/+ mice (χ (1, n =38) = 4.02, 
p < 0.05). As a consequence, late stage behavioural tests and the histological 
analyses are based on correspondingly reduced and unequal group sizes. 
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Weight 
Figure 6.7 shows the weights of the two groups of animals throughout the 
lifespan. There was a significant interaction between genotype and time for body 
weight measured monthly from 2 to 19 months old (Greenhouse-Geisser corrected F 
(12.04, 145.89) = 27.30, p < 0.001, ε = .179). Post-hoc tests found that HdhQ150/Q150 
had significantly smaller body weight compared to age-matched Hdh+/+ mice at 
every time point from 3 months of age onwards, all p < 0.05 FDR-adjusted. Body 
weight was not significantly correlated with any of the behavioural measures for 
HdhQ150/Q150 mice and Hdh+/+ mice alike, all p > 0.05. Modest, non-significant 
correlations with body weight were found with a number of measures (see 
Appendix 3), and body weight was included as a covariate where r > 0.3.  
   
Figure 6.7 Left: Survival rates excluding cases where there was no recovery 
from anaesthesia (at 7 and 19 month scans). Right: Weights of animals weighed 
in the middle of each month. Error bars represent standard error of the mean 
(S.E.M). * p < 0.05 FDR-adjusted, ** p < 0.01 FDR-adjusted, *** p < 0.001 FDR-
adjusted.  
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Behavioural changes at 19 months old  
Descriptive statistics for all behavioural tests are shown in Figure 6.8. 
 
Circadian-related activity  Transfer/habituation activity was measured 
over the first 2 hours of the testing period. There was no difference in activity levels 
between HdhQ150/Q150 mice and Hdh+/+ mice (F (1, 26) = 0.003, p > 0.05). With weight 
as a covariate, HdhQ150/Q150 mice were more active than Hdh+/+ mice during the light 
phase (F (1, 26) = 5.26, p < 0.05 FDR-corrected), and during the dark phase (F (1, 26) 
= 4.49, p < 0.05 FDR-corrected). 
 
Rotarod HdhQ150/Q150 mice had a significantly shorter latency to fall from 
the rotating rod averaged over 2 trials compared to Hdh+/+ age-matched mice, F 
(1,27) = 9.8, p<0.05. 
 
Open Field Test  Individual t-tests found that total distance moved, total 
time spent moving, velocity, and rearing frequency were significantly reduced in 
HdhQ150/Q150 mice compared to Hdh+/+ mice (t (20) = 2.39, 2.42, 2.31 and 2.75 
respectively, all p < 0.05 FDR-corrected). However, when body weight was a 
covariate, the difference between groups was no longer significant, all p > 0.05. 
Analysis of the univariate main effects revealed that the difference in performance 
between HdhQ150/Q150 and Hdh+/+ mice was driven by HdhQ150/Q150 mice engaging in 
rearing behaviour significantly less frequently compared to Hdh+/+ mice, (F (1,22) = 
10.075, p < 0.05). There was also a main multivariate effect of weight (Wilks’ λ = 
.333, F (4, 19) = 5.58 p > 0.05), however this did not affect any one behavioural 
measure specifically, with no univariate main effect of weight for any measure, all p 
> 0.05. 
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Figure 6.8 Behavioural Assessment at 19 months old. A: Total number of beam 
breaks per hour over a 24-hour period B: Average number of beam breaks in the 
first 2 hours in the boxes, during the light phase (18:00-05:59) and the dark phase 
(06:00-17:59) C. Latency to fall on Rotarod test, averaged over 2 trials. D-H Open 
Field Test measured on 2 consecutive days. D: Velocity (cm/s) E: Total Distance 
Moved (cm), F: total time spent moving, G: Frequency of rearing behaviour. F. Map 
of movements made in 20-minute period by a single HdhQ150/Q150 mouse and single 
Hdh+/+ mouse. Error bars A-E represent ± standard error of the mean. * p < 0.05, 
** p < 0.01, all FDR-adjusted for multiple comparisons.  
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Figure 6.9 Results of the VBA analysis at 7 months of age. Colour bar represents t-
statistics. T = 3.301 represents p < 0.001 uncorrected. T = 2.42 represents p < 
0.01 uncorrected. Statistics are showed overlaid on an average C57 / Bl6 T2-
weighted image.  
Structural changes detectable with MRI 
Voxel Based Analysis At 7 months old, with TBV as a covariate, results 
from the voxel-wise analysis revealed an increase in localised relative density in the 
lateral ventricles in HdhQ150/Q150 mice compared to Hdh+/+ mice at the voxel level at 
p ≤ 0.001 uncorrected, df = 41, z = 3.07, and at the cluster-level (k = 936), p < 0.05 
uncorrected. The results are shown in Figure 6.9. At 20 months, with the reduced 
sample size, there were no differences between Hdh+/+ and HdhQ150/Q150 mice at p < 
0.001 uncorrected. For the HdhQ150/Q150 mice and Hdh+/+ mice alike, there was no 
difference found in density from 7 months to 20 months, p > 0.001 uncorrected.  
 
Atlas based morphometry  After visual inspection, segmented volumes 
for the globus pallidum and lateral ventricles were removed from the analysis for 2 
Hdh+/+ mice and 2 HdhQ150/Q150 mice at 7 months due to imperfect segmentation. 
For ex vivo images, the cortex was not included in the analyses for 5 Hdh+/+ mice, 
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due to imperfect segmentation and/or damage to the cortex in sample preparation. 
The relationship between TBV and volume in the specific regions of interest are 
shown in Table 6.1. When testing the homogeneity of regression slopes between 
Hdh+/+ and HdhQ150/Q150 mice, a significant interaction effect was seen for all of the 
regions with the exception of the globus pallidum and right thalamus, indicating 
that the relationship between TBV and both cortical and sub-cortical volume differs 
between Hdh+/+ and HdhQ150/Q150 mice, such that any differences seen between the 
two groups of mice will also be dependent on a difference in TBV. Thus, TBV was 
added as a covariate and statistical analyses on both the absolute volumes and the 
volumes with TBV as a covariate are reported.  
 
  TBV was significantly reduced at 7 months of age in HdhQ150/Q150 mice (-
5.66%) compared to age-matched Hdh+/+ mice (F (1, 43) = 11.03, p < 0.01). Similarly, 
at 19 months of age, TBV was also significantly reduced (-11.68%) in HdhQ150/Q150 
mice compared to Hdh+/+ mice (F (1, 26) = 20.35, p < 0.001). There was no main 
effect of time-point on TBV (F (1, 25) = .431, p > 0.05) with no significant change in 
volume observed from 7 to 19 months old in either Hdh+/+ of HdhQ150/Q150 mice. For 
ex vivo images acquired at 20 months old, the cerebellum and brain stem were not 
included in the measure of TBV due to artefacts related to ex vivo preparation in 
this region in a number of images, thus TBV is not directly comparable to the in vivo 
measurements. There were no genotype differences in TBV in these ex vivo images 
(4.08%, F (1, 34) = 1.70, p > 0.05). 
 
In the basal ganglia, absolute caudate-putamen volume was significantly 
reduced in HdhQ150/Q150 mice at 7 months (-7.5%, F (1, 42) = 16.65, p < 0.01 FDR-
corrected), and at 19 months (-14.3%, F (1, 26) =13.35, p < 0.01 FDR-corrected). In 
the ex vivo images acquired at 20 months, the reduction in absolute caudate-
putamen volume in HdhQ150/Q150 was smaller than the in vivo measurements (-
5.63%), and this difference was not significant (F (1, 34) = 1.82, p > 0.05). 
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After adding TBV as a covariate in the analysis, caudate-putamen atrophy in the 
HdhQ150/Q150 mice was still evident at 7 months (F (1, 41) = 4.46, p < 0.05 
uncorrected), whereas at 19 months and 20 months ( ex-vivo) there was no 
localised atrophy in the caudate-putamen (F (1, 25) = 0.069, p > 0.05, and F (1,33) = 
.279, p>0.05 respectively). Absolute globus pallidum volume was also reduced in 
HdhQ150/Q150 mice at 7 months (- 7.8 %, F (1, 38) = 9.55, p < 0.01 FDR-corrected), and 
at 19 months (-16.16%, F (1, 26) = 5.92, p < 0.05 FDR-adjusted), whereas at 20 
months, there was no difference in volume on ex vivo images (1.69%, F (1, 34) = 
.156, p >0.05). After adding TBV as a covariate in the analysis, there was no 
difference in globus pallidum between HdhQ150/Q150 and Hdh+/+ mice at 7 months (F 
(1, 37) = 1.25, p > 0.05), 19 months of age (F (1, 25) = 0.01, p > 0.05), and at 20 
months ex vivo (F (1, 33) = .766, p > 0.05).  
 
  The volume of the absolute thalamus shows a similar reduction to the basal 
ganglia structures in HdhQ150/Q150 mice (- 7.19%) compared to Hdh+/+ mice at 7 
months old (F (1, 42) = 12.14, p < 0.01 FDR-corrected). At 19 months, absolute 
thalami volume was also reduced (-12.20%) in HdhQ150/Q150 mice (F (1, 25) = 17.77, p 
< 0.01 FDR-corrected). Similarly, in ex vivo images acquired at 20 months, absolute 
thalami volume was also reduced (-7.11%) in HdhQ150/Q150 mice (F (1, 34) = 4.73, p < 
0.05 uncorrected). The right thalamus was found to be larger than the left thalamus 
at each time point, p < 0.05 uncorrected. After adding TBV as a covariate in the 
analysis, there was no difference in volume between the two groups of mice at 7 
months (F (1, 41) = 1.73, p > 0.05), 19 months (F (1, 24) = 0.099, p > 0.05), and 20 
months ex vivo (F (1, 33) = 2.87, p > 0.05). 
 
Absolute hippocampus volume was significantly reduced in HdhQ150/Q150 
mice at 7 months (- 6.61%, F (1, 42) = 12.98, p < 0.01 FDR-corrected), and at 19 
months old (-12.44%) compared to Hdh+/+ mice (F (1, 26) = 20.45, p < 0.01 FDR-
corrected). In the ex vivo images acquired at 20 months, absolute hippocampal  
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Figure 6.10 Absolute results of Atlas-Based Segmentation of T2-weighted 
images. Error bars represent standard errors of the mean. TBV: Total brain 
volume; L: left hemisphere, R: right hemisphere. Note that for TBV 
calculations from ex vivo images at 20-months, the cerebellum and brain stem 
were excluded due to artefacts.  
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volume showed a similar decrease as total brain volume (-4.11%) in HdhQ150/Q150 
mice (F (1, 34) = 1.39, p > 0.05). After adding TBV as a covariate in the analysis, 
hippocampi volume was unaltered at 7, 19, and 20 months of age (F (1, 41) = 1.53, p 
> 0.05, F (1, 25) = 1.74, p > 0.05, and F (1, 33) = .198, p > 0.05 respectively). 
 
Compared to total brain volume, the absolute neocortex volume showed a 
similar degree of atrophy (-5.70%) in HdhQ150/Q150 mice at 7 months (F (1, 42) = 9.34, 
p < 0.05 FDR-corrected), and at 19 months old (-10.53%, F (1, 26) = 8.07, p< 0.05 
FDR-corrected). At 20 months ex vivo, the absolute neocortex volume reduced by 
9.00% in HdhQ150/Q150 mice (F (1, 29) = 5.43, p < 0.05 uncorrected). After adding TBV 
as a covariate in the analysis, there was no difference in volume between the two 
groups of mice at 7, 19, and 20 months old (F (1, 41) = .965, p > 0.05, F (1, 25) = 
0.02, p > 0.05 and F (1, 28) = .180, p > 0.05 respectively). 
 
Similarly, the absolute cerebellum appeared to be relatively spared in 
HdhQ150/Q150 mice; absolute cerebellum volume was not significantly reduced at 7 
months old (-2.29%; HdhQ150/Q150 = 27.04 ± .32 mm3, Hdh+/+ = 27.67 ± .52 mm3, F (1, 
42) = 1.06, p > 0.05), or at 19 months (-4.24%; HdhQ150/Q150 = 26.96 ±.83 mm3, Hdh+/+ 
= 28.21 ± .48 mm3, F (1, 26) = 1.96, p > 0.05). However, after adding TBV as a 
covariate, the difference in cerebellum volume between HdhQ150/Q150 and Hdh+/+ 
mice was significant at 7 months of age (F (1, 41) = 6.71, p < 0.05 uncorrected), but 
not at 19 months old (F (1, 25) = 2.25, p > 0.05). In order to examine whether 
cerebellum volume was relatively larger or smaller at 7 months after accounting for 
total brain volume (TBV), the normalised ([ROI/TBV]*100) statistics were calculated 
and revealed that normalised cerebellum volume is larger in HdhQ150/Q150 mice 
(12.54 ± .11 % of TBV) compared to Hdh+/+ mice ( 12.09 ± .12 %). Thus, the 
cerebellum appears to be spared at both timepoints in HdhQ150/Q150 mice. 
 
For the ventricles, the difference in absolute volume between HdhQ150/Q150 
(mean = 3.08 ± .0.058 mm3) and Hdh+/+ mice (mean = 3.31 ± .065 mm3) was 
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significant at 7 months old (6.82%, F (1, 40) = 7.35, p < 0.05), whereas at 19 months, 
the 4.54% difference in ventricular volume was not significant ( mean HdhQ150/Q150 = 
3.59 ±.31 mm3, mean Hdh+/+ = 3.76 ± .18 mm3, F (1, 27) =.288, p > 0.05). Ex vivo 
measurements at 20 months showed that absolute ventricular volume was reduced 
by 15.10% in HdhQ150/Q150 mice (2.29 ± .11mm3 vs. 2.69 ± .11 mm3 for Hdh+/+ mice, F 
(1, 33) = 6.67, p < 0.05 uncorrected). After TBV was added as a covariate, the 
difference in ventricular volume was not significant at 7 months (F (1, 39) = .437, p 
> 0.05), and at 19 months (F (1, 25) = 3.04, p > 0.05), whereas ex vivo 
measurements of ventricular volume were significantly reduced in HdhQ150/Q150 
mice (F (1, 32) = 6.23, p < 0.05 uncorrected).  
 
In the HdhQ150/Q150 mice, after accounting for TBV, there was a strong 
negative correlation between latency to fall on the rotarod test, and volume in the 
right thalamus, r = -.832, p < 0.05 FDR-corrected. A moderate relationship was 
found with the left thalamus, r = -.668, p < 0.05 uncorrected. In Hdh+/+ mice, the 
relationship with the thalamus was weak, r = -.299 and -.098 for left and right 
hemisphere respectively, p > 0.05. Performance on the Open Field test was not 
significantly correlated with regional volume for HdhQ150/Q150 mice and Hdh+/+ mice 
alike, all p > 0.05 FDR-corrected. Average non-perseverative behaviour over a 24-
hour period was found to be correlated with neocortical volume in Hdh+/+ mice, r = 
.642, p < 0.05 FDR-corrected, whereas the same relationship was weaker in Hdh 
Q150/Q150 mice, r= .304, p > 0.05. There was no relationship with perseverative 
behaviour.  
 
Cortical thickness HdhQ150/Q150 mice had significantly thinner cortices compared 
to Hdh+/+ mice on in vivo MRI images (F (1, 24) = 13.30, p < 0.001). Post-hoc tests, 
with TBV as a covariate, at the two time-points separately found that at 7 months 
old, prior to the onset of motor signs, the difference in cortical thickness between 
HdhQ150/Q150 and Hdh+/+ (-2.8%) was not statistically significant (F (1, 37) = 2.53, p > 
0.05). At 19 months old, the motor cortices in the HdhQ150/Q150 mice were 
Cardiff University  2014
 
209 
 
approximately 8.7 % thinner compared to age-matched Hdh+/+ mice (F (1,23) = 
9.226, p < 0.01). In accordance with the in vivo results, for measurements made on 
higher-resolution images acquired ex vivo at 20 months, the motor cortices were 
approximately 9.3% thinner in HdhQ150/Q150 mice compared to age-matched Hdh+/+ 
mice (F (1,30) = 9.33, p < 0.01 with TBV as a covariate).  
For measurements from histologically stained sections, the motor cortices in the 
HdhQ150/Q150 mice were approximately 5.4 % thinner compared to age-matched 
Hdh+/+ mice, but this difference did not meet statistical significance (t (15) = 1.05, p 
> 0.05). A multivariate analysis found that cortices were significantly thinner when 
measured using chemically stained tissue sections, compared to ex vivo MRI (Wilks’ 
λ =.117, F (1,12) = 90.37, p < 0.001).  
 
 
Figure 6.11 Cortical thickness measures from MRI images at different ages 
(left) and myelin-stained 40 µm brain sections at 20months old (right). Error 
bars represent standard errors of the mean. ** represents p< 0.01. Both the 7 
and 19 month scans were acquired in vivo. All data are averaged across 
Bregma positions, and MRI measures are averaged across hemispheres. 
Chapter 6  2014
 
210 
 
Figure 6.11 shows the cortical thickness MRI measurements at each time-point and 
the measurements obtained from the stained sections. There was a main effect of 
Bregma position for the in vivo measurements at 7-months (F (3,126) = 275.5 and 
191.8 for left and right hemisphere), and  at 19 months (F (3,78) = 73.73 and 85.2 
for left and right hemisphere respectively), and ex vivo MRI measures ( F (2.27, 
74.80) = 148.84, ε = .756) and measurements made on stained sections (F (1.54, 
20.02) = 13.11,  ε = .513), all p < 0.001. For all main effects, the cortex was 
significantly thicker in more anterior brain slices compared to more posterior slices 
in measurements. However there was no interaction between Bregma position 
measured and genotype, all p > 0.05. In terms of laterality effects, there was no 
difference between measurements taken in the left and right hemisphere from in 
vivo measurements at 7 months (F (1, 37) =4.08, p > 0.05) and 19 months (F (1, 23) 
2.47, p > 0.05), however there was a difference between hemispheres on the ex 
vivo MRI images at 20 months (F (1, 30) = 13.95 p < 0.01). For both Hdh+/+ and 
HdhQ150/Q150 mice, there was no relationship between cortical thickness at any 
age/preparation, and motor function, after correcting for multiple comparisons 
using the false discovery rate (FDR), all p > 0.05. 
White matter microstructural changes  
At 7-months of age, prior to the onset of motor signs, there was no difference in 
tensor based values or free water fraction in the corpus callosum between 
HdhQ150/Q150 mice [n =20] and age-matched Hdh+/+ mice [n = 23], all p > 0.05. At 19-
months of age, prior to correcting for free water contamination, all diffusivity 
values were lower in the HdhQ150/Q150 mice compared to Hdh+/+ mice (t(30) = 2.3, 
2.13, and 2.3 for MD, AD and RD respectively, p < 0.05 uncorrected, p = 0.056 FDR-
corrected). After free water correction, the differences in diffusivity values were not 
significant (t (29) = 1.77, 1.72, and 1.60, p > 0.05 uncorrected), and there was no 
difference in FA values between groups (t (29) = .567, p > 0.05). The free water 
fraction did not differ between HdhQ150/Q150 (.282 ± .011) and Hdh+/+ mice (.281 
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±.010), at 7 months (t, 41) = -.077, p > 0.05), or at 19 months, (HdhQ150/Q150=.239± 
.014, Hdh+/+ = .253±.011; t (29) = .790, p > 0.05). There was a significant difference 
between uncorrected and free water corrected tensor values for FA at 7-months (F 
(1, 40) = 953.65, p < 0.001), and 19-months, (F (1, 29) = 264.56, p < 0.001), and MD 
at 7-months (F (1, 40) = 884.28, p < 0.001), and at 19-months (F (1, 29) = 583.56, p < 
0.001). Examining change over time, free water corrected FA values were found to 
be significantly reduced at 19-months of age compared to 7-months in both 
HdhQ150/Q150 mice (t (13) = 2.93, p < 0.05 FDR-corrected) and Hdh+/+ mice (t (15) = 
2.92, p < 0.05 FDR-corrected). There was no change in MD values over time for 
either group of mice, both p > 0.05. Free water fraction in the corpus callosum was 
found to decrease from 7-months to 19- Months (t (29) = 2.16, p< 0.05) although 
this did not survive correction for multiple comparisons. Free water correction FA 
was positively correlated with locomotor velocity on the Open Field task in 
HdhQ150/Q150 mice, r = .691, p < 0.05 uncorrected, whereas the same relationship 
was not found in Hdh+/+ mice, r = -.240. 
 
 
 
 
  
 
 
Figure 6.12 Mean tensor-based values for tract reconstructions along the corpus 
callosum at 7 months and 19 months of age, for uncorrected values and values 
corrected for free water contamination (Pasternak, Sochen, Gur, Intrator, & Assaf, 
2009). Error bars represent standard error of the mean.  
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Free water fraction was negatively correlated with rearing frequency (normalised 
for body weight) on the Open Field task in Hdh+/+ mice, r = -.574, p < 0.05 FDR-
corrected, whereas the same relationship was not significant in HdhQ150/Q150 mice, p 
> 0.05. 
Discussion 
 The HdhQ150 mouse model of HD has previously been well characterised in 
terms of behavioural phenotype and neuropathology (Brooks, Jones, et al., 2012). 
However, characterisation of neuropathology has been restricted to ex vivo 
techniques that are limited to cross-sectional designs and beset by methodological 
issues with tissue fixative altering the tissue structure under examination. In this 
first application of in vivo MRI to the HdhQ150 model, total brain volume (TBV) was 
reduced at 7-months, prior to the onset of motor signs, and at 19-months of age, 
when motor signs were present. TBV was found to interact with genotype in 
accounting for differences in regional volume loss; at 7-months old, the relationship 
between TBV and regional volume was stronger in Hdh+/+ mice compared to 
HdhQ150/Q150 mice, whereas at 19-months old, the relationship between TBV and 
regional volume was stronger in HdhQ150/Q150 mice. Localised atrophy not wholly 
accounted for by global volume loss was evident in the caudate putamen at 7-
months of age along with an increase in localised density in the lateral ventricles. 
The cerebellum was relatively spared at both time points in HdhQ150/Q150 mice. At 
19-months old, localised atrophy in numerous sub-cortical and cortical regions was 
not significant after controlling for global volume loss, although cortical thinning 
was evident. White matter microstructural abnormalities were not detected in the 
corpus callosum at any age. The results of this study partly fit with previous work in 
the same mouse model suggesting neuropathology follows a ventral to dorsal 
pattern (Brooks, Jones, et al., 2012), and the selective sparing of the cerebellum fits 
with the anterior to posterior pattern of pathology previously observed. The results 
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also fit with the findings observed in patients; a smaller intracranial adult brain 
volume was also found in pre-symptomatic HD carriers (Nopoulos, et al., 2010). 
Relationship between brain structure and motor function  
HdhQ150/Q150 mice were found to have prominent motor deficits at 19-
months, with a shorter latency to fall from the accelerating rotarod, a reduction in 
rearing frequency on the open field test, and altered non-perseverative locomotion 
averaged over a 24-hour period. A novel finding was a relationship between motor 
function and brain structure in HdhQ150/Q150 mice detected with in vivo MRI. 
Fractional anisotropy in the corpus callosum, measured using tractography analysis 
of diffusion MRI data, was positively correlated with motor speed in HdhQ150/Q150 
mice, suggesting that observed changes are not purely driven by changes in grey 
matter and that altered white matter microstructure may be related to some of the 
behavioural symptoms seen in HD. A counter-intuitive relationship was found 
between thalami volume and the latency to fall on the rotarod test specifically in 
HdhQ150/Q150 mice; larger thalami were associated with a shorter latency to fall on 
the rotarod test. This direction of effects highlights the difficulty in interpreting 
regional volume measures as a reduction in volume does not necessarily indicate 
cell loss, but could be sensitive to other pathological processes such as cellular 
swelling or an inflammatory response. The same relationship was not evident in 
Hdh+/+ mouse, suggesting that this relationship is specific to HD. Future work would 
involve testing other symptom modalities to ascertain whether this structure-
function relationship is specific to motor signs or whether cognition is also 
associated with atrophy. 
White matter microstructure in the HdhQ150 model of HD 
The lack of any white matter microstructural changes in the HdhQ150/Q150 
mice can be interpreted in a number of ways. In patients, diffusion MRI has 
revealed abnormalities in the corpus callosum in pre-symptomatic and manifest HD 
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participants alike (Di Paola, et al., 2012; Di Paola, et al., 2014; Phillips, et al., 2013), 
also see Chapter 4. However, white matter anatomy differs between species 
(Treuting & Dintzis, 2012), and it is not known if there are functional subdivisions in 
the mouse corpus callosum as there are in human neuroanatomy that may dilute 
any effects when analysed as a single homogenous structure. Furthermore, the 
diffusion MRI sequence acquired is likely to be less optimal compared to the 
sequences acquired in patient work, with more issues with image artefacts caused 
by the higher magnetic field and motion artefacts due to differences in positioning 
in the scanner and respiration speed compared to human imaging. Many of the 
post-processing stages in this chapter were not originally designed for mouse brain, 
and were modified for use in this study. Thus some of the processing may be sub-
optimal, for example, it was not possible to conduct EPI-correction on the images. 
Thus, it is not clear whether tissue microstructure is not a feature of pathology in 
the HdhQ150/Q150 mouse model, or whether methodological limitations means that 
sensitivity is not sufficient to detect an effect. Future planned electron microscopy 
analyses would be able to resolve this.  
Sub-cortical atrophy in the HdhQ150 model of HD 
In this study, localised caudate-putamen atrophy was only evident at 7-
months old, with no continued decline in localised volume found at 19-months old 
after accounting for whole brain volume. In contrast, in patient studies caudate and 
putamen volume were found to be significantly reduced over a 12-month, 24-
month, and 36-month period in pre-symptomatic and manifest participants alike 
(Tabrizi, et al., 2012; Tabrizi, et al., 2011; Tabrizi, et al., 2013). Reasons for the 
discrepancy in results include the inability to delineate the caudate from the 
putamen in the mouse brain as they are not separated by the internal capsule as in 
the human brain, which may dilute any specific effects. Further, a change in volume 
over 12-months in the mouse lifespan does not readily translate to a period of time 
in patient work, although clearly 12-months for a mouse line with a lifespan of 
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approximately 22 months represents a much longer lag period, which may explain 
the lack of selective, localised changes.  
 
Although atrophy was evident in many structures in HdhQ150/Q150 mice, the 
degree of atrophy was not found to be significant in any region except from the 
caudate-putamen after accounting for total brain volume. The pattern of atrophy 
observed in this study is different to what is seen in the pre-symptomatic stage of 
the human disease, where localised sub-cortical atrophy is evident in many 
structures (as shown in Chapter 4). Interpreting a reduction in whole brain volume 
in terms of biophysical changes and in relation to previous immunohistochemistry 
findings is not straightforward due to the difference in the scale of the results. A 
progressive pathology has been shown in HdhQ150/Q150 mice in the striatum in the 
number of cells which stain for S830, an antibody for mutant huntingtin 
(Sathasivam et al., 2001), and the number of intra-nuclear inclusions, with an 
increase from 8- to 18-months of age observed (Bayram-Weston, et al., 2012). The 
volume of the striatum was found to be reduced compared to Hdh+/+ mice from 6 
months of age onwards (Bayram-Weston, et al., 2012), which was detected in the 
current study in vivo as localised striatal atrophy at 7 months of age. Similarly, the 
total number of neurons was also found to be reduced compared to Hdh+/+ mice 
from 6 months of age onwards, however both the volume and neuronal count did 
not continue to decline with increased age (Bayram-Weston, et al., 2012), and 
nuclear inclusions were observed in widespread areas of the brain from 6 months 
of age. This specific lack of a progressive phenotype combined with evidence 
showing diffuse mutant huntingtin staining from an early age supports the pattern 
of results observed in this study.  
Evidence for developmental effects 
An unexpected finding was the lack of decline in whole brain volume from 7- 
to 19-months of age, suggesting either that widespread atrophy occurs early in the 
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disease course in this mouse model and is not progressive, or that the mutant gene 
has an effect on development. A smaller intracranial volume has previously been 
found in pre-symptomatic HD participants (P. Nopoulos et al., 2010), and in chapter 
4, pre-symptomatic and early HD participants were found to have reduced whole 
brain volume, however whole brain volume loss has been found to increase over 
time in both pre-symptomatic and manifest HD participants (Domínguez et al., 
2013; Majid et al., 2011; Tabrizi, et al., 2011), suggesting that there is further loss 
with subsequent neurodegeneration. 
 
HdhQ150/Q150 mice had a significantly reduced body weight compared to age-
matched Hdh+/+ mice from 3 months of age onwards, suggesting that 
developmentally, these mice do not reach the normal mature adult weight seen in 
Hdh+/+ mice. Combined with evidence showing reduction total brain volume at 7 
months, these results could be indicative of abnormal developmental processes in 
this model of HD. Although this cannot be determined from the data, the concept 
that mutant huntingtin may have effects on developmental processes is not new 
(Mehler & Gokhan, 2000; Nguyen, Gokhan, Molero, & Mehler, 2013) and huntingtin 
has been found to regulate cortical neurogenesis (Godin et al., 2010). Thus, further 
study should be directed toward exploring the contribution of neurodevelopmental 
processes in HD.  
Selective effect of anaesthesia in Hdh Q150/Q150 mice 
In terms of survival, there was no difference in the lifespan of the 
HdhQ150/Q150 mice compared to Hdh+/+ mice up until 19 months of age, which was 
expected as the HdhQ150 model has a normal lifespan (Lin, et al., 2001). However, 
it was found that HdhQ150/Q150 mice were less tolerant of anaesthesia required for 
the MRI acquisition at 19-months old, and the mortality rate was significantly 
higher in HdhQ150/Q150 mice compared to Hdh+/+ mice, with more mice not 
recovering from anaesthesia. This could be explained by a number of factors, such 
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as a difference in metabolic rate in the aged HdhQ150/Q150 mice, a change in oxygen 
consumption rate affecting the survival rate for hypoxemia, a difference in 
thermoregulatory efficiency, or differential hepatic glycogen reserves in the two 
groups of animals with the HdhQ150/Q150 mice more at risk of hypoglycaemia. As 
mutant HTT is expressed throughout the entire body, it is likely that deficits in 
hepatic, renal and/or cardiac systems affected the response to anaesthesia in the 
HdhQ150/Q150 mice; cardiac abnormalities have recently been shown in HdhQ150/Q150 
mice (Mielcarek et al., 2014), and hepatic dysfunction is an area of recent research 
attention in HD (Chiang, Chern, & Juo, 2011; Hoffmann et al., 2014; Stüwe et al., 
2013). This highlights that the suitability of an anaesthetic procedure is dependent 
on the strain, age and weight of the mouse (Gargiulo et al., 2012), which is 
problematic in longitudinal studies where these factors are not fixed. Further work 
is required to examine the effects of different anaesthetic procedures on the 
measures under examination (diffusion properties, tissue volume) in order to 
determine the effect of altering anaesthetic procedures throughout the course of 
an experiment to adapt to the change in age and/or weight of the animal.  
Methodological considerations 
A strength of this study was the longitudinal design, allowing for the 
examination of disease progression and neuropathology over time. However, the 
lack of histological validation available at the pre-symptomatic, 7-month time-point 
is a limit of the study. The study was planned so that 5 HdhQ150/Q150 mice and 5 
Hdh+/+ mice would be humanely sacrificed at 7 months in order to validate the MRI 
findings with histology, however the unexpectedly high rate of mice failing to 
recover from the anaesthesia during MRI affected the sample size. The reduced 
sample size meant that it was necessary to retain all mice in the study in order to 
achieve sufficient power for the second time-point. This unexpected effect also 
resulted in a change in anaesthetic procedure which was not ideal for experimental 
consistency across time-points, but was necessary for animal welfare and to be able 
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to acquire longer diffusion sequences. Pilot studies were conducted using the 
original anaesthetic protocol, however only with C57BL6/J mice and not with knock-
in mice. This suggests that the reaction to the anaesthesia is strain and genotype 
specific, and future studies would pilot the anaesthesia with the specific strain 
under examination.  
 
It was not possible to achieve sufficient neuronal counts from the 
immunohistochemistry conducted in this study. This was because some of the steps 
in the protocol were specifically used to optimise MRI acquisition, which may have 
been detrimental to the immunohistochemistry. For the ex vivo imaging, this 
included the extensive washing procedure before scanning, and retaining the brains 
in the skull to reduce motion, both of which were found to improve the image 
quality during piloting. However, the transfer of brains from sucrose to buffer for 
washing prior to MRI may explain the issues with tissue contamination experienced, 
and retaining the brains in the skulls meant that the 24-hour post-fixation period 
may not have been sufficient. Future work is required to achieve an optimal 
protocol for both MRI and histology combined, with a shorter wash duration and 
longer fixation period.  
 
 The effect of correcting for free water contamination on the statistical 
outcome of the results showed that partial volume was an issue in the mouse brain 
and efforts should be made to correct for this. The relationship between free water 
fraction and rearing behaviour in Hdh+/+ mice suggest that the amount of free water 
may be functionally relevant, which is in agreement with the results presented in 
the patient cohort in chapter 4 and is a novel finding in HD.  
 
It is normal practice in the research literature to use homozygous knock-in 
mice (Brooks, Higgs, Jones, et al., 2012) as was done in this study. However, this 
represents an important difference when translating to patient work. This is 
because the majority of HD patients are heterozygous with one normal Htt allele 
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and one CAG-expanded allele and the contribution the remaining wild-type Htt 
gene makes to the disease is a contentious issue ((Aziz et al., 2009; Aziz, Roos, 
Gusella, Lee, & Macdonald, 2012; Cattaneo, Zuccato, & Tartari, 2005; Djoussé et al., 
2003). Because homozygous HD patients are rare, there have been only a handful 
of studies comparing the disease features with heterozygous HD patients. These 
strudies converge to show that homozygosity for the HD mutation did not affect the 
age at onset of symptoms or clinical severity (Myers et al., 1989; Squitieri et al., 
2003; Wexler et al., 1987), whereas the rate of disease progression was affected 
(Squitieri, et al., 2003). 
 
Finally, the discrepancy between the MRI and histology based measures for 
cortical thickness can be explained in terms of methodology. The poor tissue quality 
that resulted from the immunohistochemistry processing stages may explain why 
the measures of cortical thickness obtained from stained sections do not show the 
same genotype differences as those seen with MRI measurements, with a reduced 
sample size due to poor quality samples being removed from the analysis. There 
were also differences in terms of the software used to measure cortical thickness, 
which are likely to differ in terms of sensitivity to detect effects. The 
immunohistochemistry was only conducted on one hemisphere, whereas the MRI 
measurements came from both hemispheres, whilst working with half hemispheres 
increased the damage suffered by the tissue during processing. Future work will 
involve analysing the second hemisphere using electron microscopy. 
Concluding comment 
In conclusion, this longitudinal study suggests in vivo MRI has the sensitivity 
to detect disease-related macrostructural changes in a mouse model of 
Huntington’s disease, with the most marked finding being a loss of total brain 
volume before the onset of motor signs. There was no evidence for white matter 
microstructural abnormalities at any time point; although future planned electron 
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microscopy analyses will be able to validate this null result. Finally, this work 
highlights a number of methodological considerations for longitudinal MRI-
histology studies.  
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7  In vivo MRI evidence that 
neuropathology is attenuated by 
environmental modifiers in the YAC128 
Huntington’s disease mouse model  
Chapter Summary 
 
The aim of this final experimental chapter was to examine whether in vivo 
high-field magnetic resonance imaging (MRI) can detect a disease-modifying effect 
in gross tissue macrostructure and/or more subtle effects in white matter 
microstructure following an environmental intervention.  
 YAC128 transgenic and wild type mice were exposed to a high-level 
intervention paradigm involving both cognitive training and associated dietary 
restriction throughout their lifetime. The combination of interventions was 
designed to maximise the influence of the environmental effect rather than 
specifically probe the role of either cognitive training or food restriction, to 
determine whether such an intervention was sufficient to induce an effect. At 20-
months old, mice were scanned with T2-weighted and diffusion-weighted 
sequences. Locomotor activity level and performance on the rotarod and serial 
discrimination task were assessed to measure motor and cognitive function 
respectively. A region-of-interest (ROI) approach measured gross structural changes 
whereas water diffusivity indicative of tissue microstructure was assessed using 
tractography analysis. 
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Results support previous ex-vivo findings of a disease-modifying effect of 
environmental factors on neuropathology and show novel findings of white matter 
alterations following exposure to environmental modifiers.   
Introduction 
 
There is some evidence that ‘environmental’ rehabilitation such as cognitive 
stimulation may have beneficial effects on the speed of symptom progression in HD 
patients (Zinzi et al., 2007). Similarly, in genetic mouse models of HD there is now a 
substantial body of research showing that various forms of environmental 
enrichment can delay symptom progression and ameliorate disease severity 
(Dellen, Blakemore, Deacon, York, & Hannan, 2000; Dellen, Cordery, Spires, 
Blakemore, & Hannan, 2008; Spires et al., 2004).  Cognitive stimulation has been 
shown to retard symptom progression (Wood, et al., 2011), whilst enriched living 
conditions slowed the decline in motor performance and delayed the onset of 
disease-related neuropathology (Hockly, et al., 2002). Dietary restriction also 
slowed the progression of neuropathological, metabolic and motor abnormalities in 
a  mouse model of HD (Duan et al., 2003).  A shared potential shortcoming in these 
mouse studies is the use of fixed tissue and ex vivo techniques to demonstrate 
effects on neuropathology, as the fixing, embedding and sectioning procedures 
used in these techniques causes tissue shrinkage and deformation (Biedermann et 
al., 2012).  
 
Learning-induced plasticity at the white matter microstructural level has 
been detected in  rats using in vivo diffusion MRI (Sagi et al., 2012) suggesting that 
just as in humans, diffusion MRI may have the sensitivity necessary to detect an 
effect of environmental modification in the rodent brain  (Sagi, et al., 2012; Scholz, 
Klein, Behrens, & Johansen-Berg, 2009). Nevertheless, in vivo MRI and particularly 
diffusion MRI is technically more challenging in the mouse brain compared to the 
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rat brain, due to the difference is size and thus spatial resolution required. The 
ability to detect environmental modification effects in the mouse brain using in vivo 
techniques would allow for longitudinal designs which are imperative for a time-
dependent disease such as HD. For this reason, in order to assess the effects of 
environmental modification on neuropathology at a level detectable with in vivo 
MRI, a high level of environmental modification was used in order to maximize the 
chance of detecting any amelioration in neuropathology or behavioural phenotype, 
with the notion of specifically targeting the role of both interventions separately in 
subsequent studies in the event of disease modification with the present 
manipulations.  
A whole brain fiber tractography approach was used  to compare specific 
white matter fiber pathways in 3-dimensions (Jones, 2008) between wild type and 
diseased mice, and between control and experimental groups. In order to be able 
to compare with results presented in the previous experimental chapters, the 
corpus callosum was examined.  The aim of this work was to replicate the disease-
modifying effects of a cognitive stimulation and dietary restriction regime 
previously seen in HD mice, including the effects on neuropathology seen with ex 
vivo techniques, using in vivo MRI. 
Methods 
Animals 
 
A total of 22 YAC128 hemizygote transgene carrier mice (10 female, 12 
male) and 23 wild type litter-mate mice (17 female, 6 male) were used. The YAC128 
mice have 128 CAG repeats and were selected based on the HD-related phenotypic 
uniformity and low inter-animal variability (Slow, et al., 2003b), age-dependent 
striatal neurodegeneration, and longer lifespan compared to the commonly used R6 
mouse lines.  Genetic background, breeding, housing, and genotyping information 
are detailed in Chapter 2. 11 transgenic mice and 11 wild type mice were randomly 
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allocated into the experimental group, and the remaining 11 transgenic and 12 wild 
type mice were randomly allocated into the control group.   
 
Environmental Modification (EM) Regime 
 
The environmental modification (EM) regime combined dietary restriction 
with cognitive training using an operant learning task, giving the animals both 
cognitive and motor stimulation during the training periods, as well as exposure to 
a different environment than the home cage, in order to deliver a high level of 
environmental modification.  Food restriction involved providing mice with a 
limited number of food pellets which were adjusted based on the animals weight in 
order to achieve a weight loss of 10% from their non-restricted weight. Animals 
were weighed daily and food delivery was adjusted accordingly.  
 
All cognitive training occurred between the hours of 08:30 and 18:00. 
Animals were trained 5 times a week for 30 minutes a day throughout their lifespan 
on a stimulus response learning task containing an implicit learning component (Jay 
& Dunnett, 2007),  previously shown to be sensitive to striatal dysfunction 
(Trueman, et al., 2005) and genotype differences in knock-in HD mice (Trueman, 
Brooks, Jones, & Dunnett, 2007). 
 
For the cognitive enrichment, 16 operant 9-hole chambers (Campden 
Instruments, Loughborough, UK) measuring 14 cm x 13.5 cm x 13.5 cm were used in 
parallel. The chamber contained a horizontal array of 9 holes 11mm in diameter, 
placed 2mm apart and 15mm above floor level. Each hole contained an LED light 
and a photocell beam to detect when the nose of the mouse entered the hole. Only 
five of the nine holes were utilised in this experiment, with the remaining holes 
blocked and inaccessible.  
 
In preparation for the delivery of the cognitive stimulation regime, mice 
were first trained in the operant boxes. A simple association task was used for the 
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first 3 days to train the mice to associate the magazine light with reward delivery by 
presenting the reward (strawberry milkshake) into the food magazine in a non-
contingent manner. Next, mice were trained to make a response for a reward 
(strawberry milkshake) using a continuous reinforcement task, which required the 
mouse to respond to a light stimulus in hole C of the array by poking their nose 
once into the illuminated hole in order to elicit reward delivery. This was completed 
daily until the mice met a performance threshold.  Mice were then moved on to the 
5-choice serial reaction time task whereby the stimulus light now appeared 
randomly in any of the 5 holes of the array and a single correct response to the lit 
hole resulted in reward delivery. After reaching an adequate level of performance 
(>40 responses), the mice were introduced to the serial implicit learning task (SILT), 
described in detail in Jay and Dunnett (2007).  Briefly, the mouse was required to 
make a chained response consisting of 2 consecutive correct responses in order to 
receive a reward. At the start of each trial, the house lights were off and one of the 
ﬁve open holes was illuminated at random. The first response (S1) is the same as 
for the 5-choice task, but if the mouse made a correct response, the illuminated 
light was turned off and a second hole (S2) was lit. A successful nose-poke to S2 
resulted in the simultaneous extinction of the stimulus light, illumination of the 
magazine light and delivery of the reward. Embedded within the random 
presentations of 2 light sequences, was a single predictable 2-light sequence.  
 
Two versions of the task were employed to test the mice. In the ﬁrst version 
the S2 was continuously illuminated until the mouse responded. The mice remained 
on this until their performance reached asymptote. With the second version the S2 
was illuminated for 0.5 s and the mouse could make a correct response in the 
location where the light had been for up to 10 seconds after extinction of the light. 
In both versions of the task a correct response to S2 was reinforced by delivery of 5 
µl of strawberry milk (Trueman, et al., 2007). Performance on the task was 
operationalized in a number of ways.  For the S1 stimuli, accuracy (% correct 
responses over total number of trials initiated) was analysed by hole (A-E), whereas 
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the S2 stimuli were calculated by step-size, the distance (number of steps/holes) 
between the S1 and S2 stimuli. Performance was monitored in each training block 
to avoid ceiling and floor effects. 
 
 At approximately 18 months of age, the performance of the transgenic mice 
on the more stringent second version of the SILT task began to approach a floor 
effect which we recognized may bias the MRI measurements (Figure 7.1). 
Consequently, to ensure both transgenic and wild type animals were receiving 
acute and comparable cognitive stimulation, all mice were moved to the less  
stringent ‘version 1’ SILT schedule whereby the S2 was continually lit and 
performance was monitored to ensure all animals were stimulated cognitively.    
  
Figure 7.1 Cognitive enrichment performance at 18-months old.  Response 
accuracy and response time to Stimulus 1 (S1; A and C) and Stimulus 2 (S2; B and 
D) on the Serial Implicit Learning Task (SILT; Jay and Dunnett, 2007) for wild-type 
(WT) and transgenic (TG) mice. Axis crossing point represents chance 
performance levels. Error bars show standard error of the mean.  
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Image Acquisition 
 
MRI acquisition and animal preparation details are described fully in Chapter 
2.  A transmit 1H 500 watt echo-planar imaging (EPI) volume coil was used with a 
mouse head receive-only surface coil. Paravision 5.0 software (Bruker Biospin) was 
used for data acquisition.  All scans were performed in vivo, with animals 
anesthetised with isofluorane (5% for induction, 1.8-2.2% for maintenance) mixed 
with carrier gas (30% pure oxygen, 70% air) delivered at 1 litre/minute.   
 
At 20 months old, all 44 animals underwent a 2D Rapid Acquisition with 
Refocused Echoes (RARE) T2-weighted scan (repetition time (TR) 4000 ms, echo 
time (TE) 35 ms) with a FOV of 1.54 x 1.54 cm and slice thickness of 0.40 mm, in-
plane resolution of 120 x 120 um, 30 slices bandwidth 50000 Hz, RARE factor of 2, 
with 8 averages. A subset of animals (n=32, 16 WT [8 control, 8 trained], 16 
transgenic carriers [8 control, 8 trained]) had a diffusion MRI scan in the same 
session. A 4-shot DTI-EPI sequence was used to investigate white matter 
microstructure. 27 adjacent axial slices of 320 µm in thickness were acquired with a 
repetition time (TR) of 14604 ms and an echo time (TE) of 20 ms.  Diffusion 
gradients were applied for 4 ms (δ) with a 10 ms gap (Δ) between pulses. 4 
averages were used to increase the signal to noise ratio. The in-plane resolution 
was 213 x 213 µm at a FOV of 2.24 cm x 2.24 cm and an acquisition matrix of 96 x 
96.  4 dummy scans were used at the beginning of the acquisition in order to 
stabilise the magnetisation equilibrium. Data were acquired with a b-value of 1000 
s/mm2 applied over 30 diffusion-weighted directions  (D. Jones & Simmons, 1999) 
uniformly distributed in three dimensional space with 5 b = 0 s/mm2 images 
without diffusion weighting.  Respiratory-gating was used to minimise respiratory 
motion artefacts using procedures provided with the Bruker Paravision 5.0 system.  
 
Image processing 
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Processing of the T2-weighted images was carried out using Analyze 10.0 
(Mayo Clinic) software, whereas diffusion MRI images were processed using 
ExploreDTI software (Leemans, et al., 2009). One T2- and diffusion scan was 
corrupted and not included in the analysis.  For the T2-weighted images, skull-
stripping was first performed using a Brain Extraction Tool (Smith, 2002), modified 
for rodent brains. Diffusion images were processed according to the methodology 
detailed in Chapter 2. 
 
 Region of interest (ROI) analysis   In order to compare with 
previously published data, mean volume for different ROI’s were calculated  for the 
T2-weighted images based on the mouse brain histology atlas (Paxinos & Franklin, 
2004)  by a single rater blinded to the animal’s genotype or  experimental group. In 
order to avoid hemispheric differences due to handedness bias, all images were 
drawn on the hemisphere to the left of the screen, with the original and flipped 
image used 
 
The striatum, lateral ventricles and cortex were determined a priori as ROI’s 
and were manually identified according to the image contrast on the T2-weighted 
image. In order to avoid poor reproducibility due to inconspicuous structure 
boundaries, 5 slices were selected at approximately Bregma 1.42, 1.10, 0.14, -0.22 
and -0.58. Manual delineation was mainly performed in the coronal view on a slice-
by-slice basis and refined in the axial and sagittal view to ensure the structure 
boundaries appeared as smooth as possible in all the three views. All slices 
contained clear anatomical landmarks and provided reproducible coverage of the 
structures being analysed. In all 5 slices, the regions of interest were drawn for the 
striatum, lateral ventricles, and cerebral cortex, and for reproducibility, the ventral 
boundary for all three ROI’s was a 10° angle from the jawbone as shown in Figure 
7.3. Structures were examined separately in both hemispheres. ROI’s were also 
drawn on every brain slice for the whole brain region in order to get a measure of 
whole brain volume. 
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Reproducibility was tested using the coefficient of variation and Cronbach's 
alpha. The intra-rater coefficient of variation (CV) was <4.5% for volume measures 
from ROI’s drawn on T2-weighted images, with the exception of the lateral 
ventricles which were more variable, with 9.54% CV. Cronbach’s alpha was 0.9 for 
all metrics indicating excellent internal consistency, with the exception of the 
lateral ventricles (alpha = 0.6). 
 
Tractography analysis   The methodology is the same as in Chapter 6, 
with whole-brain deterministic tracking conducted using ExploreDTI (Leemans, et 
al., 2009) and based on the constrained spherical deconvolution algorithm 
(Tournier, et al., 2004; Tournier, et al., 2008). Multiple waypoint ROI’s which were 
drawn manually in native space on color-coded fiber orientation maps by a single 
operator blinded to the genotype and training status of the mouse. The mean FA 
and MD were then calculated for all reconstructed pathways by averaging the 
values sampled at each step along the pathways (D. Jones et al., 2005). As an 
extension to the segmentation presented in chapter 6, tract-specific means of FA, 
ADC and eigenvalues were calculated in the genu, body and splenium segments of 
the corpus callosum, as different segments of the callosum may differ in their 
susceptibility to neurodegeneration due to the different inter-hemispheric 
connections. As in chapter 6, an initial seed ROI was drawn on the colour-coded 
diffusion image (Pajevic & Pierpaoli, 2000) on the mid-sagittal slice in order to 
capture all the tracts passing through this ROI, which included many association 
fibers and fibers of the external capsule (see Figure 7.4).  The analysis was then 
restricted to the corpus callosum with external capsule tracts excluded through two 
additional ‘AND’ gate ROI’s drawn in the sagittal plane in line with the medial 
cingulum in both hemispheres as visualised in the coronal plane. For the genu of 
the corpus callosum, the seed region was drawn from the most anterior section of 
the genu to the posterior boundary where the anterior commissure crosses the 
midline. For the body of the corpus callosum, the seed region was drawn from the 
anterior boundary where the anterior commissure crosses the midline, and the 
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posterior boundary was the start of the splenium defined by the position of the 
lateral ventricles as seen on the MD map. 
 
Behavioural outcome measures 
 
Three outcome measures were used at 20 months of age to assess 
functional change due to EM. The rotarod test (B. Jones & Roberts, 1968) was used 
to assess overall performance in motor coordination, balance and endurance (see 
Chapter 2 and 6) with the average of the two runs taken as the outcome measure. 
Automated home-cage analysis was used to measure  locomotor activity, with total 
number of beam breaks made in 5-minute intervals recorded over a 30-minute time 
period, on MED-PC® software (Vermont, USA).   
 
The water T-maze serial discrimination task was used as a measure of 
procedural discrimination learning and cognitive flexibility (Brooks, Nari Janghra, et 
al., 2012). The arms of the maze were 30 cm high and 7 cm wide, the stem was 
21.5 cm long and the two perpendicular side arms each 37 cm long. The maze was 
filled at 23 ± 2 °C to a depth of 22.5 cm with water whitened with milk to conceal an 
escape platform  (6 × 6 × 21.5 cm high) positioned 1 cm below the surface at the 
end of one of the maze arms depending on the task. In the watermaze, testing was 
conducted in low light conditions; illumination came from one of two standard 
angle poise 40 W lamps placed over the end of each arm. Mice were placed into the 
water and swam toward the ‘T’ where they had to make a choice to turn either left 
or right. A choice was deemed to have been made when the entire body had 
entered an arm. A correct choice would be a turn toward the escape platform, 
which allowed the mouse to exit the maze. An incorrect choice led to the mouse 
being temporarily blocked into that arm, thus elongating the length of time in the 
water, before being allowed to swim to the escape platform. Briefly, the rules to 
learn were a simple directional discrimination (for example always go left) followed 
by a reversal (always go right), which was followed by a visual discrimination (for 
example go to light) and reversal (go to dark), which was followed by a switch to 
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the original rule (always go left). During the directional discrimination tasks one of 
the two lamps was randomly illuminated for each trial, whereas during the visual 
discrimination tasks the platform location was randomly allocated. When mice 
were able to select the correct arm with 90% accuracy (maximum of 100 trials), 
they were assumed to have learned the rule and were progressed to the next rule. 
 
Statistical analysis 
 
Because gender distribution was unbalanced across groups, an analysis of 
variance was implemented using a regression model (SPSS 10.0) with the associated 
main and interaction effects with genotype, EM exposure, and gender as 
independent variables using the enter method. A mixed-model ANOVA was used to 
examine the main and interaction effects with genotype, EM exposure, and gender 
at 5-minute intervals in the automated home-cage analysis, with time as the within-
subject variable (5-, 10-, 15-, 20-, 25-, 30-minutes). When correcting for multiple 
comparisons due to multiple ROI’s, it was acknowledged that alterations in 
different ROI’s may not be independent measures, resulting in the Bonferroni 
method being overly conservative. Thus, Type I error was controlled with the false 
discovery rate (FDR) at 5% (q < 0.05), with the q-value software (Storey, 2002).    
 
Results 
 
Results are expressed as mean ± standard error of the mean (S.E.M).  Unless 
reported, there were no interactions between gender and the two independent 
variables, genotype and environmental modification (EM) exposure.  1 scan 
(Diffusion and T2) of a transgenic enriched mouse corrupted. 
 
Survival Rate  
 Genotype and exposure to EM had no effect on survival rate, both p > 0.05,  
with mice scanned prior to the end point and humanely scarified thereafter. 
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Body weight  
 
Genotype, EM group, and gender did not explain the variance in body 
weight measured on the day of scanning, F (3, 40) = .758, p > 0.05, R2 = .054, 
R2Adjusted = -.017.  Exposure to EM had no effect on body weight β = .543, t = 1.075, p 
> 0.05, and there was no difference in body weight between YAC128 and wild-type 
mice at 20-months old,  β = .444, t = .875, p > 0.05,  in line with previous findings 
(Brooks, Higgs, Janghra, Jones, & Dunnett, 2012). There was also no effect of 
gender on body weight, β = -.194, t= -1.118, p > 0.05, and no interaction effect 
between EM exposure and genotype, β = -.875, t = -1.260, p > 0.05.   
Cognitive Training Performance  
At 20-months old, and averaged over the final 5 trial days, there was no 
difference between wild-type and YAC128 mouse in accuracy to respond to the S2 
stimuli  across the step sizes, F (1,20) = 2.04, p ≥ 0.05. Similarly, there was no 
difference in response accuracy to S1, F (1,20) = .314, p ≥ 0.05.The mice were able 
to detect and use the predictable stimuli to increase response accuracy (t(21) = 
4.11, p ≤ 0.001), however there was no difference between the genotypes in 
performance to the predictable stimuli (genotype x predict, F (1,20) = .152, p ≥ 
0.05), in line with previous work (Brooks et al., 2012).  
 
Behavioural outcomes 
 
The contribution of genotype, environmental modification (E.M.) and 
gender to the regression model predicting performance on the behavioural tests is 
shown in Table 7.1, along with model statistics.  For the home-cage analysis, activity 
levels were assessed at 5-minute intervals over a 30-minute time window (Figure 
7.2A).  Exposure to EM had a significant effect on locomotor activity (p < 0.05 FDR-
corrected); mice exposed to EM were more active over a 30-minute time period 
compared to control mice, making significantly more beam breaks in the activity 
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Figure 7.2 Behavioural Outcome Measures. [A] Activity levels over 30-minutes 
shown as the mean number of light beam breaks; EM mice made significantly more 
beam breaks, p <0.05.  [B] Latency to fall on the rotarod test. C] Percentage of 
correct trials on the Water T-Maze task to the 5 rules:  Direction (Left-Right), 
Direction Reversal, Light/Dark Discrimination, Light/Dark Rule Reversal, and 
Original (Direction discrimination). WT: wild type. TG: transgenic. Error bars: 
standard error of the mean.   
boxes.  Genotype and gender had no effect on locomotor activity, and there was no 
interaction between EM exposure and genotype, p > 0.05.  
On the rotarod test, it was found that genotype, EM group, and gender 
explained a significant amount of the variance in latency to fall (Figure 7.2B). Both 
exposure to EM and genotype significantly predicted latency to fall, with EM 
exposed mice able to stay on the rotating rod longer (mean = 84.5 ± 7.56 s) 
compared to mice in the control group   (mean = 69.1 ± 7.57s), and transgenic mice 
able to stay on the rotating rod for less time (61.98 ± 6.90 s) compared to wild-type 
mice (90.85±7.17 s). 
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Table 7.1 Multiple regression analysis for behavioural measures.  E.M: 
environmental modification. Uncorrected p values shown.  
 
 
 
 
 
 
 
 
 
  Gender did not significantly predict rotarod performance. There was no 
interaction between genotype and EM exposure for latency to fall, suggesting wild 
type mice and transgenic mice benefited from EM in a similar manner. 
 
On the watermaze task, genotype, EM group, and gender did not explain a 
significant amount of the variance on any discrimination trial, all p > 0.05.   EM 
exposure did not have an effect on performance accuracy on the water–maze serial 
discrimination task, p > 0.05 (Figure 7.2C).  Genotype  significantly predicted the 
ability to discriminate between light and dark, with  YAC128 mice making  fewer 
correct choices in the light- dark discrimination stage, , with a performance 
accuracy of 60.52 ± 1.07% compared to 65.04±1.43% in wild types, however this did 
not survive correction for multiple corrections, FDR-adjusted p = 0.056. 
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There were no differences between transgenic and wild type mice on the reversal 
stages of the T-maze task, possibly because all mice were performing at chance 
level.   There was no interaction between EM and genotype for performance 
accuracy of the water T-maze, suggesting a beneficial effect of EM specifically in the 
motor domain.  
 
Tissue Macrostructure 
 
As shown in Figure 7.3, mean whole brain volume was 437.72 ± 3.36 mm3 
for wild-type mice, and 432.99 ± 2.68 mm3 for YAC128 mice. Genotype, EM group, 
and gender did not explain a significant amount of the variance in whole brain 
volume; neither EM exposure or genotype predicted whole brain volume, all p > 
0.05. Whole brain volume was not significantly correlated with volume in the left 
and right caudate in wild-type mice, r = -.220 and .330 respectively, p > 0.05, or in 
YAC128 mice, r = -.348 and -.286 respectively, p > 0.05. Similarly, whole brain 
volume was not significantly correlated with cortical volume in the left and right 
hemisphere in wild-type mice, r = .131 and -.108 respectively, p > 0.05, or in YAC128 
mice, r = .343 and .022 respectively, p > 0.05.   
There was also no relationship between whole brain volume and lateral 
ventricular volume in wild-type mice, r =.268, p > 0.05, and YAC128 mice, r = .153, p 
> 0.05.  Thus, it was not necessary to include whole brain volume as a covariate in 
the subsequent analyses. 
Genotype, EM group, and gender explained a significant amount of the 
variance in the absolute caudate-putamen volume in the left and right hemisphere, 
both p < 0.05 FDR-corrected.  EM exposure did not predict the raw volume in the 
left or the right caudate-putamen, p > 0.05. In contrast, genotype significantly 
predicted volume in the left and right hemisphere, p < 0.01 FR-corrected, with 
caudate-putamen volume being reduced by 15.57 % in the left hemisphere and 
17.81% in the right hemisphere in YAC128 mice compared to controls. 
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Figure 7.3 Top. Manual segmentation of ROI’s on the T2-weighted image with 
approximate Bregma positions. Bottom.  Mean raw volume (mm3) showing a main 
effect of genotype. Error bars represent standard error of the mean. TG: 
transgenic, WT: wild-type. EM: environmental modification.  *** p < 0.001 
uncorrected.  
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Table 7.2 Multiple regression analysis   for macrostructural measures from the T2-
weighted image. Uncorrected p values shown.  
 
 
When the interaction term (Genotype * EM exposure) was added, the model 
remained significant with an increase in the amount of variance explained in the 
left hemisphere, F (4, 33) = 7.388, p < 0.001, R2 = .471, R2Adjusted = .407, and in the 
right hemisphere, F (4, 33) = 16.056, p < 0.001, R2 = .661, R2Adjusted = .619.   The 
interaction between genotype and EM exposure had a significant effect on left 
caudate-putamen volume, β = 1.323, t = 2.173, p < 0.05 but not on right caudate-
putamen volume, β = .184, t = .378, p > 0.05.  Post-hoc analyses in the left 
hemisphere for YAC128 and wild-type mice separately found that EM exposure 
significantly predicted left caudate-putamen volume in transgenic mice, β= .486, t = 
2.310, p < 0.05, but not in wild-type mice, β = -.097, t =-.398, p > 0.05, suggesting 
that EM exposure has a selective effect on left caudate-putamen volume in YAC128 
mice, reducing the degree of disease-related atrophy.   A Post-hoc t-test comparing 
wild-type control mice with YAC128 mice exposed to EM found that volume in the 
left caudate putamen in EM-exposed YAC128 mice was significantly smaller than 
wild-type control mice, t (10) - -2.972, p < 0.05, suggesting that EM exposure 
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reduced  disease-related atrophy in the left caudate-putamen, but does not 
ameliorate it.  
 
Genotype, EM group, and gender explained a significant amount of the 
variance in raw cortical volume in the left and right hemisphere, both p < 0.05 FDR-
corrected. EM exposure did not predict the raw volume in the left or right cortex, p 
> 0.05. In contrast, genotype significantly predicted volume in the left and right 
hemisphere, p < 0.01 FDR-corrected, with cortical volume reduced by 4.45% in the 
left hemisphere and 3.73% in the right hemisphere in YAC128 mice compared to 
wild-type mice. The interaction between genotype and EM exposure had no effect 
on volume in the left and right cortex, β = -.046 and .179, SE= 299.82 and 266.25 
µm, t= -.067 and .260, both p > 0.05.  
 
Genotype, EM group, and gender did not explain a significant amount of the 
variance in the lateral ventricle volume, both p > 0.05, and genotype and EM 
exposure did not predict ventricular volume. Gender was found to predict 
ventricular volume, however the interaction between gender and genotype, and 
between gender and EM exposure, did not predict lateral ventricle volume, both p 
> 0.05. 
 
Tissue Microstructure 
 
For the tractography based analysis of the corpus callosal reconstructions,  
FA values in the genu segments were predicted by exposure to environmental 
modifiers, p < 0.05 uncorrected, as shown in Table 7.3.  The interaction between 
genotype and exposure to environmental modifiers was not a significant predictor 
of FA values in the genu segment, β = -1.522, SE = .033, t = -1.830, p > 0.05.   
 
In the body of the corpus callosum, both genotype (p < 0.05 FDR-corrected) 
and exposure to environmental modifiers (p< 0.001 uncorrected) significantly 
predicted FA values. The interaction between genotype and exposure to 
[
C] 
[
B] [
B] 
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environmental modifiers was also a significant predictor of FA values, β = -2.059, SE 
= 0.028, t = -2.64, p < 0.05. Post-hoc analyses found that exposure to environmental 
modifier was a significant predictor of FA values for wild-type mice, β  = .694, SE = 
0.027, t = 2.61, p < 0.05 uncorrected, with the average FA value in the body of the 
corpus callosum 11.03% higher for wild-type mice exposed to environmental 
modifiers, compared to control wild-type mice. However, exposure to 
environmental modifier did not predict FA values forYAC128 mice, β = .015, SE = 
.020, t = 0.052, p > 0.05.  
 
In the splenium portion of the corpus callosum, gender significantly 
predicted FA values, p < 0.05 uncorrected, with no effect of genotype or 
environmental modification.  The interaction between gender and genotype, and 
gender and EM group did not significantly predict FA values in the splenium, both p 
> 0.05.  
 
The interaction between genotype and exposure to environmental modifiers did 
not significantly predict MD values in any callosal segment, all p > 0.05, and did not 
predict FA values in the genu or splenium segment of the corpus callosum, p > 0.05. 
Chapter 7   2014
 
240 
 
 
Figure 7.4. Reconstructed pathways and statistics in the corpus callosum shown in 
the axial plane on a MD map with principal diffusion vectors. The genu (red), body 
(yellow) and splenium (blue) were reconstructed using a single ROI drawn on the 
mid-sagittal slice, with two AND gates to remove external capsule fibers.    WT: 
Wild type, EM: environmental modification. * p < 0.05 uncorrected.  
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Discussion 
 
In this chapter, in vivo MRI was used for the first time in a mouse model of 
HD to examine the effects of an environmental intervention on neuropathology. 
The environmental intervention regime involved both cognitive enrichment and 
dietary restriction and was found to have disease-modifying effects in the YAC128 
mouse model of HD. Changes were observed in both tissue macrostructure and 
tissue microstructure as well as motor function, replicating previous ex vivo work 
and providing additional information on the role of white matter in the neural 
response to environmental modifiers. These findings provide the initial data with 
which to base subsequent and more detailed study in order to dissect the effects of 
cognitive training and food restriction. 
Table 7.3 Multiple regression analysis for microstructural measures from the 
diffusion MRI image. CC: corpus callosum.  FA: fractional anisotropy. MD: mean 
diffusivity. Uncorrected p values shown.  
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Genotype Differences 
 
 Transgenic YAC128 mice displayed motor deficits on the rotarod test and 
more subtle cognitive deficits on the Water T-maze serial discrimination task, in line 
with previous findings (Brooks, Higgs,  Janghra, et al., 2012; Slow, et al., 2003b) 
although there was no difference on the reversal stage of the Water T-maze as 
previously shown (Brooks, Janghra, et al., 2012). A floor effect was seen in both wild 
type and transgenic mice on the reversal tasks, suggesting that age-related decline 
in the wild type mice masked any genotype differences. Using in vivo T2-weighted 
MRI, a reduction in striatal and cortical volume was found in the YAC128 mice 
compared to wild type mice, in line with previous ex vivo MRI and histological work 
using the same mouse line (Lerch, Carroll, Spring, et al., 2008; Slow, et al., 2003b) 
and replicating human imaging findings  (Aylward et al., 2012; Nopoulos, et al., 
2010; Paulsen, et al., 2010). 
 
 Environmental Modifier Effects  
 
Exposure to environmental modifiers (EM) increased both locomotor 
activity levels and latency to fall on the rotarod test irrespective of genotype but did 
not have an effect on performance on the watermaze task, suggesting a specific 
beneficial effect in the motor domain. This dissociation effect is the reverse of that 
seen previously in HD mice following exposure to exercise, where exercise 
improved cognitive more than motor performance (Harrison, et al., 2013) and 
suggests different environmental modifiers may have differential functional effects 
despite similar effects on neuropathology. In this study, the effect of environmental 
modifiers on brain structure interacted with genotype. Transgenic mice exposed to 
EM had reduced striatal atrophy compared to control transgenic mice, detectable 
on the T2-weighted MRI images. Post-hoc analyses showed that wild type control 
mice had significantly larger striatal volumes compared to transgenic mice exposed 
to EM, suggesting that long-term exposure to environmental modifiers reduces 
neuropathology in transgenic HD mice, but does not ameliorate it altogether.  This 
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replicates previous ex vivo findings of a selective benefit in HD mice (Dellen, et al., 
2000; Hockly, et al., 2002).  
 
A novel finding is the change in tissue microstructure in the corpus callosum 
following environmental modification (EM). Tractography analysis (Jeurissen, et al., 
2011; Tournier, et al., 2004) was used to examine tract-specific measures in the 
corpus callosum.  The corpus callosum was segmented into 3 parts; exposure to 
environmental modification was shown to predict fractional anisotropy (FA) values 
in the genu and body of the corpus callosum, with FA values higher in mice exposed 
to EM. This suggests that white matter microstructure is altered by environmental 
modification in wild-type and YAC128 mice alike.  The increase  in FA values  found 
following  long-term dietary restriction combined with  cognitive enrichment is in  
line with previous findings; postmortem diffusion MRI revealed  higher FA in the 
forelimb motor cortex in rats exposed to motor learning (Sampaio-Baptista et al., 
2013),  and in vivo diffusion MRI revealed higher FA in the corpus callosum in rats 
exposed to a spatial navigation task (Blumenfeld-Katzir, Pasternak, Dagan, & Assaf, 
2011). The current study adds to this, providing evidence of experience-dependent 
white matter plasticity after a striatal learning paradigm, during which neurogenesis 
is unlikely to occur.  Taken together with previous work showing an increase in 
myelin staining after a cortical learning intervention (Sampaio-Baptista, et al., 
2013), this study adds weight to the idea that white matter structural plasticity, and 
growth of new myelin, can occur without the generation of new neurons.  
 
Whereas previous rodent work has demonstrated experience-dependent 
plasticity with diffusion MRI in rats, the current study is the first to examine 
experience-dependent plasticity with diffusion MRI in a genetic mouse model of 
HD.  Using In vivo diffusion MRI and tractography analysis, this study showed for 
the first time a significant interaction between genotype and exposure to 
environmental modifiers for fractional anisotropy (FA) values in the body of the 
corpus callosum. Unlike the interaction seen in caudate-putamen volume, exposure 
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to EM had a specific effect on white matter microstructure in wild-type animals, 
with wild-type mice exposed to EM having increased FA values in the callosal body 
compared to control wild-type mice.  Thus, it appears that the benefits of exposure 
to environmental modifiers may be different in the HD brain, with the disease 
possibly reducing the propensity for environmentally-induced white matter 
plasticity. However, the beneficial effect of environmental modifiers on motor 
performance and a reduction in disease-related atrophy suggests that the YAC128 
do undergo experience-dependent plasticity, and again highlights the multiple 
mechanisms involved in neural plasticity. It cannot be determined from this study 
whether the lack of changes to white matter microstructure in YAC128 mice is due 
to the effects of mutant Huntingtin or due to the degree of atrophy in the brain at 
this stage in the disease. Future work is required to examine the effects of 
environmental interventions at multiple time points, including early time points 
before neuropathology is evident.  
 
This study provides proof of principle that T2-weighted MRI has the 
sensitivity required to replicate findings from previous ex vivo work.  This study 
does not aim to dissociate the specific effects of cognitive stimulation and dietary 
restriction on neuropathology, although previous work has shown ameliorative 
effects of both (Duan, et al., 2003; Wood, et al., 2011).  However, considering the 
high cost associated with pre-clinical MRI compared to traditional histological 
methods, this study provides a basis for future research focused on dissociating 
these effects with MRI as an outcome measure.  
 
The purpose of the study was to assess whether environmental modifiers 
produced structural brain changes that were detectable with in vivo MRI, thus a 
high level of modification was used to maximise the likelihood of detecting an 
effect. There are a number of factors associated with the delivery of the 
modification regime used in this study which would need to be controlled for in 
future studies aiming to dissociate the effects of specific modifiers. Alongside 
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cognitive stimulation and dietary restriction, increased handling, increased sensory 
stimulation, and increased motor activity during the cognitive task may have acted 
as modifiers, as well as the effect of fluid intake due to dietary restriction (i.e. 
increased hydration). In addition, the potentially confounding effects of anaesthesia 
on cognitive performance have recently been suggested (Shen et al., 2013)  and 
should be addressed in future studies where cognitive performance is an outcome 
measure. Further research is necessary to dissect out the contribution of each 
element and examine the possibility of interactive effects.  
 
This original finding of environmentally induced changes in tissue 
microstructure detected using a diffusion MRI sequence combined with the 
changes found in tissue macrostructure with T2-weighted MRI suggest a multi-
modal in vivo imaging approach is valuable for evaluating intervention outcomes in 
mouse models of disease. The fact that this in vivo data replicates previous ex vivo 
studies increases confidence in the use of longitudinal designs in the future to 
assess how different enrichment regimes interact with ageing and disease 
progression, and help ascertain the temporal contingency between learning and 
effects on neuropathology, with clear clinical relevance. 
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8 General Discussion 
 
The known single genetic mutation that causes Huntington's disease (HD) 
means that the disease is an important model for studying the associations 
between gene and brain function. Based on this, the primary aim of this thesis was 
to characterise the structural changes that occur in the HD brain at different 
disease stages, using a variety of MRI techniques in both a patient cohort and 
animal models. The purpose of using two species was to allow for bi-directional 
translation, with improved insights in human neuropathology providing the basis 
for translational research in mouse models, and increased biological specificity from 
work in animal models informing knowledge and research in the human condition, 
in order to improve our understanding of the relationship between 
neuropathology, phenotype and genetics. A summary of findings is presented, 
following by a discussion on the translation of findings between patients and mouse 
models, methodological issues that arose, and finally future directions and planned 
work.  
 
White matter microstructure in HD 
 
 White matter microstructure was examined in both the patient cohort and 
in two different mouse models of HD using diffusion tractography analysis. The 
work in this thesis sought to rectify the reliance on the diffusion tensor model for 
tractography analysis in the HD literature (Bohanna, Georgiou-Karistianis, & Egan, 
2011; O. Phillips, et al., 2013; O. Phillips, et al., 2014), applying more advanced 
tractography based on spherical deconvolution approaches capable of resolving 
multiple fiber orientations within an imaging voxel. In the patient cohort (chapter 
4), a reduction in fractional anisotropy (FA) and an increase in mean diffusivity (MD) 
values was found in the corpus callosum in HD participants, indicative of white 
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matter degeneration. An increase in MD values and a reduction in restricted 
volume fraction, a proxy measure of axon density, were found in the subgenual 
subdivision of the cingulum bundle specifically in HD participants, again suggestive 
of microstructural degeneration. In contrast, in the HdhQ150 knock-in mouse 
model (chapter 6), differences in DTI indices were only found in mice at the later 
time point, when motor signs were evident, and only on data uncorrected for free 
water contamination. After correcting for free water contamination, there was no 
genotype effect on DTI indices in the corpus callosum, although an effect of ageing 
was detected, with FA decreasing over time in both Hdh+/+ and HdhQ150/Q150 mice. 
This raises issues for previous studies which do not account for free water in the 
diffusion signal, as atrophy based artefacts cannot be disentangled from changes in 
white matter microstructure.  
 
In the YAC128 transgenic mouse model (chapter 7), white matter 
microstructural differences were evident in the corpus callosum between 
transgenic and wild-type mice. An effect of genotype was only evident in the body 
of the corpus callosum, with increased FA and no difference in MD in YAC128 mice 
compared to controls, assessed at a time point late in the disease course, when 
motor signs were evident. Due to the inherent limitations in interpreting a change 
in FA, it is not clear whether the change seen in both the mouse model and patient 
cohort represents a convergence or divergence of results, given that FA values 
differ from controls but in opposite directions. Nevertheless, they both suggest that 
white matter microstructure is affected in HD in the corpus callosum. FA as a metric 
is highly sensitive to microstructural changes (A. Alexander, Lee, Lazar, & Field, 
2007) but lacks specificity to different sub-components of white matter 
microstructure, for example, changes in axonal membranes, axon morphology, 
axon density, myelination (Beaulieu, 2002), fiber architecture and the orientational 
dispersion of fibers in the voxel (Budde & Annese, 2013; Pierpaoli, Jezzard, Basser, 
Barnett, & Chiro, 1996) can all modulate FA. Thus the interpretation of an increase 
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versus a decrease in FA values in HD patients or a HD mouse model in terms of a 
specific biophysical process is not possible from diffusion MR data alone.  
 
Additional white matter pathways were investigated in the patient cohort. 
Despite the corticospinal tract being the main motor output pathway in the human 
brain, there were no statistically significant differences between HD participants 
and healthy controls in any microstructural indices in the corticospinal tract, 
although there was a trend for an increase in MD values, a reduction in myelin 
water fraction obtained from multi-component relaxometry, and a reduction in 
restricted volume fraction obtained from the CHARMED acquisition. In the cingulum 
bundle, which has not previously been examined as a distinct white matter pathway 
in HD, differences between HD and control participants were evident selectively in 
the subgenual subdivision of the cingulum, suggesting that specific white matter 
fiber populations are affected in HD early in the disease course.  
 
Myelin water fraction and restricted volume fraction are both non-tensor 
based white matter microstructural indices that have never been examined 
previously in HD. They potentially provide increased biological specificity compared 
to traditional DTI indices, such as FA and MD, and thus may be useful in 
understanding which white matter sub-components are affected in HD. In chapter 
4, there was a trend for a reduction in both myelin water fraction and restricted 
volume fraction in HD participants in the corpus callosum, corticospinal tract, and 
cingulum bundle; the magnitude of differences between HD and control 
participants was larger for these indices (tract and algorithm specific, commonly > 
10% difference) compared to the DTI indices (commonly < 5% difference), however 
the difference between groups was not statistically significant after correcting for 
multiple comparisons, with the exception of restricted volume fraction in the 
subgenual cingulum. This is likely due to an insufficient sample size to detect a 
group difference; the sample size required has been found to vary depending on 
the microstructural metric and the white matter tract under investigation. Diffusion 
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tensor derived indices (FA and MD) have been shown to require smaller sample 
sizes to detect the same effect size compared to the more advanced, biological 
specific metrics, such as myelin water fraction and restricted volume fraction (De 
Santis, Drakesmith, Bells, Assaf, & Jones, 2014). However, this must be qualified by 
the observation that the same biological effect can have different effect sizes in 
different metrics (Tavor, Hofstetter, & Assaf, 2013). Despite this, a relationship was 
found in chapter 4 between restricted volume fraction, a proxy for ‘axon density’, 
and disease burden in HD, suggesting that non-tensor metrics may be clinically 
useful in characterising HD. 
 
Taken together, the results presented in this thesis suggest that white 
matter microstructure is affected early in HD, and evidence has been provided to 
implicate multiple fiber populations. Work in this thesis also highlights that 
different mouse models of HD produce different neuropathology and further in 
vitro validation is required. The clinical relevance of these microstructural changes 
will be discussed later in this chapter.  
 
Changes in tissue macrostructure in HD 
 
Changes in tissue macrostructure were explored in both the patient cohort 
and in two different mouse models of HD using T1 and T2 weighted MRI, along with 
immunohistochemistry in the mouse brain. Surprising consistencies across the 
patient and mouse studies were found, although there are also disparities, both 
across species, and across different mouse models. In the pre-symptomatic and 
early HD patient cohort (chapter 5), no difference was found in intracranial volume, 
whereas total brain volume was found to be reduced by approximately 5.8%. In the 
HdhQ150 knock-in mouse model in chapter 6, total brain volume was reduced to a 
similar degree (5.6%) at the early time point prior to the onset of motor symptoms, 
whereas at the later time point, brain volume was reduced by 11.6%. On the 
contrary, in the transgenic YAC128 mice in chapter 7, no difference was observed in 
General Discussion   2014
 
250 
 
total brain volume, despite MRI being acquired at a later stage in the disease when 
motor signs were present. This discrepancy is likely due to methodological issues; in 
chapter 6 an automated and optimised method was used for brain extraction which 
included dilating a mask image to enhance the contrast between brain tissue and 
CSF, and only the brain tissue was included in the total brain volume measure. In 
contrast, in chapter 7, whole brain volume was determined using manual 
segmentation, which is likely to be more variable and less accurate across subjects. 
 
In terms of sub-cortical atrophy, volume loss was consistently found in the 
striatum in patients and both mouse models of HD. The magnitude of atrophy was 
higher in patients (15-25% for caudate and putamen separately) compared to 
HdhQ150/Q150 mice at the early time point before motor signs (7%), whereas the later 
time point in both mouse models revealed a similar degree of atrophy in the 
caudate-putamen (~19% in HdhQ150/Q150, ~ 15-18% in YAC128 mice).  
 
The cerebellum and the cerebral cortex were found to be relatively spared 
in both the patient cohort and the HdhQ150 mouse model, although cortical 
thinning was evident at the later time point in the HdhQ150 mouse model. Cortical 
atrophy was evident in the YAC128 mouse, although the magnitude of atrophy (< 
5%) was less than that in the caudate-putamen. Taken together, this suggests that 
cortical atrophy occur later in the disease time course, in line with previous work (P. 
Nopoulos, et al., 2010). The hippocampus and amygdala were also found to be 
spared in the patient work, suggesting that despite a global reduction in brain 
volume, localised volume loss is a feature of HD even at an early stage in the 
disease.  
 
Atrophy was not restricted to the grey matter; white matter atrophy was 
also evident, and the volume of the corpus callosum was found to be reduced in the 
patient cohort, in line with previous findings (Crawford et al., 2013). The similarities 
found in neuropathology seen across patient and mouse studies, particularly in the 
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HdhQ150 mouse model suggest that in vivo pre-clinical MR has the sensitivity to 
detect changes in tissue macrostructure that are representative of that seen in 
early stage disease in patients. Finally, work presented in chapter 7 suggests that in 
vivo MRI is sensitive to the effects of environmental modification in the caudate-
putamen selectively in transgenic HD mice, implicating a mechanism mediated by 
the striatum and providing additional support to work suggesting that HD may be 
amenable to environmental, non-pharmaceutic based therapeutics.  
 
Neural correlates of clinical performance 
 
In chapter 3, HD participants were found to have selective cognitive deficits 
in memory and specific executive functions, with fewer disturbances seen in tasks 
requiring attentional processing. A composite cognitive score was formed in order 
to reduce the number of comparisons required and examine the relationship 
between brain structure and cognitive function. Patients were found to have 
significant motor and psychomotor slowing, but there was no significant difference 
in the composite score compared to healthy matched controls. In both controls and 
HD participants, composite cognitive function correlated with total white matter 
and total grey matter volume, suggesting that the battery of tests used were 
sensitive to individual variations in global tissue macrostructure. 
 
 In HD participants specifically, motor slowing was highly correlated with 
free water fraction in the cingulum and corpus callosum, as well as with sub-cortical 
atrophy. Cognitive functioning also correlated with sub-cortical atrophy and tissue 
microstructure abnormalities in the corpus callosum and subgenual cingulum, with 
worse cognitive performance associated with a higher degree of atrophy, increased 
MD values in the corpus callosum, and reduced restricted volume fraction (‘axon 
density’) in the subgenual cingulum. A genetic marker of disease severity, the 
Disease Burden Index (Penney, et al., 1997) was found to be related to sub-cortical 
atrophy, cortical thickness and tissue microstructural measures in the corticospinal 
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tract, corpus callosum and cingulum bundle. This suggests that changes in both 
tissue macrostructure and tissue microstructure are clinical relevant and serve as 
biomarkers of genetically-determined disease severity. Similarly, a non-genetic 
index of disease severity, the Total Functional Capacity scale, was correlated with 
tissue microstructural measure in the corticospinal tract and corpus callosum, again 
highlighting the clinical significance of white matter abnormalities in HD. In chapter 
4 and 5 respectively, disease burden was sensitive to variations in free water 
fraction in the whole cingulum as well as in the subpopulation of fibers in the 
subgenual subdivision of the cingulum, and to variations in cortical thickness in the 
isthmus cingulate gyrus. Taken together with the microstructural abnormalities 
found in the subgenual cingulum in HD participants, this suggests that the cingulum 
and cingulate gyrus are sensitive to disease progression in the pre-symptomatic and 
early stages of HD. This is particularly noteworthy, as previous studies in prodromal 
HD have found an increase in volume and thickness of the rostral anterior cingulate 
in prodromal HD subjects (P. C. Nopoulos, et al., 2010; H. D. Rosas et al., 2005; 
Tabrizi, et al., 2009), thus it appears that specific regions of the cingulate and 
specific fiber populations of the cingulum may respond to neurodegeneration 
differently. 
 
Similar associations between functional performance and MRI measures 
were found in a mouse model of HD in chapter 6. In the HdhQ150/Q150 mice, selective 
motor deficits were observed on the rotarod test and in locomotor activity. A 
counter-intuitive positive association was found between atrophy in the thalamus 
and performance on the rotarod test, suggesting that atrophy to the thalamus is 
functionally relevant for motor performance. In agreement with the patient work in 
the corpus callosum, free water fraction, a relatively under-explored metric of 
tissue microstructure, was correlated with locomotor velocity in HdhQ150/Q150 mice 
selectively. This thesis represents the first application of free water fraction as a 
distinct white matter metric. The convergence across species showing the 
functional and clinical relevance of free water fraction demonstrates that it 
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provides added value as a biomarker of disease severity, and should be adopted as 
a metric alongside tensor metrics in diffusion MRI studies of neurodegenerative 
diseases. 
 
Translation of findings 
 
It is useful to examine consistencies across species in terms of the effects of 
mutant Huntingtin, in order to be able to probe the biophysical basis of 
neuroimaging results using in vitro techniques not possible in most human patient 
studies. However, it was not the intention of this thesis to achieve a direct 
translation between species for a number of reasons. Firstly, the neurological 
differences between humans and mice, in terms of anatomy, white matter 
architecture, vasculature, and metabolism, means that results seen in one species 
will not necessarily be evident in, or relevant in the other. Moreover, mouse models 
are simply models of the disease, shown by the differences in neuropathology and 
phenotype across different mouse models in chapters 6 and 7. Thus, the most 
accurate representation will be achieved in patients themselves. The reliance on 
anaesthesia for MRI in rodents means that the relationship between cognition and 
brain structure may be confounded (Eckel et al., 2012) and further investigation is 
required to fully understand how anaesthesia affects the MRI measures under 
investigation.  
 
Despite these caveats, work using HD mouse models does have translational 
potential if applied intelligently, and there are many reasons why mouse models 
are needed, for example, in assessing therapeutics not previously tested in humans. 
Mouse models are also helpful in characterising neuropathology at later disease 
stages; chorea is a relatively common motor symptom at later disease stages which 
is problematic for acquiring sufficient quality MRI images without the use of 
sedation. Therefore, it is important to understand the points of similarity and 
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difference between species in order to translate findings in both directions and 
improve the interpretability of any results.  
 
As shown in the above sections, a number of common findings emerged in 
both patients and mouse models, which support the interpretation that the mutant 
huntingtin gene affects both tissue macrostructure and white matter 
microstructure in the brain at different stages in the disease course. Further work is 
planned in the mouse models using in vitro techniques to validate the MRI results 
and increase the biophysical specificity of the findings, as discussed in more detail 
below.  
 
Methodological considerations 
 
In the patient work, great effort was taken to achieve education matching, 
along with age and gender for the control group, which is a key strength of the 
work presented. Previous studies which have applied deterministic tractography in 
HD have not matched groups for years of education (Bohanna, Georgiou-Karistianis, 
& Egan, 2011; Phillips, et al., 2013; Phillips, et al., 2014; Poudel, et al., 2014) , 
despite it being a well-known confound when measuring both brain structure 
(Gönül et al., 2009) and cognitive performance (Steffener et al., 2014), and has 
been found to mitigate the clinical impact of other neurodegenerative diseases 
such as Alzheimer’s disease (Amieva et al., 2014; Shpanskaya et al., 2014) and 
Parkinson’s disease (Armstrong et al., 2012; Hindle, Martyr, & Clare, 2014). 
 
An inherent limitation with the patient work that is common to the 
literature is a bias in terms of symptom profile, with the healthier, less apathetic 
and more motivated gene carriers more likely to consent to being part of research, 
and more likely to turn up to scheduled appointments. Thus, the most 
psychiatrically and cognitively unwell participants are not captured in research 
studies, which may mean an important pathological feature of the disease which 
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results in more severe psychiatric and cognitive symptoms is missed. Efforts were 
made to recruit apathetic participants as well as those with executive deficits which 
affect the ability to present for scheduled appointments; reminder letters and 
phone calls on the day before were helpful, as were the provision of taxis to 
transport participants to the research centre. A second limitation is that it was not 
possible to stratify the patient group into pre-symptomatic and early-stage HD due 
to the small sample size. Philosophically, this is not a big problem because disease 
progression in HD does not occur in a non-continuous way, and thus the functional 
and neuropathological profile of a participant approaching symptom onset and an 
early-manifest participant is not likely to be different. However, in terms of being 
able to compare results with previous studies and add new results to the literature, 
this is a limitation.  
 
Finally, a limitation of the animal work, which will be referred to in the next 
section, was the lack of in vitro validation of in vivo MRI results. Measures of 
cortical thickness in ex vivo tissue sections revealed significantly smaller group 
differences compared to measurements made on MRI images. As discussed in 
previous chapters, the protocol for ex vivo MRI acquisition may have been 
detrimental to the immunohistochemistry analyses, and further optimisation work 
is required to achieve an optimal protocol for both techniques. Despite this, 
preliminary pilot results from the electron microscopy analysis are promising 
(Appendix 4) and should increase the biological specificity of the results presented.  
 
Future directions 
 
Time did not permit a comprehensive in vitro validation of the in vivo MRI 
results presented in chapter 6; however electron microscopy analysis is currently 
being carried out in the corpus callosum to analyse the white matter changes at a 
greater level of detail, and achieve a quantitative measure of myelin thickness and 
axon diameter.  
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  In chapters 3, 4, and 5, it is recognised that the sample size in the patient 
cohort was small, and recent work has shown that the sample size needed to detect 
differences between groups varies depending on the microstructural metric and the 
white matter tract under investigation (De Santis, et al., 2014). Thus, future work 
involves the continued recruitment of HD participants and healthy matched 
controls and the acquisition of multi-component relaxometry and CHARMED 
sequence. Furthermore, to investigate non-tensor based metrics further, CHARMED 
data were also acquired post mortem in the HdhQ150 mouse brains. Future work 
involves adapting the processing code, currently only implemented in the human 
and rat brain, to examine restricted volume fraction in the mouse and compare 
with in vitro analyses, such as the electron microscopy work detailed above.  
 
Finally, an increased patient sample size would allow for a logistic regression 
analysis to be performed, which would inform on which macrostructural and/or 
microstructural metrics are most sensitive to HD. Achieving a sensitive and reliable 
biomarker in HD would be a major advancement in the field, as it would mean that 
intervention studies could be conducted prior to the onset of symptoms with the 
aim to delay or prevent the onset of symptoms, as opposed to slowing down 
symptom progression as is the case currently. It is likely that a combination of 
biomarkers may be most sensitive to disease progression in HD, and a larger sample 
size would allow logistic regression to determine an optimal combination of 
biomarkers which have adequate sensitivity and specificity required for 
intervention studies.  
 
Concluding comment 
 
 Research undertaken for this thesis has consistently shown that white 
matter microstructure is of clinical relevance in Huntington’s disease, with evidence 
showing distinct fiber populations affected, alongside more widespread 
macrostructural changes. In terms of white matter microstructure, a number of 
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potential imaging biomarkers have emerged from this body of work that give more 
specific information about the tissue and pathology compared to tensor-derived 
metrics. The free water fraction, which is the fraction of the diffusion MRI signal 
assigned to the cerebrospinal fluid (CSF) partial volume component after removing 
the signal from brain tissue, was found to change linearly with both a genetic 
marker of disease severity and with total functional capacity in patients, and was 
sensitive to both motor slowing in patients and motor signs in a mouse model of 
HD.  In addition, the restricted volume fraction, which is a proxy measure of axon 
density derived from the multi-shell CHARMED diffusion sequence, was found to be 
reduced in HD participants in the subgenual cingulum specifically, and sensitive to 
cognitive functioning. Moreover, in the mouse brain, sub-cortical atrophy and white 
matter microstructure in the corpus callosum were shown to be altered by an 
environmental intervention which was also found to modify motor signs. Taken 
together, this work puts forward evidence for potential structural neuroimaging 
biomarkers of disease progression in HD, with far-reaching implications in terms of 
removing barriers for treatment trials in pre-symptomatic HD populations, a key 
component in ultimately moving the field one step closer to disease-modifying 
treatments for HD.  
  
References  2014
 
258 
 
Appendix 1 Solutions 
ABC solution 
5ul A (DAKO) 
5 ul B (DAKO) 
1ml 1 % serum in 1 x TBS 
Antifreeze 
 5.45g Di-sodium hydrogen orthophosphate (A) 
1.57g Sodium di-hydrogen orthophosphate (B) 
400ml Distilled water ( C ) 
A, B and C dissolved fully and pH 7.3-7.4 then add: 
300ml Ethylene Glycol 
300ml Glycerol 
Chemical-grade 0.1M Phosphate Buffer Saline (MRI) 
950 ml Distilled water   
9.5 ml Sodium Phosphate Monobasic Dihydrate 0.2 M 31.2 g / l (Sigma) 
40.5 ml Sodium Phosphate Monobasic Dihydrate 0.2 M 28.4g / l (Sigma) 
8.0 g Sodium Chloride (Sigma)    
0.2 g Potassium Chloride (Sigma)    
pH 7.4 
10% Iron Alum  
50g Ammonium iron(III) sulfate dodecahydrate (Sigma) 
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500 ml Distilled water  
Paraformaldehyde solution (PFA) 1 L 
40g PFA (4%) 
1L Prewash buffer 
Heat to dissolve 
pH 7.3 (orthophosphoric acid) 
Phosphate Buffer Saline 
90g di-sodium hydrogen orthophosphate (Bhd) 
45g Sodium Chloride (Sigma) 
5000 ml Distilled water 
pH 7.3 
Quench 
 10ml Methanol (Fisher Scientific) 
10ml Hydrogen Peroxide 30% ( VWR Prolabo BHD) 
80ml Distilled Water 
Solochrome cyanine 
0.2 g solochrome cyanine 
 0.5 ml concentrated sulphuric acid (H2SO4)  
10% Iron Alum (see above) 
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Sucrose solution 
25g sucrose (Fisher Scientific) 
100 ml phosphate buffered saline (Sigma) 
TBS 
12g Trizma base 
9g sodium chloride 
1000ml Distilled water 
pH 7.4 
TNS 
6g Trisma base (Sigma) 
1000ml Distilled water 
pH 7.4 
0.2% Triton X-100 in TBS (TXTBS) 
250 ml 1 x TBS 
500 ul Triton X-100 (Sigma) 
pH 7.4 
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Appendix 2  
Ordinal International Standard 
Classification of Education (ISCED) scale  
 
Please indicate by ticking the box in the right hand column, the highest education 
level you have achieved 
 
  Please tick 
ISCED 0 Pre-primary education 
(nursery school) 
 
ISCED 1 Primary school (key stage 
1,2) 
 
ISCED 2 Comprehensive 
school/college 
(key stage 3) 
 
 
ISCED 3 Sixth form (key stage 4)  
ISCED 4 College of further 
education 
 
ISCED 5 University (further/higher 
education institutions) 
 
ISCED 6 Tertiary studies leading to 
an advanced research qualification 
(e.g. Masters, PhD ) 
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Appendix 3  
Statistical assumptions  
 
Justification for including covariates 
Age as a covariate in patient cohort study  For the work in 
patients, age was significantly correlated with many of the cognitive tests (see Table 
Appendix 3.1), however there was no significant interaction between genotype and 
age for the cognitive tests, Wilks’ λ = 0.081, F (20, 32) = 1.57, p > 0.05, justifying the 
inclusion of age as a covariate in the analysis in Chapter 3.  
In Chapter 4, for deterministic tracking in the corpus callosum, a bivariate 
correlation analysis between age and the MR measures found that Pearson’s r was 
> 0.3, indicating moderate correlation for a number of measures. For segment I, r > 
0.3 for MD estimated with DTI and CSD tracking. For segment II, r > 0.3 for MD 
estimated with CSD and DRL tracking. For segment III, r > 0.3 for MD measures with 
DTI, CSD, and DRL tracking, and for myelin water fraction and free water fraction 
estimated with CSD, and for FA measures estimated with DRL. For segment IV, r > 
0.3 for MD measures from all tracking algorithms, and myelin water fraction and 
free water fraction estimated with CSD. Finally, in segment V, r > 0.3 for MD 
measures from all tracking algorithms, and myelin water fraction and free water 
fraction estimated with CSD, and for free water fraction estimated with DTI.  For 
restricted volume fraction,  using CSD tracking, r > 0.3 for segment II, II and IV, 
whereas  r > 0.3 using DRL in segment III only, and r < 0.3 in all segments using DTI 
tractography. For deterministic tracking in the corticospinal tract,  a bivariate 
correlation analysis between age and the MR measures found that Pearson’s r was 
> 0.3 for MD and AD values obtained using CSD in the right corticospinal tract, 
whereas for tracking with DRL, r > 0.3 for myelin water fraction in the left 
corticospinal tract.  For deterministic tracking in the cingulum, a bivariate 
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correlation analysis between age and the MR measures found that there was no 
significant correlation between age and any of the measures in the whole cingulum 
or sub-genual subdivision of the cingulum for control and HD gene positive 
participants, all r < 0.3, p > 0.05. For the relationship between MD values in the 
right retrosplenial subdivision and age, r = .325, p > 0.05.  
The relationship between age and volume measures (chapter 5) can be seen in 
Table Appendix 3.1. 
 
Table Appendix 3.1 Relationship between age and volume. Pearson’s 
correlation coefficient r shown along with p value. L: left, R: right.  
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Intracranial volume as a covariate in local macrostructure 
analysis 
In chapter 5, intracranial volume was significantly correlated with cerebral 
white matter volume, cerebral cortical volume, cerebellum cortical volume, and 
volume in the thalamus, caudate, putamen, and globus pallidum (all r > 0.3, p < 0.05 
uncorrected) in control and HD human participants alike, justifying the inclusion of 
ICV as a covariate.  
 
In Chapter 6, intracranial volume (ICV) was found to significantly correlate 
with all sub-cortical volume measures in both Hdh+/+ and HdhQ150/Q150  mice, r > 0.3  
for volume of the thalamus, globus pallidum, caudate-putamen, hippocampus and 
neocortex.  
 
As detailed in Chapter 7, whole brain volume was not significantly 
correlated with caudate volume, cerebral cortical volume or lateral ventricular 
volume in wild-type mice or transgenic mice, all p > 0.05, thus, it was not necessary 
to include whole brain volume as a covariate in the subsequent analyses. 
 
 
Table Appendix 3.2 Pearson’s correlation coefficient for relationship between 
cognitive tests and age. For all coefficients > 0.3, or < -0.3, age was added as a 
covariate in the analysis. PAL: Paired Associate Learning. IGT: Iowa Gambling Task, 
RT: reaction time. ID: Intra-dimensional. ED: Extra-dimensional.  
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Removal of outliers 
Outliers were first identified by examining box-and-whisker plots for each 
dependent variable, for controls/wild-type and HD patients/genetic mice 
separately. Outliers that were ± 3 standard deviations from the mean were 
removed. For diffusion MRI analysis, outliers that were both ≥ 2 standard deviations 
from the mean with low FA values (< 0.2) not expected in white matter were also 
removed.   
 
In chapter 4, for DTI, CSD AND DRL tracking of the corpus callosum, the 
same 2 outliers (1 control, 1 HD) were removed, with extreme low FA values and/or 
extreme high MD values.  1 outlier (control) was removed for the free water 
fraction measure for CSD, DRL and DTI measures with extreme high values. 1 outlier 
was removed for the restricted volume fraction for all tracking algorithms for both 
the corpus callosum and corticospinal tract reconstructions. No other outliers were 
identified for the corticospinal tract reconstructions. 
 
For the automated segmentation pipeline implemented in Chapter 6, a 
number of segmented images were removed from the analysis after inspecting the 
images for data quality. The cerebellum and olfactory bulb were distorted in a 
number of images, so these two regions were not included in the total intracranial 
volume measurement for consistency across all images.  3 images were excluded 
from the analysis due to either image artefacts or damage to the brain.   
Test of assumptions for mixed-model ANOVA 
All assumptions were tested after the removal of outliers. For human 
chapters, for analyses where age was a covariate in the analysis, it was not possible 
to test the assumptions for each level of the ANOVA. Instead, for these analyses the 
assumptions were tested on the residuals of the general linear model. 
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The sphericity assumption 
This assumption requires that the variance of population difference scores 
for any two conditions are the same as the variance of the population difference 
scores for any other two conditions. Mauchly’s test of sphericity was used to test 
this assumption when there were more than 2 levels for the within-subject 
independent variable. Where the assumption of sphericity was violated the 
corrected Greenhouse-Geisser value was used when ε < 0.75, and the Huynh-Feldt 
correction when ε > 0.75.  
Corpus callosum tracking (Chapter 4)  The assumption of sphericity 
was violated for a number of different measures for all 3 tractography algorithms. 
For tracking using CSD, for MD values, free water fraction, myelin water fraction 
and restricted volume fraction, the assumption of sphericity was violated, χ2 (9) = 
25.54, 49.25, 22.89 and 27.20 respectively, p < 0.05 and thus the corrected 
Greenhouse-Geisser value was used.  
For tracking using DRL, the assumption of sphericity was violated for FA, 
MD, free water fraction values and restricted volume fraction,  χ2 (9) = 30.85, 23.11, 
47.77 and 29.31 respectively. For myelin water fraction, the assumed of sphericity 
was not violated, χ2 (9) = 11.67, p > 0.05.  
Likewise, for tracking using DTI, for MD, free water fraction and restricted 
volume fraction, the assumption of sphericity was violated, χ2 (9) = 24.50, 36.82, 
and 21.55 respectively, p < 0.05 and thus the corrected Greenhouse-Geisser value 
was used.  
Corpus Callosum volume (Chapter 5) The assumption of sphericity 
was violated for volume measures in the 5 segments of the corpus callosum, χ2 = 
17.62, p < 0.05, ε = .799 therefore the Huynh-Feldt correction was used.  
Longitudinal mouse study (Chapter 6) For cortical thickness at 20-
months old, the variance of population difference scores for the different cortical 
sections did not differ from the variance due to genotype, , χ2 (5) = 0.71, p > 0.05. 
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Normally distributed dependent variables  
Mixed models only requiring approximately normal data as the mode is 
quite robust to violations of normality, meaning that assumption can be a little 
violated and still provide valid results.  The Shapiro-Wilk test was used to formally 
test normality at α = .001.  
Chapter 3 Cognitive Testing For the ID/ED test, the Shapiro-Wilks (S-
W) test indicated that the ID shift data was not normally distributed, S-W = .67, df 
=13, p < 0.001 for control participants, and S-W= .771, df = 15, p < 0.001 for HD 
participants. The data were transformed, however the distribution was still non-
normally distributed for control participants, S-W = .692, df =13, p < 0.001.  The 
Kruskal-Wallis non-parametic test was used to examine group based differences for 
this measure. For all other cognitive tests, p > 0.001.  
Chapter 4 Tracking of white matter pathways  For all measures 
obtained using DTI and CSD tracking of the corpus callosum, there was no violation 
of normality, p ≥ 0.001. Similarly, for all measures obtained using CSD and DRL 
tracking of the corticospinal tract, there was no violation of normality, p ≥ 0.001. 
Likewise, with DRL tracking in the cingulum and the distinct subdivisions, there was 
no violation of normality, all p ≥ 0.001. 
Chapter 5 Macrostructural measures  For all volumetric measures in 
cortical and sub-cortical regions, the assumption of normality was met for both 
healthy control and HD participants, all p ≥ 0.001. 
 
Chapter 6 Longitudinal mouse data  For measures of lateral ventricle 
volume, corpus callosum thickness, and cortical thickness from 
immunohistochemistry stained sections, there was no violation of normality for 
wild-type (df = 8) or HdhQ150 mice (df = 6), all p ≥ 0.001.  Similarly, for cortical 
thickness measures obtained at 19-months of age from MRI images, there was no 
violation of normality for wild-type (df = 18) or HdhQ150 mice (df =10), all p  ≥ 
0.001.  
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For volumetric measures obtained from atlas-based segmentation, there 
was no violation of normality for raw volumes for Hdh+/+ or HdhQ150/Q150 mice. 
However, when values were normalised for total intracranial volume, for many 
regions the data was not normally distributed. A log-transform was applied in order 
to transform the data to a normal distribution, all p > 0.001.  
 
For diffusion tensor parameters obtained from deterministic tract 
reconstruction of the corpus callosum, all values were normally distributed at both 
time-points, before and after correction for free water contamination, all p > 0.05.  
Homogeneity of variances  
To test that the error variance of the dependent variance is equal for each 
combination of the within-subjects factor and between-subjects factor, Levene’s 
test for homogeneity of variances was used.   Where Levene’s test of equality of 
error variance was violated, data were log-transformed. If the assumption was still 
violated with the transformed data, a non-parametric Mann-Whitney test was used 
rather than an ANOVA.  
Cognitive testing (Chapter 3)  For all of the individual cognitive tests, 
there was no violation of the assumption of equal error variance, all p > 0.05. 
Similarly, for the composite cognitive score formed, F (1, 25) = .121, p > 0.05.  
Corpus callosum tracking (Chapter 4)  For tracking using both DTI, 
CSD and DRL, Levene’s test of equality of error variances indicated equal variance 
for FA, MD, free water fraction, myelin water fraction and restricted volume 
fraction in all segments and both hemispheres, all p > 0.05.   
Corticospinal tract reconstruction (Chapter 4)  For tracking using 
CSD and DRL, Levene’s test of equality of error variances indicated equal variance 
for all metrics in both hemispheres, all p > 0.05.   
Cingulum tract reconstruction (Chapter 4)  For MD values in the 
right subgenual subdivision of the cingulum, Levene’s test was violated, F (1, 21) = 
Cardiff University  2014
 
271 
 
9.05, p < 0.01. A log(10) transformation was conducted and equal variance was 
found in the transformed MD values, p >0.05.   
Volumetric measures (Chapter 5)  The assumption of equality of 
equal variance was violated for volumes of the cerebellum white matter, 
cerebellum cortex, and the putamen calculated using Freesurfer, p < 0.01, thus a 
log transformation was conducted. 
Longitudinal Mouse Data (Chapter 6)  For measurements on the  
immunohistochemistry stained sections, Levene’s test of equality of error variances 
indicated equal variance for cortical thickness measurements, F (1,15) = 0.676, p > 
0.05, and corpus callosum thickness in all 4 measured regions, F (1,11) = 1.25, 0.75, 
0.023, and 0.41 for genu, anterior body, mid-body and splenium respectively p > 
0.05. For the average lateral ventricle surface area, there was equality of error 
variance, F (1, 13) = 1.80, p > 0.05. Similarly, for cortical thickness measures at 20 
months, for the left and right hemisphere respectively, there was equal variance in 
all 4 measured regions, F (1, 26) = 0.734, 0.068, 0.064, 0.639, 0.252, 1.33, 1.43 and 
0.23 respectively, all p > 0.05.  
For transformed, normalised volumes obtained from atlas based 
segmentation, Levene’s test indicated equal variance at 7-, 19- and 20- months of 
age for all structures under investigation, p > 0.05 for left and right hemisphere at 
each time point respectively. 
For the deterministic tracking of the corpus callosum, for uncorrected 
values, there was equal variance at 7- and 19-months for: FA (F (1, 28) = 2.94 and 
0.49, p > 0.05) 
Equality of Covariance 
For a multivariate ANOVA approach, it is assumed is that the vector of the 
dependent variables follow a multivariate normal distribution, and the variance-
covariance matrices are equal across the cells formed by the between-subjects 
effects. Box's M test was used to test the null hypothesis that the observed 
References  2014
 
272 
 
covariance matrices of the dependent variables are equal across groups. The Box's 
M test statistic is transformed to an F statistic with df1 and df2 degrees of freedom.  
In line with statistical protocol (Mayers, 2013), a significant level of α = .001 was 
used for this test. Where the test was violated, a log transformation was applied 
and the assumption tested with the transformed values.  
 
Chapter 4 Deterministic Tractography  For CSD tracking in the 
corpus callosum, Box’ test of equality of covariance was not violated for FA, MD, 
free water fraction, F (15, 1419.7) = 1.29, 1.37 and 1.71, respectively, p > 0.01, nor 
was the assumption violated for myelin water fraction, F (15, 645.77) = 2.4, p > 
0.001 and restricted volume fraction, F (15, 419.53) = 2.03, p > 0.01. For DTI 
tracking in the corpus callosum, there was no violation of the assumption of 
equality of covariance for FA ( F (15, 1129.94) = 1.07, p > 0.5),  MD (F (15, 2095.89) 
= 1.59, p > 0.5) free water fraction (F (15, 1199.83) = 2.04, p > 0.01),  myelin water 
fraction, F (15, 1188.83) = 2.21, p > 0.001, or restricted volume fraction, F (15, 
1948.74) = 0.84, p > 0.05.   
As shown in Table Appendix 3.3, for DRL tracking, Box’ test of equality of 
covariance was not violated for FA, MD or free water fraction in the corpus 
callosum or corticospinal tract, all p > 0.001. For free water fraction in the cingulum 
and the cingulum subdivisions, the assumption was violated and the data were  
transformed, p > 0.001.  For restricted volume fraction and myelin water fraction in 
the corticospinal tract and cingulum bundle, p > 0.001. 
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Chapter 5.  As shown in Table Appendix 3.5, the assumption of equality of 
covariance was violated for putamen, globus pallidum and cerebellum white matter 
volumes obtained using Freesurfer. After transformation, all p > 0.001.  
 
Longitudinal Mouse Data (Chapter 6)  For cortical thickness 
measures made from MRI images obtained at 19 months old, Box’s test of equality 
of covariance was not violated, F (36,1188.016) = 0.959, p > 0.05. For transformed, 
normalised volumes obtained from atlas based segmentation, Box’s test indicated 
equal covariance at 7-, 19- and 20- months of age for all structures examined, all p > 
0.001.  
 
Table Appendix 3.4 Box’s test of equality of covariance for tensor metrics 
sampled from DRL tracking in chapter 4, α = .001 
Table Appendix 3.5 Box’s test of equality of covariance for volume metrics from 
automated volume segmentation in chapter 4, α = .001. WM: white matter.  
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Appendix 4 
Preliminary electron microscopy in the 
HdhQ150 mouse model 
Using the right hemisphere from the HdhQ150 mouse model study detailed in 
chapter 6,  200µm sections were cut on a sliding vibratome and sections were 
stored at 4○ in PBS + azide for less than 1 week. Sections were then transported to 
the Electron Microscopy Unit (Cardiff University), where they were prepared for 
transmission electron microscopy (TEM). The tissue were embedded by an osmium 
post-fixation and epoxy resin embedding standard method and the quality of the 
obtained images below suggest that measures of myelin thickness and axon density 
will be possible with the tissue.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Appendix 4.1 Preliminary TEM images showing the 3 sampling 
areas corresponding to the genu, body and splenium of the corpus 
callosum.   
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